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EXECUTIVE SUMMARY  
Pharmacists play a key role in the delivery of essential health services. Evidence from published 
research suggests that the expertise of the health professionals involved in care delivery influences 
health system performance. Studies also show that the use of competency frameworks alongside 
standards of practice facilitates the improvement of professional performance and aids expertise 
development.  
The research reported in this thesis aimed to identify and evaluate foundation and advanced level 
pharmacy practice competencies. Its first objective was to evaluate pharmacists' perception of 
relevance to practice of the competencies contained in the FIP Global Competency Framework 
(GbCF v1), focusing on countries in Africa. Its second objective was to identify and evaluate the 
competencies that are relevant for global advanced pharmacy practice. 
The findings of an online cross-sectional survey of 469 pharmacists from fourteen African 
countries demonstrates that 90% of the foundation level pharmacy practice competencies 
contained in the GbCF v1 are relevant to practice. This finding validates the GbCF v1 as a 
mapping tool that can be used to develop country-specific frameworks for early career 
practitioners in the countries represented in this survey. 
A systematic literature review and a content analysis of two national frameworks identified 64 
competencies and 237 behaviours for advanced pharmacy practice. A panel of experts (n=14) from 
four of the six WHO regions developed consensus on these competencies and behaviours. Overall 
agreement via consensus showed that 89.5% of the content of the frameworks were broadly 
similar. A crossover mapping experiment involving advanced practitioners (n=42) from four 
countries showed within-subject agreement for matching competencies in the frameworks. This 
agreement was significant for 87% of the competencies (k ≥ 0.25; p ≤ 0.05). Subsequent semi 
structured interviews (n=17) showed the identified competencies were relevant to practice with 
general agreement obtained on similarity between the two frameworks. These findings 
demonstrate the existence of a core set of competencies that are applicable to advanced pharmacy 
practitioners from different countries.  
The research reported in this thesis provides evidence that was previously lacking on the validity 
of the Global Competency Framework in specific countries in Africa. It also provides preliminary 
data on the competencies that are required for global advanced pharmacy practice.  Overall, these 
findings provide valuable insights that can be developed through further research to serve as a 
driver for global policy.  
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INTRODUCTION 
Universal health coverage and equitable access to essential health services requires a 
workforce that is effective, efficient and capable of providing high quality care at all times to 
all patients. Evidence from published research demonstrates that the expertise of the health 
professionals involved in care delivery has an impact on the overall quality of care provided 
in the health sector (Campbell et al., 2013; Department of Health, 2000; World Health 
Organization, 2013).  
Strengthening workforce capacity via education and training is recognised as a key strategy 
for ensuring a health workforce that is continuously fit for practice (World Health 
Organization, 2013). In line with this recognition, competency-based education and training 
(CBET) for both undergraduate and practicing health workers is advocated globally, and has 
been implemented in many countries around the world (Organisation for Economic Co-
operation and Development (OECD), 2013). 
Even though research into the effectiveness of CBET in the health professions is currently 
limited, published studies show the usefulness of competency frameworks— a key attribute 
of CBET— in the development of health professionals (Brownie et al., 2011a). Studies show 
that when the competencies essential for professional practice are identified, compiled to 
form a framework, and used alongside standards of practice, it aids improvement of 
performance and facilitates the attainment and maintenance of fitness to practise. It also 
assures consistency of practice and fosters continuing professional development (Antoniou et 
al., 2004; Austin et al., 2004; Brownie et al., 2011a; Coombes et al., 2011; Mills et al., 2005). 
Consequently, the use of competency frameworks to benchmark standards of practice and aid 
the identification of learning gaps and developmental needs have become features of 
professional practice in pharmacy and in the health professions globally (Bruno et al., 2010).  
The International Pharmaceutical Federation Education Initiative, (FIPEd)— which is the 
pharmacy education development arm of the academic section of the International 
Pharmaceutical Federation (FIP)— has been at the forefront of advocacy for strengthening 
educational institutions, processes and collaborations for the development of the global 
pharmacy workforce (International Pharmaceutical Federation (FIP), 2013). FIPEd advocates 
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the need to identify the core competencies essential for pharmacy practice. The overall goal 
for this is to provide an infrastructure for global guidance on the practice-based expectations 
of the pharmacy workforce (Bruno et al., 2010).  
FIPEd acknowledges that no single framework or model adequately fits all practice contexts 
particularly in view of the variations that exist between countries. However, FIPEd also 
recognises that a global framework of behavioural competencies that can be used as a 
mapping tool to create country-specific frameworks for pharmacy practice and professional 
development is beneficial and relevant (Bruno et al., 2010; FIP Education Initiatives, 2012; 
International Pharmaceutical Federation (FIP), 2013). In line with this goal, the FIP Global 
Competency Framework (GbCF v1) for foundation level pharmacy practice was developed in 
2010 (International Pharmaceutical Federation, 2010). On-going validation of the GbCF v1 
has so far demonstrated its competencies to be generally applicable to practice in 64 countries 
around the world (Bruno, 2011). 
The research that was conducted and reported in this thesis provides details of two studies 
undertaken to identify and evaluate the core competencies required of the global pharmacy 
workforce. It gives specific details on the validation of the FIP Global Competency 
Framework (GbCF v1) in some countries in Africa. It also reports on a study designed to 
identify and evaluate the competencies required of the global advanced pharmacy workforce.  
 
This thesis is divided into five chapters. Chapter one gives an overview of the role of the 
pharmacy profession in assuring care quality. It provides a review of professional 
development in pharmacy, competence and competency-based education & training in the 
health professions, the concept and development of expertise, and some relevant adult 
learning theories. Chapter two presents the outcome of a systematic literature review 
conducted for this research. It also includes the research questions, aims and objectives of the 
two studies reported in this thesis. Chapter three gives details of the study conducted to 
evaluate and validate the FIP Global Competency Framework (GbCF v1) in countries in 
Africa. The study conducted to identify and evaluate the advanced practice competencies 
required of the global pharmacy workforce is presented in chapter four while chapter five 
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provides the research conclusions including study strengths, limitations and the overall 
implications of the findings in relation to pharmacy practice. 
 20
1.1 The Global Health Workforce: An Overview  
Many countries in the world, particularly those in Sub-Sahara Africa and South East Asia, are 
critically lacking in number of physicians, nurses, midwives and other health workers 
including pharmacists (Campbell et al., 2013; World Health Organization, 2013, 2008). The 
African region with about a quarter (24%) of the global disease burden— including a high 
incidence of HIV/AIDS, malaria, tuberculosis and other infectious diseases; poor and 
inadequate access to essential health services; and high maternal & infant mortality rate— 
has only 3% of the world’s health workforce (Campbell et al., 2013).  
Recent data show that the number of health workers in Africa is still far below the current 
World Health Organisation (WHO) threshold of 59.4 per 10,000 population required to 
prevent avoidable maternal deaths (Campbell et al., 2013). In line with evidence from 
published research that have shown that health workforce density correlates with health 
outcomes (World Health Organization, 2007, 2006), available estimates suggests that many 
of the countries in the region have made limited progress towards attaining most of the 
health-related Millennium Development Goals (MDGs) (United Nations Development 
Programme, 2014). 
Pharmacists, as the third largest health professional group, play a key role in the delivery of 
essential health services and medicines expertise. There is clear evidence that pharmaceutical 
care services provided by pharmacists positively influence and enhance the quality of care 
delivered in the health sector. It also has a positive impact on health improvement (Giberson 
et al., 2011).  Therefore, pharmacists present an available human resource pool for health that 
can be harnessed to contribute to the global health agenda of universal coverage and 
equitable access to health services. Consequently, strengthening the capacity of the pharmacy 
workforce is an integral strategy for enhancing health system performance. This underscores 
the need for a capable and knowledgeable pharmacy workforce possessing the necessary 
skills relevant for population needs.  
 
 
 
Chapter 1 RESEARCH BACKGROUND 
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1.1.1 Pharmacy practice and healthcare quality  
Patients, their families and health service funders expect to receive safe, reliable and 
consistent high standards of care at all times. This demand carries an ethical obligation for 
health professionals involved in care delivery to develop and maintain competence 
individually and collectively as a profession (Bates et al., 2004). The term ‘high standard of 
care’ suggests a care quality that exists in a continuum and while minimum acceptable 
standards do exist, the provision of the highest possible care attainable should be the goal of 
every health system (Manasse, 2003). 
Vincent, Taylor-Adams and Stanhope (1998) identified six factors that influence the quality 
of care delivered in the health sector including organisational and management factors, the 
work environment, team factors, individual (staff) factors, tasks factors and patient 
characteristics. Even though it is clear that a number of factors contribute to the quality of 
care delivered in the health sector, an increasing body of evidence identifies patient harm 
arising from drug-related adverse events and human errors as important causes of morbidity 
and mortality (Department of Health, 2000; Design Council and Department of Health, 2004; 
Institute of Medicine, 2000; Wilson et al., 2012, 1995).  
Medicines play an essential role in most disease preventive programmes and in almost all 
treatment plans (International Pharmaceutical Federation and World Health Organization, 
2000). Medicines often have their therapeutic effects co-existing with unwanted and 
unintentional drug effects that cause harm to patients.  
'It is not all about numbers: the goal of universal health coverage 
requires a paradigm shift, going beyond a discourse on shortages 
but rather focusing more explicitly on the (…) quality and 
productivity of the health workforce' [The Universal Truth: No 
Health Without a Workforce. Forum Report of the Global Health 
Workforce Alliance & World Health Organisation 2013, Recife, 
Brazil (Campbell et al., 2013; p. iv)]. 
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Pharmacists as the custodians of medicines play are particularly concerned with care quality 
as it relates to medication use, availability, affordability, safety and effectiveness (Ray and 
Breland, 2011). Emerging empirical evidence show that pharmacists minimise associated 
risks from drug use and in so doing contribute to the quality of care delivered in the health 
sector (Fairbanks et al., 2007; Giberson et al., 2011; Lada and Delgado, 2007; Zellmer, 
2001). 
In 1997, the WHO introduced the concept of a seven-starred pharmacist where a pharmacist 
is seen as a caregiver, communicator, decision-maker, teacher, life-long learner, leader and 
manager (World Health Organization, 1997). The International Pharmaceutical Federation 
(FIP) in 2000 adopted this concept in its policy statement on Good Pharmacy Education 
Practice and added another component: ‘a researcher’ (International Pharmaceutical 
Federation, 2000).  
The complex body of knowledge, skills and experience that pharmacists require for effective 
performance in these different roles and the increasing requirement for professional 
accountability, rapid technological advancements in the health sector, and the changing 
population dynamics that have resulted in an increase in prevalence of chronic diseases, 
underscore the need for a robustly trained pharmacy workforce (Bates et al., 2004; Davies et 
al., 2004, 2002). It emphasizes the need for a workforce that is consistently competent, 
flexible and capable of performing up to the desired standards of practice at all times 
(Duggan, 2013). 
1.1.2 Contemporary pharmacy practice 
Since the late 1970’s, pharmacy practice has shifted from a focus on drugs and drug products 
to a patient-oriented practice model (Van Mil et al., 2004). The goal of practice in this later 
model is to provide care directly to patients to produce definite outcomes that improve 
quality of life (American Society of Hospital Pharmacists, 1993, p. 1). The pharmacist in this 
practice model is directly involved in the care process and accepts personal responsibility for 
the outcomes of care provided (Council on Credentialing in Pharmacy, 2010a).  
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As a result, the roles undertaken by the contemporary pharmacist have expanded and some 
role changes have also occurred. Traditional pharmacy roles like drug dispensing, 
distribution, compounding and supplies have also become redefined. For example, drug 
dispensing and prescription filling in most developed countries like the USA, Canada and 
United Kingdom are now largely automated with the use of robotic dispensing technology 
(Ray and Breland, 2011).  
Support staff like the pharmacy technicians and pharmacy assistants have been co-opted and 
recognised as part of the skill mix of the pharmacy workforce. These support staff are now 
trained to carry out duties such as drug dispensing and prescription filling with the 
pharmacist serving in supervisory capacity in many instances. Other roles like manufacturing 
and compounding of pharmaceuticals have become largely automated and/or have been taken 
up by specialized and commercial pharmaceutical companies (Council on Credentialing in 
Pharmacy, 2010a).  
Along with these changes, new areas of pharmacy practice have developed and the 
contemporary pharmacist is now increasingly being recognised as playing a key role in many 
specialised and advanced practice settings (Cooksey et al., 2002; Giberson et al., 2011). 
Evidence from fields of medical practice like nuclear medicine, ambulatory and primary care, 
emergency medicine and others, have shown clear benefits from the inputs of pharmacists 
(Giberson et al., 2011). The contemporary pharmacist is now involved in a team-based role 
alongside other health practitioners, the primary aim of which is to optimise patient safety 
and care quality. 
This increasing need for pharmaceutical care services requires a pharmacy workforce that is 
capable, adaptable and continuously fit for purpose. It places a demand on the pharmacists to 
develop and advance in knowledge, skills and in up-to-date training relevant to practice 
context (Cooksey et al., 2002; Duggan, 2010). A white paper published by the Institute of 
Medicine show that professional practice consistent with current knowledge is a key factor 
influencing patient safety along the care process curve. This further emphasises the 
importance of the education and training activities of both ‘would-be’ and practicing health 
professionals (Institute of Medicine, 2000).  
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It highlights the importance of the education and training activities of undergraduate and 
practicing pharmacist and implies that these activities need to be clearly defined and 
elucidated. Such activities also need to be designed and delivered in a way that creates an 
avenue for professional development, and the continuous maintenance of competence and 
fitness to practice (Coombes et al., 2011).  
 
 
 
 
 
 
"The overall quality of the healthcare system that serves the public 
is ultimately dependent on the expertise, attitudes, behaviour and 
commitment of the individual health professionals and other staff 
who work within that system" [The Department of Health (DoH) of 
the United Kingdom in its document: ‘Trust, Assurance and Safety, 
the regulation of health professional in the 21st century’ (2007; p. 
14)]. 
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1.2 The Concept of Competence 
The primary goal of professional pharmacy practice is to improve public health by the safe, 
effective and appropriate use of medicines (Council on Credentialing in Pharmacy, 2010a). 
Integral to assuring patient safety by health professionals is the concept of competence. 
Competence has been described in a number of ways and was initially articulated in relation 
to performance improvement and increased task efficiency in the fields of human resource 
management and work organisation (Boyatzis, 1982; McClelland, 1994; McCowan, 1998; 
Spencer and Spencer, 1993; Whiddet and Hollyforde, 2003).  
According to Brownie and colleagues, the initial conceptualization of competence was 
carried out to fulfill two interrelated objectives: ‘a closer specification of job-related tasks 
performed as part of roles at work, and the rationalisation of the training system’ (Brownie et 
al., 2011a; p.31). Since its conceptualization in industry and organisational development, 
competence in the field of educational research and training has evolved from a single-
element representing knowledge to a more complex model that includes expertise and the 
application of that which has already been learnt into everyday practice (Albanese et al., 
2007).  
1.2.1 Defining competence 
The term ‘competence’ stems from the Latin root word for cognisance or responsibility 
(Weinert, 1999). It is widely used in various fields of scientific discourse and often takes it 
meaning from the context in which it is applied. For instance, competence is used in the 
fields of immunology, biology, management, economics, linguistics and developmental 
sciences to give precise meanings that are unrelated (Weinert, 1999; Winterton et al., 2006). 
The heterogeneity in the meaning of competence and the fact that it finds use in everyday 
parlance has made it a challenging term to comprehensively define in a way that provides 
consensus in every field of discourse (Lingard, 2009). 
Early definitions of competence and related terminologies were based on technical and 
vocational (skill-based) measures of performance (Bates and Bruno, 2008). For example, 
White (1959; p.318) used competence to describe those ‘personality characteristics that are 
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associated with superior performance and high motivation’ while Elkin (1990) associated 
competence with job performance at the micro-level and described it as a high level 
managerial attribute. Kane used the term to refer to ‘the degree to which an individual can 
use knowledge, skills and judgment associated with the profession to perform effectively in 
the domain of possible encounters defining the scope of professional practice’ (Kane, 1992; 
p.31).  
Other contemporary definitions of competence have been proposed. Kak and colleagues 
defined competence as ‘the ability to perform a specific task in a manner that yields desirable 
outcomes’(Kak et al., 2001; p.3) while Epstein and Hundert defined competence in healthcare 
practice as ‘the habitual and judicious use of communication, knowledge, technical skills, 
clinical reasoning, emotions, values, and reflection in daily practice for the benefit of the 
individual and the community being served’ (Epstein and Hundert, 2002; p.226). Boursicot et 
al., (2010; p.1) defined competence as ‘what an individual is able to do in clinical practice' 
while the term has been used in the field of pharmacy education to refer to 'the overarching 
capacity of an individual to perform’ (Bates and Bruno, 2008; p.21).  
The existence of different definitions for competence is attributed to the many theoretical and 
epistemological assumptions distinct to the different contexts in which competence has been 
conceptualised (Winterton et al., 2006). As a result, competence could mean different things 
to different people depending on the context in which it is used or applied. 
1.2.2 Component of competence 
Components that describe competence (Figure 1.1) as commonly seen in education and 
research literature in the health professions include knowledge, skills, abilities and attitudes 
based on values and judgment (Carraccio et al., 2002; Clifford and Plumridge, 2003; 
Delamare - Le Diest and Winterton, 2005; Fernandez et al., 2012; Ten Cate and Scheele, 
2007; Winterton et al., 2006). 
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Figure 1.1: Components of competence 
 
Knowledge as described by Winterton et al (2006; p.7), is a social-construct that arises as a 
result of an interaction between ‘intelligence (defined as the capacity to learn) and situation 
(defined as the opportunity to learn)’. Knowledge describes what a person understands. It 
involves both a theoretical and/or practical understanding of a concept or subject. It is 
embedded in facts, principles and procedures (Kak et al., 2001, p. 3). Knowledge can be 
acquired either through formal learning (for example, codified knowledge obtained in a 
formal learning environment) or through informal learning via practice and hands-on 
experience. 
Skill refers to the learned capacity to perform pre-determined tasks. It is a function of 
acquired knowledge and the manner in which such knowledge is applied (Winterton et al., 
2006). It is also defined as a ‘goal directed well-organised behaviour that is acquired through 
practice and performed with economy of effort’ (Winterton et al., 2006; p.7).  Skill is a 
measure of expertise and often correlates to the wages and supervisory requirement of a 
worker. A highly skilled professional will be expected to require minimal supervision relative 
to a novice worker (Cowan, 1997). 
Abilities on the other hand are the inherited or acquired attributes that an individual brings to 
a new task. Ability is acquired through previous experience in the specific domain of practice 
or in some instances it could refer to an inherited capacity to carry out some tasks. Abilities 
also involves reasoning, memory and those mental processes that are required for solving 
novel problems (Fernandez et al., 2012) 
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Attributes refer to the personal traits, behaviours or individual characteristics a worker 
requires to successfully perform a job-related task (Fernandez et al., 2012; Gonczi et al., 
1990). Attributes are not necessarily part of the core knowledge or skill requirements of a job 
but are necessary for on-the-job success. They include such things as the knowledge of the 
professional practice and the ethical issues that border such practice. Attributes also include 
those intangible components of competence that cannot be formally taught but that are 
fostered and acquired through training with competent role models as well as through 
experience and personal growth (Fernandez et al., 2012).  
1.2.3 The Lexicon of competence 
Competence allows a professional to identify and link knowledge, skills, abilities and 
attributes in a way that maintain standards of performance. A professional judged competent 
provides a guarantee to the society that he/she would be able to perform up to acceptable 
standards at all times. The various fields of discourse in which competence has been 
conceptualised as well as the different definitions and usage of the term has led to a number 
of debates around the concept and the exact meaning of competence-related terminologies 
(Delamare - Le Diest and Winterton, 2005; Winterton et al., 2006). 
In some fields of practice, for example in personnel management, interest in the concept of 
competence is related to individual behaviours concerned with personnel efficiency. In this 
scenario, levels of performance are classified as being high or low with a goal towards 
seeking out attributes that differentiate superior performers from average performers, or 
between effective and ineffective performers (Boyatzis, 1982; Delamare - Le Diest and 
Winterton, 2005; McClelland, 1994; Spencer and Spencer, 1993).  
Some authors have viewed competence in a job-related (functional) sense and are concerned 
with the successful completion of activities and tasks that make up specific jobs. This 
functional view of competence is concerned with on-the-job success and the execution of job 
roles according to prescribed standards of practice (Boam and Sparrow, 1992; Collins et al., 
2000; Holton and Lynham, 2000; Smith, 1993; Snyder and Ebeling, 1992). Other authors 
have made no distinction between the job-related tasks undertaken by individuals and how 
individuals behave on the job. These authors describe competence as consisting of both the 
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successful completion of job tasks and the personal behaviours that influence such 
performance (Whiddet and Hollyforde, 2003).  
A number of competence-related terminologies have also been proposed. Boyatzis used the 
term competency (plural competencies) to refer to ‘an underlying characteristic of a person 
that results in effective and/or superior performance’ (Boyatzis, 1982; p.97). Snyder and 
Ebeling (1992) on the other hand, used the term competencies to refer to the plural of 
competence while other authors like Smith (1993) and Boam & Sparrow (1992) used the 
term in relation to job-related competence. Spencer & Spencer defined competency as the 
'underlying characteristic of an individual that is casually related to criterion-referenced 
effective and/or superior performance in a job or situation’ (Spencer and Spencer, 1993; p.9). 
Burgoyne described being competent as the ability to meet the demands of a given job and 
having competencies as acquiring the necessary attributes that enable competent performance 
(Burgoyne, 1988). 
Woodruffe (1991) described areas of competence as the various aspects of a job role that can 
be performed by an individual and competency as those specific but distinct behaviours that 
influence competent performance (Woodruffe, 1991). McBeath (1990) and Brown (1993) 
gave no distinction between competence and competency and used both terms as synonyms. 
In pharmacy education, the term competences and competencies have also been described: 
competences is used to refer to ‘the ‘functional’, the ‘what’ attached to competence while 
competencies (singular, ‘competency’) relate to the qualities of capability, the ‘how’ of 
competence’ (Bates and Bruno, 2008; p.31&32) 
The lack of consensus in the definition of competence as well as the inconsistencies in the 
meaning of the various terminologies used in describing competence is recognised as a 
possible limiting factor in the advancement of competence-related discussions in the health 
professions (Brownie et al., 2011b; Rethans et al., 2002). It has been suggested these 
inconsistencies have limited the full integration of competency-based approaches for the 
development of education and training programmes in the health professions (Brownie et al., 
2011a; Frank et al., 2010). 
  
 
 
30
Winterton et al., (2006) noted that previous attempts to establish harmonised and coherent 
meaning to common competence-related terminologies were unsuccessful. Brownie and 
colleagues, however, urge clarifying the meaning of these terminologies in health 
professional education so as to ensure the achievement of a well-articulated educational 
policy goal that can be communicated to all stakeholders in the health sector (Brownie et al., 
2011a).  
In an effort to clarify the concept of competence and advance the medical profession, the 
Royal College of Physicians and Surgeons of Canada in 2009 convened a ‘theory to practice 
consensus conference’ of International Competency-Based Medical Education (ICBME) 
collaborators. One of the tasks of this group was to propose consensus definitions of 
competency-based education terms that will be useful to medical educators globally (Frank et 
al., 2010).  
Table 1.1 gives the definition of competency-based terminologies as proposed by the ICBME 
collaborators.  
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Table 1.1: Definition of CBME and related terms (Adapted from Frank et al., 2010) 
 
The ICBME collaborators also proposed the concept of competence to be seen as a multi-
dimensional, dynamic, contextual and developmental concept (Frank et al., 2010, p. 641). 
Accordingly, competence is a dynamic concept acquired over time through training and 
experience. It marks a milestone to be achieved in relation to a particular task, skill or 
knowledge (Frank et al., 2010; Fraser and Greenhalgh, 2001). 
Competence 
The array of abilities across multiple domains or aspects of physician performance in a 
certain context. Statements about competence require descriptive qualifiers to define the 
relevant abilities, context, and stage of training. Competence is multi-dimensional and 
dynamic. It changes with time, experience and setting.
Competency
An observable ability of a health professional, integrating multiple components such as 
knowledge, skills, values, and attitudes. Since competencies are observable, they can be 
measured to ensure their acquisition. Competencies can be assembled like building blocks 
to facilitate progressive development.
Competency-based medical education
An outcome-based approach to the design, implementation, assessment and evaluation of 
medical education programs using an organising framework of competencies.
Competent 
Possessing the required abilities in all domains in a certain context at a defined stage of 
medical education or practice. 
Dyscompetence
Possessing relatively less ability in one or more domains in a certain context at a defined 
stage of medical education and practice
Incompetent
Lacking the required abilities in all domains in a certain context at a defined stage of 
medical education and practice 
Progression of competence
For each aspect or domain of competence, the spectrum of ability from novice to mastery. 
The goal of medical education is to facilitate the development of a physician to the level of 
ability required for optimal practice in each domain. At any given point in time, and in a 
given context, an individual physician will reflect greater or lesser ability in each domain.
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Based on the definitions outlined by the ICBME collaborators, the term competent is applied 
to someone who through experience increases in proficiency via a mix of initial professional 
training, on-the-job learning, instructional assessment and formal qualification (Frank et al., 
2010). This definition recognises that competence can develop or recede over time as result 
of an individual’s practice or learning environment (Frank et al., 2010).  
1.3 Competence, Performance and Capability 
The terms performance and capability are used in a number of ways to connote competence 
in some literature (Fraser and Greenhalgh, 2001; Sherbino et al., 2008; While, 1994).  
Performance is described as that observable part of competence or the resulting behaviour 
that arises from competence (Fraser and Greenhalgh, 2001; Kak et al., 2001; While, 1994). It 
is defined as the ‘manner in which a practitioner has carried out a particular task or function’ 
(Department of Health, 2006). It is also defined as ‘the accomplishment of a given task 
measured against pre-set and known standards of accuracy, completeness, cost and speed’ 
(BusinessDictionary.com, 2012).  
Professional performance is defined as ‘the quality of clinical practice in the workplace’ (The 
Royal College of Pathologists, 2012). It describes what a professional actually does in real-
life practice and reflects the knowledge, skills and experience a practitioner brings to his/her 
professional practice (Boursicot et al., 2010; Kak et al., 2001; Miller, 1990).  
It also encompasses those actions that can be observed and measured and deemed relevant for 
effective practice within an organisation (Kak et al., 2001). 
Professional performance in the healthcare professions is an important component affecting 
patient safety and the overall quality of care in the health sector (Bates and Bruno, 2008; 
Cooksey et al., 2002). Safe, effective and consistent performance should be the hallmark of 
all professional practice. Therefore, the measurement of performance carried out according to 
individual levels of proficiency should be the focal point in the regulation of health 
professionals (Bates and Bruno, 2008).  
Professional performance is that part of competence that can be observed in a simulated or 
controlled scenario as well as in real life practice (Epstein and Hundert, 2002). Anecdotal 
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evidence and other research studies show that possessing the knowledge and ‘know how’ 
about a certain aspect of a job-related task does not always guarantee or imply successful on-
the-job performance in daily practice (Frenk et al., 2010; McRobbie et al., 2006).  
The knowledge/performance loop (Figure 1.2) describes the relationship between knowledge, 
its application and performance.  
 
 
 
 
 
 
Figure 1.2: The knowledge/performance loop (Adapted from Knoco Ltd®) 
 
Southgate and Dauphinee posit the relationship between competence and performance to be a 
complex one (Southgate and Dauphinee, 1998). A licensed pharmacist judged competent is 
expected to be able to carry out his/her professional duties up to the standards of acceptable 
practice. However, what this individual actually ‘does do’ in real life termed ‘performance’ 
will depend on a number of factors. As a result, competence being one of the many 
determinants of performance, does not always predict performance. 
In distinguishing performance from competence, Miller in 1990 proposed a measure for 
assessing clinical competence based on levels of professional expertise. In the Miller’s 
pyramid (Figure 1.3) a clear distinction is made between cognition and actual performance. 
The lower two levels of the Miller’s pyramid illustrate the acquisitions of knowledge while 
actual performance in practice is illustrated by the upper two levels of the Miller’s pyramid.  
 
Learning 
Knowledge Performance 
Application 
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Figure 1.3: Miller’s pyramid for assessing clinical competence 
 
The first tier of the pyramid which is the ‘knows level’, involves the strict recall of facts, 
principles and theories that underpin professional practice at a given level. Possessing this 
knowledge however does not guarantee that a practitioner would be able to apply such 
knowledge in a way that ensures successful performance in practice (Epstein and Hundert, 
2002). At the second tier of the pyramid, that is the ‘knows how’ level; a professional is able 
to integrate acquired knowledge with the skills and abilities required to solve problems or 
describe procedures (Epstein and Hundert, 2002). The ‘knows’ and ‘knows how’ levels of the 
Miller’s pyramid make up the cognition/knowledge level and is where novice practitioners 
usually sit.  
The third and fourth level of the pyramid, the ‘shows how’ and ‘does’ level, are the stages of 
actual performance. These upper two levels are concerned with actual behaviour based on 
both knowledge and skills. For example, a novice mental health pharmacy practitioner (that 
is, a specialist in training), can possess the knowledge about mental health drugs (‘knows’ 
level); he/she may also ‘know how’ these drugs are to be administered in terms of dosage 
regimen and may be able to describe this knowledge succinctly (‘knows how’ level). 
However, the actual ability to integrate this specific knowledge into real-life practice, that is, 
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the ‘shows how’ level, where actual performance can be observed (the ‘does’ level), is 
termed performance.  
Capability is another term commonly associated with competence. Capability is defined as 
‘the extent to which individuals can adapt to change, generate new knowledge and continue 
to improve their performance’ (Fraser and Greenhalgh, 2001; p.799). Fraser and Greenhalgh 
(2001) argue that capability should be considered to be more than competence. It should be 
seen as existing in a continuum from a low to high level. It also would depend on the level of 
knowledge, skill, training and experience of an individual. 
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1.4 Competency-Based Education and Training (CBET) 
According to McCowan (1998), the competency-approach to education and training has its 
roots in the theories of scientific management by Frederick Taylor,  behaviourism by Edward 
Thorndike, and John Dewey’s theory of progressive education.  
CBET focuses on the desired performance characteristics that professionals are expected to 
acquire and then goes on to establish the measurable and observable metrics that determine 
those characteristics (Frank et al., 2010; Leung, 2002; Schilling and Koetting, 2010). 
 
 
 
 
 
Traditional educational models begin with the determination of the knowledge which the 
learner needs to acquire and how this knowledge will be imparted. CBET on the other hand, 
is organised around the task analysis of future roles and the determination of the abilities 
needed by professionals to perform effectively in those roles (Gruppen et al., 2010; Leung, 
2002).  
These abilities are then organised as competencies that are further portrayed in terms of their 
building blocks. Then, working backwards, milestones that the learner will need to attain as 
these competencies are acquired are identified (Frank et al., 2010). Appropriate methods of 
instruction and assessment can thereafter be selected to facilitate the development of these 
competencies and to measure the progress of the learner as each milestone is attained 
(Carraccio et al., 2002; Frank et al., 2010; Voorhees, 2001). 
CBET is employed extensively in vocational and technical training of workers in Europe, the 
USA, Canada and Australia. In the USA, competency-based training was initially utilised in 
teacher education in the mid-1960’s and early 1970’s amid concerns of poor student 
In a sense, CBET begins with the end in mind; ‘it 
consists of the functional analysis of occupational 
roles, translation of these roles into outcomes, and the 
assessment of trainee’s progress on the basis of their 
demonstrable performance’ (Leung, 2002; p.693). 
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performance and inadequate teacher training programs (McCowan, 1998; Schilling and 
Koetting, 2010; Spady, 1977). In Europe, CBET was promoted in the 1980’s in vocational 
education and training in a bid to develop a workforce that was competitive in the global 
economy (Winterton et al., 2006). 
 
 In 1990, the Society of Teachers of Family Medicine initially introduced a comprehensive 
CBET model in medical education in the USA (Frank et al., 2010). In the past three decades, 
CBET has gained popularity in medicine and other healthcare disciplines particularly in 
relation to the recognition of the potential relevance of this approach to the increasing need 
for accountability, efficiency, cost-effectiveness, quality improvement and flexibility of the 
health workforce (Brownie et al., 2011a; Schilling and Koetting, 2010) . 
 
The pharmacy profession has also advocated the use of competency-based approaches in the 
education and training of would-be and practising pharmacist (Bates and Bruno, 2008; 
Clifford and Plumridge, 2003). CBET is actively promoted as a key approach towards 
assuring the development of a high quality pharmacy workforce (Bates and Bruno, 2008; 
Bruno et al., 2010). 
1.4.1 Rationale and limitations of competency-based education and training  
In an analysis of the rationale for the use of competency-based education in medical 
education, Frank and colleagues list four major principles that justify its use. These include: 
 
- A focus on outcomes: Reports have identified a non-alignment of professional 
competencies acquired by practitioners in the health sector with the changing needs of the 
population (Frenk et al., 2010; National Research Council, 2003).  Advocates of CBET argue 
that the use of the competency approach, which focuses on the resulting outcomes of 
education, ensures that graduates learn and acquire competencies that are directly relevant to 
future roles (Albanese et al., 2007; Gruppen et al., 2012, 2010; Voorhees, 2001). It also 
ensures that competencies in all domains identified as being essential for practice are attained 
(Brownie et al., 2011a; Neufeld et al., 1993).  
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- An emphasis on abilities: Proponents of CBET criticise objective-based approaches 
used in traditional education models for over-emphasising knowledge at the expense of other 
components of competence such as skills, attitudes and attributes based on values and 
judgements (Frank et al., 2010). They argue that CBET model ensures that the learning 
curriculum in is organised around competencies that can be tailored to learning needs 
(Voorhees, 2001). This provides an integrated learning experience that continuously takes 
into account prior learning elements, ensuring that that health professionals are better 
equipped to serve successfully in their future roles (Carraccio et al., 2002; Frank et al., 2010; 
Gruppen et al., 2012, 2010). 
- A de-emphasis on time-based training: Learning objectives in the traditional 
education model are time-bound and do not take into account individual variability in 'time-
taken' to attain a specific competency (Frank et al., 2010). Proponents of CBET argue that a 
curriculum which is flexible in relation to the period of time taken to attain a competency 
maybe more efficient and engaging compared to a stringent time-based curriculum (Carraccio 
et al., 2002; Gruppen et al., 2010). This de-emphasis on time as a marker of competency 
ensures that transitions between various levels of practice are based solely on providing 
evidence of having attained the required competencies to perform at that level of practice, 
regardless of the time spent in doing so. The individualised learning process in CBET ensures 
that judgments on the performance of an individual can be carried out by an assessor 
independent of the performance of other learners (Gruppen et al., 2012; Long, 2000). 
- Promotion of learner-centeredness: A CBET curriculum arguably provides clearly 
defined goals tailored into achievable milestones (Leung, 2002). Using these milestones, 
learners on a CBET program are potentially able to take responsibility for their progress and 
development and can adjust their learning accordingly (Frank et al., 2010). This provides a 
transparent pathway for achieving competencies by both the learner and facilitator and 
thereby promotes a focus on the learner’s own development (Carraccio et al., 2002; Frank et 
al., 2010). 
Even though CBET has been actively pursued and advocated in the education of health 
professionals, a number of criticisms have been leveled against this approach: 
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- Critics of CBET argue that breaking down competencies into discrete observable 
behaviours may lead to the creation of an endless list or check-list of behaviours that are ill-
defined, complex and time consuming (Leung, 2002). They argue that this could lead to 
frustration on the part of both the learner and the teacher (Gonczi et al., 1990).  
- Designing and implementing a CBET program involves the functional analysis of 
occupational roles to identify the competencies and the building blocks required for success 
in that role (Albanese et al., 2007). Leung (2002) in a critique of CBET highlights the 
difficulty in identifying all the competencies, behaviours and relevant knowledge that truly 
and adequately cover all future work roles. This factor, Leung argues, limits the feasibility of 
CBET in medical education as it can lead to a reduction in the knowledge content of any 
curriculum developed from a CBET approach. Other authors have also argued that atomising 
these competencies into units of observable behaviours is fraught with difficulties and 
reductive in nature (Talbot, 2004).  
Nonetheless, proponents of CBET argued that this limitation represents operational 
difficulties that can be overcome through constant reviews and feedbacks from the end-users 
(Obiols, 2008).  Contemporary notions of CBET in health professional education have also 
attempted to overcome this limitation through the development of frameworks containing 
core competencies (Brownie et al., 2011b; The Draft CanMEDS 2015 Physician Competency 
Framework - Series IV, 2015). These core competencies, which are developed from a needs-
based assessment of society needs, are often dynamic and subject to change in accordance 
with changing population needs. 
- The CBET approach has also been criticised for emphasising discrete observable 
behaviours and ignoring the complex interplay of contextual, social and cultural factors that 
often dominate real-life professional practice (Leung, 2002). Hyland in 1993 acknowledged 
that the assessment of competence is not value free. Nonetheless, the competency approach 
has still been proven to be a valuable for practitioner development as well as ensuring fitness 
to practice (Antoniou et al., 2005, 2004; Bates et al., 2004).  
- The functional analysis of future job roles in CBET is often carried out based on the 
assumptions of uniformity in the way that professionals carry out job-related tasks. Gonczi 
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argues that some discrete tasks associated with professional work can be carried out 
satisfactorily using different methods as a result of experience. Therefore, an over-emphasis 
on specific methods or standards of performance for certain tasks, which is a common feature 
of many CBET models, maybe problematic and limiting (Gonczi et al., 1990; Talbot, 2004).  
Proponents of CBET argue that while this limitation held true for the early conceptions of 
competence where measures of competence were based on vocational performance; this is no 
longer the case for contemporary CBET approaches. For example, in the health professions, 
competencies are delineated in terms of expected outcomes and not based on vocational skills 
thereby negating a strict adherence to specific methods of performance (Hill et al., 2006; The 
Draft CanMEDS 2015 Physician Competency Framework - Series IV, 2015). 
- Critics have also argued that the use of a checklist of behaviours and milestones 
maybe superficial and could be demotivating to learners. They reason that CBET encourages 
learners to focus on the successful completion of tasks and the attainment of distinct 
milestones. These milestones, they argue, are often based on minimum acceptable standards 
and therefore may not promote critical thinking, a strive for excellence, and the development 
of expertise on the part of the learner (Gonczi et al., 1990; Leung, 2002).  
Proponents have however argued that while this feature was common in traditional 
vocational conceptions of competence, contemporary competency-based approaches and 
competency frameworks are designed based on acceptable standards. Therefore, competency-
based education using appropriate competency frameworks in the right context, can provide a 
route-map towards the attainment of expertise and excellence in practice (Bates and Bruno, 
2008; Coombes et al., 2011).  
1.4.2 Competency frameworks  
Competencies refer to the knowledge, skills, attitudes and behaviours, which an individual 
requires to practice up to acceptable standards. A collection of competencies and their 
corresponding behaviour(s) is called a competency framework.  
A competency framework provides a map of the competencies valuable for performance in 
an organisation (Brownie et al., 2011a). Competency frameworks generally contain similar 
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elements organised in the same way. Related competencies and their corresponding 
behaviourals descriptors are grouped into cluster. The competency clusters are the highest 
elements of the framework while the behavioural indicators are the baseline elements 
(Whiddet and Hollyforde, 2003). 
1.4.2.1 Development of competency frameworks  
There are three approaches commonly employed in the development of competency 
frameworks (Wright and Morgan, 2012). These are: 
i. The work-orientated approach,  
ii. The worker-orientated approach and 
iii. The multi-method-orientated approach  
 
The work-orientated approach involves the functional analysis of professional roles with a 
goal towards identifying areas of practice that are central to job performance. Areas of 
practice are broken down into roles that are further divided into the specific tasks required to 
perform such roles. These tasks are then divided into sub-tasks. The work-orientated 
approach is particularly useful if practical tasks are a major part of the job role. It also 
enables the easy identification of levels of competence. A limitation of this method, however, 
is the possibility of creating a lengthy checklist of competencies that may be difficult to 
manage and assess (Gonczi et al., 1990; Wright and Morgan, 2012). 
 
The worker-orientated approach focuses on identifying the general attributes that 
practitioners require to perform effectively in their job roles. It specifies competence in terms 
of its components, and assesses competence based on the demonstration of pre-defined 
competency attributes. This approach has been criticised for often being based on a small 
number of competencies necessary for practice (so called core competencies). Consequently, 
it is possible in this method, to ignore or overlook specific competencies that may actually be 
important to a particular job role (Gonczi et al., 1990; Wright and Morgan, 2012). 
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Multi-method-orientated approach attempts to integrate the work- and worker-orientated 
approach by linking job roles, tasks and sub-task of professional practice with the general 
attributes of the practitioner (Wright and Morgan, 2012). 
1.4.2.2 Competency frameworks in pharmacy  
A preliminary scoping Internet search using the key words 'competency frameworks' and 
'practice standards' in the healthcare professions returned an extensive array of published 
literature. The search showed a number of frameworks developed and available for medicine, 
nursing, pharmacy, public health, physiotherapy and other allied health professions. The 
keyword word search also yielded a number of national and organisational level competency 
frameworks for pharmacy practice in Australia, Ireland, United Kingdom and New Zealand. 
A 2012 and 2014 survey of the FIP member organisations by FIPEd also identified other 
competency frameworks for pharmacy practice from Canada, USA, Thailand and Singapore.  
 
Examples of these include frameworks that delineate the competencies required for early 
career practitioners in United Kingdom [the RPS Foundation Level Framework (RPS-FLF) 
developed by the Royal Pharmaceutical Society of Great Britain (RPS)], Australia [the 
National Competency Standards Framework for Pharmacists in Australia developed by the 
Pharmaceutical Society of Australia (PSA) with the aid of the RPS-FLF], New Zealand 
[Competency Standard for the Pharmacy Profession Framework developed by the Pharmacy 
Council of New Zealand (PCNZ)], Canada [Professional Competencies for Canadian 
Pharmacists at Entry to Practice developed by the National Association of Pharmacy 
Regulatory Authority (NAPRA)], Singapore [Competency Standards for Pharmacists in 
Singapore developed by the Singapore Pharmacy Council (SPC) with the aid of the RPS-
FLF] and Ireland [Core Competency Framework for Pharmacists in Ireland that was 
developed by the Pharmaceutical Society of Ireland (PSI) with the aid of the RPS-FLF].  
 
These frameworks describe the professional practice profile of early career pharmacists and 
are primarily used to design the training programme for initial registration in pharmacy in the 
respective countries (National Association of Pharmacy Regulatory Authorities, 2014a; 
Pharmaceutical Society of Australia, 2010; Pharmacy Council of New Zealand, 2011; 
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Singapore Pharmacy Council, 2011; The Pharmaceutical Society of Ireland, 2013; The Royal 
Pharmaceutical Society of Great Britain, 2014). Others include the Model Standards of 
Practice for Canadian Pharmacists, which defines the practice standards against which the 
performance of pharmacists may be judged and assessed by the regulatory authorities 
(National Association of Pharmacy Regulatory Authorities, 2009), and the New Zealand 
National Pharmacists Services Framework which aligns the PCNZ competency standards to 
the specific roles and responsibilities provided by pharmacists in New Zealand (District 
Health Board of New Zealand, 2007). 
 
Two other national frameworks called the Advanced Pharmacy Practice Framework (The 
Advanced Pharmacy Practice Framework Steering Committee (APPFSC), 2012) and the RPS 
Advanced Pharmacy Framework (RPS-APF) (Royal Pharmaceutical Society of Great Britain, 
2013a) have also been developed for advanced pharmacy practitioners in Australia and 
United Kingdom respectively. The American College of Clinical Pharmacy have also 
developed a framework, the Clinical Pharmacist Competencies Framework, that delineates 
the knowledge and skills that specialists clinical pharmacists require to practice up to 
acceptable standards (American College of Clinical Pharmacy, 2008a) 
 
On a global level, the FIP Global Competency Framework (GbCF v1) has been developed 
and it delineates the competencies and corresponding behavioural indicators required for 
global foundation level pharmacy practice (International Pharmaceutical Federation, 2010). 
This framework has undergone a number of expert reviews and validation via consensus 
methodologies and is currently undergoing further validation through an online survey of 
pharmacists practicing in different countries around the world.  
 
In general, competency frameworks are used extensively in pharmacy practice to benchmark 
standards and accreditation, design and develop undergraduate and post graduate training 
curricular, regulate career entry and support career progression. Chapter 2 of this report 
presents a systematic literature review conducted to evaluate the methodologies used to 
develop competency frameworks in pharmacy. The literature review also presents evidence 
on the effectiveness of such frameworks in pharmacy. 
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1.5 The Concept of Expertise  
The overall quality of care delivered in the health sector is dependent on a number of factors, 
one of which is the expertise of the health professionals involved in care delivery 
(Department of Health, 2007). It is therefore an evident expectation that practitioners in the 
health sector develop and advance towards attaining expert levels of practice in their fields 
(Obiols, 2008). 
 
One of the critiques of the competency approach to professional education has been its 
perceived limitation in promoting the development of expertise (Gonczi et al., 1990; Leung, 
2002). An understanding of the nature of expertise and it various components can provide a 
background for the development of education and training programs that actively promote 
practice progression and expertise development. 
 
An understanding of the nature of expertise and how this level of practice might be actively 
pursued and achieved is therefore important (Dunphy and Williamson, 2004; Schmidt and 
Boshuizen, 1993). Furthermore, clear understanding of the nature of expertise in the health 
professions can provide a framework for planning optimal service delivery at all levels of 
practice.  
1.5.1 Defining expertise 
Expertise broadly refers to knowledge, skills or abilities used in performing specific tasks in a 
given domain (Farrington-Darby and Wilson, 2006). The term is also used to refer to the 
quality of the output of professional performance, for example, the quality of the decision 
taken by an expert practitioner. Other authors have used the term to refer to the process 
through which professional performance is undertaken and the mechanisms that underlie such 
superior performance (Ericsson, 2000).  
1.5.2 Expert vs. novice practice  
An expert is an individual who has attained a level of superior performance through training, 
experience or extensive practice in a given domain. An expert is widely recognised by his/her 
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peers and the general public as a person who is a reliable source of knowledge, skill and 
technique. They are also seen to be capable of judging rightly and wisely within their domain 
of expertise (Dunphy and Williamson, 2004).  
 
A novice generally refers to an individual who is new to a field of practice or one whose 
practice is at the beginner level (Patel, et al., 1999). It could also refer to an individual who 
lacks extensive knowledge, skills or practical experience in their domain of practice (Dunphy 
and Williamson, 2004). Novices differ from experts in terms of their depth of knowledge, 
experience and ability to apply theoretical or generic knowledge in solving problems 
(Gilhooly, 1990). Existing literature on medical expertise have broadly differentiated 
between expert and novice practitioners in terms of their level of experience with reference to 
differences in cognitive processes and skills (Cuthbert et al., 1999; Hoffman, 1996).  
 
Experts can be distinguished from novice practitioners in relation to the level of proficiency 
attainable in a given domain. Levels of proficiency can be measured in terms of academic 
and professional qualifications, professional status or peer recognitions, experience and 
length of practice in that domain (Chi, 2006; Hoffman, 1996; Manley and Garbett, 2000). 
Some studies differentiate between novice, intermediates, sub-experts and expert 
practitioners (Patel, et al., 1999). Intermediates are seen as individuals who still possessed 
generic knowledge or skill in a given domain of practice, even though, their practice maybe 
above the beginner level (Boshuizen and Schmidt, 1992; Cuthbert et al., 1999; Patel, et al., 
1999). Examples of intermediates include medical residents and interns. Sub-experts include 
individuals who possess significant generic knowledge across a field of practice but lack 
adequate specialised knowledge in that field (for example, specialists in training). Sub-
experts could also refer to an individual who is an expert in a different but related field of 
practice; for example, a cardiologist solving an endocrine problem (Patel et al., 1994). 
Another study categorised experts as basic-experts and super-experts. Super-experts referred 
to the ‘top experts’ in a specialised field while basic-experts are those with expert knowledge 
but lesser practical experience in their field of practice (Raufaste et al., 1998).  
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1.5.3 Absolute and relative expertise 
Research into the nature of expertise is based on two broad conceptions of expertise: 
- Absolute or exceptional expertise and  
- Relative expertise  
 
Pioneering studies of expertise involved the identification and assessment of individuals 
whose performance in their given domain of practice were deemed to be exceptional (Chi, 
2006). This view of expertise, termed absolute expertise, sees expertise as a status that is 
already attained. Studies of absolute expertise are associated with the critical assessment of 
expert behaviour with a goal towards understanding how such individuals performed in their 
domain of practice (Chase and Simon, 1973; de Groot, 1965, 1946; de Groot and Gobet, 
1996; Ericsson et al., 2007; Newell and Rosenbloom, 1981). These studies sought to establish 
the characteristics that distinguished expert performers based on the tacit assumption that 
expert performance arises as a result of an innate superiority in abilities or talents (Alderson, 
2010; Bloom, 1985; Chi, 2006).  
The studies were conducted in fields where objective measures of expert performance were 
readily available; notably, in the game of chess where expert performance is measurable 
using the Elo scale (Chase and Simon, 1973; de Groot, 1946; de Groot and Gobet, 1996; 
Simon and Chase, 1973). Studies of absolute expertise were also conducted in sports, music 
and arts— where a clearly defined criteria for measuring expert performance exists (Baker et 
al., 2003; Ericsson, 2000, 1996; Taylor, 1975)  
Relative expertise does not view expertise as an absolute endpoint or status, but as a journey 
that can be undertaken by less proficient practitioners in order to develop their practice over 
the course of a professional career (Alderson, 2010; Chi, 2006). In this view, experts are 
defined in relation to their proficiency levels when compared with novice practitioners (Patel, 
et al., 1999; Patel and Groen, 1991). For example, experts and novice practitioners may be 
differentiated based on their depth of knowledge with the experts group defined as the more 
knowledgeable persons in a particular domain while the less knowledgeable group of 
individuals are called novices (Chi, 2006).  
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The goal of research in the study of relative expertise is to compare and contrast expert and 
novice performance in the same domain and on the same task. The aim is to understand the 
processes that underpin each type of performance and identify the factors that influence 
expert and novice performance (Chi, 2006).  
 
Research on medical expertise have been conducted in the fields of nursing, anaesthesiology, 
radiology and medicine (Cuthbert et al., 1999; Eraut and Boulay, 2001; Schmidt and 
Boshuizen, 1993). These studies were based on the concept of relative expertise (Cuthbert et 
al., 1999; Eraut and Boulay, 2001) and involved the analysis of expert performance in select 
tasks, compared to novice practitioners (Alderson, 2010; Arocha and Patel, 1995; Boshuizen 
and Schmidt, 1992; Hobus et al., 1987; Lesgold et al., 1988; Patel and Groen, 1991; Raufaste 
et al., 1998; Schmidt and Boshuizen, 1993).  Others involved the study of knowledge 
organisation and decision-making processes of expert practitioners (Crandall and Getchell-
Reiter, 1993; Elstein et al., 1978; Elstein and Schwarz, 2002; Gale and Marsden, 1983; Xiao 
et al., 1997). 
1.5.4 Characteristics of expertise 
Pioneering studies of expertise initially suggested that experts possessed higher levels of 
cognitive functions like superior memory, intelligence and superior powers of speed (Chase 
and Simon, 1973; de Groot, 1946; Simon and Chase, 1973). These attributes were assumed to 
be the factors that distinguished expert performers and were also thought to be generalisable 
to experts in other domains.  
 
Further research however proved most of the specific characteristic attributes of expertise 
observed therein to be domain specific (Ericsson, 2000; Ericsson and Lehmann, 1996). For 
example, in a study of the characteristics of elite chess players, the superiority of an expert 
chess player’s memory was found to be limited to regular chess positions and did not extend 
to the ability to recall random positions. This superiority in memory recall was also not 
replicable in other domains of practice where the experts had no experience (Chase and 
Simon, 1973; Djakow et al., 1927; Ericsson, 2000; Simon and Chase, 1973).  
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Ceci and Ruiz (1992) studied the characteristics of experts practising in sport and found that 
the superior performance demonstrated by a particular group of experts did not extend to 
other domains of practice where the same sets of skills and levels of cognitions were required 
(Ceci and Ruiz, 1992; Farrington-Darby and Wilson, 2006). Doll and Mayr (1987) found that 
high intelligence quotients (IQ) did not correlate with superior performance and did not 
distinguish between novice and expert performers in a particular field of practice (Doll and 
Mayr, 1987). The findings of the Doll & Mayr study confirmed the results of an earlier study 
conducted by Taylor in 1975 which showed that IQ did not correlate with creative abilities 
among expert artists and scientists when compared with novice practitioners in the same field 
(Taylor, 1975).  
 
Another study by Ceci and Liker (1986) showed that expert reasoning did not correlate with 
general intelligence, rather, such reasoning tapped from the skills developed by these experts 
through experience (Ceci and Liker, 1986). These examples show the relative independence 
of expertise on general abilities, superior memory and innate cognitive abilities like 
intelligence (Ericsson et al., 2007). 
 
In a review of the influence of general basic capacities on performance in elite practice, 
Ericsson and Lehman in 1996 found that measures of general capacities like visual acuity, 
memory recall and reaction time, did not predict successful performance in a given field of 
practice The higher levels of performance observed in experts were shown to be dependent 
on specific attributes acquired through experience and extensive practice in their fields of 
practice (Ericsson, 2000; Ericsson et al., 1993; Ericsson and Lehmann, 1996).  
 
Even though the findings of the early studies of expertise were difficult to generalise for a 
number of reasons including the highly specific study population and quasi–experimental 
methods used in the design; a number of themes associated with the nature of expertise did 
emerge (Ericsson et al., 2007). Factors like perception and pattern recognition, experience 
and extensive practice, structure and organisation of expert knowledge, and expert training 
and coaching were all found to contribute to expert performance (Dunphy and Williamson, 
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2004; Ericsson, 2000, 1996; Ericsson et al., 2007; Gilhooly, 1990; Hoffman, 1996; 
Schumacher and Czerwinski, 1992).  
 
These characteristics have also been delineated by studies of medical expertise (Alderson, 
2010; Eraut and Boulay, 2001; Hoffman, 1996; Patel et al., 1994; Schmidt and Boshuizen, 
1993). Table 1.2 gives a summary of the characteristic features of expert performance as 
proposed by Dunphy and Williamson (2004).  
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Table 1.2: Characteristics of expertise (Adapted from Dunphy and Williamson, 2004) 
 
Characteristics 
 
Description 
Pattern recognition Able to recognise complex patterns 
Knowledge  Possess high levels of declarative and procedural knowledge 
Expert knowledge is organised and reflective of a deep 
understanding of context 
Possess knowledge conditionalised on a set of circumstances. 
Can flexibly retrieve knowledge with little attentional effort 
Skills  Performance of skills may be automatic  
Cognitive space  As knowledge becomes automated, additional cognitive space 
is available for deliberation 
Metacognition 
monitoring  
Able to skilfully and/or automatically monitor situations 
holistically 
Teaching ability  Not necessarily good teachers  
 
Flexibility  High levels of contextual flexibility 
Can consider more possibilities than average practitioner 
Varying levels of flexibility in approaches to new situations 
 
A) Perception and pattern recognition  
Perception and pattern recognition are cognitive abilities found to be crucial features of 
expert performance. Perception refers to the unified awareness of a given environment 
through the organisation, identification and interpretation of stimulus obtained from sensory 
processes with an aim towards representing and understanding that environment (Johns and 
Saks, 2008).  
Pioneering work by de Groot in 1965 provided initial evidence on the influence of perception 
on expert performance (de Groot, 1965; de Groot and Gobet, 1996).  
When compared to novices, experts were shown to be able to perceive meaningful patterns 
holistically. Experts had the ability to perceive domain-specific elements in parallel with the 
relational elements of a given situation, unlike novices who perceived them serially 
(Ericsson, 2000; Gilhooly, 1990; Johnston, 2005). This ability to perceive meaningful 
patterns is termed pattern recognition and is the feature which enables experts to rapidly 
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recognise the key attributes of a given problem with a resultant effect of rapid decision-
making (Lesgold et al., 1988; Patel and Groen, 1991; Xiao et al., 1997).  
Perception and pattern recognition has also been demonstrated in medical expertise and arises 
from experience. Available evidence show that these two features of expertise influence 
clinical reasoning, problem solving and rapid decision-making in clinical practice (Eraut and 
Boulay, 2001; Patel, et al., 1999; Pelaccia et al., 2011). 
 
B) Expert knowledge, its organisation and structure 
Experts possess specialized domain specific knowledge relevant for superior performance in 
their field of practice (Hoffman, 1996). The exclusivity and highly specialised nature of 
expert knowledge correlates with the increasing complexity of the task they perform in their 
area of expertise (Johnston, 2005). Expert knowledge differ in terms of the quantity of 
knowledge accumulated through experience and the way this knowledge is organised and 
structured (Hoffman, 1996; Schmidt and Boshuizen, 1993). 
Experts are able to use working and long term memory to store and retrieve information 
encoded around key features of domain-specific principles and solutions (Ericsson, 2000). 
Novices on the other hand, have limited knowledge and this knowledge is encoded around 
basic domain-specific first principles (Ericsson, 2003). This makes the reliable retrieval 
knowledge by novices even more difficult when solving novel or complex problems (Eraut 
and Boulay, 2001; Patel et al., 1994).  
Experts exhibit superior but dynamic mental cause-effect knowledge models that represent 
entities, events, properties and functional relations of domain specific elements (Boshuizen 
and Claessen, 1985; Hoffman, 1996; Larkin, 1983; Schumacher and Czerwinski, 1992). The 
dynamic and superior quality of these mental representations allow for contextual and content 
dependent knowledge adaptation and flexibility, leading to rapid and intuitive problem 
solving with a resultant superiority in performance (Gilhooly, 1990; Lesgold et al., 1988; 
Patel, et al., 1999). This attribute also allows for the assimilation, re-organisation and storage 
of accumulated knowledge for future retrieval. 
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The ability to use stored information to solve problems is observed in medical expertise, 
where expert practitioners are able to rapidly retrieve prior domain-specific knowledge to 
solve related problems in their domains (Allen et al., 1988; Gilhooly, 1990; Schmidt and 
Boshuizen, 1993). When compared to novice practitioners, medical experts are able to solve 
problems using forward reasoning. Forward reasoning refers to the process of drawing 
inferences from available data and using those inferences to simultaneously move towards 
the solution of the problem (Larkin et al., 1980; Patel, et al., 1999).  
Expert problem solving is also schema-driven. This means, experts are able to combine 
domain-specific scientific knowledge with the practical knowledge they acquire through 
experience. They use these two forms of knowledge to hone in on cues present in a given 
problem for rapid decision-making (Didierjean and Fernand, 2008; Gale and Marsden, 1983; 
Gilhooly, 1990; Patel, et al., 1999). This ability is largely unconscious although the end 
product is reflected upon and regulated by conscious deliberations (Eraut and Boulay, 2001). 
In contrast to experts, problem solving in novice practice is search-driven, in that novices 
reason backwards by using scientific first principles to reach a solution to a problem. As a 
result, decision making in novice practice is slow and not fluid.  
C) Experience and deliberate practice  
Extensive experience and training in a given domain of practice is often assumed to lead to 
improved performance. Although, this improvement has been shown empirically to occur in 
the early years of initial practice in a given domain, a number of studies have shown the 
existence of a time bound limit on performance (Ericsson et al., 1993).  
 
In 1981, Newell and Rosenbloom proposed the power law of practice which posits that 
learning occurs at a rapid rate upon the onset of practice but declines over time with 
continued practice (Newell and Rosenbloom, 1981). Research into the nature of expertise has 
demonstrated the veracity of this law (Baker et al., 2003). Studies show that improvement in 
performance arises as a result of the accumulated effects of prolonged practice and/or 
increased learning. This monotonic increase in performance occurs according to a power 
function. After sometime, when an acceptable level of proficiency has been attained, 
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continuous performance improvement may not be tangible or noticeable (Baker et al., 2003; 
Ericsson, 2006; Ericsson et al., 1993).  
 
Other studies show that novice practitioners are able to improve their practice through 
experience and supervision. After sometime, usually within a few months and less than a year 
of practice, novice practitioners attain a certain level of rule-based proficiency. Additional 
experience and with further practice in routine activities, usually within 2-3years, a level of 
competence is attained where practice is up to the minimum acceptable standard and becomes 
mostly independent. Thereafter, further improvement in performance appears to be 
unpredictable with practitioners able to maintain a stable but average level of performance 
(Ericsson, 2004).  
 
At this stage, performance becomes largely automated, routine and requires little effort. Most 
practitioners are able to maintain this pedestrian level of practice throughout their career, a 
phenomenon that is tagged arrested development as shown in Figure 1.4 (Ericsson, 2004). In 
order to overcome the phenomena of arrested development associated with automaticity, 
aspiring expert practitioners must actively seek out more demanding tasks with appropriate 
levels of challenge beyond their current levels of proficiency (Ericsson, 2006). This kind of 
practice, termed deliberate practice, is what stimulates continuous learning and further 
improvement in performance (Ericsson, 2006, 2004; Ericsson et al., 2007). 
 
Ericsson proposed the theory of deliberate practice (Ericsson, 2006, 2004, 1996; Ericsson 
and Lehmann, 1996). According to this theory, the performance level achieved by experts is 
determined by the amount of time ‘spent performing a well-defined task with an appropriate 
difficulty level for that particular individual, with informative feedback, and opportunities for 
repetition and corrections of errors’ being provided (Ericsson, 1996; p.20).  
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Figure 1.4: Influence of experience and deliberate practice on expert performance 
(Adapted from Ericsson, 2006, 2004) 
 
Deliberate practice fosters two kinds of learning; it improves the range of skills already 
possessed by the practitioner and extends the reach and range of those skills (Ericsson, 2006; 
Ericsson et al., 2007). 
 
D) Expert training and coaching 
 
Early research into the nature of expertise proposed the ‘10-year rule’ which theorised that 
practitioners will need to commit to high levels of training for a minimum of 10-years to 
reach expert levels of practice (Simon and Chase, 1973). The 10-year rule which stemmed 
from pioneering research in the field of chess has been shown to hold true in the fields of 
music (Ericsson et al., 1993), sports (Ericsson, 1996), meteorology and aviation (Hoffman, 
1996) but not in medical expertise (Alderson, 2010).  
 
Ericsson and colleagues argue that it is not so much as the time spent in training that 
determines expertise; but rather the quality and nature of the training undergone by a 
practitioner (Ericsson et al., 2007). Furthermore, they argue that the important factor in 
training is to spend as much time as required in deliberate practice while also citing the 
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influence of the expertise of the coach as an important training factor (Ericsson, 1996; 
Ericsson et al., 1993).  
1.5.5 Theories of expertise development 
Dreyfus and Dreyfus, (1986), proposed a five-staged model of skill acquisition in a seminal 
work, Mind over Machine. According to this model, an individual develops expertise in a 
stage-wise fashion from novice, advanced beginner, competent, proficient up to an expert 
level (Fig. 1.5). 
Dreyfus & Dreyfus model of skill acquisition distinguishes these five stages of proficiency 
based on:  
A) The depth of knowledge acquired 
B) The level of skill attained  
C) Contextual perception and  
D) The decision-making process of the practitioner  
 
According to this model, (Figure 1.5), skill acquisition arises as a result of experience within 
the given vocation. As a novice, much of one’s practice involves a strict adherence to taught 
rules and guidelines with no perception of contextual or situational peculiarities. The goal of 
practice at this level is to complete a given job task successfully. Decision-making is non-
discretional and without the benefit of prior experience.  
Over time and with practice, a novice is able to improve and advance to the next stage of 
development to become an advanced beginner.  
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Figure 1.5: A model of skill acquisition (Adapted from Dreyfus and Dreyfus, 1986) 
 
An advanced beginner has the benefit of additional knowledge from experience with some 
form of situational awareness being involved in decision-making. Practice at this level still 
remains task-oriented and rule-based with complex decision-making delegated to a more 
experienced co-worker. Progress from novice to this stage of practice can be achieved within 
a year of practice (Benner, 1984).  
Through further training and experience, an advanced beginner is able to progress to become 
a competent practitioner. A competent practitioner is capable of handling complex situations 
with performance at this level of practice being more coordinated, routine and standardised. 
Experience and prior exposure to the domain of practice benefits practise and decision-
making at this stage is analytical, situational and based on perceived long-term goals. 
Advancement to this stage of practice can be achieved within two years of practice in a 
specific domain (Benner et al., 1996). Thereafter, a practitioner is able to progress to being 
proficient. 
A proficient practitioner has a holistic approach to practice and takes actions based on the 
recognition of situational peculiarities. Decision-making at this stage of development is a 
direct consequence of an understanding of the given situation due to prior experience. Job 
tasks are carried out without much deliberation with performance being quick and more fluid. 
Automaticity of performance is attained at this level of practice and this level can be achieved 
within 3-5years of practice (Benner et al., 1996).  
Expert
Proficient
Competent
Advanced beginner
Novice
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Further progression leads to the attainment of an expert level of practice. Experts are able to 
make decisions intuitively, are more involved in decision-making, are able to see situations 
holistically and in parallel with the other elements of the situation, and are therefore capable 
of weighing suitable alternatives. With increasing experience from different situations, 
patterns become clear, actions become obvious and performance becomes even more 
seamless. This level of practice is attainable within 10years of practice in a given domain 
(Ericsson, 1996; Ericsson et al., 1993; Ericsson and Lehmann, 1996).  
Dreyfus & Dreyfus theory of skill acquisition was developed as a critique of artificial 
intelligence. The theory was mostly anecdotal, phenomenal and not based on empirical data 
from scientific experiments (Eraut, 2000). It was explained using examples involving chess 
players and the stepwise process in learning to ride a bike or a car (Dreyfus & Dreyfus 1986).  
The theory acknowledges the role of training and resultant experience in the development of 
expertise and proficiency.  It makes a clear distinction between a trained individual and an 
experienced one and explains how learning is consolidated and enforced through experience. 
It therefore acknowledges progression towards an ability to undertake complex task in an 
intuitive manner as being dependent on experience in the required domain. Dreyfus & 
Dreyfus theory of expertise development has been applied and shown to be true in the field of 
nursing (Benner, 1984; Benner et al., 1996). 
Ericsson (2004 and 2006) proposed a model for expertise development in medicine (Figure 
1.6). In this model performance is initially seen to increase with increasing years of training 
and experience as the medical practitioner progresses from being a student, to medical 
resident, and up to the point of becoming a specialist. Upon completion of medical and 
specialist training, no further increases in performance is observable and a stable but 
pedestrian level of performance is attained (Ericsson, 2006, 2004).  
  
An early study conducted by Butterworth and Reppert (1960) demonstrated this scenario. In 
this study, recordings of heart sounds and murmurs of sick and healthy patients were 
presented to groups of medical students, resident doctors, certified cardiologists and general 
practitioners simultaneously. 
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Figure 1.6: Development of medical performance as a function of experience and 
instruction (Adapted from Ericsson, 2004) 
 
Medical students showed the lowest level of diagnostic accuracy followed by medical 
residents with the highest level of accuracy recorded in the group of certified specialists. It 
was also observed that general practititioners did not show a corresponding increase in 
diagnostic accuracy with more experience, rather, performance was observed to decrease as a 
function of ‘time gone by’ since the completion of medical training. In this group of 
practitioners, an increase in number of years gone by after training was associated with a 
gradual decline in performance (Butterworth and Reppert, 1960).  
 
This study suggests continued and specialised training likely promotes improved 
performance in specific tasks related to that domain of practice (Ericsson, 2004). Similar 
findings from other studies have corroborated this feature and show that continued training 
has a positive influence on performance (Crowley et al., 2003; Hatala et al., 1999; Norman et 
al., 1989; Wolf et al., 1994). In these studies, practitioners who went through short-term 
training courses with feedback were observed to show enhanced performance, but this 
performance declined gradually after training. Practitioners who retained elements of such 
training for up to a six-month period also showed observable decline in performance 
thereafter (Hatala et al., 1999; Horiszny, 2001; McGuire et al., 1964).  
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Taken together, these studies demonstrate a relationship between training activities and 
increased and sustained improvement in performance (Ericsson, 2004). This implies that 
clearly defined, continuous and guided practice with feedback from other experts promotes 
learning and development of expertise in  novice practitioners (Ericsson, 2004).  
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1.6  Expertise Development in Pharmacy  
An initial period of undergraduate pharmacy education and training is required prior to being 
registered to practice as a pharmacist. This period is traditionally thought to equip an 
individual with the requisite knowledge needed to perform up to the minimum standards of 
acceptable practice at initial registration (Eraut, 2000). Thereafter, it is expected that a ‘day 1’ 
pharmacist develops his/her practice and advance in knowledge and skills through experience 
and life-long learning (Hill et al., 2006). This progression in knowledge and skill acquisition 
attained through experience is termed professional development and describes the continuous 
improvement in practice that occurs as a result of continuing learning. 
 
Professional development deals with the on-going learning of skills and knowledge by a 
practitioner to enable both personal development and career advancement (Daugherty, 2009; 
Institute of Medicine, 2010; Speck and Knipe, 2005). It covers all the aspects of formal and 
informal learning activities that are situated in practice (Daugherty, 2009).  
 
Professional development encompasses two closely related concepts: continuing education 
(CE) and continuing professional development (CPD). Continuing education (CE) is a form 
of didactic learning undertaken by professionals in order to update knowledge and maintain 
and translate knowledge into practice (Institute of Medicine, 2010). It is defined by the 
Accreditation Council of Pharmacy Education as ‘a structured educational activity designed 
or intended to support the continuing development of pharmacists and/or pharmacy 
technicians to maintain and enhance their competence’ (Accreditation Council of Pharmacy 
Education, 2014).  
 
CPD on the other hand, incorporates continuing education as a subset and includes all the 
other types of learning activities undertaken by a practitioner either formally or informally, 
and on the job (Institute of Medicine, 2010). CPD is defined as the ‘system of maintaining, 
improving, and broadening knowledge and skill throughout one’s professional practice’ 
(Institute of Medicine, 2010; p.18). In pharmacy, it is defined as ‘the responsibility of 
individual pharmacists for systematic maintenance, development and broadening of 
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knowledge, skills and attitudes, to ensure continued competence as a professional throughout 
their careers’ (International Pharmaceutical Federation, 2002, p. 2).  
 
Compared to CPD, continuing education has a narrow focus, is teacher-driven and often 
serves the primary purpose of providing an avenue for obtaining credits for re-licensure and 
recertification (Institute of Medicine, 2010). CPD on the other hand is learner-driven, self-
directed and outcome-based. It affords the learner the opportunity to identify learning gaps 
and undertake activities tailored to individual learning needs (Institute of Medicine, 2010; 
Rouse, 2004). 
 
CPD involves a five-staged cyclical process of self-appraisal, planning, action, 
documentation and evaluation (Figure 1.7) (International Pharmaceutical Federation, 2002). 
The first stage of the CPD cycle involves self-appraisal through reflection. This phase aims to 
identify learning gaps and areas that require improvement at an individual level. Such 
appraisal can be carried out personally by the learner or by the learner’s peers, colleagues, 
supervisor or employer or as a requirement by a professional or health authority. The second 
stage of the CPD cycle is the identification of the resources and actions required to meet CPD 
needs.  
 
The third phase of the CPD cycle involves active participation in relevant CPD activities and 
may include formal activities like short courses, workshops, seminars and self-study. It may 
also include informal activities such as meetings and discussions with colleagues or mentor 
as well as informal on-the-job learning that occurs during practice. The fourth phase of the 
CPD cycle involves documentation and recording of all the CPD activities undertaken with 
documented evidence provided where necessary. The final phase of the CPD cycle is the 
evaluation of the outcome of all the CPD activities undertaken in order to determine the 
effectiveness of those learning activities. It also involves the evaluation of the challenges 
encountered by the learner in the CPD cycle.  
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Figure 1.7: Continuous professional development cycle (Adapted from International 
Pharmaceutical Federation, 2002) 
 
The CPD cycle is repeated periodically to ensure that continuing professional development 
occurs throughout one’s professional career (Institute of Medicine, 2010; International 
Pharmaceutical Federation, 2002). In recent years, participation in CE and CPD activities has 
become a mandatory requirement to maintain license to practice pharmacy in a number of 
countries (International Pharmaceutical Federation, 2009). Mandatory CPD is now a 
regulatory prerequisite for retaining the annual practicing certificate (APC) for pharmacists in 
New Zealand (Harrison et al., 2012; Pharmacy Council of New Zealand (PCNZ), 2004). In 
2004, the Royal Pharmaceutical Society of Great Britain introduced CPD for pharmacists in 
UK. In 2007 maintaining evidence of CPD activities relating to an individual’s area of 
practice became a mandatory professional requirement for retaining license to practice 
pharmacy (Department of Health, 2008; Royal Pharmaceutical Society of Great Britain, 
2007, 2003a).  
 
In 2010, CPD became mandatory for registered pharmacists in Australia (Coombes et al., 
2012). Many other countries around the world including Portugal, France, Ireland, Nigeria, 
Kenya and others have implemented mandatory CPD activities for pharmacy practitioners 
(International Pharmaceutical Federation, 2009).  
Self-Appraisal
(1)  
Personal Plan
(2)
Action
[Implementation]
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Documentation
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1.6.1 Models of expertise development in pharmacy  
Pharmacy practice has both a horizontal and vertical dimension (Modernising Pharmacy 
Career Programme, 2012; Pharmaceutical Society of Australia, 2010). The horizontal 
dimension defines the breath or scope of practice while the vertical dimension describes the 
depth of practice; also referred to as performance level.  
 
Scope of practice describes those actions, processes and activities which a practitioner is 
educated, licensed and competent to carry out (Anderson, 2012). Depth of knowledge, skills 
and experience defines the scope of practice of a health practitioner (Council on 
Credentialing in Pharmacy, 2010a). It sets the boundaries of practice for an individual 
practitioner as authorised by the relevant professional regulator (The Federation of State 
Medical Boards of the United States, 2005).  
 
Performance level on the other hand, is concerned with capability and reflects the expertise 
and professional advancement of a pharmacy practitioner (Coombes et al., 2011; 
Modernising Pharmacy Career Programme, 2012). A practitioner development model for 
pharmacy has been suggested by Coombes et al., (2011). This model, as shown in Figure 1.8, 
describes the pathway of development for a pharmacist. It depicts the expansion in roles and 
responsibilities that arises as a result of an increase in proficiency. 
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Figure 1.8: Pharmacists development strategy, roles and responsibilities (Adapted from 
Coombes et al., 2011) 
 
In this model, the acquisition and consolidation of knowledge and skill is the focal point of 
practice in the early years; that is, from the undergraduate level to a general level of practice. 
As performance increases due to experience, further training and/or formal education, a 
threshold performance level is attained above which practice is termed advanced. Advanced 
pharmacy practice is defined as practice ‘that is so significantly different from that achieved 
at initial registration that it warrants recognition by professional peers and the public of the 
expertise of the practitioner and the education, training and experience from which that 
capability was derived’ (Pharmaceutical Society of Australia, 2010; p.5).  
Pharmacists who practice at an advanced level are more involved in contributing knowledge 
and skills for the development of colleagues and other professionals in contrast to early 
career pharmacists. These advanced practitioners have a greater contribution to leadership 
and management and are involved in the training of other pharmacists, research and in the 
development of inter- and intra-professional working relationships (Coombes et al., 2011).  
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Figure 1.9 is an example of how scope of practice and performance level may be used to 
describe the professional practice profile of a pharmacist involved in a ‘patient-facing’ role. It 
is a model of practice progression and describes how scope of practice may change as result 
of changes in depth of knowledge, skills and experience (performance level) (Council on 
Credentialing in Pharmacy, 2010a).  
 
According to this model, the scope of practice of a pharmacy practitioner can be broad or 
narrow. An entry-level pharmacist will have a broad scope of practice but possess only a 
limited amount of knowledge and skill, reflecting the level of professional practice expected 
of a novice pharmacist. This pharmacist will practice only at a general level.  
 
 
 
Figure 1.9: Defining professional pharmacy practice using scope of practice and 
performance level (Adapted from Council on Credentialing in Pharmacy, 2010) 
  
Over time and with progress in skill and knowledge acquisition, such a pharmacist may 
choose to limit his/her scope of practice, in which case they will be involved in managing 
either specific disease states or a specific patient population (for example, a specialist-in-
training pharmacist). As depth of knowledge and skills increases significantly through 
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experience in a specific domain, the pharmacist progresses and attains advanced level skills, 
knowledge and professional capability and is able to deal with complex health issues in a 
specific patient population or specific disease states (for example, certified oncology or renal 
pharmacist). Such a pharmacist is described as a ‘focused advanced pharmacist’.  
 
Conversely, a pharmacist though advanced in knowledge and skills may choose to remain 
within a broad scope of practice. In this latter case, even though the capability/performance 
level of such a practitioner is high, their scope of practice will remain broad and will involve 
dealing with complex health issues from a wide variety of patients or disease states. Such a 
pharmacist will be recognised as ‘an advanced generalist’ pharmacist. Therefore in the 
pharmacy profession, a narrow scope of practice does not always signify advancement or 
development of high level expertise in contrast to the medical profession where a narrowing 
in the scope of practice of a practitioner (that is, specialisation) signifies an enhanced level of 
expertise obtained through advanced training (Pharmaceutical Society of Australia, 2010).  
 
Davies (2002) (cited in Obiols, 2008; p. 26) proposed another model that describes the 
pathway for progression from a registered pharmacist up to the attainment of advanced/expert 
level practice (Figure 1.10). This model describes a stepwise increase in proficiency that 
occurs through experience and increase in knowledge and skills.  
The model depicts four levels of competence:  
- Registered pharmacist 
- General pharmacist practitioner  
- Advanced pharmacist practitioner and  
- Consultant pharmacist 
 
The model also defines two distinct training phases culminating in the award of a ‘certificate 
of completion of training’. In this model, the novice ‘registered pharmacist’ is able to 
increase in knowledge and skills through experience and progresses to being a ‘general 
pharmacist practitioner’.  In order to progress from a ‘general pharmacist practitioner’ to an 
‘advanced pharmacist practitioner’, a general pharmacist practitioner must undertake general 
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level training over a period of two to three years with the award of a certificate of completion 
of general training (CCGT) at the end of training. Thereafter, further progression is attained 
via advanced training in a single discipline or specialty with the award of a certificate of 
completion of advanced training (CCAT).  
 
 
Key: MRPhs – Member Royal Pharmaceutical Society, GPP – General pharmacy 
practitioner, APP – Advanced pharmacy practitioner, CP – Consultant pharmacist, CCGT – 
Certificate of completion of general training, CCAT – Certificate of advanced training, PG1 
– Postgraduate degree certificate, PG2 – Postgraduate diploma, PG3 – Postgraduate 
masters. 
Figure 1.10: A Strategy for practitioner development (Adapted from Davies, 2002) 
 
Figure 1.11 describes a development model for pharmacists practising within the National 
Health System (NHS) of the United Kingdom. This model depicts the horizontal dimension 
of competence progression and maps the pathway of career advancement for pharmacists 
within the NHS. 
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Figure 1.11: A pharmacist development model - NHS (Adapted from Davies, 2007) 
 
The model combines both formal educational programmes and training activities to enable 
practitioner progression. These enabling programmes are undertaken at two broad levels of 
practice: the general and the advanced level. Each level of training is undertaken using 
competency frameworks, that is, the RPS Foundation Level Framework (RPS-GLF) and the 
RPS Advanced Pharmacy Framework (APF-RPS) respectively.    
In this model, individual practitioners are required to evaluate themselves against the 
competencies contained in the framework relevant to their specific level of practice. 
Documented evidence of progression is then collated and presented in form of a portfolio for 
peer review and evaluation (Davies et al., 2004; Duggan, 2013).  
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1.6.2  Professional recognition, credentialing and recertification in pharmacy 
The need to promote continuing development and demonstrate evidence of practitioner 
progression and capability has driven the introduction of defined professional recognition and 
credentialing processes by many health professions around the world (Department of Health, 
2012).  
Credentialing is defined by the Council on Credentialing in Pharmacy, as the ‘process of 
granting a credential (a designation that indicates qualifications in a subject or an area of 
practice)’. It is also defined as the ‘process by which an organization or institution obtains, 
verifies, and assesses qualifications to provide patient-care services’ (Council on 
Credentialing in Pharmacy, 2010; p.e65) and the ‘process used by health care organisations to 
validate professional licensure, clinical experience, and preparation for specialty practice’ 
Galt (2004; p.661). Credentials generally refer to documented evidence of professional 
qualifications that an individual possesses. In pharmacy, examples of credentials include 
academic qualifications, license to practice, residency training certificates, and other post-
registration certifications (Council on Credentialing in Pharmacy, 2010b).  
Professional recognition, which may also be referred to as credentialing, is defined as a 
‘quality assured process which recognises a practitioner’s attainment of the required 
knowledge and skills at a particular level of practice’ (Joint Partners Credentialing Task 
Group (JPCT), 2013; p.35). Professional recognition serves as a guarantee of an individual’s 
capability and competence to deliver specific services and procedures (Joint Partners 
Credentialing Task Group (JPCT), 2013). It is useful for supporting progression and 
advancement for practitioners who aspire to attain higher-level practice, is a quality assured 
means for demonstrating the competence and capability of a practitioner to peers, patients, 
employers, general public and other stakeholders, and provides access to professional 
development programmes relevant for practice progression beyond initial registration 
(Duggan, 2010). Although professional recognition is not linked to a regulatory function, it 
however provides a useful means for revalidation (Joint Partners Credentialing Task Group 
(JPCT), 2013).  
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Some countries have a defined professional recognition process in pharmacy. For example, 
the Board of Pharmacy specialties (BPS) of the USA has a defined certification process for 
six specialty programs: ambulatory care pharmacy; nuclear pharmacy; nutritional support 
pharmacy; oncology pharmacy; pharmacotherapy pharmacy and psychiatric pharmacy 
(Board of Pharmacy Specialties, 2016, 2013a). The National Association of Pharmacy 
Regulatory Authorities in Canada (NAPRA) certifies pharmacists with advanced skills and 
training in four specialty areas: anticoagulation management, asthma management, diabetes 
management and advanced pharmacotherapy management (National Association of 
Pharmacy Regulatory Authorities, 2014b) while in the United Kingdom, the Royal 
Pharmaceutical Society recognises advanced pharmacy practitioners in three stages: 
advanced stage I, advanced stage II and mastery stage. This recognition culminates in the 
award of specific post-nominal to the practitioner for having attained a specific stage of 
advanced pharmacy practice (Duggan, 2013). 
Initial certification by the BPS is based on a combination of post-registration training, 
experience in a defined specialty and achieving a pass grade in a formal specialty 
examination (Board of Pharmacy Specialties, 2013c; p.13). This is in contrast to Canada 
where initial certification is achieved via a combination of knowledge, knowledge application 
and performance-based assessments. Knowledge and knowledge application assessment 
involves taking a formal examination in the specialty area while performance based 
assessment includes a portfolio and an on-site practice review and audit (National 
Association of Pharmacy Regulatory Authorities, 2014b). The professional recognition 
process of the RPS in United Kingdom involves formal assessment via self-assessment of 
competence using the RPS Advanced Pharmacy Framework and/or an interview. The 
assessment methods include structured portfolio review, multi-source feedback (MSF), on-
site practice reviews via direct observed practice (DOP) or structured case-based evaluation 
methods (Joint Partners Credentialing Task Group (JPCT), 2013). 
Practitioners certified by the BPS of USA are awarded 'post-nominals' specific to their 
practice areas and are also required to undertake periodic recertification every seven (7) 
years. This recertification process is a three-step process and includes self-evaluation, peer 
review of a portfolio of evidence and a formal assessment process. The formal assessment 
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may include either undertaking an examination or accumulating a defined number of 
continuing education credits in an accredited and BPS-approved education programme in the 
required specialty (Board of Pharmacy Specialties, 2016).  
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1.7 Learning Theories  
Learning can be defined as a ‘process in which a learner attends to surrounding 
circumstances and is changed by the exposure to them’ (Dressel and Marcus, 1982; p.21). 
Burner described learning as an active process through which a learner develops new ideas 
and concepts based on their past or present knowledge (Bruner, 1977). An understanding of 
how adults learn can provide a theoretical framework for the design of training and 
development activities that promote learning (Norman, 1999). A number of theories that 
explain how adults learn exist. This section will give a brief overview of a few of the adult 
learning theories that may be useful for pharmacy practice. 
1.7.1 Andragogy 
Malcolm Knowles defined andragogy as the ‘art and science of helping adults learn’ 
(Knowles, 1980; p.43). The term andragogy stems from two root words: andr- meaning 
‘man’ and agogos- meaning ‘leading’ (Smith, 1996).  Andragogy as proposed by Knowles 
provides a theoretical framework on adult learning based on five key assumptions: 
- Self-concept: Knowles recognises adult learners as independent and self-
directed learners capable of being responsible for their own learning. Andragogy 
therefore proposes that educational activities intended for adult learners should be 
undertaken with the active participation of the individual learner in the design and 
implementation of such activities. 
- Experience: Andragogy places an emphasis on the role of an adult’s past 
experience. According to this theory, the volume and quality of an adult’s past 
experience serves as an on-going resource for learning and will therefore have a 
bearing on any current learning situation. Therefore, adult learning activities need to 
be designed in a way that takes cognisance of the influence of their past experiences. 
- Readiness to learn: According to this theory, self-recognition of knowledge 
gaps in the adult learner triggers a readiness to learn. As a result of this self-
recognition, an adult learner undertakes specific learning activities in order to 
improve his/her own effectiveness or performance. This readiness to learn can be 
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triggered by a number of stimuli. According to Knowles, involving the adult learner 
in career planning and exposing the adult learner to more effective role models whom 
he/she can aspire to emulate are some of the possible avenues through which a 
readiness to learn can be triggered (Knowles, 1980). 
- Orientation to learning: Adults have a problem-centred orientation towards 
learning and will be more willing to learn if what is to be learnt will prove relevant in 
coping with real life situations. Therefore in designing learning experiences for adult 
learners, emphasis should be placed on organising such activities around areas that are 
immediately relevant to solving real-life problems. Such activities should not be 
designed around subject maters that have no direct bearing on the life situation of the 
learner.  
- Motivation: In adults, the motivators for learning are largely internal and not 
external. Internal drivers like the need for self-recognition, self-actualisation and 
greater self-confidence provide potent motivation for learning. Learning programs 
should therefore be designed in a way that incorporates such motivating factors. 
The assumptions of andragogy as described by Knowles were mostly philosophical and 
stemmed from years of observations and practice in adult education (Knowles, 1980, 1968). 
It was not based on initial empirical data. The model has however been applied in a variety of 
adult learning settings that have produced evidence that support the veracity of the theory 
(Malcom Knowles & Associates, 1985).  
1.7.2 Social learning theory 
Bandura (1971) proposed a theory of social learning which emphasises the influence of 
environmental and cognitive factors on learning and human behaviour. According to this 
theory, human behaviour is shaped through experience, imitation and observation of role 
models within a social environment. Consequently, the role models that a learner is 
consistently exposed to in a social group will determine the type of behaviour that the learner 
repeatedly observes and subsequently models. This kind of learning occurs in a social context 
through observation, imitation and modelling of observed behaviour.  
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Four sub-processes govern this modelling process: 
i. Attention 
ii. Retention 
iii. Motoristic reproduction of behaviour  
iv. Reinforcement and motivation 
This theory posits that simply exposing the learner to the behaviour to be learnt does not 
guarantee learning. For learning to occur, the learner needs to consciously attend to and 
recognise the key features of the behaviour to be imitated. The learner also needs to be able 
to retain and store information about the observed behaviour over a long period of time for 
future retrieval. Performance and imitation of observed behaviour alongside further practice 
promotes improvement and skill advancement. The observed behaviour can be reinforced 
either positively through incentives or negatively through punishment and this reinforcement 
leads to a change in behaviour (Bandura, 1971). It is at this stage of an observed change in 
behaviour that learning is said to have occurred (Mcleod, 2011). 
1.7.3 Social development theory 
Lev Vygotsky proposed a theory that emphasised the central role of social interaction and 
culture on cognitive development (Vygotsky, 1978). According to Vygotsky, cognitive 
development occurs through the social interaction of an individual (particularly a child) with 
a skillful tutor. Vygotsky proposed that learning occurs as the learner models behaviour and 
verbal cues provided by an expert or skillful tutor. Vygotsky described this type of social 
interaction as collaborative dialogue in learning (Vygotsky, 1978).  
Vygotsky theory of cognitive development hinged on two principles: 
i. More knowledgeable other (MKO) and 
ii. Zone of proximal development (ZPD) 
MKO refers to persons of higher understanding or ability in the specific task, concept or 
process that the learner needs to learn. An MKO may be a trained tutor or coach, a parent, a 
mentor, or the learner’s colleagues (Vygotsky, 1978). ZPD on the other hand refers to the 
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difference between what an individual can achieve on his/her own and what is achievable 
with guidance from a partner who is more skilled or experienced (Vygotsky, 1978). Vygotsky 
sees the ZPD as the point where learning can be maximised through the provision of guided 
feedback and instructions by the MKO, thereby enabling the learner develop higher mental 
capacities and capabilities. This kind of learning is active and involving and is seen by 
Vygotsky to be an effective way of developing skills and knowledge.  
The learning concept described by Vygotsky is observed in apprenticeships, internships, 
scaffolding and other instructional techniques where more advanced peers are involved in 
task structuring in way that ensures novice practitioners successfully complete such tasks 
(McLeod, 2012). The principle of MKO and ZPD ensure that learning is facilitated and 
integrated in practice. Therefore, using this theory, novices are capable of developing 
competence through engagement and social interactions with fellow practitioners or expert 
colleagues (McLeod, 2012).  
1.7.4 Lifelong learning  
Age theory is one of the broad branches of adult learning theories initially proposed to 
explain and understand how adults learn (Levinson et al., 1979; Sheehy, 1976). Age theory 
sought to determine the concerns, challenges or problems that hinder learning as people age. 
Theorist under this branch of inquiry focused on reporting age-related issues that affected 
learning. This branch of inquiry provided initial evidence that confirmed that learning was an 
activity that continued throughout a person's life cycle. It also provided initial insight into 
lifelong learning (Trotter, 2006).  
 
Lifelong learning encompasses all the learning activities that an individual undertakes 
formally and informally throughout their professional career (Institute of Medicine, 2010). 
Health professionals involved in care delivery are required to continually engage in learning 
so as to achieve both personal and professional growth (Institute of Medicine, 2010). The 
importance of lifelong learning in the health professions is underscored by rapid 
advancement in technology, use of sophisticated therapies and the changing healthcare 
environment, which requires practitioners to continually improve their skills and increase in 
knowledge. Lifelong learning ensures that health professional involved in care delivery 
  
 
 
76
continually take responsibility for their development so as to keep up to date, attain and 
maintain competence as well as fitness to practise (Institute of Medicine, 2010).  
1.7.5 Experiential learning  
Kolb (1984; p.38) defines learning as a ‘process whereby knowledge is created through 
transformation of experience’. Kolb used a four-staged cyclical process to propose the theory 
of experiential learning (Figure 1.12).  
The four stages include: 
A. Concrete experience 
B. Observation and reflection 
C. Abstract conceptualisation and 
D. Active experimentation 
 
 
Figure 1.12: Kolb's learning cycle 
 
According to this theory, the cycle of learning begins with the learner experiencing an 
activity in the learning environment. Thereafter, the learner consciously reviews, analyses 
and reflects on this experience. It is from this reflection that the learner is able to translate 
experience into concepts or models. This ensuing conceptualisation serves as a guide for the 
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learner to plan and actively test concepts in new situations. The learning cycle can commence 
at any stage but upon commencement, the learner has to continue the cycle sequentially. 
Kolb identified four basic learning styles that correspond to each stage in the learning cycle. 
These include: 
• Assimilators who learn better by reflection and abstract conceptualisation. They are 
able to create theoretical models from abstract concept and are capable of applying 
these models to new experiences. 
• Accommodators who learn primarily through concrete experiences and 
experimentation and will therefore learn better when they participate and are involved 
in practical ‘hands-on’ experiences. 
• Convergers who learn primarily through abstract conceptualisation and active 
experimentation. They learn better when abstract concepts and ideas are applied to 
practice. 
• Divergers who learn primarily through concrete experiences and reflective 
observation. They learn better through reflection and generating ideas and concepts 
from their experiences. 
Although research on pharmacists' preferred learning style and learning approach is currently 
limited, evidence from two studies by Austin (2004) and Loewen et al., (2014) suggest 
pharmacists are predominantly assimilators and convergers. Research in the field of medicine 
show that general practitioners are predominantly assimilators (Robinson, 2002) and 
accommodators (Christensen et al., 1985) while neurosurgeons and residents favour the 
assimilating and diverging learning styles (Lai et al., 2014).  
Other studies show that post-graduate medical (Gurpinar et al., 2011), pharmacy (Williams et 
al., 2013) and undergraduate nursing (D’Amore et al., 2012) students have a preference for 
converging and assimilating learning styles. Conversely, a study by Pungente et al., (2003) 
showed an even distribution of learning styles among a group of first year pharmacy students 
although more of the students (36%) preferred the accommodator style of learning. A study 
by Smits et al (2004) indicates the accommodator learning style is associated with an increase 
in knowledge but not with change in performance. 
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Evidence from published studies by Gurpinar et al., (2011), Novak et al., (2006), van den 
Berg, (2015), Bitran et al., (2012), Loewen et al., (2014) and Gonyeau et al., (2006) indicate 
that preferred learning styles may change over time with respect to a change in the learning 
environment. For instance, the preferred learning style of medical students may change from 
divergers to convergers and assimilators as they progress from undergraduate education to 
the more 'hands-on' clinical practice environment (Gurpinar et al., 2011). Other studies 
involving a group of first year undergraduate pharmacy students also suggest that preferred 
learning approach may change from an initial surface learning strategy (involving 
memorising and reproducing information from lectures) to a deep and reflective learning 
approach (where the students derive meaning from theoretical knowledge and actively seek 
to apply this in solving problems) as they progress to their final year and up until post-
graduate training and practice (Smith et al., 2010, 2007).  
Published research suggests learning styles may be predictive of a successful educational 
outcome (Smits et al., 2004) and likely influences knowledge and skill acquisition as it 
relates to preferred instructional method (Austin, 2004; Christensen et al., 1985; Tsingos et 
al., 2014). Therefore, health professionals may be more inclined to partake in lifelong 
learning and continuing education activities when instructional methods are matched to their 
learning styles (Robinson, 2002; Tsingos et al., 2014). For example, evidence from the study 
by Smits et al (2004) suggest problem-based learning format may be associated with better 
performance outcomes than formal lectures for physicians (P=0.05). On the other hand, 
studies involving paediatricians (Al Shaikh, 2015) showed no correlation between learning 
styles and satisfaction with instructional methods. 
Overall, the available evidence suggests that a combination of instructional methods that take 
into consideration the diversity in preferred learning styles among health professionals is 
necessary for the design of a learning curriculum that would provide a successful educational 
outcome and promote lifelong learning (Al Shaikh, 2015; Robinson, 2002; Tsingos et al., 
2014). 
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1.8 Chapter Conclusion  
This chapter provided an overview of the pharmacy profession and its role in the quality of 
care delivered in the health sector. It also gave an overview of the education, training and 
development strategies in pharmacy. An outline of the concept of competence, competency-
based education and training, the use of competency frameworks in the education of health 
professionals, some adult learning theories alongside a narrative literature review of the 
development of expertise and its theories, were also provided.  
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2.1 Developing the Research Questions  
Competent pharmacists improve therapeutic outcomes, minimise the risk associated with 
medicines use, and positively influence the overall quality of care delivered in the health 
sector (Department of Health, 2008; Giberson et al., 2011). It is therefore important to define 
and articulate the exact competencies pharmacists need to consistently perform safely, 
effectively and efficiently in their roles. These competencies once identified are often 
compiled to form a framework that provides a blueprint of the knowledge, skills, and 
attributes that are valuable for effective professional performance (Brownie et al., 2011a).  
Competency frameworks are extensively used in the healthcare professions. Many countries 
have established competency frameworks and practice standards at both national and 
organisational levels (Kak et al., 2001). A preliminary scoping internet search for 
competency literature using the key words ‘competency frameworks’ and ‘practice standards’ 
and limited to the healthcare professions returned an extensive array of published literature. 
This included frameworks developed for medicine, nursing, pharmacy, public health, 
physiotherapy, health promotion and other allied health professions.  
2.1.1 Competency frameworks in pharmacy: A systematic review of the literature 
A systematic literature review was conducted to:  
- Identify global, regional and national competency frameworks for pharmacy practice  
- Determine the methodological processes used to identify the competencies contained 
in such frameworks  
- Identify evidence of the applicability of these frameworks, and 
- Identify evidence of the effectiveness of competency frameworks in pharmacy. 
 
SCOPUS, Web of Science, OvidSP and CINAHL electronic databases were searched to 
retrieve published literature. The OvidSP platform provided access to literature from the 
following electronic databases: EMBASE, PsycINFO, PsycTESTS, Allied & Complementary 
Medicine (AMED), Health & Psychological Instruments, Health Management Information 
Consortium (HMIC), Ovid Medline Research In-Process & Other Non-indexed Citation (to 
search for grey literature), Social Policy and Practice, and International Research Abstracts.  
Chapter 2 RESEARCH QUESTIONS, AIMS AND OBJECTIVES 
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The websites of specific pharmacy journals were also searched. These included the American 
Journal of Pharmaceutical Education, American Journal of Pharmacy and Health Research, 
Academic Journal of Pharmacy, International Journal of Pharmacy Practice, Pharmacy 
Education Journal, and the Pharmaceutical Journal. 
The key words used were 'competency', competence', 'credentialing', 'competency 
framework', 'competency-based education', 'professional development', 'practice',  'standard', 
and 'pharmacy'. Free text search using Boolean operators [OR & AND] to combine words 
was conducted for the databases. Key word truncation {for example, competenc*, pharmac* 
and credential*} was used in the PubMed database to ensure all relevant Medical Subject 
Headings (MeSH) terms were included in the search. The FIP membership list was also 
consulted with the organisation websites manually searched to retrieve published 
frameworks.   
Since the systematic search was also directed by the findings of a 2012 (International 
Pharmaceutical Federation, 2012) and 2014 (International Pharmaceutical Federation, 2014) 
FIP global survey of pharmacy organisations that showed no published frameworks in other 
languages; the search result was limited to articles related to pharmacy and published in 
English from year 2000.  
In total, 785 articles were retrieved from the electronic database search queries. The articles 
provided by the search were examined and screened against the following inclusion criteria: 
- Global, regional and national competency frameworks for pharmacy practice 
- White papers, supplementary and follow up articles that reported specific 
methodological processes used in the identification of competencies and the 
development of frameworks in pharmacy 
- Evaluative studies that assessed the usefulness or effectiveness of such frameworks. 
 
Articles excluded were commentaries and editorials on competency-based education or 
competency-based curriculum development for undergraduate education. Other publications 
that did not meet the pre-defined inclusion criteria were also excluded.  Table 2.1 gives a 
summary of the search output.  
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The systematic literature search was conducted in May 2013. Relevant articles were 
thereafter gathered on a rolling basis with a subsequent search conducted in April 2014 and 
June 2015 to update literature, although no new frameworks were obtained in these later 
searches.  
Table 2.1: Summary of electronic database search output 
Database No. of hits (n) Articles reviewed (n) 
Web of Science 114 6 
SCOPUS 159 13 (5 duplicate) 
PubMed 364 4 (4 duplicate) 
CINAHL 41 7 (5 duplicate) 
OvidSP 107 13 (7 duplicate) 
 
Twenty-two relevant articles were identified from the electronic databases search. Six more 
articles were identified from the manual search of the reference lists of the retrieved studies. 
Seven national competency frameworks were also retrieved by manual search of FIP member 
organisation websites.  
2.1.2 Articles included in the literature review  
In total, 35 articles were included in the literature review: 
- Thirteen published frameworks for pharmacy practice including: the FIP 
global competency framework for foundation level pharmacy practice (International 
Pharmaceutical Federation, 2010); and 12 national frameworks that contained generic 
competencies for pharmacy practice. The national frameworks were from New 
Zealand (Pharmacy Council of New Zealand, 2011), Australia (Pharmaceutical 
Society of Australia, 2010; the Advanced Pharmacy Practice Framework Steering 
Committee (APPFSC), 2012), Canada (National Association of Pharmacy Regulatory 
Authorities, 2014a), USA (American College of Clinical Pharmacy, 2008b; National 
Community Pharmacists Association et al., 2012), United Kingdom (Royal 
Pharmaceutical Society of Great Britain, 2013b; The Royal Pharmaceutical Society of 
Great Britain, 2014), Singapore (Singapore Pharmacy Council, 2011), Ireland (The 
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Pharmaceutical Society of Ireland, 2013), Thailand (Thai Pharmacy Council, 2002), 
and the Pacific Island countries (Brown et al., 2012a). 
- Ten studies evaluated applicability or usability of a competency framework in 
pharmacy practice (Atkinson et al., 2015; Bruno, 2011; Carrington et al., 2011; 
Costello et al., 2013; Jones et al., 2012; Kennie-Kaulbach et al., 2012; Maitreemit et 
al., 2008; Meadows et al., 2004; Wright and Morgan, 2012; Obiols, 2008). 
- Eight studies evaluated pharmacist performance and identified learning needs 
using a competency framework. These included 7 longitudinal intervention studies 
(Antoniou et al., 2005; Coombes et al., 2010; Goldsmith et al., 2003; Meštrović et al., 
2012; Mills et al., 2008; Rutter et al., 2012; Stojkov Svetlana et al., 2014), and one 
study that evaluated change in performance and self-assessed level of understanding 
after a competency-based training programme (Brown et al., 2015) [Table 2.3].  
- Two articles provided further details on the methodological processes used in 
developing the Advanced Pharmacy Practice Framework [APPF] (Jackson et al., 
2015b), and the Royal Pharmacy Society Advanced Pharmacy Framework [RPS–
APF] (Royal Pharmaceutical Society of Great Britain, 2013b). 
- Two studies evaluated pharmacists' perceptions and preferred method of 
competence assessment (Jackson et al., 2015a; Joint Partners Credentialing Task 
Group (JPCT), 2013).  
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2.1.3 Key findings from the literature   
2.1.3.1 Development of competency frameworks in pharmacy 
Pharmacy practice competencies were mainly identified via initial evaluation of job roles 
[The Royal Pharmaceutical Society of Great Britain, 2014; National Association of Pharmacy 
Regulatory Authorities, 2014a], country-specific needs assessment [The Pharmaceutical 
Society of Ireland, 2013; Brown et al., 2012a], literature review [Thai Pharmacy Council, 
2002; International Pharmaceutical Federation 2010; Pharmaceutical Society of Australia, 
2010; Pharmacy Council of New Zealand, 2011; Singapore Pharmacy Council, 2011; 
National Community Pharmacists Association et al., 2012] and framework mapping via 
content analysis [Advanced Pharmacy Practice Framework Steering Committee (APPFSC), 
2012].  
The identified competencies were further evaluated via expert review with consensus 
obtained either through a nominal group technique [American College of Clinical Pharmacy, 
2008b; National Community Pharmacists Association et al., 2012; The Royal Pharmaceutical 
Society of Great Britain, 2014] or consensus development panel [International 
Pharmaceutical Federation, 2010]. The frameworks were further validated either via 
stakeholders' consultation [The Royal Pharmaceutical Society of Great Britain, 2014; 
National Association of Pharmacy Regulatory Authorities, 2014a; Singapore Pharmacy 
Council, 2011] or profession wide consultation [Thai Pharmacy Council, 2002; 
Pharmaceutical Society of Australia, 2010; International Pharmaceutical Federation, 2010; 
Pharmacy Council of New Zealand, 2011; Singapore Pharmacy Council, 2011; Advanced 
Pharmacy Practice Framework Steering Committee (APPFSC), 2012; Brown et al., 2012a; 
National Community Pharmacists Association et al., 2012]. Profession-wide consultation was 
primarily carried out via online surveys.  
Table 2.2 provides a summary of the global and national pharmacy-related frameworks 
identified in this review including details of their methodological development processes. 
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Table 2.2: Summary of identified competency frameworks in pharmacy and their method of development   
 
Framework (Country) Organisation/ Author (Year) Description Development Process Summary 
The Core Competency 
Framework for 
Pharmacists (Ireland)
The Pharmaceutical Society of 
Ireland (2013)
6 domains {professional practice, personal 
skills, supply of medicines, safe & rational 
use of medicines, public health, and 
organisation & management skills 
domain}, 25 competencies and 160 
behaviours.
Literature review, country-specific 
needs mapped againts the FIP 
Global Competency Framework 
(GbCF v1), expert panel review, 
profession-wide consultation via 
online survey.
Defines competencies essential for early 
career pharmacy practice in Ireland. Used 
to identify knowledge gaps & learning need. 
Used to plan & facilitate CPD. Used to 
develop assessment programmes for 
evaluation of pre-registration pharmacy 
graduates seeking entry into the pharmacy 
register.
Professional 
competencies for 
Canadian Pharmacists 
at Entry to Practice 
(Canada)
The National Association of 
Pharmacy Regulatory 
Authorities (2014a)
9 domains {ethical, legal & professional 
responsibilities, patient care, product 
distribution, practice setting, health 
promotion, knowledge & research 
application, communication & education, 
intra- & inter-professional collaboration, 
quality & safety domain}, 34 competencies 
and 130 behaviours
Practice & job evaluation, 
stakeholder consultation, workshop 
and expert group review.
Defines competencies required for entry to 
pharmacy practice in Canada. Used to 
assess competence at point of licensure. 
Used to identify learning needs & facilitate 
CPD.
The RPS Foundation 
Level Framework 
(United Kingdom)
The Royal Pharmaceutical 
Society of Great Britain (RPS, 
2014)
4 domains {Patient & pharmaceutical care, 
professional practice, personal practice, 
management & organisation domain}, 26 
competencies and 90 behaviours
Job-role evaluation, literature  & 
expert review, stakeholders' 
consultation, and consensus via 
expert group. 
Defines the competencies required for  
foundation level pharmacy practice in 
United Kingdom. Used to facilitate the 
development and training of foundation 
level pharmacy practitioners. Used to 
develop tools for work-based assessment of 
competence.
The National 
Competency Standards 
for Pharmacists in 
Australia (Australia)
The Pharmaceutical Society of 
Australia (2010)
8 domains {professional and ethical 
practice, communication, collaborative and 
self-management, leadership and 
management, review & supply medicines, 
prepare pharmaceutical products, deliver 
primary and preventive health care, 
promote & contribute to optimal use of 
medicines, critical analysis, research & 
evaluation domain}, 33 competencies and 
106 behaviours.
Literature & expert review,  and 
professional-wide consultation.
Defines standard of practice for pharmacists 
in Australia. Used by the Pharmaceutical 
Society of Australia to develop education & 
training programmes for pharmacist. 
Delineates the performance criteria 
expected at initial registration, revalidation 
and restoration of registration. Used by 
credentialing authorities to aid accreditation 
of practice. Used by employers to support 
recruitment and develop assessment tools.
The Advanced 
Pharmacy Practice 
Framework (Australia)
The Advanced Pharmacy 
Practice Framework Steering 
Committee (APPFSC, 2012)
5 domains {promote and contribute to 
optimal use of medicines, communication, 
collaboration & teamwork, leadership & 
management, professional & ethical 
practice, critical analysis, research & 
evaluation domain}, 30 competencies and 
114 behaviours
Mapped against the National 
Competency Standards for 
Pharmacists in Australia and the 
RPS-APF, stakeholder consultation, 
consensus via expert group, and  
profession-wide consultation.
Defines the professional practice profile of 
an advanced pharmacy practitioner in 
Australia. Used to benchmark the specific 
competencies required for advanced 
practice. Used to self-assess competence, 
identify learning needs and facilitate CPD.
Delineates competencies for advanced level 
practitioners in United Kingdom. Used by 
practitioners to self-assess & evaluate 
competence and support portfolio 
development. Used to identify learning 
needs & knowledge gaps and facilitate 
CPD. Used by employers to develop 
assessment tools. Used by the RPS to 
support credentialing processes. 
The RPS Advanced 
Level Framework 
(United Kingdom)
The Royal Pharmaceutical 
Society of Great Britain (RPS, 
2013)
6 domains {expert professional practice, 
collaborative working relationships, 
leadership, management, education, 
training and development, and research & 
evaluation domain}, 34 competencies and 
123 behaviours.
Literature review, expert group 
consultation, consensus via expert 
group, and profession wide 
consultation. 
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Framework (Country) Organisation/ Author (Year) Description Development Process Summary 
Clinical Pharmacist 
Competencies (USA)
American College of Clinical 
Pharmacy (ACCP, 2008) 
5 domains {clinical problem solving, 
judgement & decision making, 
communication & education, medical 
information evaluation & management, 
management of patient population, and 
therapeutic knowledge domain}, 18 
competencies and 100 behaviours.
Mapped against the ACCP 
competency standards, literature & 
expert review, consensus via 
nominal group.  
Delineates core knowledge and skills 
essential for clinical pharmacy practice. 
Used to self-assess practice & define CPD 
needs. Used to develop clinical pharmacy 
assessment tools. 
Entry-level 
Competencies needed 
for Community 
Pharmacy Practice 
(USA)
National Community 
Pharmacists Association 
(NCPA), National Association 
of Chain Drug Stores 
(NACDS), and Accreditation 
Council for Pharmacy 
Education (ACPE, 2012)
7 domains {pharmacist-delivered patient 
care, public health, communication skills, 
dispensing systems management, 
business management, leadership 
abilities, and legal consideration domain}, 
and 35 competencies. 
Literature review, profession-wide 
consultation, expert review and 
consensus.
Defines expectations of practice for 
community pharmacists in USA. Used to 
design training curriculum to prepare 
students for community pharmacy practice. 
Used to evaluate and assess performance 
in community pharmacy.
Standard Criteria for 
Pharmacy Practitioners 
(Thailand) 
Thai Pharmacy Council (2002) 
8 domains {knowledge in pharmaceutical 
manufacturing processes, conduct 
community health problem & drug needs 
assessment, prepare extemporaneous 
pharmaceuticals, conduct a basic health 
evaluation, provide rational drug use, 
follow-up, prevent & resolve drug-related 
problems, provide up-to-date & reliable 
information, and possess knowledge in 
pharmacy-related laws domain}, and 46 
competencies.    
Literature & expert review, and 
profession-wide consultation. 
Delineates competencies required for 
pharmacy practice in Thailand. Used to 
design training curriculum.
Pharmacy Competency 
Framework for the 
Pacific Island Countries 
Brown et al (2012) 
4 domains {organisation & management, 
professional & personal, pharmaceutical 
public health, & pharmaceutical care 
domain}, 23 competencies and 113 
behaviours.
Service- and needs-based 
assessment, literature review, 
expert and stakeholders' 
consultation, face-to-face 
interviews, focus group, and 
profession-wide consultation via 
online survey. 
Delineates competencies required for 
pharmacy service delivery in the Pacific 
Island Countries. Used to support and aid  
training. Used to evaluate staff performance 
and effectiveness.
The Global 
Competency 
Framework version 1 
(Global)
The International 
Pharmaceutical Federation 
(FIP, 2010)
4 domains {pharmaceutical public health, 
pharmaceutical care, organisation & 
management, and personal & professional 
domain}, 20 competencies and 100 
behaviours.  
Literature review, expert panel, 
stakeholders' consultation, 
consensus development panel, 
profession-wide consultation via a 
global online survey.
Delineates core competencies  for global 
foundation level pharmacy practice. Defines 
expectation for practice. Used as a mapping 
tool to develop country-specific frameworks. 
Used to design and develop training 
curriculum
The Competency 
Standards for 
Pharmacists in 
Singapore (entry to 
practice) 
Singapore Pharmacy Council 
(2011)
9 domains {promote optimal use of drugs, 
dispense medicines, compound 
pharmaceutical products, provide drug 
information & education, provide primary 
healthcare, manage drug distribution & 
supply, apply organisational skills in the 
practice of pharmacy, practise in a 
professional  & ethical manner, manage 
work issues & interpersonal relationships 
domain}, 26 competencies and 216 
behaviours.
Literature review, expert panel, and 
stakeholder consultation.
Describes the competencies essential for 
entry to pharmacy practice in Singapore. 
Used by practitioners to identify learning 
gaps and training needs. Used to facilitate 
pre-registration training programmes, 
develop assessment tools and aid 
performance appraisal. Used by employers 
to support recruitment and  conduct 
induction.
Competence Standards 
for the Pharmacy 
Profession (New 
Zealand)
The Pharmacy Council of New 
Zealand (2011)
7 domains {practice pharmacy in a 
professional & culturally competent 
manner, contribute to quality of use of 
medicines, provide primary healthcare, 
apply management and organisational 
skills, research and provide information, 
dispense medicines and prepare 
pharmaceutical produts domain}, 46 
competencies and 151 behaviours.
Literature & expert review, focus 
group and profession-wide 
consultation via online survey. 
Delineates the competency standards for 
pharmacy practice in New Zealand. Used to 
develop training curriculum and define the 
learning outcomes of such programmes. 
Used to self-assess and evaluate 
competence. Used to identify learning 
needs and knowledge gaps, and to facilitate 
CPD.
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2.1.3.2 Applicability and usability of competency frameworks 
Validation of the frameworks was mainly through evaluation of pharmacists' perception of 
applicability to practice of the identified competencies. This was primarily via web-based 
[Bruno, 2011; Atkinson et al., 2015; Jackson et al., 2015], email [Kennie-Kaulbach et al., 
2012], or postal [Maitreemit et al., 2008; Obiols, 2008] surveys. Other authors evaluated 
pharmacists' perceptions via qualitative interviews [Wright and Morgan, 2012]. 
The ranking of the identified competencies was used as a proxy measure of applicability to 
practice [Bruno, 2010; Atkinson et al., 2015; Kennie-Kaulbach et al., 2012; Carrington et al., 
2012; Maitreemit et al., 2008]. The competencies in the specific frameworks were generally 
ranked relevant to practice. However, there were disparities in weighting of relevance with 
some competencies ranked higher than others [Carrington et al., 2011; Kennie-Kaulbach et 
al., 2012; Maitreemit et al., 2001; Atkinson et al., 2015]. For example, pharmaceutical care 
competencies were generally ranked higher in relevance in the frameworks while the 
research-related competencies were ranked lowest (Atkinson et al., 2015; Bruno, 2011; 
Carrington et al., 2012; Kennie-Kaulbach et al., 2012).    
The weighting of relevance also differed in relation to respondents' area of practice [Bruno 
2011; Atkinson et al., 2015; Obiols, 2008; Maitreemit et al., 2008; Wright and Morgan, 
2012], length of practice (Obiols, 2008) and level of competence [for example, students vs. 
pharmacy practitioners (Atkinson et al., 2015); and consultants vs. non-consultants (Obiols, 
2008)].  
Other authors evaluated applicability by assessing usability of the framework in identifying 
learning needs via practitioner's self- [Carrington et al., 2011; Obiols, 2008; Meadows et al., 
2004] or peer assessment [Costello et al., 2013]. Table 2.3 gives a summary of the published 
studies that evaluated applicability and usability of a specific competency framework in 
pharmacy. 
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Table 2.3: Validation of competency frameworks in pharmacy 
 
Author (Country) Method Summary 
Atkinson et al., 2015 
(Europe)
Modified Delphi 
technique via an online 
survey
Evaluated practitioners' and students' perceptions of the 68 competencies in the Quality Assurance in 
European Pharmacy Education and Training (PHAR-QA) framework. Respondents (n=1245) used a 
4-point Likert scale to rate the relevance to practice of the identified competencies. 70% of the 
identified competencies were ranked essential to practice. However the weighting of relevance varied 
with some competencies ranked higher than others. For example, pharmaceutical care competencies 
were ranked highest while the competencies related to research and production of medicine received 
the least ranking. The weighting of relevance also differed with respect to area of practice and cadre. 
For example, community practitioners ranked 22 competencies higher in relevance than industrial 
pharmacist while licensed practitioners generally ranked the competencies higher than the student 
respondents. 
Kennie-Kaulbach et 
al., 2012 (Canada)
Modified Delphi 
technique via an online 
survey 
Evaluated applicability of the 34 competencies identified for primary care pharmacy practice in 
Canada. Respondents (n=21) ranked the competenices using a 6-point Likert scale. Final results 
showed all the competencies were essential for practice. However, the weighting of relevance 
differed with the pharmaceutical care competencies ranked higher in relevance than the research- 
and education-related competencies which were ranked least.
Bruno, 2011(Global) 
Web-based online 
survey
Evaluated pharmacists' perception of the 100 behaviours and 20 competencies contained in the FIP 
Global Competency Framework (GbCF v1). Respondents (n=470) from 64 countries ranked the 
GbCF v1 competencies on a 4-point Likert scale. Final results showed respondents ranked 90% of 
the GbCF v1 behaviours as essential for practice. The weighting of relevance differed with respect to 
area of practice. The pharmaceutical care competencies were ranked least relevant by industrial and 
academic pharmacy respondents.  
Carrington et al., 2012 
(Australia)
Email survey
Practitioners (n=35) mapped their practice against the competency framework developed for cancer 
services in Australia. Study participants self-assessed their practice and ranked the competencies 
according to relevance to practice. Respondents indicated the competencies were essential to 
practice but suggested the competencies represented 'ideal' requirements that may not always be 
demonstrated in practice, particularly in view of time constrains and work load due. 
Jones et al., 2012 
(United Kingdom)
Email survey 
Pharmacy educational and practice supervisors self-assessed their practice using the Competency 
Framework for Pharmacy Educational and Practice Surpervisors in United Kingdom. Final results 
indicated the participants (n=10) were able to map their practice against the competencies in the 
framework. Participants however expressed difficulties with understanding some of the terminologies 
used in the framework. They also reported the framework was lengthy and time consuming to 
complete. 
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Author (Country) Method Summary 
Maitreemit et al., 2008 
(Thailand)
Postal survey 
Evaluated pharmacists' perceptions of the competencies in the Standard Criteria for Pharmacy 
Practitioners in Thailand framework.The competency standard contained 7 domains and 46 
competencies. Study participants used a 5-point Likert scale to rank relevance to practice. Final 
results showed all the identified competencies were relevant to practice but with specific inter-
practice differences in weighting of relevance. For example, community pharmacists ranked the 
management skills competencies higher in relevance than hospital pharmacists while industrial 
pharmacists ranked the pharmaceutical care competencies lower in relevance than hospital and 
community practitioners.  
Meadows et al., 2004 
(United Kingdom)
Email survey to develop 
consensus via an expert 
panel 
Practitioners (n=28) evaluated usability of the Advance to Consultant Level Framework (AcLF, now 
renamed the RPS-APF) via self-assessment of practice. The framework contained 6 clusters and 
34 competencies. At the end of the study, all the practitioners were able to map their practice 
against the competencies in the framework. Practitioners however ranked their practice 
comparatively higher for two of the six clusters. These were the 'expert practice' and 'building 
working relationships' clusters.  
Obiols, 2008 (United 
Kingdom) 
Postal survey 
Evaluated the applicability of the AcLF competencies to pharmacy practice. The study also aimed 
to define the practice profile of consultant pharmacists using the framework. Advanced 
pharmacists in United Kingdom (n=390) self-assessed their practice using the framework. Final 
results showed the participants were able to map their practice against the framework. The results 
also aided the identification of the practice profile of consultant and non-consultant level 
practitioners and provided information on the types of evidence needed to support assessment. 
Qualitative interviews (n=12) indicated practitioners generally found the framework to be 
applicable to their practice. Practitioners also indicated that the framework clarified expectations of 
practice and aided identification of knowledge gaps and learning needs. Praticipants however 
reported they found the framework lengthy and time consuming to complete.
Wright and Morgan,  
2012 (United 
Kingdom)
Qualitative interviews 
Evaluated pharmacists perceptions of the AcLF competencies. Participants (n=136) generally 
found the framework useful for practice and reported that the AcLF provided a structure for 
practice advancement. They however expressed scepticism with regards to the feasibility of 
demonstrating all the competenices within the limits of the practice environment. 
Costello et al., 2013 
(Australia) 
Thematic analysis 
approach
A retrospective and comparative evaluation of learning needs identified via a competency 
framework and its correlation with the objectives of an employer-led up-skilling workshop. The 
objectives of the up-skilling workshop were designed based on the results of a prior peer-
evaluation involving 30 early career practitioners. The researchers reviewed 220 peer evaluations 
that identified learning needs and made CPD recommendations with the aid of a modified General 
Level Framework (now renamed the RPS Foundation Level Pharmacy Framework). These 
evaluations were compared with the objectives of the up-skilling training workshop. The results 
showed the identified learning needs correlated with the learning objectives of the workshop. It 
also showed the GLF was useful for identifying learnig needs and designing training workshop 
learning objectives. 
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2.1.3.3 Effectiveness of competency frameworks  
Seven longitudinal studies included in this review demonstrate significant improvement in 
pharmacists' performance when competency frameworks are used to evaluate performance, 
identify knowledge gaps and tailor learning activities. Observable and significant 
improvement from baseline performance occurred after three months (Goldsmith et al., 
2001), six months (Svetlana et al., 2014; Antoniou et al., 2005; Coombes et al., 2010), nine 
months (Rutter et al., 2012), or twelve months (Mills et al., 2008; Meštrović et al., 2012) with 
the use of the respective frameworks.  
Three of the studies were comparative studies (Antoniou et al., 2005; Mills et al., 2008; 
Goldsmith et al; 2001) and the results showed rapid and sustained improvement in 
pharmacists' performance with the use of a competency framework. The study by Goldsmith 
et al (2001) showed there was no observable improvement in performance in the control 
group that partook in an employer-led training programme not involving the use of a 
framework. The studies by Antoniou et al (2005) and Mills et al (2008) showed improvement 
in performance for both the intervention and control group, although this was more 
significant and sustained in the intervention group with a statistically significant difference 
observed between the groups (p < 0.001). 
A study by Brown and colleagues (2015) also demonstrated improvement in performance 
after a four-day competency-based training workshop as well as a positive change in 
perception and participants' self-assessed understanding of the essential competencies 
required for effective practice.  
Taken together, the seven studies provide evidence that competency frameworks aid 
improvement in pharmacy performance, support the identification of knowledge gaps and 
learning needs, and also facilitate CPD. 
Table 2.4 gives details of the design and findings of the seven studies. 
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Table 2.4: Effectiveness of competency frameworks in pharmacy 
 
Author (Country) Study design Main Findings Study Conclusion
Antoniou et al., 2005 
(United Kingdom)
Multicentred randomised control study in the United 
Kingdom with an intervention (n=74) and control (n=30) 
arm. Study participants were early career pharmacists 
and the intervention involved the use of the RPS 
Foundation Level Framework (FLF) to aid practice 
development. The FLF was initially used to define 
expected competency level and training needs. It was 
also used to evaluate baseline performance. 
Subsequent performance assessment using a 4-point 
Likert scale was conducted at 3, 6 and 12 months. The 
control group had no access to the FLF.
At 6 months, pharmacists in the intervention group 
showed improvement in performance for 24 (96%) of 
the competencies while the control group showed 
improvement in 7(28%) of the competencies.This 
performance  improvement  was sustained at 12 
months for the intervention group in contrast to the 
control group which showed overall  improvement in 
12 (48% ) of the competencies. At the end of the 
study, there was a significant difference in 
competency attainment between the two groups at 3, 
6, and 12 months (log rank = 7.97, p=0.0048).
The framework aided the identification of 
learning needs with a significant 
improvement in pharmacists' performance 
observed after 6 months. This improvement 
was sustained until the end of the12 months 
study period. The likelihood of competence 
attainment was higher with the framework 
compared to usual training. 
Coombes et al., 2010 
(Australia)
Observational study which involved using a modified 
FLF to assess performance and identify learning needs 
for 66  pharmacists in Australia. The FLF was adapted to 
the health needs in Australia via an expert group review. 
A 7-point Likert scale was used to assess and rate the 
frequency at which each of the competencies in the FLF 
was demonstrated with tailored feedback provided at 
baseline. A repeat assessment was then conducted at a 
later date (t=5 - 22months after initial assessment) and 
the mean competency score compared with baseline.
Final study results showed there was a significant 
improvement in pharmacists' performance for 57% of 
the competencies (P≤ 0.05) in the framework.
Use of FLF aids the identification of learning 
needs and supports performance 
improvement.
Meštrović et al., 2012 
(Croatia)
Longitudinal prospective cohort study involving 100 
community pharmacists in Croatia. Used a modified FLF 
adapted to the needs of Croatia via an expert panel 
review. The modified FLF was then used to tailor 
educational programmes for the development of 
competence in patient care. Subsequent overt 
observation of performance was then conducted at 12 
months and compared to baseline using a 4-point Likert 
scale to rate frequency at which each patient care 
competency was demonstrated.
Study participants demonstrated improvement in all of 
the 26 behaviours assessed for the patient care 
competency cluster with significant difference found 
between the mean behaviour scores at baseline and 
at 12 months (p< 0.0001).  
Competency framework aid identification of 
learning needs, and supports the design 
and development of individualised training 
activities. It also facilitates improvement of 
pharmacists' performance.
Rutter et al., 2012 
(Singapore)
Observation study of pharmacists in Singapore (n=35) 
using a modified FLF to assess and evaluate 
competence at two time points over 9 months. The FLF 
wa adapted to the health needs of Singapore via an 
expert group review. After initial assessment, feedback 
on training needs was given by the assessor with an 
individual learning plan formulated for each participant. A 
second assessment was then conducted at 9 months 
using a 7-point Likert scale to assess the rate at which 
each competency was demonstrated according to 
standard.
Improvement in mean competency cluster score was 
observed for all three competency cluster of the FLF 
with significant improvement in 55 (87%) of the 63 
behaviours assessed (p < 0.05). 
Use of a modified FLF facilitates 
performance improvement in pharmacists.
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Author (Country) Study design Main Findings Study Conclusion
Mills et al., 2008 (United 
Kingdom)
Two arm study having both an intervention and control group. 
Study participants were community and primary care 
pharmacists. The intervention (n=69) involved the use of the 
FLF to self-assess practice level at baseline, identify individual 
learning needs, and aid practice development over a 12 month 
period. The FLF was adapted to the needs to country needs 
via an expert group. Participants in the control group (n=31) did 
not use the FLF and they undertook the standard training 
provided by their employers.
Significant increase in the self-assessed 
competency scores was observed at 12 months 
for 14 (58%) competencies in the intervention 
group. Pharmacists in the intervention group 
demonstrated a more rapid improvement in 
performance compared to the non-intervention 
group (p<0.001).
The FLF supports the identification of 
learning needs and promotes more 
rapid improvement in performance 
compared to usual training without a 
framework.
Svetlana et al., 2014 (Serbia)
An observation study involving 32 community pharmacists in 
Serbia. Performance was assessed at two time points using a 
modified FLF.  A 4-point Likert scale was used to assess and 
rate the frequency at which each of the competencies in the 
FLF was demonstrated with tailored feedback provided at 
baseline.  A second assessment was then conducted after 6 
months with the two results compared.
 A significant increase in mean competencey 
score from baseline was observed for  23 (88%) 
competencies  at the end of the study (p < 0.05).
The modified FLFsupports structured 
performance evaluation via a check list 
of the competencies and also aids 
performance improvement.
Goldsmith et al., 2001 (United 
Kingdom)
An observational study of pharmacists' performance involving 
two arms: an intervention and control group. Study participants 
were hospital pharmacists in eight active and one control site. 
The intervention (n=24) involved the use of the FLF to assess 
performance using a 4-point Likert scale with feedback 
provided at baseline. A second assesment was conducted after 
12 weeks. Participants in the control group (n=4) underwent 
standard training provided by employers with performance 
assessed at baseline and after 12 weeks. Qualitative interview 
of the study assessors (n=20) was also conducted  to 
determine usability and ease of use of the framework.
The intervention group showed significant 
improvement in performance for 23 (96%) 
competencies in the FLF after 12 weeks 
(Wilcoxon, P =0.047 to P<0.0001).  There was no 
improvement observed in the control group. 
Interviews with the tutors indicated the framework 
had 'brought up participants practice quicker', 
meaning the framework facilitated significant 
improvement within a shorter time span than 
usual training. 
The FLF aids identification of learning 
needs and promotes more rapid 
improvement in performance compared 
to usual practice.
Brown et al., 2015 (Pacific 
Island Countries)
An observational study of performance and perceived level of 
competence. Study participants were primary care health 
professionals including pharmacists, nurses, and other allied 
health personnels (n=59). The study subjects participated in 15 
skills-based learning workshops over four days. The workshop 
involved a number of learning activities including group 
discussions, role plays and six skills-based work stations. The 
activities were designed to facilitate learning of medicine 
supply competencies selected from the Essential Medicine 
Supply Management (EMSM) Competency Framework. 
Performance on the work stations were assessed before and 
after each skills-based training by an assessor using a 5-point 
Likert scale. The study participants also self-assessed their 
perception of the EMSM competencies before and after the 
workshop. 
Improvement in perfromance was observed at the 
end of each learning activity as shown by an 
increase in mean competency score for the six 
skills-based stations [t= 3.921 to 5.258; 
p<0.0001). There was also a positive change in 
perception about the EMSM competencies with 
participants indicating that the training aided and 
improved their understanding of the requirement 
for practice.
Competency framework support the 
design and development of learning 
activities that in turn aid improvement in 
performance.   
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2.1.3.4 The assessment of competence 
The studies included in this review mainly assessed competence by evaluating performance 
through peer-assessment. This involved direct observation of procedural skills for specific 
competency-based tasks (Antoniou et al., 2005; Coombes et al., 2010; Goldsmith et al., 2003; 
Meštrović et al., 2012; Mills et al., 2008; Rutter et al., 2012; Svetlana et al., 2014). Other 
studies involved the use of a competency framework to self-assess practice (Carrington et al., 
2011; Jones et al., 2012; Kennie-Kaulbach et al., 2012; Meadows et al., 2004; Obiols, 2008) 
or evaluate understanding and confidence in carrying out the specified task (Brown et al., 
2015).  
 
The studies showed that pharmacists generally rated their practice higher in pharmaceutical 
care-related competencies than research-related competencies (Kennie-Kaulbach et al., 2012, 
and Carrington et al., 2011). The study by Obiols (2008) showed that some of the 
pharmacists underestimated their competence particularly in the expert professional practice 
and leadership domains. Also, some of the pharmacists in these studies were skeptical about 
the feasibility of demonstrating the identified competencies within the limit of the practice 
environment (Carrington et al., 2011, Obiols, 2008, Wright and Morgan, 2012). 
 
Two other studies evaluated pharmacists' perceptions and preferred method of competence 
assessment (Jackson et al., 2015a; Joint Partners Credentialing Task Group (JPCT), 2013). 
The results indicate a high preference for self-assessment, peer-review of a practice protfolio, 
and workplace peer-assessment with multisource feedback. Objective Structured Clinical 
Examination (OSCEs) and multichoice question examinations were the least preferred 
assesment methods identified by these surveys.   
 
2.1.4 Discussion  
The systematic literature review included one global and 12 national competency frameworks 
that contained generic pharmacy practice competencies (Table 2.2). The national frameworks 
were from 9 countries and were mainly identified via manual search of FIP member 
organisation websites. The website search was directed by the results of a 2012 and 2014 
survey of FIP member organisations by FIPEd which showed that 31 countries have either 
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developed and implemented or were in the process of developing a national competency 
framework for pharmacy practice (International Pharmaceutical Federation, 2014).  
 
The FIP membership list was consulted to retrieve the web addresses of the representative 
member organisation in these countries. Consequently, 35 organisation website which were 
in English language were then visited and searched. The manual website and systematic 
literature search yielded nine national frameworks that delineated the competencies required 
for foundation level pharmacy practice, and three frameworks containing advanced level 
competencies. The search also yielded the FIP Global Competency Framework for 
foundation level pharmacy practice (GbCF v1). 
 
Specialty- or role-specific frameworks were also retrieved from the manual and systematic 
literature search. These frameworks were however not included in the review since they were 
developed with the aid of some of the identified national frameworks and also contained non-
generic competencies that were only applicable to a defined role or specialty. Examples of 
such frameworks were the Leadership Competency Framework for Pharmacy Professionals 
in the United Kingdom (Royal Pharmaceutical Society of Great Britain, 2010); the Standards 
and Guidance for Pharmacy Prescribers in Northern Ireland (The Pharmaceutical Society of 
Northern Ireland, 2013) and the Framework for Pharmacists-assisted Medication Review in 
the USA (Wiener et al., 2015).  
 
However, two competency frameworks from USA— the American College of Clinical 
Pharmacists (ACCP) Clinical Pharmacy Competencies (American College of Clinical 
Pharmacy, 2008b) and the Entry-level Competencies needed for Community Pharmacy 
Practice (National Community Pharmacists Association et al., 2012)— that contained 
specific competencies for clinical and community pharmacy practice, respectively, were 
included. This was because the ACCP framework contained competencies applicable to 
advanced pharmacy roles in different specialties including oncology, critical care, nutritional 
support pharmacy and other pharmacotherapy areas. The Entry-level Competencies for 
Community Practice in the USA framework was included because it contained competencies 
that contributed to undergraduate pharmacy learning curriculum in the USA.  
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Specialty-specific competency frameworks that reported developmental and validation 
methods were also included in the review. These included the frameworks for oncology 
pharmacy in Australia (Carrington et al., 2012), a framework for primary care pharmacy in 
Canada (Kennie-Kaulbach et al., 2012), and the Pharmacy Educational and Practice 
Supervisors Framework in the United Kingdom (Jones et al., 2012).  
 
Evidence from the literature included in this review indicates that competency frameworks in 
pharmacy are mainly developed and validated via similar evidence-based methodologies. 
Frameworks were developed via a combination of literature and expert review, stakeholder 
consultations, consensus development via a nominal group or modified Delphi technique, and 
profession-wide consultation via surveys or qualitative interviews.  
In general, the literature review conducted to identify competencies also involved framework 
mapping via content analysis of other country-specific frameworks. For example: 
- The RPS Foundation Level Framework (formerly called the General Level 
framework) was one of the mapping tools used to aid the development of the 
Competency Standards for Pharmacists in Singapore (Singapore Pharmacy Council, 
2011). It was also used as a source document to develop country-specific frameworks 
applicable for early career pharmacy practice in Croatia (Meštrović et al., 2012), 
Serbia (Svetlana et al., 2014), Australia (Coombes et al., 2010), and Singapore (Rutter 
et al., 2012).  
- The RPS Advanced Pharmacy Framework [formerly called the Advanced to 
Consultant Level Framework (AcLF) and the Advanced Pharmacy Practice 
Framework in Australia were developed from similar bibliographic sources (Jackson 
et al., 2015b; The Advanced Pharmacy Practice Framework Steering Committee 
(APPFSC), 2012). The RPS Advanced Pharmacy Framework was also used a source 
document to develop the Framework for Cancer Services in Australia (Carrington et 
al., 2012). 
-  The FIP Global Competency Framework (GbCF v1) was used as a mapping 
tool to aid the development of the Pharmacy Competency Framework for the Pacific 
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Island Countries (Brown et al., 2012), and the Core Competency Framework for 
Pharmacists in Ireland (The Pharmaceutical Society of Ireland, 2013).    
This indicates the existence of a common set of competencies that are applicable for 
pharmacy practice in different countries. It corroborates similar evidence from the study by 
Bruno (2011) that demonstrates the relevance of the FIP GbCF v1 competencies to 
foundation level pharmacy practice in 64 countries. 
Framework validation mainly involved self-assessment of practice, peer-evaluation of 
performance using a competency framework, or surveys of pharmacists' perception of the 
identified competencies (Table 2.2 & 2.3). The outcome of the validation studies indicate that 
while pharmacy practitioner generally perceived the identified competencies to be relevant to 
practice; the weighting of relevance of these competencies differed with respect to area of 
practice (Atkinson et al., 2015; Bruno, 2011: Maitreemet el al., 2008; Kennie-Kaulbach et al., 
2012), level of competence and length of practice (Atkinson et al., 2015; Obiols, 2008; and 
Meadows et al., 2004). For example, three studies demonstrate that pharmacists generally 
perceived research-related competencies to be of low relevance to practice (Kennie-Kaulbach 
et al., 2012; Carrington et al., 2012; Atkinson et al., 2015).  
The relevance ranking of research-related competencies also differed with respect to area of 
practice (Bruno, 2011), level of competence and length of practice (Obiols, 2008). The study 
by Bruno (2011) showed that both patient-facing and non-patient facing sectors including 
hospital, industrial and academic pharmacy practice areas perceived the research-related 
competencies as not relevant to practice. Qualitative interviews showed that pharmacists 
identified time constrains and workload as barriers to participating (Kennie-Kaulbach et al., 
2012) and demonstrating research-related competencies in daily practice (Jones et al., 2012; 
Wright and Morgan, 2012; Carrington et al., 2012) 
Evidence from some of the studies included in this review show that competency frameworks 
facilitate rapid performance improvement of pharmacy professionals compared to training 
undertaken without a framework (Goldsmith et al., 2001; Antoniou et al., 2005; Mills et al., 
2008). The studies also show that when frameworks are used to clarify the expectations of 
practice, it aids identification of learning needs (Costello et al., 2013) and in so doing, 
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supports competence development (Coombes et al., 2010; Meštrović et al., 2012; Rutter et 
al., 2012; Svetlana et al., 2014).   
 
The study by Brown and colleagues (2015) demonstrated improvement in performance when 
a competency framework was used to tailor a training programme for healthcare 
professionals including pharmacists. It also showed a positive change in perception with an 
improvement in practitioner understanding and confidence in ability to demonstrate the 
essential competencies in daily practice. This corroborates evidence from Obiols (2008) and 
Wright and Morgan (2012) that show that competency frameworks facilitate CPD and 
provide a structure for professional and practice development. 
 
2.1.5  Limitations  
Study design was a key limitation of most of the studies included in this review. Only three 
studies were randomised control trials involving an intervention and control group 
(Goldsmith et al., 2001; Antoniou et al., 2005; Mills et al., 2008).  This makes it difficult to 
determine if the improvement in performance observed in the other studies were purely due 
to the frameworks and not due to 'time-effects' on performance. Also, the number of 
participants in the control group in the study by Goldsmith and colleagues (2001) was very 
low (n=4) and likely influenced the inability to observe any measurable change in 
performance. This feature hampers the generalisability of the findings of this study.  
 
External validity was also limited by the low response rate observed in some of the included 
studies. These studies mainly had sample size ranging from 10 to 35 participants, potentially 
limiting the generalisability of the study findings to the wider population (Jones et al., 2012; 
Goldsmith et al., 2001; Rutter et al., 2012; Carrington et al., 2012; Kennie-Kaulbach et al., 
2012).  
 
The convenience sampling approach used in most of the studies in this review (Meadows et 
al., 2004; Kennie-Kaulbach et al., 2012; Carrington et al., 2012; Jones et al., 2012) also 
hampers generalisability of the findings, particularly because the views of the study 
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participants may not be representative of the target population. Also, there were 
inconsistencies in performance assessment in the study by Coombes et al., (2010) given that 
the time frame for the second assessment was not the same for all the participants in the 
study. Some participants were assessed after five months while some were assessed after 
twenty-two months. This feature affects the reliability of the final result and overall 
conclusions of the study.  
 
In general, the eight studies that evaluated the effectiveness of competency frameworks all 
used the General Level Framework (GLF) [renamed the RPS Foundation Level Framework] 
or a modified GLF to evaluate pharmacists' performance (Coombes et al., 2010; Rutter et al., 
2012; Meštrović et al., 2012; Mills et al., 2008; Antoniou et al., 2005). This makes it difficult 
to conclude that other competency frameworks will aid similar improvement in performance.   
 
2.1.6 Conclusion 
Dissatisfaction with the outcomes of knowledge-based education training models in the 
health professions has been one of the drivers for promoting competency-based education 
and training (Albanese et al., 2007; Frank et al., 2010; Gruppen et al., 2012). However, 
accurate assessment of competence depends on the use of an appropriate performance 
standard or criteria. It is therefore imperative that the standard against which individual 
performance is to be judged is defined.  
 
In spite of the limitations in some of the studies included this review; the overall finding from 
the review suggest that competency frameworks aid the identification of learning gaps, 
supports practitioner development and may provide an avenue for defining standards and 
expectations of practice. Evidence from the literature included in this review demonstrates 
the applicability and usefulness of competency frameworks in defining performance 
indicators and tailoring assessment strategies for both formative and summative competence 
assessment.  
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2.2 Research Questions  
FIP Education Initiative (FIPEd) aims to provide evidence-based development solutions that 
support performance and quality improvement of the global pharmacy workforce 
(International Pharmaceutical Federation, 2010). In line with this goal, one of the strategies 
advocated by FIPEd is the need to define and articulate the competencies that pharmacists 
require to consistently perform in a safe, effective and efficient manner. The aim is to provide 
a tool that delineates the expectations of practice for the global pharmacy workforce (Bruno 
et al., 2010).  
Evidence from the studies included in the systematic literature review conducted for this 
research and reported in this thesis show that competency frameworks aid performance 
improvement and support practice development. In line with evidence, FIPEd in 2010 
developed a global competency framework (GbCF v1) that provides guidance on the 
practice-based expectation of the global pharmacy workforce. The framework was developed 
specifically for the early career practitioners (International Pharmaceutical Federation, 2010). 
An ongoing online survey of pharmacists' perception of the competencies and behaviours in 
the framework demonstrates the relevance of the GbCF v1 competencies for practice in 64 
countries. Data from resource-limited settings like countries in Africa were however lacking 
from this online survey and further research on validity of the framework in this region is 
therefore necessary. Also, the validation of the framework in these 64 countries demonstrates 
the feasibility of defining the pharmacy practice competencies that are globally applicable. 
Further work is therefore necessary to define the competencies that are applicable for the 
global advanced pharmacy workforce.   
 The following questions were developed for this research:   
I. Are the competencies and behaviours in the FIP Global Competency Framework 
(GbCF v1) relevant to pharmacy practice in countries in Africa? 
II. Are there core competencies for advanced pharmacy practice?  
a) Would such competencies be applicable to advanced practitioners from 
different countries? 
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b) Can a global competency framework for advanced pharmacy practice be 
developed from these competencies? 
2.3 Aims and Objectives 
The aim of the first study is to evaluate pharmacists' perception of relevance to practice of the 
competencies contained in the FIP Global Competency Framework (GbCF v1), focusing 
specifically on countries in Africa.  
The objectives are: 
 To identify the competencies in the GbCF v1 that are relevant for pharmacy practice 
in fourteen countries in Africa. 
 To delineate these identified competencies by area of pharmacy practice.  
The fourteen countries included in this research were selected based on availability of contact 
persons and willingness to participate of the respective national leadership organisations in 
the countries.  
The aim of the second study is to identify and evaluate the competencies that are relevant for 
global advanced pharmacy practice. 
 The objectives are to: 
 To identify the competencies required for advanced pharmacy practice as defined 
by different countries around the world; 
 To examine and review these competencies and identify the core advanced 
practice competencies therein;  
 To determine the relevance of these competencies to advanced practitioners in 
different countries.
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Figure 2.1: Research Framework  
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2.4 Ethical consideration 
Formal ethical approval from the research ethics committee was not required for this research 
given that none of the two studies conducted involved the use of identifiable patient 
information or data (guideline available at http://ethics.grad.ucl.ac.uk/exemptions.php). The 
two studies rather recruited pharmacists and sought their views by virtue of their professional 
roles.  
However, good research practice was adhered to at all times. An anonymised online 
questionnaire was used in the first study (chapter 3; Appendix 5) and informed consent was 
sought from each of the participants prior to enrollment in the crossover experiment 
conducted in the second study (Chapter 4; Appendix 7). Study participants were provided 
with advance information on the requirement of the online survey via an invite (Appendix 1), 
one-page flyer (Appendix 2) and cover letter (Appendix 5). In the second study, participants 
were informed of the structure and content of the expert panel (Appendix 14), crossover 
experiment (Appendix 6) and interview (Appendix 10) prior to participation. 
Participation was voluntary and confidentiality maintained at all times with comments 
remaining anonymous. All data collected in the research were stored in an encrypted database 
with hard copies kept in locked filling cabinets at the Department of Practice & Policy, UCL 
School of Pharmacy, United Kingdom. Access to study data was restricted to the three 
researchers directly involved with the study. 
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3.1 Study Rationale  
The central role pharmacists' play within the health system underpins the necessity for a 
competent and highly skilled workforce that is equipped with the requisite knowledge and 
skills relevant to population health needs. This is of particular importance in resource-limited 
settings like sub-Sahara Africa where severe workforce shortages hamper access to health 
services. 
Competencies refer to the knowledge, skills and behaviours that professionals need in order 
to practice to acceptable standards. Studies show that when competency frameworks are used 
alongside standards of practice, it facilitates improvement of pharmacists' performance 
(Antoniou et al., 2005; Coombes et al., 2010; Rutter et al., 2012; Svetlana et al., 2014), 
promotes the attainment and maintenance of fitness to practise (Meštrović et al., 2012; 
Svetlana et al., 2014), aids identification of knowledge gaps and learning needs (Meštrović et 
al., 2011), and fosters continuing professional development (Brown et al., 2015; Mills et al., 
2008). Consequently, the use of competency frameworks to benchmark standards of practice 
and support practitioner development has become a feature of professional practice in 
pharmacy, and in the health professions globally.  
In 2010, the International Pharmaceutical Federation Education Initiative (FIPEd) developed 
a global competency framework (GbCF v1) for foundation level pharmacy practice 
(International Pharmaceutical Federation, 2010). This framework was designed to provide 
guidance on the practice-based expectation of the global pharmacy workforce. It was 
developed specifically for early career practitioners (Bruno et al., 2010).  
Evidence from an ongoing online survey that commenced in 2010 and generated 470 replies, 
has demonstrated the relevance of the GbCF v1 competencies and behaviours to pharmacy 
practice in 64 countries (Bruno, 2011). However, respondents from countries in Africa 
comprised only 12.3% of the sample in the survey. This present study was designed to 
determine the relevance to practice of the competencies and behaviours contained in the 
GbCF v1, focusing on countries in Africa. The overall goal is to evaluate the GbCF v1 in an 
Chapter 3 EVALUATING FOUNDATION LEVEL PHARMACY 
PRACTICE COMPETENCIES IN AN AFRICAN CONTEXT 
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African context and assess its validity for use as a tool for developing country-specific 
frameworks in the region.  
The following section will give details of the specific research methodologies used in this 
study including the sampling, data collection, data analysis methods and the study findings. 
Discussion of the study findings is also presented in this chapter while the implication for 
practice and overall conclusions of this research are provided in Chapter 5. 
3.2 Methodology  
An online cross-sectional survey of pharmacists practising in countries in Africa was used in 
this research. The suitability and rationale for the choice of this survey method include: 
 Its comparatively lower cost compared to postal and interview surveys  
 The possibility of obtaining relatively faster responses compared to postal surveys  
 The possibility of obtaining replies from target population irrespective of 
geographical location compared to postal survey  
 Ease of data handling, especially since the data generated from online surveys are less 
cumbersome to handle and analyse given that the questionnaire replies are 
automatically coded and uploaded directly on to the research database 
 The possibility of using pop-up question prompts in online surveys that ensure that 
questionnaires are less likely to be filled incompletely.  
3.2.1 Sampling  
A convenience and snowball sampling method was used in the study. Assistance with the 
project was sought and obtained from the media team of the International Pharmaceutical 
Federation (FIP). The media team assisted by disseminated the survey invite centrally via 
email to the FIP member organisations in Africa. These organisations were the twenty-four 
out of the 35 umbrella bodies representing pharmacists from twenty-three African countries 
(appendix 3). The organisations that indicated willingness to participate and gather data were 
included in the study. 
Contact persons within each of the selected organisations were specifically requested to assist 
with the project by distributing the survey invite to their members. The invite was also 
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forwarded to individual FIP members from countries in Africa. Initial mailing of the invite 
was carried out on 21 November 2012. Email reminders were thereafter forwarded monthly 
until the end of the study on 20 December 2014. 
The survey invite was also disseminated through the FIP United Nations Education Scientific 
and Cultural Organisation (UNESCO) University Twining Network (FIP/UNITWIN) in 
Africa. Invitation to assist with the project was extended to the FIP/UNITWIN country-level 
contact persons during the FIP-Country Case Studies Mini Summit that held in Ghana 
between 2nd and 3rd of March 2013. Contact persons representing five African countries 
(Namibia, Nigeria, Ghana, Uganda and Zambia) present at this summit consented to assist 
with the project in their respective countries.  
The survey invitation was forwarded via email to these contact persons on the 11th of March 
2013 for onward distribution through their respective membership mailing lists. Confirmation 
of email distribution was received and a monthly reminder email was thereafter forwarded 
through the same means until the end of the data collection period. 
Social media was also used in this study. Online groups and forums of pharmacists from 
Nigeria, Uganda, Kenya and South Africa were identified on Facebook®. The administrators 
listed for these groups were sent a direct message and invited to assist with the project. Reply 
and consent to assist was received from twelve group administrators (list provided in 
appendix 4). The survey link was then sent as a private message to these administrators for 
onward dissemination to group members via their respective Facebook® group timeline.  
The survey invite containing the URL was further customised and disseminated via Twitter® 
and Blackberry Messenger® (BBM). Users of these two platforms who were pharmacists 
were purposively selected via the FIP followers' list. These individuals were contacted 
directly via the direct messaging service of Twitter® and BBM. They were also invited to 
assist with the survey by 're-tweeting' the URL on Twitter, and/or 'broadcasting' the survey 
invite via BBM. Also, survey respondents were encouraged to assist with the project by 
forwarding the email invite containing the URL to their colleagues and contacts. Onward 
dissemination of the survey invite via all the aforementioned media created a chain/snow ball 
sampling method. 
  
 
 
106
3.2.2 Sampling frame and sample size 
A sampling frame was not possible for this study. This was because of a lack of access to 
country-level membership list due to confidentiality and data protection laws of the United 
Kingdom. Also, although the FIP-RPS Global Pharmacy Workforce Observatory that was 
launched in 2013 provides data on the number of registered pharmacists for most countries 
around the world, this information was not available for many African countries at the time 
this study was designed in 2012 (International Pharmaceutical Federation (FIP), 2015; The 
Royal Pharmaceutical Society of Great Britain and International Pharmaceutical Federation, 
2013). As a result, it was not possible to precisely and accurately estimate an optimal sample 
size a priori. Therefore, a non-probabilitic sample obtained via a convenience and snowball 
sampling technique was used. 
3.2.3 Survey questionnaire  
An online questionnaire (appendix 5) developed and validated in a previous study by Bruno 
(2011) was used in this research. The questionnaire, which was wholly reproduced from the 
GbCF v1 and available at http://www.codegnet.org.uk/gbcf/, comprised six pages and 
contained 105 questions. The first page was a cover letter that provided an overview of the 
study, including guidance on completing and submitting the questionnaire. The second page 
contained five demography-related questions that collected data on country of residence, 
length of practice, gender and area of pharmacy practice. Each of the four clusters in the 
GbCF v1 had its corresponding competencies and behavioural statements presented on one 
page. This means the four clusters in the framework were presented on four pages. 
 
Respondents were required to rank their agreement with the 100 GbCF v1 behavioural 
statements (hereafter referred to as 'behaviours') using a four point Likert scale. This means 
respondents were required to indicate whether each of the behaviours was ‘highly relevant’, 
‘relevant’, of ‘low relevance’ or ‘not relevance’ to their practice. A separate editable text box 
for comments was provided at the end of each cluster.  
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3.2.4 Response rate  
The choice of an appropriate survey method suitable to the survey sample determines the 
response rate achieved (de Vaus, 2002). Response rate is calculated as a percentage of the 
total eligible study population who successfully complete the survey.  
 
The formula for calculating response rates is given as: 
                                                        Number returned                         
           
                                          N in Sample – (ineligible + unreachable) 
 
However, it was not possible to calculate the response rate in this study for a number of 
reasons: 
- Information on the total number of pharmacists represented by each of the FIP 
member organisation from Africa was not available. Some countries had more than 
one professional body registered with FIP (for example, Egypt) and the exact number 
of pharmacist represented by these different organisations could not be obtained.  It 
was also not possible to obtain such precise information directly from the different 
professional pharmacy groups that were contacted for this study. 
- Second, it was not possible to have direct access to all the pharmacists 
practising in countries in Africa. As a result, this research relied on contact persons 
within the various membership organisations to facilitate the distribution of the survey 
invitation to individual members. In using this approach, it was not possible to 
determine the total number of pharmacist that had received the email invite per 
country. As a result, the number of non-responders could not be ascertained and the 
response rate could also not be calculated. 
3.2.4.1 Strategy used to boost responses in this study 
Advance letters, cover letters and reminder emails were the specific strategies used to boost 
survey responses. The first page of the survey questionnaire contained a cover letter that 
provided details of the survey and guidance on how to complete the questionnaire.  
Response rate = X 100 
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Prior to the implementation of the online survey, advance information about the project was 
presented at the Annual Global Deans Forum organised by FIPEd as well as at the academic 
pharmacy sessions and events during the FIP World Congress of Pharmacy and 
Pharmaceutical Sciences, at Amsterdam, Netherlands, 3-8th of October 2012. The following 
year, a 'flyer' containing information about the project was also distributed at the FIP 
conference that held at Dublin, Ireland on the 31st August to 5th September 2013 (Appendix 
2).  
Country level contact persons identified through FIPEd were also approached for assistance 
with the project via emails and/or face-to-face meeting at the 2012 & 2013 FIP conferences.  
Monthly reminder emails were routinely disseminated via the various contact persons and 
centrally through the FIP member organisations for onward distribution to individual 
members.    
3.2.5 Data handling and analysis 
Replies to the survey questions were automatically coded and uploaded on to a dedicated 
database for further analysis. The data obtained were then cleaned and reviewed for errors by 
taking a random 10% of the survey replies. This meant that 50 of the survey replies in this 
study were randomly chosen and reviewed systematically to check for missing values and 
errors. Missing values were replaced with the code 999 to ensure accurate data analysis.  
For the purpose of analysis and to ensure the results produced could be meaningfully 
interpreted, the four point Likert scale was aggregated into three categories. The 'highly 
relevant' and 'relevant' ratings were condensed into one category: 'relevant', while ‘low 
relevance’ and 'not relevant' ratings remained separate categories. The data were then recoded 
as 'not relevant' =1; 'low relevance' =2; while 'relevant' plus 'highly relevant' =3. Respondents' 
ranking of each of the 100 GbCF v1 behaviours was used to evaluate overall agreement in the 
survey.  
Frequencies and percentages were used to analyse demographic data. Inferential analysis was 
conducted using the Pearson's Chi Square (X2) test to assess homogeneity of survey replies. 
The test was also used to evaluate the relationship between survey responses, and 
respondents' area of practice, and length of practice. Multivariate analysis was used to 
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evaluate respondents' ratings in relation to country of origin. Details of the operationalisation 
of the analysis are given in the results section of this chapter.  
3.3 Results 
3.3.1 Demography 
At the end of the online survey, 469 replies were received from 14 African countries. These 
countries were: Ethiopia (1), Ghana (93), Kenya (103), Nigeria (166), Tanzania (1), Zambia 
(15), Egypt (8), South Africa (64), Zimbabwe (5), Namibia (1), Uganda (3), Sudan (1), 
Lesotho (3), and Tunisia (5).  
The study sample comprised 54% females. Respondents in hospital practice accounted for 
56.7% of the sample, followed by community (15.6%) and academic (9.2%) pharmacy 
practice. Table 3.1 gives a summary of the overall distribution of survey replies in relation to 
area of pharmacy practice.  
The average length of practice in the survey was 7.7years (S.D ± 8.1years). Maximum length 
of practice was 43years. Respondents with less than five years of post-registration practice 
comprised 47% of the sample while pre-registration candidates (intern pharmacists) 
comprised 5.5% of the sample. 
Table 3.1: Distribution of responses by area of practice 
 
Academic pharmacy 43 (9.2)
Administrative pharmacy 29 (6.2)
Community pharmacy 73 (15.6)
Hospital pharmacy 266 (56.7)
Industrial pharmacy 41 (8.7)
Laboratory & medicine control pharmacy 4 (0.9)
Military & Emergency pharmacy 2 (0.4)
Pharmacy Information 11 (2.3)
N Total (%) 469 (100)
Area of practice Replies N (%)
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3.3.2 Homogeneity of survey responses 
The observed disparity in the distribution of the survey replies suggested two cluster groups: 
a group of countries with number of replies ranging from 64 to 166, and a group with 
comparatively lower number of replies per country ranging from one to 15. Based on the 
number of replies, an arbitrary cut-off of 50 replies per country was used to regroup the 
countries represented in the survey. This was done in order to evaluate homogeneity and 
ascertain whether the sample could be treated as a group irrespective of the number of replies 
received per country. To do this, countries with more than 50 replies were defined as the 
‘high response’ countries and included Ghana, Kenya, Nigeria and South Africa. The ‘low 
response’ countries included Ethiopia, Egypt, Lesotho, Namibia, Sudan, Tanzania, Tunisia, 
Uganda, Zambia and Zimbabwe. Table 3.2 shows the number of replies within the country 
group per area of pharmacy practice.  
Table 3.2: Distribution of replies per area of practice within country group 
 
Homogeneity of the survey sample was evaluated using the Pearson's Chi Square (X2) test. 
The hypothesis tested was that "the weighting of relevance is associated with the country 
response group in the survey sample". An association between the weighting of relevance and 
the country response group in less than (or equal to) 10% of the behaviours (n =100) in the 
questionnaire was predefined as the threshold indicative of homogeneity. This would mean 
the relative proportions of the ratings in the relevance categories (that means: the ratings in 
High response countries Low response countries 
Academic pharmacy 37 (8.7) 6 (14)
Administrative pharmacy 25 (5.9) 4 (9.3)
Community pharmacy 63 (14.8) 10 (23.3)
Hospital pharmacy 252 (59.2) 14 (32.6)
Industrial pharmacy 36 (8.5) 5 (11.6)
Laboratory & medicine control pharmacy 2 (0.5) 2 (4.7)
Military & Emergency pharmacy 2 (0.5) 0.0
Pharmacy Information 9 (2.1) 2 (4.7)
N Total Sample (%) 426 (90.8) 43 (9.2)
Country Response Group (n%)
Area of practice 
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the 'not relevant', 'low relevance' and 'relevant' categories) in the two 'country response' 
groups are similar to that expected of a binomial distribution such that the sample could be 
assumed to be from the same population. This threshold was chosen based on the findings of 
a similar research conducted by Bruno (2011) which showed that respondents (n=470) from 
64 countries rated 90% of the GbCF v1 behaviours as relevant to practice. The X2 tests were 
carried out simultaneously for the 100 behaviours in the GbCF v1 questionnaire with 
statistical significance predefined as p ≤ 0.01. The outcome of these analyses is presented 
using frequency tables (Table 3.3 to 3.6).   
The analysis showed that the distribution of the ratings in the categories (this means, the 'not 
relevant', 'low relevance' and 'relevant' categories) was associated with the country response 
group for 11 behaviours (Table 3.3 to 3.6). This suggests the weighting of relevance for these 
eleven behaviours was dependent on country response group (that is, the low- or high 
response country group). These eleven behaviours were distributed across the four 
competency clusters in no observable pattern: two were in the pharmaceutical and public 
health cluster (B1 & B4); three in the pharmaceutical care cluster (B6, B12 & B19); five in 
the organisation and management cluster (B37, B42, B44, B54, B61); and one in the 
professional & personal cluster (B94) [Table 3.3 to 3.6].   
Although an association with country response group was observed for these eleven 
behaviours— which is above the predefined threshold of ≤ 10% if the GbCFv1 behaviours— 
homogeneity of the sample was still assumed for a number of reasons:  
• Inspection of the frequency tables indicated that only four of the eleven behaviours 
showing an association had >10% of the ratings in the 'not relevant' category for 
either the high response or low response country group. These four behaviours were 
the B19 (related to medicines use), B37 (related to human resource management), 
B44 (related to procurement) and B61 (related to work place management). 
• Also, it is likely that the X2 test underestimated the p-values since there were a 
number of empty cells and counts (frequency) of less than five observed in 83 of the 
behaviours in the questionnaire. This was mainly in the low response country group, 
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which suggests an absent of data due to small sample in the group rather than a 
deviation from expected frequency.  
Full discussion of this and the other reasons for assuming homogeneity in the survey 
sample is provided in the discussion section of this chapter (Section 3.6).  
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Table 3.3: Analysis of relevance rating of behaviours in relation to country response group (Pharmaceutical Public Health cluster) 
 
 
 
B1. HP | Assess the primary healthcare needs (taking into account the cultural and social setting of the patient) 10 2.3 20 4.7 396 93 1 2.3 7 16.3 35 81.4 9.67 0.01
B2. HP | Advise on health promotion, disease prevention and control, and healthy lifestyle 2 0.5 19 4.5 405 95.1 0 0 7 16.3 36 83.7 10.58 0.03
B3. MIA | Counsel patients on the appropriate use of medicines and devices (including the selection, use, 
contraindications, storage, and side effects of non-prescription and prescription medicines) taking into account 
patients preferences
3 0.7 18 4.2 405 95.1 0 0 5 11.6 38 88.4 4.85 0.07
B4. MIA | Identify sources, retrieve, evaluate, organise, assess and disseminate relevant medicines information 
according to the needs of patients and clients and provide appropriate information
2 0.5 22 5.2 402 94.3 1 2.3 8 18.6 34 79 1.12 0.01
χ2-value p
Row (N%)
Health promotion 
Low relevance Relevant Not relevant Low relevance Relevant 
Medicines information and advice 
Pharmaceutical Public Health Competencies (n=469)
Row (N%) Row (N%) Row (N%) Row (N%)Row (N%)Count Count Count Count Count Count
High Response Countries (n=426) Low Response Countries (n=43)
Not relevant
  
 
 
114 
Table 3.4: Analysis of relevance rating of behaviours in relation to country response group (Pharmaceutical Care cluster) 
 
   
Assessment of medicines 
B5. AM | Appropriately select  medicines (e.g. according to the patient, hospital, government policy, etc) 15 4.3 36 10.3 299 85.4 3 8.3 4 11.1 29 80.5 1.26 0.53
B6. AM | Identify, prioritise and act upon medicine-medicine interactions; medicine-disease interactions; 
medicine-patient interactions; medicines-food interactions
40 11.4 68 19.4 242 69.2 3 8.3 15 41.7 18 50 9.56 0.01
Compounding medicines 
B7. CM | Prepare pharmaceutical medicines (e.g. extemporaneous, cytotoxic medicines), determine the 
requirements for preparation (calculations, appropriate formulation, procedures, raw materials, equipment etc.)
22 6.3 54 15.4 274 78.3 3 8.3 7 19.4 26 72.2 0.7 0.71
B8. CM | Compound under the good manufacturing practice for pharmaceutical (GMP) medicines 29 8.3 57 16.3 264 75.4 6 16.7 4 11.1 26 72.3 3.13 0.21
Dispensing 
B9. D | Accurately dispense medicines for prescribed and/or minor ailments and monitor the dispense (re-
checking the medicines)
16 4.6 35 10 299 85.4 3 8.3 8 22.2 25 69.4 6.31 0.04
B10. D | Accurately report defective or substandard medicines to the appropriate authorities 22 6.3 45 12.9 283 80.8 4 11.1 8 22.2 24 66.7 4.04 0.13
B11. D | Appropriately validate prescriptions, ensuring that prescriptions are correctly interpreted and legal 16 4.6 35 10 299 85.5 0 0 6 16.7 30 83.4 3.03 0.22
B12. D | Dispense devices (e.g. Inhaler or a blood glucose meter) 11 3.1 18 5.1 321 91.7 0 0 9 25 27 75 20.54 <0.001
B13. D | Document and act upon dispensing errors 42 12 37 10 271 77.4 8 22.2 7 19.4 21 58.3 6.46 0.04
B14. D | Implement and maintain a dispensing error report system and a ‘near misses’ report system 38 10.9 42 12 270 77.1 5 13.9 4 11.1 27 75 0.31 0.86
B15. D | Label the medicines (with the required and appropriate information) 18 5.1 11 3.1 321 91.7 2 5.6 3 8.3 31 86.1 2.55 0.28
B16. D | Learn from and act upon previous ‘near misses’ and ‘dispensing errors 17 4.9 22 6.3 311 88.9 2 5.6 5 13.9 29 80.5 2.99 0.23
Medicines 
B17. M | Advise patients on proper storage conditions of the medicines and ensure that medicines are stored 
appropriately  (e.g. humidity, temperature, expiry date, etc.)
16 4.6 13 3.7 321 91.7 3 8.3 4 11.1 29 80.5 5.44 0.07
B18. M | Appropriately select medicines formulation and concentration for minor ailments (e.g. diarrhoea, 
constipation, cough, hay fever, insect bites, etc.)
29 8.3 38 10.9 283 80.8 4 11.1 4 11.1 28 77.8 0.35 0.84
B19. M | Ensure appropriate medicines, route, time, dose, documentation, action, form and response for 
individual patients
22 6.3 21 6 307 87.7 5 13.9 7 19.4 24 66.7 12.52 0.002
B20. M | Package medicines to optimise safety (ensuring appropriate re-packaging and labelling of the 
medicines)
32 9.1 41 11.7 277 79.1 7 19.4 6 16.7 23 63.9 5.06 0.08
Monitor medicines therapy 
B21. MMT | Apply guidelines, medicines formulary system, protocols and treatment pathways 18 5.1 8 2.3 324 92.5 1 2.8 3 8.3 32 88.8 4.61 0.1
B22. MMT | Ensure therapeutic medicines monitoring, impact and outcomes (including objective and subjective 
measures)
19 5.4 20 5.7 311 88.9 3 8.3 6 16.7 27 75 7.01 0.03
B23. MMT | Identify, prioritise and resolve medicines management problems (including errors) 10 2.9 17 4.9 323 92.3 2 5.6 2 5.6 32 88.8 0.84 0.66
Patient consultation & diagnosis 
B24. PCD |  Apply first aid and act upon arranging follow-up care 16 4.6 25 7.1 309 88 2 5.6 4 11.1 3 83.4 0.84 0.66
B25. PCD |  Appropriately refer 11 3.1 14 4 325 92.8 3 8.3 4 11.1 29 80.5 6.5 0.04
B26. PCD | l  Assess and diagnose based on objective and subjective measures 9 2.6 17 4.9 324 92.6 3 8.3 4 11.1 29 80.6 6.4 0.05
B27. PCD | Discuss and agree with the patients the appropriate use of medicines, taking into account patients 
preferences
12 3.4 25 7.1 313 89.4 2 5.6 5 13.9 29 80.5 2.61 0.27
B28. PCD | Document any intervention (e.g. document allergies, medicines and food, in patient medicines 
history)
16 4.6 38 10.9 296 84.5 5 13.9 5 13.9 26 72.2 6.08 0.05
B29. PCD | Obtain, reconcile, review, maintain and update relevant patient medication and diseases history 14 4 23 6.6 313 89.4 4 11.1 5 13.9 27 75 6.72 0.04
Low relevance Relevant 
Count Row (N%) Count Row (N%) Count Row (N%) Count Row (N%) Count
Pharmaceutical Care Competencies ( n=386)
Low Response Countries (n=36)High Response Countries (n=350)
χ2-value 
Row (N%) Count Row (N%)
pNot relevant Low relevance Relevant Not relevant
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Table 3.5: Analysis of relevance rating of behaviours in relation to county response group (Organisation & Management cluster) 
 
Budget & reimbursement
B30. BR | Acknowledge the organisational structure 14 4.7 37 12.5 244 82.7 2 6.1 8 24.2 23 69.7 3.68 0.16
B31. BR | Effectively set and apply budgets 17 5.8 45 15.3 233 79 3 9.1 8 24.2 22 66.6 2.6 0.27
B32. BR | Ensure appropriate claim for the reimbursement 31 10.5 49 16.6 215 72.9 9 27.3 5 15.2 19 57.6 7.85 0.02
B33. BR | Ensure financial transparency 16 5.4 38 12.9 241 81.7 5 15.2 7 21.2 21 63.6 7.1 0.03
B34. BR | Ensure proper reference sources for service reimbursement 28 9.5 51 17.3 216 73.3 6 18.2 5 15.2 22 66.7 2.42 0.03
Human resource management 
B35. HRM | Demonstrate organisational and management skills (e.g. Know, understand and lead on 
medicines management; risk management; self management; time management; people management; 
project management; policy management.)
7 2.4 17 5.8 271 91.9 1 3 6 18.2 26 78.7 7.14 0.03
B36. HRM | Identity and manage human resources and staffing issues 11 3.7 32 10.8 252 85.5 2 6.1 5 15.2 26 78.8 1.05 0.59
B37. HRM | Participate, collaborate, advice in therapeutic decision-making and use appropriate referral in 
a multi-disciplinary team 11 3.7 23 7.8 261 88.5 4 12.1 6 18.2 23 69.7 9.4 0.01
B38. HRM | Recognise and manage the potential of each member of the staff and utilise systems for 
performance management (e.g. carry out staff appraisals)
9 3.1 28 9.5 258 87.5 3 9.1 5 15.2 25 75.8 4.38 0.11
B39. HRM | Recognise the value of the pharmacy team and of a multidisciplinary team 6 2 20 6.8 269 91.2 1 3 5 15.2 27 81.8 3.16 0.21
B40. HRM | Support and facilitate staff training and professional development 6 2 19 6.4 270 91.5 3 9.1 4 12.1 26 78.8 7.29 0.21
Improvement of service 
B41. IS | Identify and implement new services (according to local needs) 6 2 27 9.2 262 88.8 1 3 8 24.2 24 72.8 7.35 0.03
B42. IS | Resolve, follow up and prevent medicines related problems 10 3.4 23 7.8 262 88.8 1 3 9 27.3 23 69.7 12.8 0.001
Procurement 
B43. P | Access reliable information and ensure the most cost-effective medicines in the right quantities 
with the appropriate quality
9 3.1 17 5.8 269 91.2 3 9.1 3 9.1 27 81.8 3.79 0.15
B44. P | Develop and implement contingency plan for shortages 11 3.7 27 9.2 257 87.1 5 15.2 2 6.1 26 78.8 8.5 0.01
B45. P | Efficiently link procurement to formulary, to push/pull system (supply chain management) and 
payment mechanisms
13 4.4 39 13.2 243 82.4 5 15.2 5 15.2 23 69.7 6.91 0.03
B46. P | Ensure there is no conflict of interest 14 4.7 38 12.9 243 82.3 5 15.2 5 15.2 23 69.7 6.25 0.04
B47. P | Select reliable supplies of high-quality products (including appropriate selection process, cost 
effectiveness, timely delivery) 13 4.4 27 9.2 255 86.5 3 9.1 5 15.2 25 75.8 2.83 0.24
B48. P | Supervise procurement activities 18 6.1 29 9.8 248 84 5 15.2 5 15.2 23 69.7 5.02 0.08
B49. P | Understand the tendering methods and evaluation of tender bids 22 7.5 40 13.6 233 79 3 9.1 10 30.3 20 60.6 6.86 0.03
Supply chain and management 
B50. SCM | Demonstrate knowledge in store medicines to minimise errors and maximise accuracy 12 4.1 15 5.1 268 90.9 3 9.1 5 15.2 25 75.7 7.33 0.03
B51. SCM | Ensure accurately verification of rolling stocks 11 3.7 27 9.2 257 87.2 5 15.2 3 9.1 25 75.8 8.38 0.02
B52. SCM | Ensure effective stock management and running of service with the dispensary 13 4.4 14 4.7 268 90.8 5 15.2 3 9.1 25 75.8 8.08 0.02
B53. SCM | Ensure logistics of delivery and storage 12 4.1 21 7.1 262 88.8 4 12.1 2 6.1 27 81.8 4.16 0.13
B54. SCM | Implement a system for documentation and record keeping 11 3.7 13 4.4 271 91.9 3 9.1 8 24.2 22 66.6 22.35 0.001
B55. SCM | Take responsibility for quantification of forecasting 17 5.8 20 6.8 258 87.4 6 18.2 2 6.1 25 75.8 7.02 0.03
Work place management 
B56. WPM | Address and manage day to day management issues 8 2.7 16 5.4 271 91.8 0 0 4 12.1 29 87.9 3.13 0.21
B57. WPM | Demonstrate the ability to take accurate and timely decisions and make appropriate judgments 7 2.4 13 4.4 275 93.2 1 3 2 6.1 30 90.9 2.47 0.88
B58. WPM | Ensure the production schedules are appropriately plan and manage 31 10.5 44 14.9 220 74.6 4 12.1 8 24.2 21 63.7 2.18 0.34
B59. WPM | Ensure the work time is appropriately plan and manage 8 2.7 18 6.1 269 91.2 2 6.1 5 15.2 26 78.8 5.07 0.08
B60. WPM | Improve and manage the provision of pharmaceutical services 6 2 16 5.4 273 92.5 2 6.1 4 12.1 27 81.8 4.53 0.04
B61. WPM | Recognise and manage pharmacy resources (e.g. financial, infrastructure) 9 3.1 26 8.8 260 88.2 5 15.2 3 9.1 25 75.7 10.71 0.01
Organisation & Management Competencies (n=328) Low relevance Relevant Not relevant Low relevance
Count Row (N%) CountCount Row (N%) Row (N%) Count Row (N%) Count Row (N%)
High Response Countries (n=295) Low Response Countries (n=33)
χ2-value pNot relevant Relevant 
Count Row (N%)
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Table 3.6: Analysis of relevance rating of behaviours in relation to county response group (Professional & Personal cluster) 
 
Communication skills 
B62. CS | Communicate clearly, precisely and appropriately while being a mentor or 
tutor
2 0.7 6 2.2 265 97.1 2 6.3 0 0 30 93.8 7.38 0.07
B63. CS | Communicate effectively with health and social care staff, support staff, 
patients, carer, family relatives and clients/customers, using lay terms and checking 
understanding
4 1.5 7 2.6 262 96 0 0 2 6.3 30 93.7 1.76 0.41
B64. CS | Demonstrate cultural awareness and sensitivity 6 2.2 14 5.1 253 92.6 0 0 3 9.4 29 90.7 1.64 0.44
B65. CS | Tailor communications to patient needs 5 1.8 10 3.7 258 94.5 0 0 5 15.6 27 84.4 9.23 0.03
B66. CS | Use appropriate communication skills to build, report and engage with 
patients, health and social care staff and voluntary services (e.g. verbal and non-
verbal)
3 1.1 7 2.6 263 96.3 0 0 3 9.4 29 90.7 4.5 0.1
Continuing professional education
B67.  CPD | Document CPD activities 7 2.6 33 12.1 233 85.3 3 9.4 3 9.4 26 81.3 4.29 0.12
B68. CPD | Engage with students/interns/residents 10 3.7 24 8.8 239 87.5 2 6.3 4 12.5 26 81.3 1.05 0.59
B69. CPD | Evaluate currency of knowledge and skills 5 1.8 23 8.4 245 89.8 3 9.4 2 6.3 27 84.4 6.47 0.04
B70. CPD | Evaluate learning 5 1.8 23 8.4 245 89.7 3 9.4 2 6.3 27 84.4 6.47 0.04
B71. CPD | Identify if expertise needed outside the scope of knowledge 6 2.2 25 9.2 242 88.7 3 9.4 6 18.8 23 71.9 8.52 0.02
B72. CPD | Identify learning needs 4 1.5 25 9.2 244 89.4 3 9.4 3 9.4 26 81.3 8.02 0.02
B73. CPD | Recognise own limitations and act upon them 4 1.5 16 5.9 253 92.7 1 3.1 4 12.5 27 84.4 2.62 0.27
B74. CPD | Reflect on performance 3 1.1 11 4 259 94.8 1 3.1 3 9.4 28 87.5 2.85 0.24
Legal & regulatory practice 
B75. LRP | Apply and understands Regulatory Affairs and the key aspects of 
pharmaceutical registration and legislation
7 2.6 22 8.1 244 89.4 0 0 1 3.1 31 96.9 1.92 0.38
B76. LRP | Apply knowledge in relation to the principals of business economics and 
intellectual property rights including the basics of patent interpretation
16 5.9 50 18.3 207 75.9 0 0 4 12.5 28 87.5 2.92 0.23
B77. LRP | Be aware of and identify the new medicines coming to the market 4 1.5 23 8.4 246 90.1 0 0 2 6.3 30 93.7 0.68 0.71
B78. LRP | Comply with legislation for drugs with the potential for abuse 4 1.5 11 4 258 94.5 1 3.1 0 0 31 96.9 1.79 0.41
B79. LRP | Demonstrate knowledge in Marketing and Sale 22 8.1 66 24.2 185 67.8 2 6.3 9 28.1 21 65.7 0.32 0.31
B80. LRP | Engage with health and medicines policies 3 1.1 30 11 240 87.9 0 0 1 3.1 31 96.9 2.35 0.32
B81. LRP | Understand the steps needed to bring a medicinal product to the market 
including the safety, quality, efficacy and pharmacoeconomic assessments of the 
product
17 6.2 39 14.3 217 79.5 1 3.1 2 6.3 29 90.7 2.28 0.37
Professional and ethical practice 
B82. PEP | Demonstrate awareness of local/national codes of ethics 5 1.8 12 4.4 256 93.8 0 0 2 6.3 30 93.8 0.8 0.67
B83. PEP | Ensure confidentiality (with the patient and other healthcare professionals) 4 1.5 10 3.7 259 94.9 0 0 0 0 32 100 1.72 0.42
B84. PEP | Obtain patient consent (it can be implicit in occasions) 9 3.3 16 5.9 248 90.8 1 3.1 5 15.6 26 81.3 4.26 0.12
B85. PEP | Recognise own limitations 5 1.8 11 4 257 94.1 0 0 3 9.4 29 90.7 2.11 0.3
B86. PEP | Take responsibility for own action and for patient care 5 1.8 9 3.3 259 94.9 0 0 2 6.3 30 93.7 1.28 0.53
Quality assurance & research in the workplace 
B87. QARWP | Apply research findings and understand the benefit risk (e.g. pre-
clinical, clinical trials, experimental clinical-pharmacological research and risk 
management)
31 11.4 44 16.1 198 72.5 3 9.4 4 12.5 25 78.2 0.46 0.79
B88. QARWP | Audit quality of service (ensure that they meet local and national 
standards and specifications)
15 5.5 15 5.5 243 89 2 6.3 2 6.3 28 87.5 1.22 0.54
B89. QARWP | Developed and implement Standing Operating Procedures (SOP’s) 15 5.5 15 5.5 243 89 2 6.3 2 6.3 28 87.5 0.07 0.97
B90. QARWP | Ensure appropriate quality control tests are performed and managed 
appropriately
36 13.2 52 19 185 67.8 3 9.4 2 6.3 27 84.4 4.11 0.13
B91. QARWP | Ensures medicines are not counterfeit and quality standards 16 5.9 19 7 238 87.2 0 0 5 15.6 27 84.4 4.64 0.1
B92. QARWP | Identify and evaluate evidence-base to improve the use of medicines 
and services
16 5.9 28 10.3 229 83.8 0 0 4 12.5 28 87.5 2.06 0.36
B93. QARWP | Identify, investigate, conduct, supervise and support research at the 
workplace (enquiry-driven practice)
25 9.2 45 16.5 203 74.3 4 12.5 3 9.4 25 78.2 1.31 0.05
B94. QARWP | Implement, conduct and maintain a report system of  
pharmacovigilance (e.g. report Adverse Drug Reactions)
16 5.9 11 4 246 90.1 2 6.3 6 18.8 24 75.1 11.88 0.003
B95. QARWP | Initiate and implement audit and research activities 30 11 46 16.8 197 72.1 3 9.4 6 18.8 23 71.9 0.13 0.14
Self-management 
B96. SM | Apply assertiveness skills (inspire confidence) 4 1.5 8 2.9 261 95.6 1 3.1 1 3.1 30 93.8 0.5 0.78
B97. SM | Demonstrate leadership and practice management skills, initiative and 
efficiency
4 1.5 9 3.3 260 95.3 0 0 3 9.4 29 90.7 3.22 0.2
B98. SM | Document risk management (e.g. critical incidents) 11 4 22 8.1 240 87.9 3 9.4 6 18.8 23 71.9 6.2 0.05
B99. SM | Ensure punctuality 1 0.4 8 2.9 264 96.7 0 0 2 6.3 30 93.7 1.12 0.56
B100. SM | Prioritise work and implement innovative ideas 4 1.5 10 3.7 259 94.8 0 0 2 6.3 30 93.8 0.96 0.62
χ2-value p
Count Row (N%)
Not relevant Low relevance Relevant Professional & Personal Competencies (n = 305)
Row (N%)Row (N%) Row (N%)Row (N%)Count Count Count Count Row (N%) Count
High Response Countries (273) Low Response Countries (32)
Not relevant Low relevance Relevant 
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3.3.3 Overall relevance rating  
The number of replies received varied for the four competency clusters as follows: 
• Pharmaceutical Public Health cluster – 469 replies 
• Pharmaceutical Care cluster  – 386 replies 
• Organisation & Management cluster – 328 replies 
• Professional & Personal cluster – 305 replies   
At the end of the study, 305 of the 469 total number of survey respondents provided 
responses to all the 105 questions in the GbCF v1 questionnaire. Evidence suggests the 
disparity in number of replies received per competency cluster may be due to the length of 
the questionnaire (Kalantar and Talley, 1999). Findings from a meta-analysis of randomised 
controlled trials shows that the odds of a response decreases by more than half as the number 
of pages of a survey questionnaire increases [OR: 0.39, 95% CI 0.34 to 0.45] (Edwards et al., 
2004). Nonetheless, research also demonstrates that the variation in response rates per page 
of a questionnaire does not affect the quality of the overall responses received (Iglesias and 
Torgerson, 2000). Consequently, the responses provided by the entire survey sample was 
analysed for each of the 100 GbCF v1 behaviours.  
For this analysis, behaviours that had ≤10% of the total ratings in the 'not relevant' category 
were defined as behaviours showing agreement on relevant to practice. These 'agreed' 
behaviours were subsequently defined as 'Group 1' behaviours. Behaviours with >10% of the 
overall ratings in the 'not relevant' category were those that showed disagreement. These 
'disagreed' behaviours were classified as 'Group 2'. This means, Group 2 included behaviours 
with >10% of the total ratings in 'not relevant' category. The threshold of agreement was 
defined based on the findings of the study by Bruno (2011) and is also in line with published 
literature in healthcare research that have defined consensus as 90% agreement (Herdman et 
al., 2002; Schweigert, 2011, p. 176). The output of the overall relevance analysis is presented 
using frequency tables (Tables 3.7 to 3.9). 
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Table 3.7: Relevance rating of behaviours within the Pharmaceutical Public Health 
cluster 
 
Based on the replies, there was consensus that all behaviours in the pharmaceutical public 
health cluster were relevant to practice. 
  
Count Row (N%) Count Row (N%) Count Row (N%)
B1. HP | Assess the primary healthcare needs (taking into account the cultural and 
social setting of the patient)
11 2.30 27 5.8 431 91.9 1
B2. HP | Advise on health promotion, disease prevention and control, and healthy 
lifestyle
2 0.4 26 5.5 441 94 1
B3. MIA | Counsel patients on the appropriate use of medicines and devices (including 
the selection, use, contraindications, storage, and side effects of non-prescription and 
prescription medicines) taking into account patients preferences
3 0.60 23 4.90 443 94.4 1
B4. MIA | Identify sources, retrieve, evaluate, organise, assess and disseminate 
relevant medicines information according to the needs of patients and clients and 
provide appropriate information
3 0.60 30 6.40 436 92.9 1
Medicines information and advice
Low Relevance
Pharmaceutical Public Health Competencies (n=469)
Not relevant Relevant
Group
Health promotion
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Table 3.8: Relevance rating of behaviours in the Pharmaceutical Care cluster 
 
The respondents rated 21 (84%) of the behaviours in the pharmaceutical care cluster as 
relevant to practice. There was disagreement in four (16%) of the behaviours (shaded pink).  
Further analysis was conducted to evaluate this disagreement and identify areas of practice 
that rated these behaviours as not relevant (Table 3.11).  
Count Row (N%) Count Row (N%) Count Row (N%)
B5. AM | Appropriately select  medicines (e.g. according to the patient, hospital, government policy, etc) 18 4.7 40 10.4 328 85 1
B6. AM | Identify, prioritise and act upon medicine-medicine interactions; medicine-disease interactions; 
medicine-patient interactions; medicines-food interactions
43 11.1 83 21.5 260 67.4 2
B7. CM | Prepare pharmaceutical medicines (e.g. extemporaneous, cytotoxic medicines), determe the 
requirements for preparation (calculations, appropriate formulation, procedures, raw materials, 
equipment etc.)
25 6.5 61 15.8 300 77.7 1
B8. CM | Compound under the good manufacturing practice for pharmaceutical (GMP) medicines 35 9.1 61 15.8 290 75.1 1
B9. D | Accurately dispense medicines for prescribed and/or minor ailments and monitor the dispense 
(re-checking the medicines)
19 4.9 43 11.2 324 83.9 1
B10. D | Accurately report defective or substandard medicines to the appropriate authorities 26 6.7 53 13.7 307 79.5 1
B11. D | Appropriately validate prescriptions, ensuring that prescriptions are correctly interpreted and 
legal
16 4.1 41 10.6 329 85.2 1
B12. D | Dispense devices (e.g. Inhaler or a blood glucose meter) 11 2.8 27 7 348 90.2 1
B13. D | Document and act upon dispensing errors 50 13 44 11.4 292 75.6 2
B14. D | Implement and maintain a dispensing error report system and a ‘near misses’ report system 43 11.1 46 11.9 297 76.9 2
B15. D | Label the medicines (with the required and appropriate information) 14 5.2 20 3.6 352 91.2 1
B16. D | Learn from and act upon previous ‘near misses’ and ‘dispensing errors 19 4.9 27 7 340 88.1 1
B17 . M | Advise patients on proper storage conditions of the medicines and ensure that medicines are 
stored appropriately  (e.g. humidity, temperature, expiry date, etc.)
17 4.9 19 4.4 350 90.7 1
B18 . M | Appropriately select medicines formulation and concentration for minor ailments (e.g. 
diarrhoea, constipation, cough, hay fever, insect bites, etc.)
33 8.5 42 10.9 311 80.6 1
B19. M | Ensure appropriate medicines, route, time, dose, documentation, action, form and response for 
individual patients
27 7 28 7.3 331 85.8 1
B20. M | Package medicines to optimise safety (ensuring appropriate re-packaging and labelling of the 
medicines)
39 10.1 47 12.2 300 77.7 2
B21. MMT | Apply guidelines, medicines formulary system, protocols and treatment pathways 11 4.9 19 2.9 356 92.2 1
B22 . MMT | Ensure therapeutic medicines monitoring, impact and outcomes (including objective and 
subjective measures)
22 5.7 26 6.7 338 87.6 1
B23. MMT | Identify, prioritise and resolve medicines management problems (including errors) 12 3.1 19 4.9 355 92 1
B24. PCD |  Apply first aid and act upon arranging follow-up care 18 4.7 29 7.5 339 87.8 1
B25. PCD |  Appropriately refer 14 3.6 18 4.7 354 91.7 1
B26. PCD | l  Assess and diagnose based on objective and subjective measures 12 3.1 21 5.4 353 91.5 1
B27. PCD | Discuss and agree with the patients the appropriate use of medicines, taking into account 
patients preferences
14 3.6 30 7.8 342 88.6 1
B28. PCD | Document any intervention (e.g. document allergies, medicines and food, in patient 
medicines history)
21 5.4 43 11.1 322 83.4 1
B29. PCD | Obtain, reconcile, review, maintain and update relevant patient medication and diseases 
history
18 4.7 28 7.3 340 88.1 1
Dispensing 
Medicines
Monitor medicines therapy 
Patient consultation and diagnosis 
Assessment of medicines 
Compounding medicines
Low Relevance 
Pharmaceutical Care Competencies ( n=386)
Not Relevant Relevant
Group
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Table 3.9: Relevance rating of behaviours in the Organisation & Management cluster 
 
Respondents rated 29 (90%) of the behaviours in the organisation & management as relevant 
to practice. There was disagreement in three (9.4%) behaviours (shaded pink) and these were 
further analysed to evaluate areas of practice that rated them not relevant (Table 3.11).  
Count Row (N%) Count Row (N%) Count Row (N%)
B30. BR | Acknowledge the organisational structure 16 4.9 45 13.7 267 81.4 1
B31. BR | Effectively set and apply budgets 20 6.1 53 16.2 255 77.7 1
B32. BR | Ensure appropriate claim for the reimbursement 40 12.2 54 16.5 234 71.4 2
B33. BR | Ensure financial transparency 21 6.4 45 13.7 262 79.9 1
B34. BR | Ensure proper reference sources for service 
reimbursement
34 10.4 56 17.1 238 72.5 2
B35. HRM | Demonstrate organisational and management skills (e.g. 
Know, understand and lead on medicines management; risk 
management; self management; time management; people 
management; project management; policy management.)
8 2.4 23 7 297 90.6 1
B36. HRM | Identity and manage human resources and staffing 
issues
13 4 37 11.3 278 84.8 1
B37. HRM | Participate, collaborate, advice in therapeutic decision-
making and use appropriate referral in a multi-disciplinary team
15 4.6 29 8.8 284 86.6 1
B38. HRM | Recognise and manage the potential of each member of 
the staff and utilise systems for performance management (e.g. carry 
out staff appraisals)
12 3.7 33 10.1 283 86.3 1
B39. HRM | Recognise the value of the pharmacy team and of a 
multidisciplinary team
7 2.1 25 7.6 296 90.2 1
B40. HRM | Support and facilitate staff training and professional 
development
9 2.7 23 7 296 90.2 1
Improvement of service 
B41. IS | Identify and implement new services (according to local 
needs)
7 2.1 35 10.7 286 87.2 1
B42. IS | Resolve, follow up and prevent medicines related problems 11 3.4 32 9.8 285 86.9 1
Procurement 
B43. P | Access reliable information and ensure the most cost-
effective medicines in the right quantities with the appropriate quality
12 3.7 20 6.1 296 90.2 1
B44. P | Develop and implement contingency plan for shortages 16 4.9 29 8.8 283 86.3 1
B45. P | Efficiently link procurement to formulary, to push/pull system 
(supply chain management) and payment mechanisms
18 5.5 44 13.4 266 81.1 1
B46. P | Ensure there is no conflict of interest 19 5.8 43 13.1 266 81.1 1
B47. P | Select reliable supplies of high-quality products (including 
appropriate selection process, cost effectiveness, timely delivery)
16 4.9 32 9.8 280 85.4 1
B48. P | Supervise procurement activities 23 7.0 34 10.4 271 82.6 1
B49. P | Understand the tendering methods and evaluation of tender 
bids
25 7.6 50 15.2 253 77.1 1
B50. SCM | Demonstrate knowledge in store medicines to minimise 
errors and maximise accuracy
15 4.6 20 6.1 293 89.3 1
B51. SCM | Ensure accurately verification of rolling stocks 16 4.9 30 9.1 282 86 1
B52. SCM | Ensure effective stock management and running of 
service with the dispensary
17 5.5 18 5.2 293 89.3 1
B53. SCM | Ensure logistics of delivery and storage 16 4.9 23 7 289 88.1 1
B54. SCM | Implement a system for documentation and record 
keeping
14 4.3 21 6.4 293 89.3 1
B55. SCM | Take responsibility for quantification of forecasting 22 7.0 23 6.7 283 86.3 1
B56. WPM | Address and manage day to day management issues 8 2.4 20 6.1 300 91.5 1
B57. WPM | Demonstrate the ability to take accurate and timely 
decisions and make appropriate judgments
8 2.4 15 4.6 305 93 1
B58. WPM | Ensure the production schedules are appropriately plan 
and manage
35 10.7 52 15.9 241 73.5 2
B59. WPM | Ensure the work time is appropriately plan and manage 10 3 23 7 295 89.9 1
B60. WPM | Improve and manage the provision of pharmaceutical 
services
8 2.4 20 6.1 300 91.5 1
B61. WPM | Recognise and manage pharmacy resources (e.g. 
financial, infrastructure)
14 4.3 29 8.8 285 86.9 1
Human resources Management
Supply chain and management 
Work place management 
Low Relevance 
Organisation & Management Competencies (n=328)
Not relevant Relevant
Group
Budget & reimbursement
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Table 3.10: Relevance rating of behaviours in the Professional & Personal cluster 
 
Respondents rated 36 (92%) of the behaviours in the professional and personal cluster, as 
relevant to practice. There was disagreement in three (7.7%) of the behaviours and further 
Count Row (N%) Count Row (N%) Count Row (N%)
B62. CS | Communicate clearly, precisely and appropriately while being a mentor or tutor 4 1.3 6 2 295 96.7 1
B63. CS | Communicate effectively with health and social care staff, support staff, patients, 
carer, family relatives and clients/customers, using lay terms and checking understanding
4 1.3 9 3 292 95.7 1
B64. CS | Demonstrate cultural awareness and sensitivity 6 2.0 17 5.6 282 92.5 1
B65. CS | Tailor communications to patient needs 5 1.6 15 4.9 285 93.4 1
B66. CS | Use appropriate communication skills to build, report and engage with patients, health 
and social care staff and voluntary services (e.g. verbal and non-verbal)
3 <0.1 10 3.3 292 95.7 1
B67.  CPD | Document CPD activities 10 3.3 36 11.8 259 84.9 1
B68. CPD | Engage with students/interns/residents 12 3.9 28 9.2 265 86.9 1
B69. CPD | Evaluate currency of knowledge and skills 8 2.6 25 8.2 272 89.2 1
B70. CPD | Evaluate learning 8 2.6 25 8.2 272 89.2 1
B71. CPD | Identify if expertise needed outside the scope of knowledge 9 3.0 31 10.2 265 86.9 1
B72. CPD | Identify learning needs 7 2.3 28 9.2 270 88.5 1
B73. CPD | Recognise own limitations and act upon them 5 1.6 20 6.6 280 91.8 1
B74. CPD | Reflect on performance 4 1.3 14 4.6 287 94.1 1
B75. LRP | Apply and understands Regulatory Affairs and the key aspects of pharmaceutical 
registration and legislation
7 2.3 23 7.5 275 90.2 1
B76. LRP | Apply knowledge in relation to the principals of business economics and intellectual 
property rights including the basics of patent interpretation
16 5.2 54 17.7 235 77.1 1
B77. LRP | Be aware of and identify the new medicines coming to the market 4 1.3 25 8.2 276 90.5 1
B78. LRP | Comply with legislation for drugs with the potential for abuse 5 1.6 11 3.6 289 94.8 1
B79. LRP | Demonstrate knowledge in Marketing and Sale 24 7.9 75 24.6 206 67.5 1
B80. LRP | Engage with health and medicines policies 3 <0.1 31 10.2 271 88.9 1
B81. LRP | Understand the steps needed to bring a medicinal product to the market including 
the safety, quality, efficacy and pharmacoeconomic assessments of the product
18 5.9 41 13.4 246 80.7 1
B82 . PEP | Demonstrate awareness of local/national codes of ethics 5 1.6 14 4.6 286 93.8 1
B83. PEP | Ensure confidentiality (with the patient and other healthcare professionals) 4 1.3 10 3.3 291 95.4 1
B84. PEP | Obtain patient consent (it can be implicit in occasions) 10 3.3 21 6.9 274 89.8 1
B85. PEP | Recognise own limitations 5 1.6 14 4.6 286 93.8 1
B86. PEP | Take responsibility for own action and for patient care 5 1.6 11 3.6 289 94.8 1
B87. QARWP | Apply research findings and understand the benefit risk (e.g. pre-clinical, clinical 
trials, experimental clinical-pharmacological research and risk management)
34 11.1 48 15.7 223 73.1 2
B88. QARWP | Audit quality of service (ensure that they meet local and national standards and 
specifications)
26 8.5 34 11.1 245 80.3 1
B89 . QARWP | Developed and implement Standing Operating Procedures (SOP’s) 17 5.6 17 5.6 271 88.9 1
B90. QARWP | Ensure appropriate quality control tests are performed and managed 
appropriately
39 12.8 54 17.7 212 69.5 2
B91. QARWP | Ensures medicines are not counterfeit and quality standards 16 5.2 24 7.9 265 86.9 1
B92. QARWP | Identify and evaluate evidence-base to improve the use of medicines and 
services
16 5.2 32 10.5 257 84.3 1
B93. QARWP | Identify, investigate, conduct, supervise and support research at the workplace 
(enquiry-driven practice)
29 9.5 48 15.7 228 74.8 1
B94. QARWP | Implement, conduct and maintain a report system of  pharmacovigilance (e.g. 
report Adverse Drug Reactions)
17 5.9 18 5.6 270 88.5 1
B95. QARWP | Initiate and implement audit and research activities 33 10.8 52 17.5 220 72.1 2
B96. SM | Apply assertiveness skills (inspire confidence) 5 1.6 9 3 291 95.4 1
B97. SM | Demonstrate leadership and practice management skills, initiative and efficiency 4 1.3 12 3.9 289 94.8 1
B98. SM | Document risk management (e.g. critical incidents) 14 4.6 28 9.2 263 86.2 1
B99. SM | Ensure punctuality 1 <0.1 10 3.3 294 96.4 1
B100. SM | Prioritise work and implement innovative ideas 4 1.3 12 3.9 289 94.8 1
Legal and regulatory practice 
Professional and ethical practice 
Quality assurance & research in the work place 
Self-management 
Communication skills
Continuing Professional Development (CPD)
Low Relevance 
Professional & Personal Competencies (n=305)
Not relevant Relevant
Group
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analysis was conducted to evaluate areas of practice that rated these as not relevant (Table 
3.11). 
3.3.3.1 Summary of overall relevance rating  
There was consensus on relevance to practice for 90 behaviours in the framework. Ten 
behaviours had more than 10% of the total ratings in the 'not relevant' category and therefore 
showed disagreement.  
The 'pharmaceutical public health' was the only cluster with agreement on all its behaviours. 
The ten behaviours that showed disagreement were in six competencies distributed across the 
other three clusters in the GbCF v1 questionnaire:  
• 'Assessment of medicine' (AM), 'dispensing' (D) and 'medicines' (M) 
competencies in the Pharmaceutical Care cluster;   
• 'Budget & reimbursement' (BR) and 'work place management' (WPM) 
competencies in the Organisation and Management cluster; and  
• 'Quality assurance and research in the work place' (QARWP) competency in the 
Professional & Personal cluster.  
The AM, M and WPM competencies each showed disagreement for one behaviour (B6, B20, 
B58, respectively). The QARWP competency showed disagreement in three behaviours 
(B87, B90, B95) while the D and BR competencies each showed disagreement in two 
behaviours [(B13 & B14) and (B32 & B34) respectively].  
The ten behaviours that had more than 10% of the total ratings in the 'not relevant' category 
were further analysed to evaluate the relationship between the ratings and respondents' area 
of practice. This analysis was conducted within the four clusters in the framework and the 
outcome is presented in Table 3.11. 
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3.3.4 Observed disagreement  
Further analysis of the ten 'disagreed' behaviours showed that the observed disagreement was 
associated with area of pharmacy practice for six of these behaviours. The association was in 
three behaviours in the 'pharmaceutical care' [B6, B13 and B20 (p<0.01)], one in 
'organisation & management' [B32 (p<0.05)]; and two in the 'professional & personal' [B87 
and B90 (p<0.05)] clusters, respectively (Table 3.11).  
Respondents in hospital practice were least likely to rate these ten behaviours as 'not 
relevant'. On the other hand, respondents in academic and industrial pharmacy were more 
likely to show a lack of consensus [that means % 'not relevant' > 10% (italicised on Table 
3.11)] for the behaviours in the 'pharmaceutical care' and 'organisation & management' 
clusters; a result that is consistent with the scope of practice in these areas (Table 3.11).  
The lack of consensus [% 'not relevant' >10%] in the B13 & B14 (related to dispensing), and 
B20 (related to medicine use) behaviours observed within the community practice area was 
inconsistent with practice (italicised on Table 3.11).  Nonetheless, evidence suggests this may 
be related to the peculiarities of community pharmacy practice in some developing countries. 
Published research show that dispensing activities are mostly carried out by pharmacy 
support staff and sales assistants in developing countries including Nigeria, Pakistan, Turkey 
and India (Adje and Oli, 2013; Basak and Sathyanarayana, 2009; Erdogan et al., 2012; Toklu 
et al., 2010). This may explain the 'not relevant' rating of these dispensing behaviours. 
Further discussion of this is provided in the discussion section of this chapter (3.6). 
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Table 3.11 Analysis of the 'not relevant' ratings in relation to area of practice per 
competency per cluster 
 
 
Key: Academic: Academic pharmacy; Admin: Administrative pharmacy; Comm: Community pharmacy; 
Hosp: Hospital pharmacy; Indus: Industrial pharmacy; Others*: areas of practice with low N and included 
laboratory & medicines control pharmacy, military & emergency pharmacy, and pharmacy information.  
Academic Admin. Comm. Hosp. Indus. Others*
Assessment of 
medicines 
[B6] AM | Identify, prioritise and act upon 
medicine-medicine interactions; medicine-
disease interactions; medicine-patient 
interactions; medicines-food interactions 
(n=43)
20 9.5 0 11.6 21.9 7.1 23.5 0.01
[B13] D | Document and act upon 
dispensing errors (n=50)
14.3 19 20 7.6 21.9 35.7 36.9 <0.001
[B14] D | Implement and maintain a 
dispensing error report system and a ‘near 
misses’ report system (n=43)
17.1 14.3 20.3 7.1 12.5 14.3 15.9 0.1
Medicines 
[B20] M | Package medicines to optimise 
safety [ensuring appropriate re-packaging 
and labelling of the medicines] (n=39)
20 9.5 16.9 4.4 25 14.3 31.9 <0.001
[B32] BR | Ensure appropriate claim for the 
reimbursement (n=40)
24 5 10.9 8.8 24 27.3 20.1 0.03
[B34] BR | Ensure proper reference sources 
for service reimbursement (n=34)
18.2 5 10.9 7.8 16 27.3 16.8 0.08
Workplace 
management 
[B58] WPM | Ensure the production 
schedules are appropriately plan and 
manage (n=35)
15.2 5 19.6 6.7 20 18.2 17.4 0.08
[B87] QARWP | Apply research findings and 
understand the benefit risk [e.g. pre-clinical, 
clinical trials, experimental clinical-
pharmacological research and risk 
management] (n=34)
12.5 5 20.9 10.2 9.1 0 20.4 0.03
[B90] QARWP | Ensure appropriate quality 
control tests are performed and managed 
appropriately (n=39)
12.5 0 25.6 11.9 9.1 9.1 22.8 0.01
[B95] QARWP | Initiate and implement audit 
and research activities (n=33)
12.5 5 20.9 9 9.1 0 15.78 0.11
χ2-value p-valueBehaviours 
Area of practice ( N%)
Cluster 
Professional and 
personal 
Organsiation 
and 
management 
 Competencies 
Dispensing 
Budget and 
reimbursement 
Quality assurance 
and research in 
the workplace 
Pharmaceutical 
care 
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Since the respondents in hospital practice were comparatively least likely to rate the 
'pharmaceutical care' and 'organisation & management' behaviours as 'not relevant', further 
analysis was done to test the hypothesis that the "relevance rating was associated with patient 
component in area of practice". Patient component was defined as pharmacy activities that 
involve daily interactions with patients. Pharmacy areas that predominantly involve daily 
patient interactions were defined as 'patient facing' sectors and included hospital, community, 
and military & emergency pharmacy. Academic, administrative, industrial, laboratories & 
medicine control, pharmacy information practice areas were re-grouped as 'non-patient 
facing' sectors (Table 3.12).  
Respondents in patient facing sectors like hospital pharmacy reached consensus on relevance 
to practice (N 'not relevant' <10%) for five of the behaviours that showed disagreement [B6 
& B20, B32, B34 & B58]. The converse was true for the respondents in non-patient facing 
practice areas like academic and industrial pharmacy (Table 3.12). The result is consistent 
with these areas of pharmacy practice since assessment of medicine and medicine use 
activities are not within the scope of practice of 'non-patient facing' pharmacy sectors like 
industrial, laboratory & medicine control, pharmacy information, and administrative 
pharmacy. However, the analysis only showed a statistically significant association (p≤0.05) 
with patient facing component in respondents' area of practice for the B6, B20, B32, B90 and 
B95 behaviours.  
Furthermore, the disagreement observed in this cluster was not fully explained by area of 
practice and patient component. This was because the patient facing sectors showed a lack of 
consensus (N 'not relevant' >10%) for the research-related behaviours (B87 & B95) in 
contrast to the non-patient facing sectors, although this was not statistically significant for the 
B87 behaviour (p = 0.08).   
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Table 3.12: Analysis of the 'not relevant' ratings in relation to patient component in 
practice area per competency per cluster 
 
 
The ratings of relevance were further evaluated to assess whether there was an association 
with length of pharmacy practice experience. Length of practice was defined as number of 
years of post-registration/post-license pharmacy practice. Group 1 comprised respondents 
with less than 5years post-license practice while group 2 contained respondents with 5years 
Assessment of 
medicines
[B6]  Identify, prioritise and act upon 
medicine-medicine interactions; medicine-
disease interactions; medicine-patient 
interactions; medicines-food interactions 
(n=43)
9.1 21.1 69.8 18.2 22.7 59.1 6.3 0.04
[B13] Document and act upon dispensing 
errors (n=50)
11.4 11.4 77.2 18.2 11.4 70.5 2.8 0.25
[B14]  Implement and maintain a dispensing 
error report system and a ‘near misses’ 
report system (n=43)
10.1 13.4 76.5 14.8 6.8 78.4 3.87 0.15
Medicines 
[B20] Package medicines to optimise safety 
[ensuring appropriate re-packaging and 
labelling of the medicines] (n=39)
7.4 11.7 80.9 19.3 13.6 67 11.45 0.003
[B32] Ensure appropriate claim for the 
reimbursement (n=40)
10 18.4 71.6 19.2 10.3 70.5 6.56 0.04
[B34] Ensure proper reference sources for 
service reimbursement (n=34)
9.2 16.8 74 14.1 17.9 67.9 1.72 0.44
Work place 
management
[B58] Ensure the production schedules are 
appropriately plan and manage (n=35)
9.6 18.4 72 14.1 7.7 78.2 5.74 0.06
[B87] Apply research findings and 
understand the benefit risk [e.g. pre-clinical, 
clinical trials, experimental clinical-
pharmacological research and risk 
management] (n=34)
11.7 18.2 82.4 9.5 8.1 70.1 5.02 0.08
[B90] Ensure appropriate quality control 
tests are performed and managed 
appropriately (n=39)
14.3 21.2 64.5 8.1 6.8 85.1 11.72 0.003
[B95] Initiate and implement audit and 
research activities (n=33)
11.3 19.9 68.8 9.5 8.1 82.4 6.19 0.05
Non patient-facing sectors (N%)
χ2- value p-value 
Not 
relevant
Low 
relevance
Relevant
Not 
relevant
Low 
relevance
Relevant
Competency Behaviour
Patient-facing sectors (N%)
Budget and 
reimbursemnet 
Quality assurance & 
research in the 
workplace
Dispensing
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or more post-license practice experience. The 5years length of practice cut-off was chosen 
based on the definition of early career and advanced pharmacy practice (The Advanced 
Pharmacy Practice Framework Steering Committee (APPFSC), 2012, p. 6) 
The outcome of the analysis (Table 3.13) showed a lack of consensus in the Group 1 
respondents (<5years of pharmacy practice) for the three disagreed behaviours in the 
'professional and personal' cluster. This was also the case in the Group 2 respondents for the 
B87 (related to research) behaviour. 
Table 3.13: Analysis of the ratings in the 'not relevant' category in relation to length of 
practice per competency in the professional and personal cluster 
 
 
 
The analysis also showed the weighting of relevance was significantly associated with length 
of practice for the B90 (related to quality control) behaviour. This suggests the early career 
respondents (that is, those with <5years of pharmacy practice) perceived this behaviour as not 
relevant to practice. This association was however not observed in the B87 & B95 (related to 
research) behaviours, indicating that the response rating was independent of experience.  
3.3.5 Summary of observed disagreement  
Further analysis of the ten disagreed behaviours showed the disagreement was related to area 
of pharmacy practice including the patient component. Respondents in non-patient facing 
sectors like industrial, laboratory & medicine control and pharmacy information, indicated 
[B87]. QARWP | Apply research findings and understand the benefit risk [e.g. pre-
clinical, clinical trials, experimental clinical-pharmacological research and risk 
management] 
12.1 18.4 69.5 10.4 13.4 76.2 4.06 0.391
[B90]. QARWP | Ensure appropriate quality control tests are performed and managed 
appropriately 
17 22.7 60.3 9.2 13.4 77.4 11.641 0.005
[B95]. QARWP | Initiate and implement audit and research activities 12.7 21.3 66 9.2 13.4 77.4 7.381 0.08
χ2-value p-value
Quality assurance and research in the work place
Professional & Personal Competencies (n=305)
Length of Practice
< 5years (n=141) ≥ 5years (n=164)
Not relevant 
(N%) 
Low relevance 
(N%)
Relevant 
(N%)
Not relevant 
(N%)
Low relevance 
(N%)
Relevant 
(N%)
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the disagreed behaviours in the pharmaceutical care cluster [B6 (related to assessment of 
medicines), B13 and B14 (related to Dispensing), B20 (related to packaging of medicines)] 
were not relevant to practice (Table 3.11). These respondents also indicated that the 
behaviours in the organisation and management cluster [B32 & B34 (related to budget & 
reimbursement) and B58 (related to production planning and management)] were not relevant 
to their practice.  
On the other hand, respondents in the patient facing sectors like hospital pharmacy indicated 
the disagreed behaviours in the pharmaceutical care and organisation & management clusters 
were all relevant to their practice (Table 3.11). The three disagreed behaviours in the 
professional and personal cluster [B87, B90 & B95 (related to applying research findings, 
quality assurance and audits, respectively)] were also rated 'not relevant' to practice by 
respondents in the patient facing sectors. However, respondents in the non-patient facing 
sectors reached consensus on these behaviours (Table 3.12).  
Further evaluation of the disagreed behaviours in the professional and personal cluster 
showed the weighting of relevance was significantly associated with length of pharmacy 
practice for only the B90 (related to quality control) behaviour. This association was not 
observed for the B87 (related to research) and B95 (related to audit and research) behaviours 
suggesting that the lack of consensus observed in the two groups was not related to 
experience (Table 3.13).   
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3.4 Comparative analysis of relevance rating by country  
The 100 behaviours in the questionnaire were further evaluated in relation to respondents' 
country of origin. For this analysis, only countries that had more than 50 replies— the 'high 
response' countries— were included. This was done to ensure the summary statistics 
produced from this comparative analysis could be accurately interpreted.  
The ratings for the behaviours were aggregated and analysed within their respective 
competencies in relation to respondents' country of origin. This means, the analysis was 
conducted for the 20 competencies within the four competency clusters in the questionnaire. 
This included 426 replies from four countries (Ghana, Nigeria, South Africa and Kenya) 
representing 91% of the survey sample. Table 3.14 shows the number of replies per area of 
pharmacy practice in these countries.  
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Table 3.14: Number of replies per area of pharmacy practice per country  
 
 
 
 
 
 
 
 
 
 
 
 
Area of practice 
N Country (%) 
Kenya Ghana Nigeria South Africa 
Academic pharmacy 1 (1.0) 4 (4.3) 11 (6.6) 21 (32.8) 
Administrative pharmacy 6 (5.8) 13 (14.0) 4 (2.4) 2 (3.1) 
Community pharmacy 2 (1.9) 10 (10.8) 41 (24.7) 10 (15.6) 
Hospital pharmacy 89 (86.4) 60 (64.5) 80 (48.2) 23 (35.9) 
Industrial pharmacy 1 (1.0) 3 (3.2) 26 (15.7) 6 (9.4) 
Others a 4 (3.9) 3 (3.2) 4 (2.4) 2 (3.1) 
N Total sample (%) 103 (22) 93 (19.8) 166 (35.4) 64 (13.6) 
aArea of pharmacy practice with low number of replies [including pharmacy information (n=11), military & 
emergency (n=2) and laboratory & medicine control pharmacy (n=4)].   
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3.4.1 Pharmaceutical public health cluster  
Figure 3.1 shows the mean Z scores per country for the HP and MIA competencies. This 
suggests respondents from Ghana and Kenya rated the two competencies higher in relevance 
than those in South Africa. It also shows that the weighting of relevance for the HP 
competency was highest in the Nigeria while Kenya showed the highest weighting for the 
MIA competency. Conversely, respondents from South Africa ranked the two competencies 
relatively lower in relevance than the other three countries. 
Multivariate Analysis of Variance (MANOVA) showed Pillia's trace V = 0.025, F = 1.809, df 
= 6, p = 0.094, signifying there was no statistical significant difference in weighting of 
relevance between the four countries for the two competencies.  
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Figure 3.1: Mean relevance rating in relation to country of residence for c\mpetencies 
under the Pharmaceutical Public Health cluster  
 
 
 
Key: HP – Health promotion competency; MIA – Medicines information & advice Competency. 
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3.4.2 Pharmaceutical care cluster 
Figure 3.2 illustrates disparities in mean Z scores between the four countries for the six 
competencies in this cluster. It implies that respondents in Kenya and Ghana rated the 
competencies in this cluster higher in relevance compared to respondents from Nigeria and 
South Africa.  
Multivariate ANOVA showed Pillia's trace V = 0.083, F = 1.624, df = 18, p = 0.048, 
indicating a statistical significant difference in weighting of relevance between the countries 
for the competencies in this cluster. 
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Figure 3.2: Mean relevance rating in relation to country of residence for competencies 
under the Pharmaceutical Care cluster 
 
Key: AM – Assessment of medicines competency; CM – Compounding medicines competency; D – 
Dispensing competency; M – Medicines competency; MMT – Monitor medicine therapy competency; 
PCD – Patient consultation and diagnosis competency. 
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Confirmatory post hoc analysis using Bonferroni correction method showed the observed 
variance was within the AM and PCD competencies (Table 3.15). The analysis also showed 
there was a significant difference in weighting of relevance between South Africa and Ghana 
in the AM competency (p=0.049), and between Nigeria and Ghana (p=0.021), and Nigeria 
and Kenya (p=0.045) in the PCD competency. 
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Table 3.15: Post hoc analysis of the competencies in the Pharmaceutical Care cluster 
using the Bonferroni correction method. 
 
The difference between Ghana and South Africa in the AM competency was in the B6 
(related to medicine interactions) behaviour. Seventy-one percent of the respondents from 
Ghana ranked the behaviour as 'relevant' compared to 47% in South Africa. Also, while only 
7.5% of the ratings from Ghana were in the 'not relevant' category, South Africa had 15%. 
Ghana
Kenya ND
Nigeria 0.244 ND
South Africa 0.049 0.226 ND
Compounding Medicines (CM) Ghana Kenya Nigeria South Africa
Ghana
Kenya ND
Nigeria ND ND
South Africa 0.417 0.371 ND
Dispensing (D) Ghana Kenya Nigeria South Africa
Ghana
Kenya ND
Nigeria 0.484 0.196
South Africa ND ND ND
Medicines (M) Ghana Kenya Nigeria South Africa
Ghana
Kenya ND
Nigeria 0.168 ND
South Africa ND 0.257 ND
Monitor Medicine Therapy (MMT) Ghana Kenya Nigeria South Africa
Ghana
Kenya ND
Nigeria ND 0.742
South Africa ND ND ND
Patient Consultation & Diagnosis (PCD) Ghana Kenya Nigeria South Africa
Ghana
Kenya ND
Nigeria 0.021 0.045
South Africa 0.916 ND ND
ND: No Difference; P = 1
ND: No Difference; P = 1
ND: No Difference; P = 1
ND: No Difference; P = 1
ND: No Difference; P = 1
ND: No Difference; P = 1
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This means South Africa showed a lack of consensus on relevance to practice for the B6 
behaviour. 
The difference between Nigeria and Kenya in the PCD competency was under the B25 
(related to patient referral). None of the respondents in Kenya rated the behaviour as 'not 
relevant' compared to 6% in Nigeria who did. Also, 98% of the respondents in Kenya ranked 
the behaviour as relevant compared to 89% from Nigeria. This means more respondents in 
Kenya indicated the behaviour were relevant to their practice compared to the respondents 
from Nigeria. However, the two countries agreed that the behaviour (B25) was relevant to 
practice.  
The difference between Nigeria and Ghana in the PCD competency was in the B27 behaviour 
(related to discussing with patient on medicine). None of the respondents from Ghana rated 
the behaviour as 'not relevant' compared to 6% in Nigeria. Also, 98% of respondents from 
Ghana rated the B27 behaviour as 'relevant' to practice compared to 85% in Nigeria. This 
means, more respondents in Ghana indicated the behaviour as relevant to practice, although, 
both countries agreed that the behaviour was relevant to practice. 
Overall, in spite of the observed disparity, only South Africa showed a lack of consensus on 
relevance and this was in the B6 behaviour. Consensus on relevance to practice was observed 
in the other countries for the B6, B25 and B27 behaviours.  
Since the B6, B25 and B27 behaviours are related to assessment of medicines and medicines 
use, the observed difference between the countries may be due to the sample composition. 
Eighty-six percent of the respondents in Kenya were in hospital pharmacy in contrast to 
Nigeria, Ghana and South Africa with 49%, 65%, and 36%, respectively. This disparity in 
composition was also observed in community pharmacy area [Kenya (2%), Ghana (10%), 
Nigeria (26%)] (Table 3.14), suggesting that the observed disparity was due to country-
specific differences in weighting of relevance in these three behaviours. 
  
  
 
 
138
3.4.3 Organisation and management cluster 
Figure 3.3 show disparity in mean Z scores between the four countries for the competencies 
in the organisation and management cluster. It suggests respondents from Ghana and Kenya 
ranked the six competencies in this cluster higher in relevance compared to those from 
Nigeria and South Africa. 
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Figure 3.3: Mean relevance rating in relation to country of residence for competencies 
under the Organisation & Management cluster 
 
 
Key: BR – Budget & reimbursement competency; HRM – Human resources management 
competency; IS – Improvement of service competency; P – Procurement competency; SCM – Supply 
chain and management competency; and WPM – Work place management competency.  
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Multivariate ANOVA showed Pillia's trace V = 0.136, F = 2.279, df = 18, p = 0.002, 
indicating a statistical significant difference between the countries. Confirmatory post hoc 
analysis using Bonferroni correction method showed the difference was in the BR, P and 
SCM competencies (Table 3.19). It showed statistically significant difference between 
Nigeria and Ghana in the BR (p=0.030), P (p=0.005) and SCM (p=0.026) competencies. It 
also showed a significant difference between Ghana and South Africa in the P competency 
(p=0.011), and between Nigeria and Kenya in the SCM competency (0.003). 
Table 3.16: Post hoc analysis of the competencies in the Organisation & Management 
cluster using the Bonferroni correction method. 
 
 
Budget Reimbursement (BR) Ghana Kenya Nigeria South Africa
Ghana
Kenya 0.482
Nigeria 0.03 ND
South Africa 0.591 ND ND
Human Resource Management (HRM) Ghana Kenya Nigeria South Africa
Ghana
Kenya ND
Nigeria 0.133 0.256
South Africa ND ND ND
Improvement of Service (IS) Ghana Kenya Nigeria South Africa
Ghana
Kenya ND
Nigeria 0.48 ND
South Africa ND ND ND
Procurement (P) Ghana Kenya Nigeria South Africa
Ghana
Kenya ND
Nigeria 0.005 0.079
South Africa 0.011 0.102 ND
Supply Chain and Management (SCM) Ghana Kenya Nigeria South Africa
Ghana
Kenya ND
Nigeria 0.026 0.003
South Africa 0.256 0.077 ND
Work Place Management (WPM) Ghana Kenya Nigeria South Africa
Ghana
Kenya ND
Nigeria 0.068 0.922
South Africa ND ND 0.373
ND: No Difference; P = 1
ND: No Difference; P = 1
ND: No Difference; P = 1
ND: No Difference; P = 1
ND: No Difference; P = 1
ND: No Difference; P = 1
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The difference between Nigeria and Ghana was in the B32 (related to claim reimbursement), 
B45 (related to procurement and payment), and B55 (related to quantification and 
forecasting) behaviours under the BR, P and SCM competencies respectively.  
Eleven percent of the respondents from Nigeria rated the B32 (related to claim 
reimbursement), behaviour as 'not relevant' compared to 3% in Ghana. Also, 70% from 
Nigeria compared to 75% in Ghana rated the behaviour as 'relevant'. A higher percentage of 
the respondents from Ghana (92%) rated the B45 behaviour (related to procurement and 
payment) as relevant to practice compared to Nigeria (70%). The behaviour was rated not 
relevant to practice by 8% of the respondents from Nigeria compared to 2% from Ghana. A 
higher percentage of the respondents (94%) from Ghana rated the B55 (related to 
quantification and forecasting) behaviour as 'relevant' compared to 79% from Nigeria. Ten 
percent of the respondents in Nigeria rated the behaviour as 'not relevant' compared to 2% in 
Ghana. The result therefore show consensus on relevance to practice for B45 and B55 
behaviours within Nigeria and Ghana. Nigeria however showed a lack of consensus for the 
B32 behaviour.   
The difference between Ghana and South Africa under the P competency was in the B49 
(related to tendering and evaluation of tenders and bids) behaviour. Eleven percent of the 
respondents from South Africa rated the behaviour as 'not relevant' compared to 5% from 
Ghana, while 85% in Ghana rated the behaviour as 'relevant' compared to 69% from South 
Africa. This means South Africa showed a lack of consensus for the B49 behaviour. 
The difference between Nigeria and Kenya was in the B55 behaviour (related to 
quantification and forecasting). The behaviour was relevant to the practice of a higher 
percentage of the respondents from Kenya (95%) compared to 80% from Nigeria while 10% 
of the respondents from Nigeria rated the behaviour as 'not relevant' compared to 1% from 
Kenya. This showed that while there was disparity in the weighting of relevance, the two 
countries however agreed that the B55 behaviour was relevant to practice. 
The disparity observed between the countries can be explained by the sample composition. 
Ghana had a higher percentage of its respondents in administrative pharmacy (14%) 
compared to Nigeria (2%). This possibly explains the disparity in perception of relevance 
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observed between Ghana and Nigeria in the B32 (related to reimbursement), B45 (related to 
procurement and payment) and B55 (related to quantification and forecasting of supplies) 
behaviours. 
3.4.4 Professional and personal cluster  
Figure 3.4 shows differences in mean Z scores between the four countries for the 
competencies in this cluster. It suggests respondents in Ghana and South Africa rated the 
competencies in this cluster higher in relevance than respondents in Kenya and Nigeria.  
Multivariate ANOVA of the mean Z scores showed Pillia's trace V = 0.084, F = 1.270, df = 
18, p = 0.2. This indicates there was no significant difference in weighting of relevance 
between the countries for the six competencies in this cluster. 
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Figure 3.4: Mean relevance rating in relation to country of residence for competencies 
under the Professional & Personal cluster 
 
 
 
Key: CS – Communication skills competency; CPD – Continuing professional development 
competency; LRP – Legal & regulatory practice competency; PEP – Professional and ethical 
practice competency; QAPWP – Quality assurance & research in the work place competency; and 
SM – Self-management competency.  
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3.4.5 Summary of comparative analysis of relevance by country  
Direct comparison of the mean standard scores (Z scores) per competency showed some 
disparity in relevance rating between the four countries (Figure 3.1–3.4).  
Multivariate ANOVA showed significant differences in perceived relevance to practice 
between the countries in five competencies. These competencies were the: 
 'Assessment of medicines' (AM) and 'patient consultation & diagnosis' (PCD) 
competencies under the pharmaceutical care cluster; and  
 'Budget & reimbursement' (BR), 'procurement' (P) and 'supply chain and 
management' (SCM) competencies in the organisation and management cluster.  
 
Confirmatory post hoc analysis using Bonferroni method showed that the observed 
differences were between: 
 South Africa and Ghana for the AM and P competencies;  
 Nigeria and Ghana for the PCD, BR, P and SCM competencies; and 
 Nigeria and Kenya for the PCD and SCM competencies.  
The results also showed that the: 
 Respondents from Ghana ranked the AM and P competencies higher than those from 
South Africa (Figure 3.2). 
 Respondents from Ghana ranked the PCD, BR, P and SCM competencies higher than 
those from Nigeria (Figure 3.2 and 3.3).  
 Respondents in Kenya ranked the PCD and SCM competencies higher than those 
from Nigeria (Figure 3.2 and 3.3).  
 The analysis also showed there was no difference between the four countries for the 
LRP competency (p=1). 
 
However, despite the observed disparity in weighting of relevance, the responses did not 
signify a lack of consensus on relevance to practice of the behaviours. It is likely suggestive 
of differences in perception of degree of relevance between the countries particularly because 
of the composition of the sample with respect to respondents' area of practice. 
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3.5 Main Study Findings  
The number of replies received per country represented in the survey ranged from 166 in 
Nigeria, 15 in Zambia, and 1 reply each in Namibia, Tanzania, Ethiopia and Sudan. Initial 
analysis of the sample composition showed that four countries each had 50 replies or more 
and these were classified as the high response country group. Ten countries had low number 
of replies (<50) and these were classified as the low response group.  
The patient-facing sector made up 72.3% of the overall survey sample. It also made up 74% 
of the high response country group as oppose to 55.9% in the low response group. Due to the 
disparity in sample composition observed between the high- and low response groups, an 
initial assessment of homogeneity was conducted using the X2 test. This test aimed to 
evaluate the relationship between the weighting of relevance and the country group by 
comparing the relative proportions of the ratings in the two groups (Table 3.3 – 3.6).  
The result of this test showed the ratings were associated with the country group for 11 
behaviours. This indicates that the proportion of the rating of relevance varied with respect to 
country response group. This also suggests that the sample was homogenous in response for 
89% of the GbCF v1 behaviours. Even though this was below the initial predefine 
homogeneity threshold of 90%; the responses were subsequently analysed as a group for a 
number of reasons including empty table cells and counts of less than five in more than 20% 
of the cells. Further details, and the explanation of the theoretical basis, operationalisation 
and inference drawn from the X2 test for homogeneity are discussed in full in the discussion 
section of this Chapter (3.6). 
Subsequent analysis of the overall relevance ratings showed consensus on relevance to 
practice for 90 behaviours in the questionnaire. Disagreement was observed for 10 
behaviours. These 10 behaviours were in six competencies under the pharmaceutical care, 
organisation & management, and the professional & personal clusters. The six competencies 
that contained the disagreed behaviours were the 'assessment of medicines' (AM), 
'dispensing' (D), 'medicines' (M) 'budget & reimbursement' (BR), 'work place management' 
(WPM), and the 'quality assurance and research at the workplace' (QARWP), competencies.  
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The QARWP was the competency with the most disagreed behavior. It showed disagreement 
in 3 behaviours while the D and BR competencies each showed disagreement in two 
behaviours. The AM, M and WPM competencies each had disagreement in one behaviour.  
The disagreement in the ten behaviours was related to area of practice and patient 
component— that is, the level of face-to face patient interaction in the practice areas. A 
statistically significant association with area of practice was observed in five (50%) of the 
disagreed behaviours. These were the B6 (related to assessment of medicines), B13 (related 
to dispensing), B20 (related to packaging of medicines), B32 (related to reimbursement) and 
B90 (related to quality control). These behaviours, including the B95 (related to research), 
also showed an association with patient component in area of practice.  
Generally, respondents in non-patient facing sector like industrial, academic, administrative, 
laboratory & medicines control, and pharmacy information indicated the disagreed 
behaviours in the pharmaceutical care [B6, B13, B14 & B20] and the organisation and 
management [B32, B34 & B58] clusters were not relevant to their practice.  On the other 
hand, respondents in the patient facing practice sectors like hospital pharmacy indicated these 
behaviours were relevant to their practice. 
The result is consistent with the scope of practice of the different practice areas in pharmacy. 
However, area of practice and patient component did not fully explain the disagreement in 
the research-related behaviours (B87 & B95). This disagreement was also not explained by 
practice experience although consensus on relevance was observed in the non-patient facing 
sector and within the advanced practitioner group (that is, pharmacists with 5years or more 
practice experience) [Table 3.13]. 
Furthermore specific differences in weighting of relevance were observed between the four 
main countries. These differences were in 5(25%) competencies and were primarily in seven 
behaviours: B6 under the assessment of medicines (AM) competency; B25 & B27 under the 
patient consultation & diagnosis (PCD) competency; B32 under the budget and 
reimbursement (BR) competency; B45 & B49 under the procurement (P) competency; and 
B55 under the supply chain management (SCM) competency.  
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The disparity was between:  
 Nigeria and Ghana for the PCD, BR, P, and SCM competencies;   
 Nigerian and Kenya for the PCD and SCM competencies; and  
 South Africa and Ghana in the AM and P competencies. 
 
In general, Ghana and Kenya respondents generally rated these seven behaviours higher in 
relevance than did those from Nigeria and South Africa. The result indicates that the 
observed differences in four of the seven behaviours (B25, B27, B45 &B55) were not due to 
a lack of consensus on relevance to practice in the four countries. It rather suggested a 
difference in perception of the degree of relevance due to disparity in the sample composition 
in the respective countries.  
For example, more respondents from Ghana (98%) indicated the B27, B32 and B55 
behaviours were relevant to their practice compared to Nigeria (85%). Only 47% of the 
respondents from South Africa rated the B6 behaviour as relevant to practice compared to 
71% in Ghana and Nigeria, and 77% in Kenya. A higher number of respondents in Kenya 
(98%) indicated the B25 and B49 behaviours were relevant to their practice compared to 
Nigeria (89%) and South Africa (90%) [this comprised the proportion of the ratings in the 
'relevant' category only, and does not include the rating in the 'low relevance' category].  
Overall, a lack of consensus on relevance to practice was observed in the Nigeria group for 
the B32 (related to reimbursement) behaviour, and the B6 (related to assessment of 
medicines) & B49 (related to tenders and bids) behaviours for South Africa. Full discussion 
of the study findings is provided in the discussion section of this chapter (3.6).  
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3.6 Discussion  
3.6.1 Methodology  
The goal of this study was to evaluate pharmacists' perception of the relevance to practice of 
the GbCF v1 competencies in countries in Africa. The study explicitly evaluated perception 
via an online survey using a 4-point Likert scale. The study findings show that 90% of the 
behaviours in the framework are relevant to practice for the survey respondents. However, 
majority (~91%) of the survey respondents were from four African countries: Ghana, Kenya, 
Nigeria and South Africa. This suggests that the findings of the research are likely to have 
limited generalisability beyond these four countries.  
Most of the survey respondents (72.3%) were in hospital and community pharmacy practice 
while academic, industrial, and administrative pharmacy each made up less than 10% of the 
survey sample. On the other hand, respondents from three practice areas: laboratory & 
medicine control, military & emergency, and pharmacy information, comprised less than 5% 
of the total survey sample. Though it is probable that the sample composition may be 
reflective of the general pharmacy population in the countries represented in the survey as 
suggested by available estimates (International Pharmaceutical Federation, 2012; Royal 
Pharmaceutical Society of Great Britain, 2009); the lack of accurate census data and the non-
stratified and non-probabilistic sampling method used in this study makes it difficult to be 
certain of this.  
A combination of convenience and snowball sampling technique was used in this study. Even 
though this non-probabilistic sampling approach is a potential source of bias, the methods 
were chosen due to challenges with access to pharmacists in the African region and the 
limited resources available as discussed earlier under the methodology section of this chapter 
(3.2). Furthermore, the sampling strategy used for this study is in line with published research 
that have evaluated pharmacists' perception of the competencies contained in a framework 
[(Carrington et al., 2012; Jones et al., 2012; Atkinson et al., 2015; Jackson et al., 2015; 
Bruno, (2011)]. This suggests that the methods used were within reason and evidence-based.  
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Evaluating pharmacists' perception of a competency framework via an online survey as was 
done in this research is an established and pragmatic evidence-based methodology in 
pharmacy practice. For example, Atkinson and colleagues (2015) evaluated perception of the 
competencies in the Quality Assurance in European Pharmacy Education and Training 
(PHAR-QA) Framework via an online survey. Bruno (2011) and Jackson et al., (2015) 
evaluated pharmacists' perception of applicability to practice of the FIP Global Competency 
Framework and the Advanced Pharmacy Practice Framework of Australia (APPF), 
respectively, via an online survey while Maitreemit et al., (2008) evaluated applicability of 
the competencies in the Standard Criteria for Pharmacy Practitioners in Thailand Framework 
via a postal survey. The aforementioned studies also used a Likert scale to rank relevance to 
practice of the competencies contained in the respective frameworks.  
In line with published research, respondents' perception of the relevance to practice of each of 
the 100 GbCF v1 behaviours was assessed in this study using a four point Likert Scale. 
General agreement was evaluated by comparing the proportion (percentage) of the overall 
ratings in each category on the scale. A threshold of ten percent (or less) of the total ratings in 
the 'not relevant' category was predefined as indicative of agreement on relevance to practice. 
This indicates that consensus was attained on a given behaviour when at least 90% of 
respondents rated the behaviour relevant to practice (this included the low relevance ratings).  
Although published research in health service evaluation and related fields have defined 
consensus as 70% (Sumsion, 1998) and 75% (Jones and Hunter, 1995) agreement, the 
threshold (90%) used in this research was defined empirically based on the result of the 
global online survey conducted by Bruno (2011) that involved pharmacists from 64 countries. 
This was done to ensure consistency of evidence given that while this present study focused 
regionally on countries in Africa, the study by Bruno (2011) evaluated the global pharmacy 
workforce using the same GbCF v1 questionnaire. As such, it was imperative for the 
threshold of agreement to be the similar. This threshold is also in line with other studies that 
have defined consensus as 90% (Herdman et al., 2002; Hulley et al., 2015; Schweigert, 
2011). 
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3.6.2 Homogeneity of the survey responses 
Survey replies were received from 14 countries in Africa with disparity observed in the 
number of replies received per country. An initial evaluation of homogeneity of the responses 
in the survey sample was therefore undertaken using the X2 test. The test aimed to evaluate 
whether the countries represented were homogenous in respondents' ratings of relevance for 
each of the 100 behaviours in the questionnaire. Regrouping the represented countries into a 
high- and low response group was carried out with respect to the number of replies received 
in the survey (please see section 3.3.2). This regrouping produced a 3x2 contingency table 
and the significance level (α) was predefined as 0.01.  
Although a number of published research in health service evaluation and social research 
have predefined α as 0.05; the conservative α-level of 0.01 that allowed only a 1% (or less) 
probability of obtaining a value as high as the X2-value when the null hypothesis is true, was 
chosen a priori for this analysis. This was done to curtail the risk of making a type 1 error 
(Banerjee et al., 2009) and limit the potential for error due to chance particularly because of 
the disparity in composition and areas of pharmacy practice that was likely to be observed in 
the countries represented in the survey (International Pharmaceutical Federation, 2012, 2009; 
International Pharmaceutical Federation (FIP), 2015), as was obtained in this research. For 
example, majority (74%) of the respondents in the four countries in the high response group 
in this survey were mainly in patient facing roles (hospital and community pharmacy areas). 
This is in contrast to the low response group that had 54.7%. This indicates that close to half 
(44.3%) of the respondents in the low response group were in the non-patient facing areas of 
practice compared to the high response group with about a fourth (26%), therefore signifying 
disparity in sample composition between the two groups (Table 3.2).  
Furthermore, evidence suggests that the approximate statistic produced by the X2 test is 
imprecise in small samples (Bewick et al., 2004; Cohen, 1988; Weisburd and Britt, 2007a). 
This increases the probability of obtaining a statistically significant p-value (Armitage and 
Berry, 2002; Campbell, 2007; Field, 2007) and even though consensus on definition of 'small' 
or 'large' samples is currently lacking, Campbell (2007) and Agreti (1990) suggests that a 
contingency table with expected count of less than 5 in any of the table cells is likely to be 
from a small sample. Since counts (frequency) of less than five was observed in 61 of the 
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GbCF v1 behaviours (Table 4.4-4.6), a conservative α-level of 0.01 was therefore appropriate 
in order to limit the risk of a type 1 error.   
The outcome of the X2 test indicated that the distribution of the ratings in the relevance 
categories (this means, the 'not relevant', 'low relevance' and 'relevant') was not associated 
with the country response group for 89 behaviours. This suggests that for these 89 
behaviours, the proportion of the responses in the categories on the aggregated Likert scale 
(that is, the observed frequencies in the 'not relevant', 'low relevance', and 'relevant' 
categories) were similar to that expected from a binomial distribution, for the low and high 
response country groups, respectively. This showed that the two cluster groups were 
homogenous in their responses for 89% of the GbCF v1 behaviours. Even though this was 
below the predefined threshold of 90%, homogeneity of the survey sample was still assumed 
for a number of reasons:  
• At least one empty cell (that is, n=0 in either the high or low response country group) 
was observed in 20 behaviours in the questionnaire. In such instances, the X2 test 
interprets the empty cell as an absence of observation indicative of a deviation from 
expected frequency and therefore produces a significant p-value. However these cells 
were mainly in the low response group and were likely due to a lack of data and not 
an absence of observation. For example, compared to the high response country group 
(n=426), the sample composition of the low response group (n=43) indicated that a 
number of areas of practice were not represented (Table 3.2). Even though attempts 
were made to boost survey replies in this research using monthly reminders and 
follow-up emails, the number of replies received from the low response group 
countries was still comparatively low. This feature led to the lack of data observed in 
some areas of practice in the low response countries. 
• Despite the small numbers in some of the table cells, the convention of using Fisher's 
test instead of the X2 test when the expected count is less than 5 in a 2x2 contingency 
table (Cochran, 1954, 1952; Cohen, 1988; Freeman and Julious, 2007; MacDonald 
and Gardner, 2000) was not appropriate since a 3x2 contingency table was produced 
in the analysis. Although the response categories could have been further aggregated 
and dichotomised into 'not relevant' and 'relevant' so as to produce a 2x2 contingency 
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table for a Fisher's test; this was not done as it would have led to a loss of information 
with respect to the behaviours that were rated 'low relevance' to practice by the 
respondents. This would have made it difficult to interpret the study results and 
distinguish between the behaviours that were rated 'relevant' versus those rated as 'low 
relevance'. 
• Also, available evidence from theoretical calculations (Storer and Kim, 1990) and 
computational simulations (Richardson, 1990) show that Fisher's test produces 
conservative p-values in small samples, especially when the degree of freedom is 
greater than 1. This leads to a likelihood of obtaining a non-significant result 
(Campbell, 2007; Field, 2007), especially when the contingency table contains 'both 
small and large expected frequencies' (Agresti, 1990, p. 49). Although Yates (1934), 
Fleiss (1981) and Yates et al (1999), suggest applying the Yates continuity correction 
to the X2 test when the expected count is less than 10 but greater than 5 in more than 
20% of the table cells; this two approaches were not appropriate for use in this study 
because evidence suggests the Yate's correction overly adjusts the X2 statistic in small 
samples and produces p-values that are large and likely to be non-significant 
(Armitage and Berry, 2002; Howell, 2009).  
Overall, the relevance ratings provided by the respondents in countries with low and high 
number of replies in the survey suggests broad similarity in weighting of relevance for 
majority (89%) of the GbCF v1 behaviours. This indicated that the survey respondents were 
homogenous in their responses irrespective of country of origin and the disparity in the 
number of replies received per country represented. It also suggested similarity in the 
perception of relevance of the GbCF v1 behaviours. This is in line with previous research 
(n=490) involving practitioners in 64 countries (n=490) that have shown consensus on 
relevance to practice of the GbCF v1 behaviours (Bruno, 2011). It is also in line with other 
published studies that have shown the applicability of a framework developed in United 
Kingdom (the General Level Framework, now renamed the RPS Foundation Level 
Framework) to practitioners in Australia (Coombes et al., 2010), Croatia (Meštrović et al., 
2012), Singapore (Rutter et al., 2012) and Serbia (Svetlana et al., 2014). This finding adds to 
evidence that show that there exists a core set of behaviours (and competencies) that are 
generally applicable to practitioners in different countries.  
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3.6.3 Overall perception of the relevance to practice of the GbCF v1 behaviours  
The results of the cross-sectional survey demonstrate consensus on relevance to practice for 
90 behaviours in the framework. This included all the behaviours in the ‘pharmaceutical 
public health’ cluster, 84% of the behaviours in the ‘pharmaceutical care’ cluster, 90% of 
those in the ‘organisation and management’ cluster, and 92% of the behaviours in the 
‘professional and personal’ cluster.  
More than 92% of the total ratings were in the 'relevant' category for all behaviours in the 
pharmaceutical public health cluster (Table 3.7). At least 75% of the overall ratings were in 
the 'relevant' category for all the behaviours in the pharmaceutical care (Table 3.8) and 
organisation & management (Table 3.9) clusters. However, the competencies in the 
professional & personal cluster received comparatively less weighting of relevance with at 
least 70% of the overall ratings in the 'relevant' category for all its behaviours (Table 3.10). 
This was not inclusive of the ratings in the 'low relevant' and 'not relevant' categories, 
suggesting that at least 70% of the survey respondents agreed that all the behaviours in the 
questionnaire were relevant or highly relevant to their practice. The finding is in line with the 
study by Bruno (2011), which showed that at least 70% of the respondents ranked all the 
behaviours in the questionnaire as 'relevant'. Similarly, the Bruno (2011) study also showed 
that the behaviours in the professional and personal cluster of the GbCF v1 received the least 
weighting of relevance in relation to the other three clusters in the questionnaire, as was 
obtained in this research.  
Inspection of the frequency table (Table 3.10) showed that the behaviours with least 
weighting in the professional & personal cluster were related to business (B76), marketing 
(B79), quality control (B90) and research (B87 & B95). The composition of the sample may 
explain the ratings for these behaviours since over two thirds of the respondents were in 
hospital and community practice and therefore are not routinely involved in marketing, 
business and quality control activities (Table 3.1). The sample composition did not however 
explain the relative lower weighting of relevance observed for the research-related 
behaviours (B87 & B95). The rating of these research-related behaviours suggests that the 
survey respondents perceived these behaviours to be relatively less relevant to their practice 
compared to the pharmaceutical care behaviours for example. This is in line with the findings 
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from other research that have shown that pharmacists' generally perceived research-related 
competencies as less important for their practice (Atkinson et al., 2015; Kennie-Kaulbach et 
al., 2012).   
Disagreement was observed in ten behaviours. This included four behaviours in the 
pharmaceutical care cluster [B6 (related assessment of medicines), B13 & B14 (related to 
dispensing), and B20 (related to medicines)]; three behaviours in the organisation & 
management cluster [B32 & 34 (related to reimbursement), & B58 (related to planning 
production)]; and three in the professional & personal cluster [B87 (related to research), B90 
(related to quality control), & B95 (related research)]. The disagreement in the 
pharmaceutical care and organisation & management clusters was related to area of 
pharmacy practice and patient-facing component in daily practice. Respondents in the patient 
facing sectors generally reached consensus on relevance for the disagreed behaviours under 
the pharmaceutical care [B6, B14 & B20] and the organization and management [B32, B34 
& B58] clusters in contrast to respondents from the non-patient facing sectors including 
academic and administrative pharmacy. 
This finding is consistent with evidence from previous research by Bruno (2011) that showed 
that respondents in non-patient facing sectors like academic, laboratory & medicine control, 
and industrial pharmacy rated these same behaviours as not relevant to their practice. It is 
also in line with the scope of practice of pharmacists in this sector since they do not routinely 
carry out medicine use and medicine assessment activities. 
On the other hand, a high percentage (>10%) of the respondents in academic, community, 
and hospital pharmacy rated the disagreed behaviours in the professional and personal cluster 
[B87 (related to applying research findings) and B95 (related to audit and research activities) 
behaviours] as 'not relevant' to practice. These ratings were independent of length of practice 
experience with the result showing a lack of consensus on relevance (N 'not relevant' >10%) 
in the early career (<5years practice experience) and advanced (≥5 years experience) 
practitioners (Table 3.13). Even though the respondents in the non-patient facing sectors 
reached consensus on relevance for the B87 & B95 behaviours under this cluster; the 
disagreement in the cluster was still not consistent with or fully explained by area of practice 
or patient component, particularly because research-related skills are necessary for 
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pharmacists in both the non-patient and patient facing sectors [Table 3.11, 3.12 & 3.13]. Two 
other research-related behaviours (B88 & B93) also had ≥ 20% of the total rating in the 'not 
relevant' and 'low relevance' categories.  
These findings add to the increasing body of evidence from other studies that suggets that 
pharmacists are not routinely involved in research (Armour et al., 2007; Awaisu et al., 2014; 
Fagan et al., 2006; Rosenbloom et al., 2000) and generally view research-related 
competencies to be of low relevance to practice (Hébert et al., 2013; Kanjanarach et al., 2012; 
Liddell, 1996; Saini et al., 2006). It also is in line with the findings of three studies (Kennie-
Kaulbach et al., 2012; Carringtonn et al., 2012 and Atkinsons et al., 2015) included in the 
systematic literature review reported in Chapter 2 of this thesis. Respondents in these later 
studies ranked the research-related behaviours in the respective frameworks low in relevance. 
They reported time constrains due to workload and lack of support as some of the barrier to 
participation in research-related activities in the workplace.   
This finding is significant for the global pharmacy workforce particularly because it suggests 
that if research-related competencies and behaviours are perceived as not relevant, or of low 
relevance for practice by the survey respondents; then it is likely these pharmacists may be 
less motivated or inclined to develop their research skills. The ratings of these behaviours 
also suggest that these pharmacists are not routinely involved in research-related activities. 
This is of concern given that demonstrating the value of the pharmaceutical services provided 
by pharmacists require evidence from well designed and high quality health service 
evaluation and research studies. As such the availability of practitioners that are equipped 
with research skills is paramount for the global pharmacy workforce. 
A high proportion (≥20%) of respondents in community pharmacy perceived the B13 and 
B14 (related to dispensing) behaviours as not relevant to their practice [Table 3.13]. Evidence 
suggest this may be related to the peculiarities of community pharmacy practice in countries 
with severe health workforce shortages (Adje and Oli, 2013; Erdogan et al., 2012; Machula, 
2007; Toklu et al., 2010). Research conducted in countries like Nigeria (Adje and Oli, 2013), 
India (Basak and Sathyanarayana, 2009), Pakistan (Rabbani et al., 2001), Lao (Stenson et al., 
2001) and Zambia (Machula, 2007) suggests that dispensing activities in community 
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pharmacies are mainly carried out by pharmacy assistants, and in some instances by 
untrained sales personnel or clerks This feature may explain the perception of these 
‘dispensing’ behaviours as not relevant by community pharmacists. It also underscores the 
need for formal review and training programmes for community pharmacists and their 
support staff as this poses a high risk potential for patient harm. 
3.6.4 Perception of relevance to practice of the GbCF v1 competencies in relation to 
respondents' country of origin 
Country-specific differences in weighting of relevance were observed in seven (7%) 
behaviours under 5(25%) competencies. This disparity was in the B6 (Assessment of 
medicines – M competency), B25 & B27 (Patient consultation and diagnosis - PCD 
competency), B32 (Budget and reimbursement - BR competency), B45 & B49 (Procurement 
- P competency), and B55 (Supply chain and management - SCM competency) behaviours.  
However, only Nigeria and South Africa showed a lack of consensus on relevance to practice 
for three of these behaviours. These were the B32 (related to reimbursement) for Nigeria, and 
B6 (assessment of medicines) & B49 (related to tenders and bids) behaviours for South 
Africa. This suggests that the observed disparity was not indicative of a lack of consensus for 
the other four behaviours: B25, B27, B45, and B55. It is likely to be indicative of the inter-
country differences in perception of relevance. For example, more respondents from Ghana 
(98%) rated the B27, B32 and B55 behaviours 'relevant' to practice compared to Nigeria 
(85%). Only 47% of the respondents from South Africa rated the B6 behaviour as relevant 
compared to 71% in Ghana and Nigeria, respectively, and 77% in Kenya. More respondents 
from Kenya (98%) rated the B25 and B49 behaviours as 'relevant' compared to Nigeria (89%) 
and South Africa (90%) respectively. 
The observed disparity is likely due to the sample composition in the respective countries. 
Kenya had a higher percentage of the respondents in hospital practice (86%) while Nigeria 
and South Africa on the other hand had less than 50%. More than a third of the respondents 
from South Africa were in academic pharmacy compared to Nigeria, Kenya and Ghana that 
had less than 7%.  
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Overall, though the MANOVA and post-hoc test indicated country-specific differences in 
weighting of relevance for seven behaviours, only two countries showed a lack of consensus 
on relevance to practice for three (B6, B32 & B49) behaviours. It can therefore be argued that 
the GbCF v1 competencies are relevant to practice but with specific inter-nation differences 
in weighting of relevance between the four countries for these seven GbCF v1 behaviours. 
This is in line with studies that have shown the existence of core competencies that are 
relevant and applicable to pharmacy practitioners in different countries (Bruno, 2011; 
Coombes et al., 2010; Meštrović et al., 2012; Rutter et al., 2012). 
3.7 Study Limitations 
This study has a number of potential sources of bias: 
• Online surveys are generally associated with low response rates particularly because it 
restricts the target populations to individuals with Internet access (Bowling, 2009; de 
Vaus, 2002). This feature possibly played a role in the comparatively low replies 
received from ten of the 14 African countries represented in this survey. However, 
this limitation could not be circumvented because of the geographical location of 
potential respondents, cost implication of postal and interview surveys, and the data 
protection laws of the United Kingdom (from where this study was implemented) that 
precluded the use of other survey methods.  
• The dissemination of the survey invite via the FIP media team meant that only the 
pharmacists or pharmacy organisations affiliated with FIP were asked to participate in 
the survey. This therefore excluded potential participants who are pharmacists and 
who practice in countries in Africa, but are not members of the respective national or 
regional leadership bodies or the FIP. Since the survey invite was disseminated via 
the FIP network; it implied that only the 35 FIP member organisations representing 
twenty-three African countries were contacted and invited to participate. This also 
means that 33 countries in Africa were automatically excluded from the study. This 
limitation could not be avoided given that a lack of direct access to membership lists 
or contact persons within the membership organisations in this region made the 
dissemination of the survey invite via the FIP media team the only practical approach.  
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• The survey questionnaire was only available in English language. As such this 
automatically excluded potential respondents from non-Anglophone African countries 
that may otherwise have been interested in participating, therefore precluding the 
generalisability of the survey findings to these countries. Also, repeated attempts to 
contact representative FIP membership organisations in the non-Anglophone 
countries were unsuccessful and therefore precluded the need to use translated 
versions of the survey questionnaire.  
• The length of the survey questionnaire (105 questions presented over six pages) may 
have negatively impacted on the number of survey replies. This was particularly 
obvious with the consistent decrease in number of replies per additional page of 
questionnaire. This could not be avoided given that the survey questionnaire was 
wholly reproduced from the GbCF v1. As such, the length of the questionnaire could 
not shortened. Nevertheless, evidence show that the decrease in number of replies per 
additional page of the questionnaire does not affect the overall quality of the 
responses (Iglesias and Torgerson, 2000). 
• Majority (72.3%) of the total survey respondents were in patient facing roles (hospital 
and community pharmacy; Table 3.1). As such the survey obtained limited data from 
respondents in non-patient facing roles like industrial, academic and administrative 
pharmacy. This therefore makes it difficult to generalise the findings of this research 
to practitioners in these areas of practice. Based on the sample composition, it is 
likely that the study may have benefitted from a stratified sampling approach to 
ensure all the pharmacy practice areas were adequately represented in the sample. 
However, the lack of census data and lack of access to country-level membership lists 
due to the confidentiality and data protection laws of the United Kingdom (where the 
study was conducted), made it impractical to use a quota or stratified sampling 
approach in the study.  
• Although, some authors have indicated that the anonymity provided by web-based 
surveys may provide an avenue for the submission of survey replies from ineligible 
participants (Bowling, 2009; Bryman, 2012; de Vaus, 2002); the risk of this was 
limited in this study since the URL link to the online survey was mainly distributed 
through the FIP membership organisations. Also, the demographic information 
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required respondents to indicate whether they were registered pharmacists or 
intern/pre-registration candidates (Appendix 5). As such, it would have been possible 
to exclude non-pharmacists from this analysis, although this was not necessary as all 
the respondents indicated that they were either registered or intern pharmacists.  
Overall, the convenience and chain sampling strategy and the consequent difficulty with 
calculating the survey response rate as explained earlier in the methodology section (3.2.4; 
p.107), biases the study findings and limits it generalisability even for the four countries with 
high responses in the survey sample. 
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Chapter 4 IDENTIFYING AND EVALUATING ADVANCED 
PHARMACY PRACTICE COMPETENCIES IN A GLOBAL 
CONTEXT  
In 2010, FIPEd developed the FIP Global Competency Framework (GbCF v1). This 
framework was specifically designed to serve as a source document containing the core 
pharmacy practice competencies expected of early career pharmacy practitioners (this means, 
pharmacists with less than five years practice experience) globally. Since its development, 
the GbCF v1 has been successfully used to design pre-service education and training 
curriculum for undergraduate pharmacy students (International Pharmaceutical Federation 
(FIP), 2013). It has also been used to develop country-specific frameworks for in-service 
practitioners in many countries including Ireland (The Pharmaceutical Society of Ireland, 
2013) and the Pacific Island Countries (Brown et al., 2012b). Further studies have validated 
the GbCF v1 using evidence from sixty-four countries (Bruno, 2011).  
The validation of the GbCF v1 and its subsequent use as a mapping tool for the development 
of country-specific frameworks around the world, alongside similar evidence from the field 
of medicine, has underscored the importance of a global competency framework. Further 
work is now necessary to identify the core competencies required for global advanced 
pharmacy practice.  
4.1 Study Design 
A literature review was conducted to identify the methodological processes used in the 
development of competency frameworks. The review identified four key methods. These are: 
 Systematic literature reviews; 
 Expert group and stakeholder consultation;  
 Consensus development methods; and 
 Profession-wide consultations and surveys. 
 
In line with these methods, this study was conducted in five stages. The aim and design of 
each stage was: 
 
  
 
 
161
Stage 1: Systematic literature search, review and survey of pharmacy organisations to 
identify any existing framework or practice standards for advanced pharmacy practice  
Stage 2: Content analysis of such frameworks/standards to identify and extract the 
competencies and behaviours that described advanced pharmacy practice  
Stage 3: Expert review of the outcome of content analysis and consensus development 
Stage 4: Evaluation of the competencies via a crossover mapping experiment and  
Stage 5: Qualitative interviews to obtain practitioner inputs and evaluate perceptions of 
the identified competencies.  
 
The objectives of each of these stages are presented under the relevant sections.  
 
 
 
Figure 4.1: Schematic of the study design  
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4.2 Stage 1 | Systematic Literature Search and Survey of Pharmacy Organisations  
The objective of this stage was to identify national or regional competency frameworks for 
advanced pharmacy practice.  
 
A 2012 global survey of pharmacy organisation and professional bodies conducted by FIPEd 
identified two frameworks for advanced pharmacy practice (International Pharmaceutical 
Federation, 2012). These frameworks: the Royal Pharmaceutical Society Advanced 
Pharmacy Framework (RPS-APF) and the Advanced Pharmacy Practice Framework for 
Australia (APPF); were developed from similar bibliographic sources and adapted to the 
local needs of the pharmacy workforce in the United Kingdom and Australia respectively 
(Royal Pharmaceutical Society of Great Britain, 2013b; The Advanced Pharmacy Practice 
Framework Steering Committee (APPFSC), 2012).  
 
The Australia APPF was adapted from five advanced practice frameworks developed 
specifically for paediatrics, critical care, emergency medicine, cardiology, and oncology 
pharmacy in Australia (Jackson et al, 2015). These five frameworks were all designed and 
mapped to the Competency Development and Evaluation Group (CODEG) Advanced to 
Consultant Level Framework of the United Kingdom (AcLF), and adapted to the needs of the 
Australian pharmacy workforce in the respective clinical care areas (Jackson et al., 2015a, 
2015b). Since it development, the AcLF has undergone a number of expert reviews, 
consensus and profession wide consultations culminating in its adoption by the Royal 
Pharmaceutical Society of Great Britain as the national framework for advanced pharmacy 
practice in the United Kingdom. The framework was then renamed the RPS Advanced 
Pharmacy Framework (RPS-APF) (Royal Pharmaceutical Society of Great Britain, 2013b).  
 
A literature search to identify other competency frameworks specific for advanced pharmacy 
practice (presented in Chapter 2 of this report) did not yield any additional national 
frameworks.  
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The frameworks from America (American College of Clinical Pharmacy, 2008b) and Canada 
(National Association of Pharmacy Regulatory Authorities, 2014b) contained competencies 
for specialised clinical pharmacy roles. Even though these frameworks are designed for 
complex clinical roles—which are a form of advanced pharmacy practice— they contained 
non-generic competencies that are not applicable to roles outside the specified specialties. As 
a result, these frameworks were not appropriate for inclusion in this study.   
 
A subsequent 2014 global survey of national pharmacy organisations by FIPEd also did not 
yield any new framework for advanced pharmacy practice (International Pharmaceutical 
Federation, 2014). 
 
4.3 Stage 2 | Content Analysis of Advanced Pharmacy Competency Frameworks 
The goal of this phase was to identify and extract the competencies and behaviours that 
describe the different levels of advanced pharmacy practice in the identified frameworks.  
 
The key objectives were:  
i. To identify and categorise the emergent themes from the two frameworks 
ii. To extract the specific competencies contained in the frameworks 
iii. To cross-match and map the competencies and behavioural descriptors in the two 
frameworks. 
4.3.1 Methodology  
A qualitative content analysis of the two frameworks was conducted based on the method 
described by Krippendorf (2013, p.84). To minimise subjectivity, the analysis was conducted 
semantically in accordance with the manifest content of the text in each framework. This 
means it was done based on the language used to describe the text. AU (the researcher) 
carried out an initial and iterative examination of the overall content of the two frameworks. 
This resulted in the identification of the patterns and themes in the two frameworks.  
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The cluster headings and level of practice labels in the two frameworks were then identified, 
categorised and cross-matched (Table 4.1 & 4.2). The themes that were broadly based on the 
identified cluster headings were collated to form a template. This template was used to 
extract and cross-match the competencies and the corresponding behaviours in the two 
frameworks (Table 4.3).  
The sematic differences in the labels of the cluster headings, level of practice, competencies, 
and in the description of the behaviours were identified and highlighted. The outcome of the 
content analysis was represented in a grid and presented to an expert panel for consensus 
development. This was done to limit subjectivity and assure the reproducibility and reliability 
of the research outcomes.  
4.3.1.1 Data handling and analysis 
The first objective of the content analysis was to identify patterns and categorise the 
emergent themes in the two frameworks. An initial categorisation was done in relation to the 
cluster headings and level of advanced practice identified in the frameworks.  
The cluster headings were first categorised with six clusters identified in the RPS-APF (UK) 
and five in the APPF (Australia). Observed semantic differences between the cluster headings 
in the two frameworks were underlined. Six broad themes were then developed from these 
cluster headings. Table 4.1 gives the cluster headings and the themes developed.  
Table 4.1: Domain headings in the RPS-APF (UK) and APPF (Australia)  
 
Themes 
 
RPS-APF (UK) 
  
APPF (AU)  
Expertise and expert skills  Expert professional practice  Expert professional practice  
Collaborative practice Collaborative working 
relationship 
Communication, 
collaboration and teamwork  
Leadership Leadership  
Leadership and 
management Management  Management  
Education, training & 
professional development  
Education, training and 
development 
Professional and ethical 
practice  
Critical analysis, research 
and education 
Critical appraisal, evaluation and 
research  
Research and evaluation  
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The next categorisation involved identifying the distinct level of advanced pharmacy practice 
described in the two frameworks. Three levels of advanced pharmacy practice were identified 
in each framework. Semantic differences in the labels of the levels of practice were also 
identified. The levels of practice increased in complexity from advanced stage 1 to Mastery 
in the RPS-APF, and from transition to advanced level in the APPF. 
Table 4.2 shows the labels for the stages/levels in the two frameworks (items from the APPF 
are shown in blue font). 
Table 4.2: Levels/Stages of advance practice in the RPS-APF (UK) and APPF 
(Australia) 
 
RPS-APF (UK) 
 
APPF (AU) 
Advanced stage 1 Transition level  
Advanced stage 2 Consolidation level  
Mastery  Advanced level  
 
The second objective of the content analysis was to identify and extract the specific 
competencies contained in the two frameworks. Themes developed from the cluster headings 
(shown in Table 4.1) were collated and used to extract the competencies in the two 
frameworks. Semantic differences in the competency labels were observed between the 
frameworks. These differences in the labeling of competencies are underlined in Table 4.3.  
The third objective of the content analysis was to match the extracted competencies with the 
respective behavioural descriptors in the two frameworks. Again, the themes and competency 
labels formed the template used for this matching.  
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Table 4.3: Themes and sub-themes derived from the two frameworks including the 
corresponding competencies 
 
  
THEMES SUB-THEMES CORRESPONDING COMPETENCIES 
RPS-APF (UK) APPF (AU) 
 
Expertise and 
Expert Practice  
Expert skills Expert skills and knowledge Acquire expert skills and knowledge 
Delivery of expertise 
Delivery of professional expertise 
Deliver accountable and flexible patient 
care  
Professional autonomy  Reasoning and judgment Use reasoning and judgment  
Reasoning & judgment  Professional autonomy Professional autonomy  
 
Collaborative 
Practice  
Communication Communication Use appropriate communication skills 
Team work & consultation  Team work and consultation  Engage in team work 
 
 
 
 
 
Leadership  
Strategic context & 
planning Strategic context
 Understand strategic context and 
contribute to strategic planning  
Governance 
Governance 
Understand and contribute to clinical 
governance  
Vision 
Vision 
Understand and contribute to strategic 
vision 
Innovation & service 
delivery 
Innovation Contribute to innovation and service 
development  Service development 
Motivation Motivation Motivates self and others 
 
 
 
 
 
 
 
 
Management  
National priorities Implementing national priorities Support and assist implementation of 
national priorities  
Resource Utilisation 
Resource Utilisation 
Understand and contributes to effective 
use of resources  
Standards of practice 
Standards of practice 
Applies and monitors standards of 
practice  
Managing risk 
Managing risk 
Contributes to the identification and 
effective management of risk 
Managing performance Managing performance Promote improved performance 
Project management Project management 
Understand and undertake project 
management  
Managing change Managing change 
Understand change management 
principles and lead change  
Strategic planning Strategic planning 
Understand strategic context and 
contribute to strategic planning 
Working across boundaries Working across boundaries Work across boundaries  
 
 
Education, 
Training and 
Professional 
Development  
Role model & mentorship 
Role model Serve as role model and mentor to others
Mentorship 
Education and training Conducting education and training Conduct education and training  
Professional development Professional development Contribute to professional development  
Link practice and 
education 
Links practice and education 
Links practice and education  
Educational policy Educational policy Educational policy  
 
 
 
 
 
Critical Analysis, 
Evaluation and 
Research 
Critical evaluation Critical evaluation Undertake critical evaluation activities  
Identity gaps in evidence 
base 
Identity gaps in evidence base Identifies gaps in evidence base  
Develops and evaluates 
research protocols 
Develops and evaluates research 
protocols 
 
Design and deliver research projects   to 
address gaps in the evidence  Creates Evidence  Creates evidence 
Research evidence into 
working practice 
Research evidence into working 
practice 
Apply research evidence into working 
practice  
Supervises others 
undertaking research 
Supervises others undertaking 
research 
Supervises others undertaking research 
Establishes research 
partnerships 
Establishes research partnerships 
Establish research partnerships 
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4.3.2 Content analysis results  
Thirty-four competencies in the RPS-APF and 30 in the APPF were identified and extracted 
at this stage of the content analysis. Competency labels that were identified to be 
semantically similar were matched. This means that a competency from one framework (and 
its corresponding behavioural descriptor) was cross-matched with a semantically similar 
competency from the other framework as shown in Table 4.3.  
In total, 123 behavioural descriptors defined across three levels of advanced practice were 
extracted from the RPS-APF, while 114 corresponding descriptors were extracted from the 
APPF. The behavioural descriptors under a particular competency in the RPS-APF were 
cross-matched with the behavioural descriptors of a similar competency in the APPF. The 
paired behaviours formed a ‘behavioural adjacency’. This cross matching produced 114 
behavioural adjacencies each containing a pair of behavioural dsecriptors identified to be 
related semantically.  
A matrix of the competencies and corresponding behavioural adjacencies created from this 
mapping process is presented in Tables 4.4 to 4.33. Items obtained from the APPF are 
presented in blue font while those from the RPS-APF are shown in black font in these tables. 
Observed semantic differences in the competency labels and behavioural descriptors are 
underlined on these tables.  
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Table 4.4: Analysis of the documents regarding 'expert skills'  
(Items from the APPF are shown in blue font while those from the RPS-APF are in black font. The semantic differences in the description of the 
items are underlined). 
 
 
COMPETENCY 
 
DEVELOPMENTAL DESCRIPTORS 
Advanced Stage 1 
(Transition Level) 
Advanced Stage 2 
(Consolidation Level) 
Mastery 
(Advanced Level) 
 
 
 
 
Expert skills and knowledge  
(UK) 
 
Demonstrates general pharmaceutical 
skills and knowledge in core areas 
 
Demonstrates in-depth 
pharmaceutical skills and 
knowledge in defined area(s) 
 
Advances the knowledge base in 
defined area(s) 
 
In addition for patient focused roles: Is 
able to plan, manage, monitor, advise 
and review general pharmaceutical 
care programmes for patients in core 
areas 
 
 
In addition for patient focused 
roles: Is able to plan, manage, 
monitor, advise and review in-
depth/complex pharmaceutical care 
programmes for patients in defined 
area(s) 
 
In addition for patient focused roles: 
Advances in-depth/complex 
pharmaceutical care programmes for 
patients 
 
 
Acquire expert skills and 
knowledge (AU) 
 
Demonstrates general clinical 
knowledge in core practice areas 
 
 
Demonstrates comprehensive, high 
level clinical knowledge in defined 
practice area(s) 
 
Advances knowledge in defined 
practice area(s) 
 
Able to plan, manage, monitor, advise 
and review patient care in core practice 
areas 
 
Able to plan, manage, monitor 
advise and review patient care 
programs in defined practice area(s) 
 
Advances patient care programs in 
defined practice area(s) 
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Table 4.5: Analysis of the documents regarding 'delivery of professional expertise' 
Items from the APPF are shown in blue font while those from the RPS-APF are in black font. The semantic differences in the description of the 
items are underlined). 
 
 
COMPETENCY 
 
DEVELOPMENTAL DESCRIPTORS 
 
Advanced Stage 1 
(Transition Level) 
Advanced Stage 2 
(Consolidation Level) 
Mastery 
(Advanced Level) 
 
 
Delivery of professional 
expertise  (UK)  
 
Demonstrates accountability for 
delivering professional expertise and 
direct service provision as an 
individual  
 
Demonstrates accountability for the 
delivery of professional services 
and expertise via a team or directly 
to groups of patients/clients/users  
 
Demonstrates accountability for the 
delivery of professional expertise at a 
defined higher level. May include 
providing expertise and service 
delivery nationally or at a strategic 
level 
 
Deliver accountable and flexible 
patient care (AU) 
 
Accepts accountability for patient care 
services delivered directly to 
individual patient 
 
Accepts accountability for patient 
care services delivered directly to a 
defined patient group 
 
Accepts accountability for patient 
care services delivered in a defined 
practice area(s) 
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Table 4.6: Analysis of the documents regarding 'reasoning and judgment'  
(Items from the APPF are shown in blue font while those from the RPS-APF are in black font. The semantic differences in the description of the 
items are underlined). 
 
 
COMPETENCY 
DEVELOPMENTAL DESCRIPTORS 
 
Advanced Stage 1 
(Transition Level) 
Advanced Stage 2 
(Consolidation Level) 
Mastery 
(Advanced Level) 
 
 
 
Reasoning and Judgement  
(UK)  
 
Demonstrates ability to use skills in 
a range of routine situations 
requiring analysis or comparison of 
a range of options 
 
Demonstrates ability to use skills 
to make decisions in complex 
situations where there are several 
factors that require analysis, 
interpretation and comparison  
 
Demonstrates ability to use skills to 
manage difficult and dynamic 
situations 
Recognises priorities when problem-
solving and identifies deviations 
from the normal pattern 
Demonstrates an ability to see 
situations holistically 
Demonstrates ability to make 
decisions in the absence of evidence 
or data or when there is conflicting 
evidence or data 
 
 
 
Use reasoning and judgment 
(AU) 
 
Demonstrates ability to compare 
options or apply analytical skills in a 
range of routine situations 
Demonstrates ability to make 
decisions in complex situation 
where several factors require 
analysis, interpretation and 
comparison 
 
Demonstrates ability to apply 
expertise to assess complex and 
dynamic situations 
Demonstrates ability to recognise 
priorities when problem solving and 
identify deviations from the normal 
pattern 
Demonstrates ability to interpret 
and synthesise available evidence 
and/or data to assess clinical 
situations and therapeutic option 
Demonstrates ability to assess 
clinical situations and therapeutic 
options in the absence of evidence 
or data or where there is conflicting 
evidence or data 
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Table 4.7: Analysis of the documents regarding ‘professional autonomy’ 
(Items from the APPF are shown in blue font while those from the RPS-APF are in black font. The semantic differences in the description of the 
items are underlined). 
 
 
COMPETENCY 
 
DEVELOPMENTAL DESCRIPTORS 
 
Advanced Stage 1 
(Transition Level) 
Advanced Stage 2 
(Consolidation Level) 
Mastery 
(Advanced Level) 
 
 
Professional autonomy  (UK)  
 
Is able to follow legal, ethical, 
professional and organisational 
policies/procedures and codes of 
conduct. 
 
Is able to take action based on own 
interpretation of broad professional 
policies/procedures where 
necessary 
 
Is able to interpret relevant 
policy and strategy, in order to 
establish goals and standards for 
others within the defined area(s)  
 
 
Use professional autonomy (AU) 
 
Demonstrate ability to follow legal, 
ethical, professional and 
organisational policies/procedures 
and codes of conduct 
 
Demonstrates ability to act 
according to personal interpretation 
of broad professional 
policies/procedures where 
necessary 
 
Demonstrates ability to interpret 
government health care policy 
and strategy to establish 
policies/procedures, codes 
and/or standards for others 
within defined practice area 
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Table 4.8: Analysis of the documents regarding ‘communication’ 
Items from the APPF are shown in blue font while those from the RPS-APF are in black font. The semantic differences in the description of the 
items are underlined). 
 
 
COMPETENCY 
DEVELOPMENTAL DESCRIPTORS 
Advanced Stage 1 
(Transition Level) 
Advanced Stage 2 
(Consolidation Level) 
Mastery 
(Advanced Level) 
 
 
 
Communication  (UK) 
 
Demonstrates use of appropriate 
communication to gain the co-
operation of relevant stakeholders 
(including patients, senior and peer 
colleagues, and other professionals 
where possible) 
 
Demonstrates use of appropriately 
selected communication skills to 
gain co-operation of small groups 
of relevant stakeholders within the 
organisation 
 
Demonstrates ability to present 
complex, sensitive or contentious 
information to large groups relevant 
stakeholders 
Demonstrates ability to communicate 
where the content of the discussion is 
explicitly defined 
Demonstrates ability to 
communicate where the content of 
the discussion is based on 
professional opinion 
Demonstrates ability to communicate in 
a hostile, antagonistic or highly emotive 
atmosphere 
 
Use appropriate communication 
skills (AU) 
Demonstrates use of appropriate 
communication to gain the co- 
operation of individual patients, 
colleagues and other health 
professionals 
Demonstrates use of appropriately 
selected communication skills to 
gain co-operation of patients, 
colleagues, clinicians and/or 
managers 
 
Demonstrates ability to present 
complex, sensitive or contentious 
information to large groups of patients, 
clinicians and/or managers 
Demonstrates ability to communicate 
effectively where content of 
discussion is explicitly defined 
Demonstrates ability to 
communicate effectively where the 
content of the discussion is based 
on personal opinion 
Demonstrates ability to communicate 
effectively in a hostile, antagonistic or 
highly emotive atmosphere 
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Table 4.9: Analysis of the documents regarding ‘team work and consultation’ 
(Items from the APPF are shown in blue font while those from the RPS-APF are in black font. The semantic differences in the description of the 
items are underlined). 
 
 
COMPETENCY 
 
DEVELOPMENTAL DESCRIPTORS 
 
Advanced Stage 1 
(Transition Level) 
Advanced Stage 2 
(Consolidation Level) 
Mastery 
(Advanced Level) 
 
 
 
Team work and consultation (UK)   
 
Demonstrates ability to work as a 
member of a team 
Demonstrates ability to work as an 
acknowledged member of the 
multidisciplinary team  
Works across boundaries to build 
relationships and share information, 
plans and resources 
Recognises personal limitations and 
refers to more appropriate 
colleague(s) when necessary 
Consulted with the organisation for 
advice which requires in-depth 
professional expertise 
Sought as an opinion leader both 
within the organisation and in the 
external environment 
 
Engage in teamwork and 
consultation (AU) 
Demonstrates ability to work as a 
member of the pharmacy team 
Demonstrates ability to work as a 
member of a multidisciplinary team 
 
Works across workplace boundaries 
to build relationships and share 
information, plans and resources 
 
Recognises personal limitations and 
demonstrates ability to refer to more 
experienced colleagues 
Accepts expert advice through 
consultation within the workplace/ 
organisation 
Provides expert advice within and 
beyond the workplace/organisation 
as a recognised opinion leader 
  
 
 
174
Table 4.10: Analysis of the documents regarding ‘strategic context’ and ‘strategic planning’ 
(Items from the APPF are shown in blue font while those from the RPS-APF are in black font. The semantic differences in the description of the 
items are underlined). 
 
 
COMPETENCY 
 
DEVELOPMENTAL DESCRIPTORS 
Advanced Stage 1 
(Transition Level) 
Advanced Stage 2 
(Consolidation Level) 
Mastery 
(Advanced Level) 
 
 
Strategic context AND strategic 
planning (UK)  
 
Demonstrates understanding of the 
needs of stakeholders. Practice 
reflects relevant local and national 
policy 
 
Demonstrates ability to incorporate 
relevant national policy to influence 
local strategy 
 
Demonstrates active participation in 
creating relevant national policies 
Demonstrates ability to think 4-12 
months ahead within a defined area. 
Plans the work programme to align 
with strategy  
Demonstrates ability to think over a 
year ahead within a defined area 
Thinks long term and sector wide. Takes 
the long- term perspective 
 
Understand strategic context and 
contribute to strategic planning 
(AU) 
 
Demonstrates understanding of the 
needs of stakeholders and practice 
reflects government health care 
policy 
Demonstrates ability to incorporate 
government health care policy or 
priorities to influence local strategy 
Participates in development of 
government health care policy/ strategy 
or priorities and leads its integration into 
local strategy 
 
Demonstrated ability to plan up to 12 
months ahead and in alignment with 
established strategy 
Demonstrated ability to plan more 
than one year ahead taking account 
of strategic plan 
Demonstrated ability to develop a long-
term plan taking a holistic view of the 
practice environment. 
The competency ‘strategic context’ is from the leadership domain in the APPF while ‘strategic planning’ is from the management domain in the RPS-APF. 
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Table 4.11: Analysis of the documents regarding ‘governance’ 
(Items from the APPF are shown in blue font while those from the RPS-APF are in black font. The semantic differences in the description of the 
items are underlined). 
 
 
COMPETENCY 
 
DEVELOPMENTAL DESCRIPTORS 
 
Advanced Stage 1 
(Transition Level) 
Advanced Stage 2 
(Consolidation Level) 
Mastery 
(Advanced Level) 
 
 
Governance (UK)  
Demonstrates understanding of the 
pharmacy role in governance. 
Implements this appropriately within 
the workplace 
 
 
Influences the governance agenda 
for the team and/or service 
 
Shapes and contributes to the 
governance agenda at a higher level 
 
Understand and contribute to 
clinical governance (AU) 
 
Demonstrates understanding of the 
pharmacist’s role in clinical 
governance and practice reflects the 
workplace framework 
 
 
Influences the clinical governance 
agenda for the team 
 
Shapes and contributes to the clinical 
governance agenda of the workplace/ 
organisation 
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Table 4.12: Analysis of the documents regarding ‘vision’ 
Items from the APPF are shown in blue font while those from the RPS-APF are in black font. The semantic differences in the description of the 
items are underlined). 
 
 
COMPETENCY 
 
DEVELOPMENTAL DESCRIPTORS 
 
Advanced Stage 1 
(Transition Level) 
Advanced Stage 2 
(Consolidation Level) 
Mastery 
(Advanced Level) 
 
 
Vision  (UK)  
 
Demonstrates understanding of, 
and contributes to, the workplace 
vision 
 
Creates vision of future and 
translates this into clear 
directions for others 
 
Convinces others to share the vision 
at a higher level 
 
Understand and contribute to 
the strategic vision  (AU) 
 
Demonstrates understanding of, 
and contributes to, the vision for 
professional services 
 
 
Creates the vision for 
professional services and 
translates it into clear goals for 
the pharmacy team 
 
Influences groups of colleagues, 
clinicians and/or managers to share 
the vision for professional services 
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Table 4.13: Analysis of the documents regarding ‘innovation’ and ‘service development’  
(Items from the APPF are shown in blue font while those from the RPS-APF are in black font. The semantic differences in the description of the 
items are underlined) 
 
 
COMPETENCY 
 
DEVELOPMENTAL DESCRIPTORS 
Advanced Stage 1 
(Transition Level) 
Advanced Stage 2 
(Consolidation Level) 
Mastery 
(Advanced Level) 
 
 
 
Innovation and Service 
Development (UK)  
 
 
Demonstrates ability to improve 
quality within limitations of service    
 
 
Recognises and implements 
innovation from the external 
environment 
 
Takes the lead to ensure innovation 
produces demonstrable improvement 
Reviews last year’s progress and 
develop clear plans to achieve results 
within priorities set by others  
Develops clear understanding of 
priorities and formulates practical 
short-term plans in line with 
workplace strategy 
 
Relates goals and actions to strategic 
aims of organisation and profession 
 
 
Contribute innovation and service 
development (AU) 
 
Demonstrates ability to improve the 
quality or range of services with 
limited supervision.   
 
Recognises and implements 
innovation from the external 
environment without supervision 
 
Leads efforts to ensure innovation 
produces demonstrable improvement in 
service delivery 
 
Applies priorities set by others to 
develop clear plans for services 
based on review of recent past 
performance 
 
 
Develops future plans for 
professional services based on a 
clear understanding of priorities. 
 
Relates goals and actions to strategic 
aims of the workplace or profession 
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Table 4.14: Analysis of the documents regarding ‘motivation'. 
(Items from the APPF are shown in blue font while those from the RPS-APF are in black font. The semantic differences in the description of the 
items are underlined).  
 
 
COMPETENCY 
 
DEVELOPMENTAL DESCRIPTORS 
 
Advanced Stage 1 
(Transition Level) 
Advanced Stage 2 
(Consolidation Level) 
Mastery 
(Advanced Level) 
 
 
Motivational (UK) 
 
Demonstrates ability to 
motivate self to achieve goals 
 
Demonstrates ability to motivate 
individuals and/or the team 
 
Demonstrates ability to motivate individuals 
and/or teams at a higher level. May include more 
strategic motivational activities at local, 
institutional and national levels 
 
 
Motivates self and others (AU) 
 
Demonstrates ability to self-
motivate to achieve goals 
 
Demonstrates ability to motivate 
individuals in the team. 
 
Demonstrated ability to motivate individuals 
beyond the team 
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Table 4.15: Analysis of the documents regarding ‘implementing national priorities’   
(Items from the APPF are shown in blue font while those from the RPS-APF are in black font. The semantic differences in the description of the 
items are underlined). 
 
 
COMPETENCY 
 
DEVELOPMENTAL DESCRIPTORS 
 
Advanced Stage 1 
(Transition Level) 
Advanced Stage 2 
(Consolidation Level) 
Mastery 
(Advanced Level) 
 
 
Implementing national priorities  
(UK) 
 
Demonstrates understanding of the 
implications of national priorities for 
the team and/or service 
 
Shapes the response of the team 
and/or service to national priorities 
 
Accountable for the direct delivery of 
national priorities at a higher level 
 
Support and assist implementation 
of national priorities  (AU) 
 
Demonstrates understanding of the 
implications of national health care 
priorities for the team 
 
Influences the response of the team 
to national health care priorities 
 
Leads response of the team to national 
health care priorities 
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Table 4.16: Analysis of the documents regarding ‘resource utilisation’ 
(Items from the APPF are shown in blue font while those from the RPS-APF are in black font. The semantic differences in the description of the 
items are underlined). 
 
 
COMPETENCY 
 
DEVELOPMENTAL DESCRIPTORS 
 
Advanced Stage 1 
(Transition Level) 
Advanced Stage 2 
(Consolidation Level) 
Mastery 
(Advanced Level) 
 
 
Resource utilisation (UK) 
 
Demonstrates understanding of 
the process for effective 
resource utilisation 
 
Demonstrates ability to effectively 
manage resources 
 
Demonstrates ability to 
reconfigure the use of available 
resources 
 
Understands and contributes to the 
effective use of resources (AU) 
 
Demonstrates understanding of 
the process for effective 
resource utilisation 
 
Demonstrates effective 
management of resources 
 
Demonstrates ability to assess 
and reassign resources to improve 
effectiveness of use 
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Table 4.17: Analysis of the documents regarding ‘standards of practice’  
(Items from the APPF are shown in blue font while those from the RPS-APF are in black font. The semantic differences in the description of the 
items are underlined). 
 
 
COMPETENCY 
 
DEVELOPMENTAL DESCRIPTORS 
 
Advanced Stage 1 
(Transition Level) 
Advanced Stage 2 
(Consolidation Level) 
Mastery 
(Advanced Level) 
 
 
Standards of practice (UK) 
 
Demonstrates understanding of, and 
conforms to, relevant standards of 
practice 
 
Demonstrates ability to set and 
monitor standards of practice at 
team and/or service level 
 
Accountable for the setting and 
monitoring of standards at a higher level 
 
Applies and monitors standards of 
practice (AU) 
 
Demonstrates understanding of, and 
conforms to relevant standards of 
practice 
 
Accountable for setting and 
monitoring standards of practice 
beyond the team 
 
Accountable for setting and monitoring 
standards of practice at the team level 
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Table 4.18: Analysis of the documents regarding ‘managing risk’ 
(Items from the APPF are shown in blue font while those from the RPS-APF are in black font. The semantic differences in the description of the 
items are underlined). 
 
 
COMPETENCY 
 
DEVELOPMENTAL DESCRIPTORS 
 
Advanced Stage 1 
(Transition Level) 
Advanced Stage 2 
(Consolidation Level) 
Mastery 
(Advanced Level) 
 
 
 
Managing Risk  (UK) 
 
Demonstrates ability to identify 
and resolve risk management 
issues according to 
policy/protocol  
 
Develops risk management 
policies/protocols for the team and/or 
service, including identifying and resolving 
new risk management issues 
 
Is accountable for developing risk 
management policies/procedures at 
a higher level, including identifying 
and resolving new risk 
management issues 
 
 
Contributes to the 
identification and effective 
management of risk (AU) 
 
Demonstrates ability to identify 
and resolve risk management 
issues using established 
policy/procedure 
 
Is accountable for developing risk 
policy/procedure for managing existing and 
newly identified 
 
Is accountable for developing 
policy/ procedure for managing 
existing and newly identified risks 
beyond the team. 
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Table 4.19: Analysis of the documents regarding ‘managing performance’ 
(Items from the APPF are shown in blue font while those from the RPS-APF are in black font with the semantic differences in the description of 
the items are underlined). 
 
 
COMPETENCY 
 
DEVELOPMENTAL DESCRIPTORS 
 
Advanced Stage 1 
(Transition Level) 
Advanced Stage 2 
(Consolidation Level) 
Mastery 
(Advanced Level) 
 
 
Managing Performance (UK) 
 
Follows professional and 
organisational policies/procedures 
relating to performance management 
 
Is accountable for performance 
management for a team or group of 
personnel 
 
 
Is accountable for performance 
management at a higher and/or 
institutional level 
 
 
Promote Improved performance 
(AU) 
 
 
Contributes to performance 
management processes in accordance 
with established policy/procedure. 
Refers appropriately to colleagues for 
guidance as require 
 
 
Is accountable for performance 
management of team members 
 
Is accountable for performance 
management of the team as a whole 
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Table 4.20: Analysis of the documents regarding ‘project management’ 
(Items from the APPF are shown in blue font while those from the RPS-APF are in black font. The semantic differences in the description of the 
items are underlined). 
 
 
 
COMPETENCY 
 
DEVELOPMENTAL DESCRIPTORS 
 
Advanced Stage 1 
(Transition Level) 
Advanced Stage 2 
(Consolidation Level) 
Mastery 
(Advanced Level) 
 
 
Project management (UK) 
 
Demonstrates understanding of the 
principles of project management 
 
Demonstrates ability to successfully 
manage a project at team and/or 
service level 
 
Demonstrates ability to successfully 
manage a project at a higher level 
 
 
Understand and undertake project 
management (AU) 
 
Demonstrates understanding of the 
principles of project management and 
manages simple projects. Refers 
appropriately to colleagues for 
guidance as required 
 
 
Demonstrates ability to successfully 
manage a project at team level 
 
Demonstrates ability to plan and 
supervise the implementation of a 
project 
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Table 4.21: Analysis of the documents regarding ‘managing change' 
(Items from the APPF are shown in blue font while those from the RPS-APF are in black font. The semantic differences in the description of the 
items are underlined). 
 
 
COMPETENCY 
 
DEVELOPMENTAL DESCRIPTORS 
 
Advanced Stage 1 
(Transition Level) 
Advanced Stage 2 
(Consolidation Level) 
Mastery 
(Advanced Level) 
 
 
Managing Change (UK)  
 
Demonstrates understanding of the 
principles of change management 
 
Demonstrates ability to manage a 
process of change for the team 
and/or service 
 
Demonstrates ability to manage a 
process of change at a higher level 
 
Understand change management 
principles and lead change (AU) 
 
Demonstrates understanding of the 
principles of change management 
 
Demonstrates ability to manage a 
process of change for the team 
 
Demonstrates ability to lead a change 
process beyond the team/workplace or 
across disciplines 
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Table 4.22: Analysis of the documents regarding ‘working across boundaries’ 
(Items from the APPF are shown in blue font while those from the RPS-APF are in black font. The semantic differences in the description of the 
items are underlined). 
 
 
COMPETENCY 
 
DEVELOPMENTAL DESCRIPTORS 
 
Advanced Stage 1 
(Transition Level) 
Advanced Stage 2 
(Consolidation Level) 
Mastery 
(Advanced Level) 
 
 
Working across boundaries  
(UK) 
 
Demonstrates ability to extend 
boundaries of service delivery within 
the team 
 
Demonstrates ability to extend the 
boundaries of the service across 
more than one team 
 
Demonstrates the value of extending 
service delivery across boundaries in the 
external environment 
 
Work across boundaries (AU) 
 
Demonstrates ability to extend 
boundaries of service delivery within 
the pharmacy team 
 
Demonstrates ability to extend the 
boundaries of the service across 
more than one team 
 
Demonstrates the value of extending the 
boundaries of service delivery across 
professions and/or external environment 
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Table 4.23: Analysis of the documents regarding ‘role model’ and ‘mentorship’.  
(Items from the APPF are shown in blue font while those from the RPS-APF are in black font. The semantic differences in the description of the 
items are underlined). 
 
 
COMPETENCY 
 
DEVELOPMENTAL DESCRIPTORS 
Advanced Stage 1 
(Transition Level) 
Advanced Stage 2 
(Consolidation Level) 
Mastery 
(Advanced Level) 
 
 
 
 
Role model AND mentorship  
(UK) 
 
Understands and demonstrates the 
characteristics of a role model to 
members in the team and/or service 
 
Demonstrates the characteristics of 
an effective role model at a higher 
level 
 
Is able to develop effective role model 
behaviour in others 
 
Demonstrates understanding of the 
mentorship process 
 
Demonstrates ability to effectively 
mentor others within the team 
and/or service 
 
Demonstrates ability to effectively 
mentor outside the team and/or service 
 
 
Serves as role model and mentor 
to others (AU) 
 
Understands and demonstrates the 
characteristics of a role model to 
members of the team 
 
Demonstrates the characteristics of 
an effective role model within and 
beyond the team 
 
Demonstrates ability to engender role 
model behaviour in others. 
 
Demonstrates understanding of the 
mentorship process 
 
Demonstrates ability to effectively 
mentor others within the team 
 
Demonstrates ability to effectively 
mentor outside the team 
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Table 4.24: Analysis of the documents regarding ‘conducting education and training’. 
(Items from the APPF are shown in blue font while those from the RPS-APF are in black font. The semantic differences in the description of the 
items are underlined). 
 
 
COMPETENCY 
 
DEVELOPMENTAL DESCRIPTORS 
 
Advanced Stage 1 
(Transition Level) 
Advanced Stage 2 
(Consolidation Level) 
Mastery 
(Advanced Level) 
 
 
Conducting education and 
training (UK)  
 
Demonstrates ability to conduct 
teaching and assessment effectively 
according to a learning plan with 
supervision from a more experienced 
colleague 
 
Demonstrate ability to assess the 
performance and learning needs of 
others. Demonstrates ability to plan 
a series of effective learning 
experiences for others 
 
 
Demonstrates ability to design and 
manage a course of study, with 
appropriate use of teaching, assessment 
and study methods 
 
Conduct education and training 
(AU) 
 
Demonstrates ability to conduct 
teaching efficiently according to an 
agreed plan with guidance from a 
more experienced colleague 
 
 
 
Able to assess the performance and 
learning needs of others. 
Demonstrates ability to plan a series 
of effective learning experience for 
others 
 
Demonstrates ability to design and 
manage a course of study, with 
appropriate use of teaching, assessment 
and study methods  
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Table 4.25: Analysis of the documents regarding ‘professional development’. 
(Items from the APPF are shown in blue font while those from the RPS-APF are in black font. The semantic differences in the description of the 
items are underlined). 
 
 
COMPETENCY 
 
DEVELOPMENTAL DESCRIPTORS 
 
Advanced Stage 1 
(Transition Level) 
Advanced Stage 2 
(Consolidation Level) 
Mastery 
(Advanced Level) 
 
 
Professional development   (UK)  
 
Demonstrates self-development 
through continuous professional 
development activity 
 
 
Facilitates the professional 
development of others 
 
Shapes and contributes to the 
professional development strategy 
 
 
Contribute to professional 
development (AU) 
 
Demonstrates self-development 
through regular CPD and the 
application of learning to practice 
 
Acts as a CPD facilitator for the 
profession.   
Shapes and contributes to the CPD 
strategy for the profession or other 
disciplines.   
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Table 4.26: Analysis of the documents regarding ‘links practice and education’. 
(Items from the APPF are shown in blue font while those from the RPS-APF are in black font. The semantic differences in the description of the 
items are underlined). 
 
 
COMPETENCY 
 
DEVELOPMENTAL DESCRIPTORS 
 
Advanced Stage 1 
(Transition Level) 
Advanced Stage 2 
(Consolidation Level) 
Mastery 
(Advanced Level) 
 
 
Links practice and education  
(UK)  
 
Participates in the delivery of formal 
education programmes 
 
Participates in the education and 
training in an external environment 
 
Shapes, contributes to or is accountable 
for the creation or development of 
higher education qualification(s) 
 
Links practice and education 
(AU) 
 
Participates in the formal education 
of undergraduate and postgraduate 
students 
 
Participates in the education and 
training of formal special interest 
groups in the external environment 
 
Shapes, contributes to or is accountable 
for the creation or development of 
higher education qualification(s) 
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Table 4.27: Analysis of the documents regarding ‘educational policy’. 
(Items from the APPF are shown in blue font while those from the RPS-APF are in black font. The semantic differences in the description of the 
items are underlined). 
 
 
 
COMPETENCY 
 
DEVELOPMENTAL DESCRIPTORS 
 
Advanced Stage 1 
(Transition Level) 
Advanced Stage 2 
(Consolidation Level) 
Mastery 
(Advanced Level) 
 
 
Educational Policy (UK)  |  
 
Demonstrates an understanding of 
current educational policies relevant 
to working areas of practice 
 
Demonstrates ability to interpret 
national policy in order to design 
strategic approaches for local 
workforce education planning and 
development  
 
 
Shapes and contributes to national 
educational policy 
 
 
Educational policy/Conduct 
Education and Training (AU) 
 
Demonstrates an understanding of 
current educational policies in health 
services 
 
Demonstrates ability to interpret 
national policy in order to design 
strategic approaches to local 
workforce education 
 
Shapes and contributes to national 
education and workforce planning and 
development policy 
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Table 4.28: Analysis of the documents regarding ‘critical evaluation’. 
(Items from the APPF are shown in blue font while those from the RPS-APF are in black font. The semantic differences in the description of the 
items are underlined). 
 
 
 
COMPETENCY 
 
DEVELOPMENTAL DESCRIPTORS 
 
Advanced Stage 1 
(Transition Level) 
Advanced Stage 2 
(Consolidation Level) 
Mastery 
(Advanced Level) 
 
 
Critical evaluation (UK)  
 
Demonstrates ability to critically 
evaluate and review literature 
 
Demonstrates application of critical 
evaluation skills in the context of 
working practice 
 
Is recognised as undertaking peer review 
activities within working practice 
 
Undertake critical evaluation 
activities (AU) 
 
Demonstrated ability to critically 
evaluate literature sources 
 
Demonstrated application of critical 
evaluation skills in the context of 
practice 
 
Recognised as undertaking peer review 
activities in practice 
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Table 4.29: Analysis of the documents regarding ‘identifies gaps in the evidence’. 
(Items from the APPF are shown in blue font while those from the RPS-APF are in black font. The semantic differences in the description of the 
items are underlined). 
 
 
 
COMPETENCY 
 
DEVELOPMENTAL DESCRIPTORS 
 
Advanced Stage 1 
(Transition Level) 
Advanced Stage 2 
(Consolidation Level) 
Mastery 
(Advanced Level) 
 
 
 
Identifies gaps in the evidence 
base  (UK) 
 
Demonstrates ability to identify 
where there is a gap in the evidence 
base to support practice  
 
Demonstrates ability to formulate 
appropriate and rigorous research 
questions 
 
Demonstrates ability to design a 
successful strategy to address research 
questions 
 
Identifies gaps in evidence base  
(AU) 
 
Demonstrates ability to identify gaps 
in the evidence base for practice 
 
Demonstrates ability to formulate 
appropriate and rigorous research 
questions to address evidence gaps  
 
Demonstrates ability to design an 
appropriate research strategy to address 
research question. 
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Table 4.30: Analysis of the documents regarding ‘develops and evaluates research policies’ and ‘creates evidence’. 
(Items from the APPF are shown in blue font while those from the RPS-APF are in black font. The semantic differences in the description of the 
items are underlined). 
 
 
COMPETENCY 
 
DEVELOPMENTAL DESCRIPTORS 
 
Advanced Stage 1 
(Transition Level) 
Advanced Stage 2 
(Consolidation Level) 
Mastery 
(Advanced Level) 
 
 
Develops and evaluates research 
protocols AND Creates evidence 
(UK)  
Demonstrates ability to describe the 
core features of research protocols 
Demonstrates ability to design a 
rigorous protocol to address 
previously formulated research 
questions  
 
Demonstrates active involvement in 
the critical review of research 
protocols  
 
Demonstrates ability to generate 
evidence suitable for presentation at 
local level 
Demonstrates ability to generate 
new evidence suitable for 
presentation at research symposia 
Demonstrates authorship of primary 
evidence and outcomes in peer-reviewed 
media  
 
 
Design and deliver research 
projects to address gaps in the 
evidence base  (AU) 
 
Demonstrates ability to describe the 
core features of research protocols 
Demonstrates ability to design a 
research protocol to address 
previously formulated research 
questions 
Demonstrates active involvement in the 
critical review of research protocols 
Demonstrates ability to generate 
evidence suitable for presentation at 
local level 
 
Generates new evidence suitable for 
presentation at research symposium 
Demonstrates authorship of primary 
evidence outcomes in peer-reviewed 
media. 
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Table 4.31: Analysis of the documents regarding ‘research evidence into working practice’. 
(Items from the APPF are shown in blue font while those from the RPS-APF are in black font. The semantic differences in the description of the 
items are underlined). 
 
 
COMPETENCY 
 
DEVELOPMENTAL DESCRIPTORS 
 
Advanced Stage 1 
(Transition Level) 
Advanced Stage 2 
(Consolidation Level) 
Mastery 
(Advanced Level) 
 
 
Research evidence into working 
practice (UK)  
 
Demonstrates ability to apply the 
research evidence base into working 
practice  
 
Demonstrates ability to apply 
research and evidence-based 
practice within the team and/or 
service 
 
 
Is able to use research evidence to shape 
policy/procedure at an organisational 
and/or national level 
 
Apply research evidence into 
working practice (AU) 
 
Demonstrates ability to apply 
research into own practice 
 
Demonstrates ability to apply 
evidence-based practice within the 
team 
 
Is able to use research evidence to shape 
workplace/organisational 
policy/procedure 
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Table 4.32: Analysis of the documents regarding ‘supervises others undertaking research’.  
(Items from the APPF are shown in blue font while those from the RPS-APF are in black font. The semantic differences in the description of the 
items are underlined). 
 
 
COMPETENCY 
 
DEVELOPMENTAL DESCRIPTORS 
 
Advanced Stage 1 
(Transition Level) 
Advanced Stage 2 
(Consolidation Level) 
Mastery 
(Advanced Level) 
 
 
Supervises others undertaking 
research (UK) 
 
Demonstrates understanding of the 
principles of research governance 
 
Demonstrates understanding of the 
principles of research governance 
 
Is a research project supervisor for 
postgraduate students 
 
Supervises others undertaking 
research (AU) 
 
Demonstrates understanding of the 
principles of research governance. 
 
Demonstrates understanding of the 
principles of research governance. 
 
Is a research project supervisor for 
postgraduate students 
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Table 4.33: Analysis of the documents regarding ‘establishes research partnerships’.  
(Items from the APPF are shown in blue font while those from the RPS-APF are in black font.The semantic differences in the description of the 
items are underlined). 
 
 
COMPETENCY 
 
DEVELOPMENTAL DESCRIPTORS 
 
Advanced Stage 1 
(Transition Level) 
Advanced Stage 2 
(Consolidation Level) 
Mastery 
(Advanced Level) 
 
 
Establishes Research Partnerships 
(UK)  
 
Demonstrates ability to work as a 
member of the research team 
 
Demonstrates ability to establish 
new multidisciplinary links to 
conduct research project 
 
Demonstrates ability to show leadership 
within research teams concerning the 
conduct of specialist research 
 
Establish Research Partnerships 
(AU) 
 
Demonstrates ability to work as a 
member of a research team 
 
Demonstrates ability to establish 
new multidisciplinary links to 
conduct research project 
 
Demonstrates ability to show leadership 
within research teams concerning the 
conduct of research 
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4.3.3 Summary of content analysis results  
The competencies and behavioral descriptors in the frameworks were presented in relation to 
the cluster headings and three distinct levels of advanced practice in the two frameworks. In 
total, six cluster themes and 30 competency sub-themes were developed from the content 
analysis.  
Sixty-four competencies and 237 behavioural descriptors were identified and extracted from 
both frameworks under the subthemes. Thirty-four competencies and 123 behavioural 
descriptors were extracted from the RPS-APF while 30 competencies and 114 descriptors 
were obtained from the APPF.  
The analysis showed that eight of the RPS-APF competencies were condensed into four 
corresponding competencies in the APPF. These competencies were the: 
 'strategic context' and 'strategic planning' competencies in the RPS-APF, which were 
merged into 'understand strategic context and contribute to strategic planning' in the 
APPF;  
 'innovation' and 'service development' competencies in the RPS-APF were condensed 
into 'contribute to innovation and service development' in the APPF;  
 'role model' and 'mentorship' competencies in the RPS-APF were condensed into 
'serve as role model and mentor to others'; and 
 'develops and evaluates research protocol' and 'creates evidence' competencies in the 
RPS-APF were condensed into 'design and deliver research projects to address gaps in 
the evidence' in the APPF.  
The content analysis also identified sematic difference between the frameworks. These 
differences were in three of the cluster headings (Table 4.1), the three levels of practice labels 
(Table 4.2), 25 of the competency labels (Table 4.3), and in 103 of the behavioural 
descriptors (Tables 4.4 to 4.33) obtain from the two frameworks. 
Generally, the competencies labels in the APPF were more descriptive and action-oriented 
than those in the RPS-APF.  Semantic differences in description of behaviours were observed 
in most of the behavioural adjacencies formed in the content analysis with 11 containing 
behaviours that were described using the same words. The adjacencies with similar 
behaviours were formed under the: 
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 Advance stage 1 (transition level) descriptors of five competencies including: 
'resources utilisation' & 'contribute to effective use of resources'; 'standards or 
practice' & 'monitor standards of practice'; 'managing change' & 'understand change 
management'; develops and evaluates research protocol' & 'design/deliver research 
projects to address gaps'; and 'supervise others undertaking research' & 'supervise 
others undertaking research', competencies in the RPS-APF and APPF respectively.  
 Advance stage 2 (consolidation level) descriptors of three competencies: 'working 
across boundaries' & 'working across boundaries'; 'supervise others undertaking 
research' & 'supervise others undertaking research'; and 'establish research 
partnerships' & 'establish research partnerships', competencies in the RPS-APF and 
APPF respectively.   
 Mastery (Advance level) descriptors in three competencies: 'conduct education and 
training' and 'conduct education and training'; 'link practice and education' and 'link 
practice and education'; and 'supervise others undertaking research' and 'supervise 
others undertaking research', competencies in the RPS-APF and APPF respectively.  
The results of the content analysis were collated and presented to an expert panel for further 
review and consensus development. The outcome of the review is reported in the following 
session (stage 3 of this study).   
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4.4 Stage 3 | Expert Review and Consensus Development   
The content analysis results as shown in Tables 4.4 to 4.33 were collated and presented to a 
panel of experts for further review and consensus development. The objectives of the panel 
review was to obtain expert opinion and develop consensus on the: 
 Outcome of the content analysis shown in Table 4.4 to 4.33 in terms of its semantic 
accuracy  
 Similarity or dissimilarity between the behaviours in each of the behavioural 
adjacencies formed in the content analysis. 
4.4.1 Methodology  
A convenience sample of expert pharmacy practitioners was used in this study. These experts 
were identified via consultation with national pharmacy organisations and professional 
bodies who have already developed (or were in the process of developing) a competency 
framework in their countries. These countries were United Kingdom, Australia, Singapore, 
Serbia, Croatia, Ireland and USA. Experts involved in the development of such frameworks 
or practice standards in these countries and those previously involved with the development 
of the FIP global competency framework were invited. Five other experts who had been 
involved in professional development and training of advanced practitioners in UK, Nigeria, 
Ghana and Malta were identified by FIPEd and invited to participate in the panel.  
In total, twenty-five experts were invited and 14 consented to participate in the panel. This 
represented a response rate of 56%. Twelve of these experts provided inputs through a face-
to-face panel meeting while two other members of the panel provided inputs via an online 
software called Qualtrics®. Qualtrics® is an online survey software with built in platform for 
creating, publishing and hosting online surveys. The software also contains a feature that 
allows for the dissemination of survey links for anonymous completion. Responses to the 
survey are accessed in real time and can be analysed on the platform or exported to other 
statistical analysis software packages like SPSS.  
The expert panel was convened on 5th of September 2013 at the FIP International Conference 
of Pharmacists and Pharmaceutical Scientists that held in Dublin, Ireland. This means, 
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experts who did not plan to attend the conference were unable to participate in the face-to-
face panel meeting. The panel meeting lasted for two hours. The panel members worked in 
pairs with each reviewing one cluster in the first round. This means that the six pairs of 
experts each reviewed the competencies and behavioral adjacencies under one of the six 
competency themes in the first round. 
The experts were required to indicate whether a behavioural adjacency formed under a 
competency contained similar or dissimilar behaviours. This means the experts assessed each 
behavioural adjacency in their allocated cluster to judge whether the semantic differences 
observed meant the two behavioural descriptors contained therein were similar or dissimilar.  
A 'Yes' vote indicated they were similar while a 'No' vote indicated dissimilarity. The result 
of the first round was collated with the clusters switched between the pairs for a second round 
of consensus building. This was repeated a third time and the overall outcome of the review 
including the comments were collated and fed back to the group. This included the inputs 
obtained from the two experts who completed the exercise using the Qualtrics® software. 
Each round lasted for twenty minutes and final consensus was obtained when the entire group 
reached unanimous decision on similarity or dissimilarity between the descriptors in a 
particular behavioural adjacency.  
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4.4.2   Results 
4.4.2.1 Demography  
The expert panel comprised:   
- 6 experts in clinical/hospital pharmacy 
- 5 experts in academic pharmacy  
- 2 experts in regulatory pharmacy, and  
- 1 expert in Administrative pharmacy   
Nine countries were represented in the panel and these were from four of the six WHO 
regions. These included Europe (Malta, UK, Ireland and Croatia), Africa (Nigeria), the 
Americas (USA), and Western Pacific (Australia, Singapore, Japan) regions. The mean 
length practice of the panel members was 26years [SD: ±10years; min.- max: 8-37years]. 
The competencies and behavioural adjacencies formed in the content analysis (Table 4.4 to 
4.33) were presented to the panel. Consensus on similarity or dissimilarity between the 
behavioural descriptors in each of the 114 behavioural adjacencies is presented in Table 4.34 
to 4.44.  
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4.4.2.2 Similarity and dissimilarity between contents of two advanced pharmacy 
frameworks 
A) Expertise and Expert skills theme 
Table 4.34: Similarities and differences between behaviours derived from the 
competencies under the theme ‘Expertise and Expert skills’. 
(Items from the APPF are shown in blue font while those from the RPS-APF are in black 
font. The semantic differences in the description of the items are underlined). 
 
Competency 
Behavioural adjacencies (n)  
Row 
Total 
With Similar 
behaviours 
With Dissimilar 
behaviours 
Expert skills and knowledge | acquire 
expert skills and knowledge 
2 4 6 
Delivery of professional expertise | 
deliver accountable and flexible 
patient care 
- 3 3 
Reasoning and judgment | use 
reasoning and judgement  
6 - 6 
Professional autonomy | use 
professional autonomy 
3 - 3 
  Column Total (%)  11 (61) 7 (39) 18 
 
Based on consensus, 11 (61%) of the 18 behavioural adjacencies created form the 
competencies in this theme, each contained similar behaviours while 7 (39%) of those 
adjacencies contained behaviours that were dissimilar.  
The behaviours in the adjacencies found to be dissimilar are shown below alongside the 
comments made by the expert panel. (Items from the APPF are shown in blue font while 
those from the RPS-APF are in black font). 
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• Four of the six adjacencies created under the competencies ‘expert skills and 
knowledge’ and ‘acquire expert skills and knowledge’ derived from the RPS-
APF and APPF respectively contained behaviours that were not similar.  
The dissimilar behaviours were:  
“Demonstrates general pharmaceutical skills and knowledge in core areas” AND 
“Demonstrates general clinical knowledge in core areas”  
Expert comment: ‘The first statement refers to knowledge and skills, second 
to knowledge only. Also first refers to pharmaceutical knowledge, which is 
much broader than clinical knowledge’. 
“Demonstrates in-depth pharmaceutical skills and knowledge in defined area(s)” AND 
“Demonstrates comprehensive, high level clinical knowledge in defined practice area(s)” 
Expert comment: ‘The first statement refers to knowledge and skills while the 
second refers to knowledge only. Could also argue that ‘in-depth’ and 
‘comprehensive’ are not the same, as comprehensive could mean broad rather 
than deep knowledge’ 
“In addition for patient focused roles: Advances in-depth/complex pharmaceutical care 
programmes for patients” AND Advances patient care programs in defined practice area(s) 
Expert comment: ‘Loss of distinction that complex issues are being dealt 
with and loss of pharmaceutical care in the second statement makes this 
different from the first’. 
“Demonstrates accountability for the delivery of professional expertise at a defined higher 
level. May include providing expertise and service delivery nationally or at a strategic level” 
AND “Accepts accountability for patient care services delivered in a defined practice area(s)” 
Expert comment: ‘The two statements define practice at different levels’ 
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• Based on consensus, the three behavioural adjacencies created under the 
competencies ‘Delivery of professional expertise’ and ‘Deliver accountable and 
flexible patient care’ derived from the RPS-APF and APPF respectively, contained 
behaviours that were not similar. 
The three adjacencies with dissimilar behaviours were: 
“Demonstrates accountability for delivering professional expertise and direct service 
provision as an individual” AND “Accepts accountability for patient care services delivered 
directly to individual patient” 
Expert comment: ‘The two statements are dissimilar; the second statement is 
also too broad as patient care services could mean anything’ 
“Demonstrates accountability for the delivery of professional services and expertise via a 
team or directly to groups of patients/clients/users” AND “Accepts accountability for patient 
care services delivered directly to a defined patient group” 
Expert comment: ‘The two behaviours are dissimilar. Demonstrating 
accountability is different from accepting accountability, as it is possible to 
accept accountability without necessarily demonstrating it’ 
“Demonstrates accountability for the delivery of professional expertise at a defined higher 
level. May include providing expertise and service delivery nationally or at a strategic level” 
AND “Accepts accountability for patient care services delivered in a defined practice area(s)” 
Expert comment: ‘The two statements define practice at different levels’ 
• There was consensus agreement that the behaviours in the six behavioural adjacencies 
created under the ‘reasoning and judgment’ and ‘use reasoning and judgement’ 
competencies derived from the RPS-APF and APPF respectively were similar. There 
was also agreement that the behaviours in the three behavioural adjacencies created 
under the ‘professional autonomy’ and ‘use professional autonomy’ competencies 
derived from the RPS-APF and APPF respectively, were similar.
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B) Collaborative Practice theme 
Table 4.35: Similarities and differences between behaviours derived from the 
competencies under the theme ‘Collaborative Practice' theme. 
(Items from the APPF are shown in blue font while those from the RPS-APF are in black 
font. The semantic differences in the description of the items are underlined). 
 
Competency 
Behavioural adjacencies (n)  
Row 
total 
With Similar 
behaviours 
With Dissimilar 
behaviours 
Communication | use appropriate 
communication skills 
6 - 6 
Team work | engage in team work and 
consultation  
6 - 6 
Column Total (%) 12 (100) - 12 
 
Under the ‘Collaborative practice' theme, there was consensus that all the behaviours that 
made up the six behavioural adjacencies created under the ‘communication’ and ‘use 
appropriate communication skills’ competencies derived from the RPS-APF and APPF 
respectively were all similar.  
Also, there was agreement that all the behaviours that made up the six behavioural 
adjacencies created under the ‘team work’ competency in the RPS-APF and ‘engage in team 
work and consultation’ competency in the APPF were similar. 
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C) Leadership theme 
  Table 4.36: Similarities and differences between behaviours derived from the 
competencies under the ‘Leadership’ theme. 
(Items from the APPF are shown in blue font while those from the RPS-APF are in black 
font. The semantic differences in the description of the items are underlined). 
 
Competency 
Behavioural 
adjacencies (n) 
 
Row total 
With 
Similar 
behaviours 
With 
Dissimilar 
behaviours 
Strategic context and Strategic planning | 
Understand strategic context and contribute 
to strategic planning  
6 - 6 
Governance | understand and contribute to 
clinical governance  
3 - 3 
Vision | understand and contribute to the 
strategic vision  
3 - 3 
Innovation and service development | 
Contribute to innovation and service 
development 
6 - 6 
Motivational | motivates self and others 3 - 3 
Column Total (%) 21 (100) - 21 
 
Although semantic differences were identified in the description of the behaviours under the 
five (5) competencies in this theme, it was agreed by consensus, that the twenty-one (21) 
behavioural adjacencies created under these competencies contained behaviours that were all 
similar. 
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D) Management theme 
Table 4.37: Similarities and differences between behaviours derived from the 
competencies under the ‘Management’ theme. 
(Items from the APPF are shown in blue font while those from the RPS-APF are in black 
font.  The semantic differences in the description of the items are underlined). 
Competency 
Behavioural adjacencies 
(n) 
 
Row 
Total 
With 
Similar 
behaviours 
With 
Dissimilar 
behaviours 
Implementing national priorities | 
support and assist the implementation 
of national priorities 
2 1 3 
Resource utilisation | understands and 
contributes to the effective use of 
resources  
3 - 3 
Standards of practice | applies and 
monitors standards of practice  
2 1 3 
Managing risk | contributes to the 
identification and effective 
management of risk 
3 - 3 
Managing performance  | Promote 
improved performance  
2 1 3 
Project management | understand and 
undertake project management  
2 1 3 
Managing change | understand change 
management principles and lead 
change  
3 - 3 
Working across boundaries | working 
across boundaries 
3 - 3 
Column Total (%) 20 (83.3) 4 (16.7) 24 
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Twenty-four behavioural adjacencies were created under the competencies in the 
‘Management’ theme. There was consensus that 20 (83.3%) of those adjacencies contain 
behaviours that were similar while 4 (16.7%) contained behaviours that were not similar.  
• One behavioural adjacency created under the competency ‘implementing national 
priorities’ and ‘support and assist the implementation of national priorities’ derived 
from the RPS-APF and APPF respectively, contained behaviours that were dissimilar. 
These behaviours were:  
“Accountable for the direct delivery of national priorities at a higher level” AND “Leads 
response of the team to national health care priorities” 
Expert comment: ‘the two behaviours are not similar; being accountable for 
delivery of a service is not the same as leading the response of a team’  
• An adjacency created under the competency ‘Standards of practice’ and ‘applies and 
monitors standards of practice’ derived from the RPS-APF and APPF respectively, 
contained behaviours that were not similar. These behaviours were: 
“Demonstrates ability to set and monitor standards of practice at team and/or service level” 
AND “Accountable for setting and monitoring standards of practice beyond the team” 
Expert comment: ‘The two statements describe behaviours at different levels of 
practice’.  
• An adjacency created under the competency ‘managing performance’ ‘promote 
improved performance’ derived from the PRS-APF and APPF respectively, contained 
behaviours that were also not similar. These behaviours were: 
“Is accountable for performance management at a higher and/or institutional level” AND “Is 
accountable for performance management of the team as a whole”  
Expert comment: ‘Statement 2 assumes one type of performance management 
whereas statement 1 is broader and can encompass participation in disciplinary 
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panels and other panels without being accountable for that individual’s performance 
management’. 
• One adjacency created from the ‘project management’ and ‘understand and undertake 
project management’ competencies derived from the RPS-APF and the APPF 
contained behaviours that were not similar. These behaviours were: 
“Demonstrates ability to successfully manage a project at a higher level” AND 
“Demonstrates ability to plan and supervise the implementation of a project” 
Expert comment: ‘Statement 1 involves management while statement 2 encompasses both a 
managerial and leadership role’. The two statements describe different behaviours. 
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E) Education, Training and Professional Development  
 
Table 4.38: Similarities and differences between behaviours derived from the 
competencies under ‘Education, Training & Professional Development’ theme. 
(Items from the APPF are shown in blue font while those from the RPS-APF are in black 
font. The semantic differences in the description of the items are underlined). 
 
Competency 
Behaviours (n)  
Row 
total 
Similar 
behaviours 
Dissimilar 
behaviours 
Role model and mentorship | serves as role 
model and mentor to others 
6 - 6 
Conducting education and training | conduct 
education and training  
3 - 3 
Professional development | contribute to 
professional development  
3 - 3 
Links practice and education | links practice 
and education  
2 1 3 
Educational policy | educational policy  3 - 3 
 
Column Total (%) 
 
17 (94.4) 
 
1 (5.6) 
 
18 
 
Of the 18 behavioural adjacencies created under the five competencies in this theme, there 
was consensus that the behaviours in 17 (94.4%) adjacencies were similar while the 
behaviours in one (5.6%) adjacency were not similar. The dissimilar behaviours are shown 
below alongside the comments made by the expert panel. 
The dissimilar behaviours were under the competency ‘links practice and education’ and 
‘links practice and education’. The dissimilar behaviours were: 
“Participates in the education and training in an external environment” AND “Participates in 
the education and training of formal special interest groups in the external environment” 
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Expert comment: ‘Statement 1 is more generic while statement 2 specifies the 
specific group to be trained and the two statements are therefore dissimilar. 
F) Critical appraisal, Evaluation and Research theme 
Table 4.39: Similarities and differences between behaviours derived from the 
competencies under the Evaluation & Research’ theme. 
(Items from the APPF are shown in blue font while those from the RPS-APF are in black 
font. The semantic differences in the description of the items are underlined).  
 
Competency 
Behavioural Adjacencies 
(n) 
 
Row total 
Similar 
behaviours 
Dissimilar 
behaviours 
Critical evaluation | Undertake critical 
evaluation activities  
3 - 3 
Identifies gaps in the evidence base | 
identifies gaps in evidence base  
3 - 3 
Develops and evaluates protocols/creates 
evidence | design and deliver research 
projects to address gaps in the evidence base  
6 - 6 
Research evidence into working practice | 
apply research evidence into working practice 
3 - 3 
Supervises others undertaking research | 
supervises others undertaking research  
3 - 3 
Establishes research partnership | establish 
research partnerships 
3 - 3 
Column Total (%) 21 (100) - 21 
 
There was consensus that the twenty-one behavioural adjacencies created under the 
evaluation and research theme all contained behaviours that were similar.  
Table 4.40 to 4.44 provides a summary of the overall consensus on similarity between 
behaviours in the 114 adjacencies created from the two frameworks. 
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Table 4.40: Consensus opinion on similarity and dissimilarity between behaviours in the adjacencies per competency theme  
 
  
 
Competency	Themes 
Behavioural	Adjacencies	N	(%)	
N similar 
behaviours  
N dissimilar 
behaviours  
Expertise & Expert Skills 11 (61) 7 (39) 
Collaboration Practice 12 (100) 0 (0) 
Leadership		 21 (100) 0 (0) 
Management 20 (83) 4 (17) 
Education, Training & Professional 
Development 
20 (94) 1 (6) 
Evaluation and Research  21 (100) 0 (0) 
N	Column	Total	(%)	 102	(89.5)	 12	(10.5)	
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Figure 4.2: Heatmap showing similarity between behaviours in the adjacencies formed per competency theme  
 
 
The heatmap shows the degree of similarity between the adjacencies formed in the six competency themes identified from the two frameworks. 
The darker regions show a higher percentage of similar behaviours. The expertise and expert skills theme had the least percentage of similar 
behaviours while the collaborative practice, leadership and evaluation & research themes had the highest percentage of similar behaviours.  
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4.4.2.3 Summary of expert panel review and consensus development results 
Overall, there was consensus that 102 (89.5%) behavioral adjacencies created from the 
content analysis contained behaviours that were similar. The adjacencies with similar 
behaviours were formed under three of the six competency themes. These were the 
'collaborative practice', 'leadership' and 'evaluation & research' themes. 
The twelve adjacencies with dissimilar behaviours were under the 'expertise and expert 
skills', 'management', and 'education, training & professional development' themes. These 
were: 
 Seven adjacencies under 'expertise and expert skills'. This comprised four 
adjacencies under the 'expert skills and knowledge' ('acquire expert skills and 
knowledge'); and three adjacencies under the 'delivery of professional 
expertise' ('deliver of accountable and flexible patient care') competencies, 
respectively.  
 Four adjacencies under 'management', including an adjacency under the 
'implementing national priorities' (support and assist implementation of 
national priorities); 'standard of practice' ('applies and monitors standards of 
practice'); 'managing performance' ('promote improved performance'); and 
'project management' ('understand and undertake project management') 
competencies, respectively.  
 One adjacency from the education, training & professional development 
created from the 'link practice and education' ('links practice and education') 
competency. 
The result demonstrates parity between the frameworks with consensus developed that 
approximately 90% of the behaviours contained in the two frameworks were similar.  
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4.5 Stage 4 | Crossover Mapping Experiment   
The goal of this stage was to assess the functional equivalence between the two advanced 
pharmacy frameworks identified in this study. It aimed to evaluate the outcome of assessment 
produced by the two frameworks. The objectives were:  
 To evaluate the outcome of two self-assessments produced by a group of advanced 
practitioners from different countries  
 To determine whether the outcome of assessment produced by the two frameworks 
were similar for the same group of individuals. 
[Advanced pharmacy practice is practice that is so significantly different from that achieved 
at initial registration that it warrants recognition by peers of the expertise of the practitioner 
and the education, training and experience from which that capability was derived (An 
Advance Pharmacy Practice Framework for Australia (p.6)]. 
 
4.5.1 Methodology  
A crossover experiment was used for this study. Study participants in the crossover 
experiment self-assessed their competence with one framework at a specified time T1. After 
three months, the same group of practitioners carried out a second self-assessment using a 
different framework.  
The study was conducted via email and participants completed the two self-assessments over 
a six-month period. The experimental document for the first assessment was forwarded to the 
participants via email between 7th to 21st February 2014. This was the timeframe within 
which each participant completed and signed the consent and enrollment forms required for 
the study. Thereafter, they were given six weeks from the time of receipt to complete and 
return the first framework. The first assessment period ended on 24 March 2014. The three-
month washout period was calculated pro rata based on when participants returned the 
completed first assessment document. Overall, the second assessment commenced on 26 May 
2014 and ended on 4 August 2014. 
To be included in the study, the participant had to: 
 Have at least five years post-licence experience in pharmacy 
 Duly sign and complete the consent and enrolment forms and also agree to carry out 
the two consecutive self-assessments required. 
Exclusion criteria were: 
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• Practitioners with less than five years post-licence pharmacy practice experience 
• Practitioners unable to commit to the two self-assessments required. 
Practitioners were also required to meet the general description of one of the three levels of 
advanced pharmacy practice. That is the: advanced stage 1 (transition); advanced stage II 
(consolidation) or Mastery (advanced level) [Please see Appendix 9 for detailed description]. 
4.5.2 Sampling 
The pharmacy leadership organisations in the United Kingdom, New Zealand and Australia 
were approached and invited to assist with the project. These organisations were the: 
Pharmaceutical Society of Australia (PSA), Society of Hospital Pharmacists of Australia 
(SHPA), Royal Pharmaceutical Society of Great Britain, United Kingdom Clinical Pharmacy 
Association (UKCPA), and Pharmaceutical Society of New Zealand (PSNZ).  
The organisations were invited to assist by disseminating the survey invite to their individual 
members via their mailing lists. The survey invite contained an overview and contact details 
of the study researchers. The research protocol, consent and enrollment forms were 
subsequently forwarded directly to individuals who responded to the invitation and indicated 
their willingness to be part of the study.  
4.5.2.1 Experimental design  
Study participants who successfully enrolled and consented to be part of the study were 
assigned an experimental code. This code was used to randomly allocate participants to either 
of two groups: A or B, using simple random allocation software.  
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Figure 4.3: Schematic of the sequence of self-assessment proposed for this study.  
 
 
Key: FW 1: Royal Pharmaceutical Society Advanced Pharmacy Framework [RPS-APF 
(UK)]; FW 2: Advanced Pharmacy Practice Framework for Australia [APPF (AU)]. 
 
Study Participants assigned to Group A first self-assessed their competency using FW1 while 
those in Group B used FW2. After the three-months ‘wash-out’ period (between 26 February 
to 23 May 2014), participants in Group A 'crossed over' and assessed their practice using 
FW2 while those in Group B did same with FW1. Using this method, study participants 
carried out self-assessment of competence at the same time and in a predefined order of FW 
1: FW2 for those in Group A; and FW2: FW1 for those in Group B.  
The study was open-label with no blinding to group assignment. The schematic of the self-
assessment sequence is presented in Figure 4.3. After randomisation, the study participants 
self-assessed their competence using the two frameworks in the order defined by group 
assignment. Each framework was reproduced as a questionnaire using Microsoft® Word with 
the inclusion of checkboxes for participants to assess their level of practice for each 
competency.  
The first section of the assessment document collected demographic data while the second 
section contained matrices of competencies with the corresponding behaviours. Participants 
judged their competence individually and used the checkboxes provided to indicate their self-
assessed level of practice per competency. Participants were also asked to indicate the type of 
Group B 
(FW 2) 
Group A 
(FW1) 
Group A 
(FW 2) 
Group B 
(FW 1) 
                                                                                    T1                                        T2  
  
 
Randomisation 
  
 
    
 washout period 
                                                                     (Three months) 
Study 
participants 
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evidence they had available to support their assessment. A checklist of examples of evidence 
that could be used was also provided for each competency and participants were allowed to 
use as many evidence categories. They were however not required to submit such documents 
for confidentiality reasons.  
Respondents were followed up three times within each assessment period. Reminder emails 
was forwarded every fortnight during this period.  
4.5.2.2 Data handling  
Contact with study participants was primarily through emails. All responses provided by the 
study participants were confidential and only the study investigators had access to the data 
obtained. The arbitrary experimental codes assigned to each participant ensured that no 
identifiable information was included in the database. All data collected was kept in locked 
filing cabinets in the FIP Collaborating Centre, UCL School of Pharmacy, United Kingdom.  
The replies received from the practitioners were coded and entered into predefined template 
using Microsoft® Excel software. This was then uploaded and analysed with SPSS® version 
21. Measures to minimize missing data were incorporated into the research design by pre-
informing practitioner that answers to all questions in the self-assessment documents will 
need to be provided in order for the document to be accepted. One practitioner with 
incomplete assessment document was contacted for explanation at the end of the first 
assessment. This practitioner explained that the missing ranking indicated 'nil' competence 
for the affected competencies. 
4.5.3 Data analysis  
The analysis aimed to assess within-subject agreement between the two frameworks. When 
participants ranked their practice on the same level for matching competencies, then, there 
was agreement (between the frameworks) for that competency. 
 For example, when participants consistently ranked their practice on the same level for the 
'reasoning & judgment' competency in the RPS-APF, and the matching 'use reasoning & 
judgement' competency in the APPF, then, there was agreement between frameworks for that 
competency. When level of practice differed for the same competency, then, there was 
disagreement. 
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This agreement was expressed using percentages. Kappa statistic, which is a measure of 
chance-corrected agreement between rankings at different time points, was also used to 
evaluate within-subject agreement. 
K-values of 0<k<0.21 indicated slight or poor agreement; 0.21<k<0.41 fair agreement; 
0.41<k<0.61 moderate agreement; 0.61<k<0.81 substantial or good agreement; k≥0.81 
excellent agreement; and k=1 indicated perfect agreement (Cohen, 1960; Landis and Koch, 
1977; Viera and Garrett, 2005). When the Kappa statistic value showed less than excellent 
agreement (that is, when k<0.81), and where the k-values were not statistically significant, 
further analysis using the Wilcoxon signed-ranked test was conducted.  
Cramer's V was also used to measure association between the competencies. Values of 
V≤0.30 indicated weak association; 0.30<V≤0.50 moderate association; V>0.50 strong 
association while V=1 indicated a perfect association (Cohen, 1988). Moderate, strong and 
perfect association implied the ranking in the first assessment was predictive of the ranking in 
the second assessment for matching competencies (Field, 2007; Weisburd and Britt, 2007b).   
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4.5.4 Results  
4.5.4.1 Demography 
Forty-two pharmacists from four countries: Australia, New Zealand, United Kingdom and 
Australia; completed the two self-assessments required for the crossover study.  
Figure 4.4 illustrates the participant recruitment process. 
Figure 4.4: Flow chart showing participant recruitment  
 
 
 
 
 
 
 
 
 
 
 
 
Mean length of practice was 19 years [SD: 11; Min-Max: 5-52years]. More than half (57%) 
of the study participants indicated they were leading-edge practitioners (please see Appendix 
9 for full description of level of competence).  
Table 4.41 shows composition of the sample in relation to area of practice and country of 
origin while Table 4.42 shows participants' self-assessed level of competence. 
Pharmacy organisations 
approached (N=4) 
Pharmacists assessed for 
eligibility (N=59) 
Enrolled, consented and 
randomised (N=56) 
 
Declined (N=4) 
Completed first self-assessment 
(N=44) 
Dropout (N=12) 
Completed second self-assessment 
(N=42) 
Dropout (N=2) 
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Table 4.41: Area of practice and country of origin of crossover study participants 
 
 
 
 
Table 4.42: Crossover study participants' level of competence 
 
 
 
UK Australia
New 
Zealand
Ireland
Hospital 10 (26) 15 (38) 13 (3) 1 (3) 39 (93)
Community 0 (0) 0 (0) 1 (100) 0 (0) 1 (2)
Academia 1 (100) 0 (0) 0 (0) 0 (0) 1 (2)
Primary health 
organisation 
0 (0) 0 (0) 1 (100) 0 (0) 1 (2)
Area of Practice
 Country of Origin N (%)
 Total (%)
11 (26) 15 (36) 15 (36) 1 (2) Total (%) 42 (100)
Specialist-in-training 8 (19)
Experienced practitioner 10 (24)
Leading-edge practitioner 24 (57)
Level of practice N (%)
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4.5.4.2 Agreement in the Expertise and Expert skills cluster  
Within-subject agreement ranged from 55% to 86% for the four competencies in this cluster. 
This means more than half of the study participants consistently ranked their practice on the 
same level for these competencies in the two self-assessments.  
Table 4.43 shows the agreement per level of practice in this cluster including the Kappa 
statistic values.   
Table 4.43: Within-subject agreement per level of practice for the Expertise and Expert 
skills cluster   
 
 
Percentage agreement however varied between the countries. The lowest percentage 
agreement was in New Zealand (30%) in the 'professional expertise' competency. The 
agreement per country was 60% (or more) for the other competencies in the cluster (Figure 
4.5).  
  
Competencies
Total N 
(%)
Kappa 
statistic 
Agreement per level of advanced practice (N=42)
1 8 23 32 (76)
Reasoning & Judgment 2 12 22
0.725 
(p<0.0001)
0.516 
(p<0.0001)
0.253 
(p=0.024)
0.424 
(p<0.0001)
Delivery of expertise 2 7 14 23 (55)
Expert skills 2 13 13 28 (67)
36 (86)
Professional autonomy
(k)Adv. Stage 1 
(Transition)
Adv. Stage 2 
(Consolidation)
Mastery 
(Advanced)
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Figure 4.5: Percentage agreement in the Expertise and Expert skills cluster 
 
The kappa (k) statistic values were suggestive of fair (0.21<k<0.41), moderate (0.41<k<0.61) 
and substantial (0.61<k<0.81) agreement. The values were statistically significant (p ≤ 0.05) 
and showed less than excellent agreement (k<0.81) for all four competencies in the cluster. 
This was suggestive of inconsistency in ranking of competencies in the two assessments.   
This was further evaluated using the Wilcoxon signed-rank test. The test showed no 
statistically significant within-subject difference between the ranking of competence in the 
first (median rank: 10) and second (median rank: 10) assessment for the four competencies in 
the cluster (Z = -0.838, p=0.402; maximum rank score attainable =12). There was also no 
significant within-subject difference between the two assessments in the country groups 
{UK: p=0.343, Australia: p=0.952 and New Zealand: p=0.574}. 
Cramer's V, which was used to assess the strength of the association between competencies 
showed weak (V≤0.30) association under the 'professional expertise' competency for New 
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Zealand. The association was moderate 0.30<V≤0.50 for the UK group and strong (V>0.50) 
for the Australia group. This implies that the respondents in the New Zealand group were less 
consistent in their ranking for the 'delivery of expertise' competency. A perfect association 
was found within the UK and New Zealand group for the 'reasoning & judgement' 
competency (V=1) while moderate to strong association was observed in the other 
competencies in cluster for the three countries. This means the ranking in the first assessment 
was predictive of the ranking in the second assessment for matching competencies in this 
cluster.    
Overall, the results of these analyses (Table 4.43 and Figure 4.5) demonstrate agreement 
between the two frameworks for the competencies in this cluster. 
Figure 4.6 shows the outcome of the analysis of the evidence used to support self-
assessments. It showed that leading edge practitioners [which is equivalent to the highest 
level/stage of advance practice and designated 'mastery' level in the RPS-APF and 'advanced 
level' in the APPF] used six main evidences to support their assessments.  
These were: 'member of, or advice local/hospital committee'; 'member of regional, national or 
international committee'; 'active research participation'; 'research development and 
leadership'; 'managing process & leadership (at the local level)'; and 'managing process and 
leadership (international level)'. 
Experienced practitioners {designated 'advanced stage 2' in the RPS-APF and 'consolidated 
level' in the APPF}, used four main evidences to support their assessments in this cluster: 
'professional standing & peer status', 'document expert practice', 'managing process & 
leadership (at the local level)' and 'staff management'.  
Specialists-in-training practitioners [equivalent to the 'advanced stage 1' in the RPS-APF and 
'transition level' in the APPF] used 'educational development, design and provision' and 'other 
documentation' (Figure 4.6).   
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Figure 4.6: Evidence used to support self-assessment in the Expertise and Expert skills 
cluster 
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4.5.4.3 Agreement in the Collaborative Practice Cluster   
Within-subject agreement for the two competencies in this domain was 64% (Table 4.44). 
This indicates that approximately two-thirds of the participants consistently ranked their 
practice on the same level for the competencies in this cluster. 
Table 4.44: Within-subject agreement per level of advance practice for the 
Collaborative Practice competencies 
 
 
Figure 4.7: Percentage agreement in the Collaborative Practice cluster 
 
The percentage agreement however varied between the countries in the cluster. The lowest 
agreement was 50% and this was from New Zealand in the 'communication skills' 
competency (Figure 4.7). The kappa (k) statistic values were indicative of fair agreement 
Competencies
Communication skills
Agreement per level of advanced practice (N=42)
Total N 
(%)
Kappa 
statistic 
(k)Adv. Stage 1 
(Transition)
Adv. Stage 2 
(Consolidation)
Mastery 
(Advanced)
1 9 17 27 (64)
0.376 
(p=0.002)
Team work 0 8 19 27 (64)
0.352 
(p=0.004)
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(0.21<k<0.41). The values were statistically significant but also indicated some within-
subject change in ranking for the two competencies in the cluster (Table 4.44).  
Further evaluation using the Wilcoxon signed-rank test showed a statistically significant 
within-subject difference in ranking of the competencies between the first (Median rank: 5) 
and second (Median rank: 6) assessments (Z = -2.027, p = 0.043; maximum rank score 
attainable = 6). It shows that respondents underestimated their competence in the first 
assessment. This difference was however not significant within the country groups {UK: 
p=0.131, Australia: P=0.431 and New Zealand p=0.176}, even though, the median ranks 
differed between the first (Median rank: 4) and second (Median rank: 5) assessments for UK 
and New Zealand but not for Australia. This suggests that participants from UK and New 
Zealand were less consistent in their ranking in this cluster compared to Australia.  
Cramer's V measure of association indicated a strong relationship (V>0.50) between 
matching competencies in the cluster. This association was however relatively less in the 
'team work' competency (0.55<V<0.65) compared to the 'communication skills' competency 
(0.65<V<0.80).  
Figure 4.8 shows the outcome of the analysis of evidences used to support self-assessments. 
It showed that leading edge practitioners used five main evidences to support their 
assessments. These were: 'member of local or trust committee', 'member regional, national 
and international committee', 'research development and leadership', 'professional standing 
and peer status', and 'managing process and leadership (international level)'. Experienced 
practitioners used four main evidences to support their assessments in this cluster. These 
were the 'educational development, design and provision', 'active research participation', 
'professional standing and peer status', and 'staff management'. Specialists in training mainly 
used 'other documentation' evidence to support their practice 
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Figure 4.8: Evidence used to support self-assessment in the Collaborative Practice 
cluster 
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4.5.4.4 Agreement in the Leadership Cluster   
Observed within-subject agreement ranged from 43% to 69% for the five competencies in the 
leadership cluster (Table 4.45). 
Table 4.45: Within-subject agreement per level of practice for the Leadership 
competencies 
 
The lowest agreement was in Australia (20%) and New Zealand (20%) for the 'governance' 
and 'strategic context and planning' competencies respectively. This indicates that the two 
countries were less consistent in their ranking for these two competencies (Figure 4.9).  
The kappa (k) statistic values were indicative of slight (0<k<0.21), fair (0.21<k<0.41), and 
moderate (0.41<k<0.61) agreement. These values were statistically significant for all the 
competencies except the 'national priorities' competency. The k-values also showed some 
disagreement in ranking of level of practice between the two self-assessments (Table 4.46).  
Further evaluation using the Wilcoxon signed-rank test showed no significant within-subject 
difference in ranking between the first (Median rank: 13) and second (Median rank: 14) 
assessments (Z = -0.897, p = 0.370; maximum rank score attainable = 15). The median scores 
however suggested the participants underestimated their competence in the first assessment. 
There was also no significant difference within the country groups {UK: p=0.717, Australia: 
P=0.705 and New Zealand p=0.775}. 
0.426 
(p<0.0001)
0.13 
(p=0.214)
0.558 
(p<0.0001)
0.455 
(p=0.001)
0.227 
(p=0.044)
6 10 11 27 (64)
Motivation 1 14 8 23 (55)
3Governance 5 10 18 (43)
Vision 5 14 10 29 (69)
Innovation & service dev.
Strategic context & planning 6 18 4 28 (67)
Competencies
Agreement per level of advanced practice 
(N=42) Total N 
(%)
Kappa 
statistic 
(k)Adv. Stage 1 
(Transition)
Adv. Stage 2 
(Consolidation)
Mastery 
(Advanced)
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Figure 4.9: Percentage agreement in the Leadership cluster 
 
No association was observed between rankings for the 'strategic context & planning' 
competency in the Australia group. A weak association was observed within the New 
Zealand group for 'motivation' (V≤0.30) competency. Moderate (0.30<V≤0.50) and strong 
(V>0.50) association was found within the three countries for the other competencies in the 
cluster. This means the ranking in the first assessment was predictive of the ranking in the 
second assessment for matching competencies. A perfect association (V=1) was observed 
within the UK group for the 'vision', and 'innovation' competencies. 
Overall, the results of these analyses (Table 4.46 and Figure 4.9) show some inconsistency in 
ranking in two competencies, although, this was not statistically significant within the groups. 
Figure 4.10 shows the outcome of the analysis of evidences used to support self-assessment 
in this cluster. Leading edge practitioners used five main evidences to support their 
assessments. These were: 'member of local or trust committee'; 'member regional, national 
and international committee'; 'active research participation'; 'managing process and leadership 
(local level)'; and 'managing process and leadership (international level)'. Experienced 
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practitioners used three main evidences to support their assessments in this cluster. These 
were 'member of, or advice local/hospital committee', 'staff management' and 'other 
documentation'. Specialist-in-training mainly used the 'other documentation' evidence to 
support their practice in this cluster. 
Figure 4.10: Evidence used to support self-assessment in the Leadership cluster 
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4.5.4.5 Agreement in the Management cluster   
Within-subject agreement ranged from 45% to 67% for the eight competencies in this cluster 
(Table 4.46). The percentage agreement varied between the countries with the lowest 
agreement observed in the Australia group for the 'project management' (30%) and 'working 
across boundaries' (20%) competencies (Figure 4.11). 
Table 4.46:Within-subject agreement per level of practice for the Management 
competencies 
 
The kappa (k) statistic values were indicative of slight (0<k<0.21) to moderate agreement 
(0.41<k<0.61). These values were statistically significant for all the competencies except the 
'national priorities' competency but showed some disagreement between the frameworks 
(Table 4.47). Further evaluation using the Wilcoxon signed-rank test showed there was no 
statistically significant within-subject difference in ranking between the first (median rank: 
18.5) and second (median rank: 19.5) assessments {Z = -1.197, p=0.231, maximum rank 
score attainable = 24}. The median ranks indicate that participants underestimated their 
competence in the first assessment. Wilcoxon-signed rank test also showed no significant 
difference between rankings in the three countries {UK: p=0.306, Australia: p=0.648, New 
Zealand p=0.509}. 
National priorities 4 11 4 19 (45)
0.161 
(p=0.098)
Resource utilisation 5 12 11 28 (67)
0.479 
(p<0.0001)
Standard of practice 3 11 10 24 (57)
0.340 
(p<0.0001
Managing risk 5 10 8 23 (55)
0.328 
(p=0.001)
Managing performance 5 13 2 20 (48)
0.215 
(p=0.016)
project management 4 10 10 24 (57)
0.357 
(p<0.0001)
Managing change 6 15 7 28 (67)
0.474 
(p<0.0001)
Working across boundaries 3 5 9 17 (41)
0.170 
(p=0.049)
Kappa 
statistic (k)
Competencies
Agreement per level of advanced practice 
(N=42)
Total N (%)
Adv. Stage 1 
(Transition)
Adv. Stage 2 
(Consolidation)
Mastery 
(Advanced)
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Figure 4.11: Percentage agreement in the Management cluster 
 
Cramer's V showed a weak (V≤0.30), moderate (0.31<V≤0.50) to strong (V>0.50) association 
between matching competencies. Weak association was from Australia in the 'national 
priorities' and 'managing risk' competencies. Moderate and strong association was found in 
the other competencies for the three countries.  This means that for these competencies, the 
ranking in the first assessment was predictive of the ranking in the second assessment. 
Overall, the results (Figure 4.11 and Table 4.46) demonstrate agreement between the 
frameworks for the competencies in this domain. 
Figure 4.12 shows the outcome of the analysis of evidences used to support self-assessment 
in this cluster. It showed that leading edge practitioners used seven main evidences to support 
their assessments. These were: 'member regional, national and international committee'; 
'active research participation'; 'research development and leadership'; professional standing & 
peer status'; 'managing process and leadership (local level)'; managing process and leadership 
(international level)', and 'staff management'. Experienced practitioners used five main 
evidences to support their assessments in this cluster. These were 'member of, or advice 
local/hospital committee', 'active teaching role', 'management process and leadership (local)', 
'staff management' and 'other documentation'. Specialist-in-training mainly used three 
evidences to support their assessment. These were 'educational development, design and 
provision', 'documented expert practice', and 'other documentation'.  
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Figure 4.12: Evidence used to support self-assessment in the Management cluster 
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4.5.4.6 Agreement in the Education, Training & Professional Development cluster   
Within-subject agreement ranged from 57% to 71% for the five competencies in this cluster 
(Table 4.47). This means more than half of the participants consistently ranked their practice 
on the same level for all the competencies in this domain. The percentage agreement however 
varied between the countries with the lowest agreement observed in Australia (40%) and 
United Kingdom (50%) for the 'professional development' competency (Figure 4.13). 
Table 4.47: Within-subject agreement per level of practice for the Education, Training 
& Professional Development competencies  
 
 
The k-values were indicative of fair (0.21<k<0.40) to moderate agreement (0.41<k<0.61). 
These were all statistically significant and also suggested some within-subject disagreement 
(Table 4.48). Further evaluation using the Wilcoxon signed-rank test showed there was no 
statistically significant within-subject difference in ranking between the first (median rank: 
12) and second (median rank: 12) assessment {Z= -0.543, p=0.587; maximum rank score 
attainable = 15}. This was also not significant within the country groups {UK: p=0.438, 
Australia: p=0.783, New Zealand: p=0.589}. Cramer's V showed perfect association (V=1) 
for the 'professional development' competency within the New Zealand group; and for the 
'educational policy' competency within the Australia group. Moderate (0.30<V≤0.50) to 
strong (V>0.50) association was observed within the three country groups for the other 
competencies in the cluster. This means that for these competencies, the ranking in the first 
assessment was predictive of the ranking in the second assessment.  
0.285 
(p=0.007)
0.299 
(p=0.006)
0.42 
(p=0.001
0.60 
(p<0.0001)
Link practice to education 8 12 6 26 (62)
Educational Policy 13 14 3 30 (71)
18 5 25 (60)
Professional development 5 14 5 24 (57)
Kappa 
statistic (k)
Adv. Stage 1 
(Transition)
Adv. Stage 2 
(Consolidation)
Mastery 
(Advanced)
Role model & mentorship 3 13 10 26 (62)
0.394 
(p=0.001)
Competencies
Agreement per level of advanced practice 
(N=42)
Total N (%)
Education & Training 2
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Overall, the results (Figure 4.13 and Table 4.48) demonstrate agreement between the 
frameworks for the competencies in this domain. 
Figure 4.13: Association between matching competencies in the Education, Training 
and Professional Development cluster 
  
Figure 4.14 shows the outcome of the analysis of evidences used to support self-assessment 
in this cluster. It showed that leading edge practitioners mainly used seven evidences to 
support their assessments. These were: 'member of, or advice local/hospital committee'; 
'member regional, national and international committee'; 'active research participation'; 
'research development and leadership'; 'professional standing or peer status'; 'managing 
process and leadership (local level)'; and 'managing process and leadership (international 
level)'. Experienced practitioners used four main evidences to support their assessments in 
this cluster. These were 'active teaching role', 'educational development, design and 
provision',  'staff management' and 'other documentation'. Specialists-in-training mainly used 
two main evidences to support their assessments. These were 'documented expert practice' 
and 'other documentation'. 
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Figure 4.14: Evidence used to support self-assessment in the Education, Training and 
Professional Development cluster 
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4.5.4.7 Agreement in the Critical appraisal, Evaluation & Research cluster  
Within-subject agreement ranged from 52% to 60% for the seven competencies in this 
cluster. This means more than half of the participants consistently ranked their practice on the 
same level for all the competencies in the cluster (Table 4.48). The percentage agreement 
varied between the countries with the lowest agreement observed in Australia and New 
Zealand for the 'develop research protocols' (30%) and 'apply research' (40%) competencies 
respectively (Figure 4.15). 
Table 4.48: Within-subject agreement per level of practice for the Critical appraisal, 
Evaluation & Research competencies 
 
 
The kappa (k) statistic values were indicative of fair (0.21<k<0.41) to moderate 
(0.41<k<0.61) agreement. These values were statistically significant for all seven 
competencies. The k-values indicated inconsistencies in ranking of matching competencies. 
Further evaluation using the Wilcoxon signed-rank test showed there was no statistically 
significant within-subject difference in ranking between the first (median rank: 13) and 
second (median rank: 13.5) assessments for the competencies in this cluster {Z= -1.465, 
p=0.143; maximum rank score attainable = 18}.  This was also not significant within the 
countries {UK: p=0.932, Australia: p=0.206, New Zealand: p=0.345}.  
0.551 
(p<0.0001)
Supervises others undertaking 
research
11 8 6 25 (60)
0.289 
(p=0.005)
0.382 
(p<0.0001)
0.466 
(p<0.0001)
0.351 
(p<0.0001)
Apply research evidence 7 6 8 21 (50)
Develop & evaluates research 
protocols
12 6 7 25 (60)
Critical evaluation 5 9 8 22 (52)
Identifies gaps in evidence base 11 6 7 24 (57)
Competencies
Agreement per level of advanced practice 
(N=42)
Total N 
(%)
Kappa 
statistic (k)
Adv. Stage 1 
(Transition)
Adv. Stage 2 
(Consolidation)
Mastery 
(Advanced)
0.539 
(p<0.0001)
Establishes research partnership 12 7 5 24 (57)
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Figure 4.15: Percentage agreement in the Critical appraisal, Evaluation & Research 
cluster  
 
  
A perfect association (V=1) was observed within the UK group for the 'establish research 
partnership' competency. Moderate (0.30<V≤0.50) to strong (V>0.50) association was 
observed within the three groups for most (83%) of the competencies in the cluster. This 
means the ranking in the first assessment was predictive of the ranking in the second 
assessment for all the competencies in the cluster.  
Overall, the results (Figure 4.15 and Table 4.48) demonstrate agreement between the 
frameworks for the competencies in this cluster. 
Figure 4.16 shows the outcome of the analysis of evidences used to support self-assessment 
in this cluster. It showed that leading edge practitioners mainly used seven main evidences to 
support their assessments. These were: 'member of, or advice local/hospital committee', 
'member regional, national and international committee', 'active research participation', 
'research development and leadership', 'professional standing and peer status', 'managing 
  241
process and leadership (international level)' and 'staff management'. Experienced practitioners 
used five main evidences to support their assessments in this cluster. These were 'member of, 
or advice local/hospital committee', 'active teaching role', 'research development and 
leadership', 'managing process and leadership (local level)', and 'other documentation'. 
Specialists in training mainly used the 'other documentation' evidence to support their 
assessment. 
Figure 4.16: Evidence used to support self-assessment in the Critical appraisal, 
Evaluation and Research cluster 
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4.6  Summary of crossover study results  
The study sample mainly comprised pharmacists in hospital practice (93%) with more than 
half  (57%) of the participants indicating they were leading-edge practitioners. Participants 
were able to rank their practice on the continuum of advanced pharmacy practice for all 64 
competencies in the two frameworks. The ranking of level of practice was however not 
consistent between the two self-assessments for some competencies.  
Direct observed agreement ranged from 43% in the 'national priorities' competency to 86% in 
the 'reasoning & judgement' competency. The k-values indicated slight (0<k<0.21), fair 
(0.21<k<0.41), moderate (0.41<k<0.61) and substantial (0.61<k<0.81) agreement for all the 
matching competencies evaluated:  
 Slight agreement was observed in three (10%) competencies: 'governance', 'working 
across boundaries' and 'national priorities'. The k-values for two of these competencies 
('governance' and 'national priorities') were not statistically significant (p > 0.05).  
 Fair agreement was observed in fourteen (47%) competencies: 'delivery expertise', 
'communication', 'team work', 'motivation', 'standard of practice', 'managing risk', 
'project management', 'managing performance', 'role model & mentorship', 
'professional development', 'education & training', 'critical evaluation', 'identifies gaps 
in the evidence base' and 'apply research evidence'.  
 Moderate agreement was observed in twelve (40%) competencies: 'professional 
autonomy', 'expert skills', 'strategic context & planning', 'vision', 'innovation & service 
development', 'resource utilisation', 'managing change', 'link practice and education', 
'educational policy', 'develops and evaluates research protocol', 'supervises others 
undertaking research' and establish research partnerships'. 
  Substantial agreement was observed in the 'reasoning and judgment' competency. 
However, none of the competencies showed excellent agreement based on the Kappa values 
obtained. Wilcoxon signed rank test showed a statistically significant within-subject 
difference in the collaborative practice cluster. This difference was not observed in the other 
five clusters. Cramer's V showed no association (V=0) under 'strategic context and planning' 
competency within the Australia group. This indicates that for this competency, the ranking 
of this competency in the first assessment was not predictive of the ranking in the second 
assessment for the participants from Australia. 
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A weak association (V≤30) was observed in three (10%) competencies. This was within the 
New Zealand group for the 'motivation' competency under the leadership cluster, and in the 
Australia for the 'national priorities' and 'managing risk' competencies under the management 
cluster. Moderate (30<V≤50) and strong (V>50) associations were observed within the three 
country groups for 20 (67%) competencies while a perfect association was found within the 
groups for 6 (20%) competencies. The perfect association (V=1) was in the: 
 'reasoning and judgement' competency under the expertise & expert skills cluster; 
 'vision' and 'innovation' competencies under 'leadership' cluster; 
 'professional development' and 'educational policy' competencies under the education, 
training and professional development cluster; and 
  'develops research protocols' competency under the 'evaluation & research clusters. 
 
The moderate, strong and perfect associations suggest that individual rankings in the first 
assessment were predictive of the rankings in the second assessment within the countries 
groups. This was observed for 26 (87%) competencies. 
The evidences used to support assessment also varied between the three levels of practice. 
Leading edge practitioners, equivalent to the highest level of advance practice, used five main 
evidences to support their practice in the six clusters. These evidences were: 'member of, or 
advice local/hospital committee'; 'member of regional/national or international committee'; 
'active research participation'; research development & leadership'; and 'managing process & 
leadership (international level)' evidences. The experience practitioners mainly used the 'staff 
management' and 'other documentation' evidences to support their assessment in all clusters. 
They were however less able to support their assessment in the evaluation and research 
cluster. The specialist-in-training respondents mainly used the 'other documentation' evidence 
to support their practice. Generally, specialist-in-training and experienced practitioners were 
less able to support their assessment in the evaluation and research cluster compared to the 
leading-edge practitioners.  
Overall, the results demonstrate within-subject consistency in ranking for 26 (87%) of the 
competencies identified in the two frameworks. 
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4.7 Stage 5: Qualitative Interviews 
The aim of this stage was to explore participant perception of the two advanced pharmacy 
frameworks used in this study. It also aimed to obtain practitioners' inputs on the two self-
assessment processes.  
4.7.1 Participants recruitment  
At the end of the crossover study, all 42 participants who successfully completed the two 
assessments were approached and invited, via email, to participate in a semi-structured 
telephone interview. The geographic location of the study participants precluded face-to-face 
interviews and so telephone interviews were conducted.  
The interviews were conducted over three weeks from July 7th to August 5th 2014. Verbal 
permission for recording was obtained from the participants at the start of the conversation 
and the interviews lasted for 15-20minutes.  Each conversation was recorded and transcribed 
verbatim. The transcriptions were then read and thematically coded manually. A copy of the 
transcripts was also forwarded to the respective participants. The interview schedule is 
presented in Appendix 10 while the invite is presented in Appendix 11.  
4.7.2 Results 
4.7.2.1 Demography  
Participants were interviewed until redundancy with seventeen participants interviewed in 
total. These participants were from the four countries represented in the crossover study and 
included 7 (47%) from Australia, 4 (27%) from New Zealand, 5 (42%) from United 
Kingdom, and 1 (100%) from Ireland. 
Eighty-eight percent of the interviewees were in hospital practice while two (12%) were in 
academia. Majority were leading edge practitioners (76%), three were experienced 
practitioners (18%), and one was a specialist-in-training (6%). The average length of practice 
was 17 years (S.D: 8years). 
Participants were asked open-ended questions covering two broad themes: the self-
assessment process, and perceptions about the two frameworks (Appendix 10).  
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4.7.2.2 Emergent interview themes  
A) Prior self-assessment experience  
This code described previous self-assessment experience prior to the study. The question that 
elicited the code aimed to determine whether the study participants had participated in a 
formal self-assessment process before the study.  
Eight of the interviewees (47%) had formal self-assessment experience prior to the study but 
this was at the foundation level for the majority.  
'Yes, we have something similar to what you've got in UK and it is the Queensland 
GLF, so have only done this at the foundation level, not at the advance level'. 
A35, female, experience practitioner, Australia 
'Yes, but this is the first time I have done this at this level. Ever since I completed my 
post-graduate diploma which was basically mapped against the GLF, I haven’t used 
anything else to sort of guide my development or see where I am at'. 
A48, male, experienced practitioner, UK 
'Yes, but not the same as this; we have to do it for our recertification. We carry out a 
self-assessment against our competency standards once every three years'.   
 B11, Female, leading edge practitioner, New Zealand 
However two of the interviewees had used one of the frameworks for formal self-assessment 
at an advanced level. 
'Yes, I was involved with the CODEG process in 2006, so I have used the framework 
(RPS-APF) on a few occasions since then'.  
B26, male, leading edge practitioner, UK 
Yes, I am familiar with the process; I have just completed my portfolio for submission 
to the RPSGB faculty using the RPS-APF.' 
B5, female, leading edge practitioner, UK 
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Others had not undertaken any formal self-assessment prior to the study, but have used one or 
both of the frameworks to develop organisation-specific frameworks. 
'No, not formally, but, I have been involved in the development of the Australian 
Accident & Emergency Medicine Pharmacy Framework, so I have worked a bit with 
the APPF but have never used it to assess my own practice'.  
A51, Female, experience practitioner, Australia  
'No, not formally in my own practice, though I am involved in building evidence for 
advanced practice in emergency pharmacy for my hospital in Queensland. So, I have 
experience with the Australian framework'  
B31, male, leading edge practitioner, Australia  
Some of those with no prior self-assessment experience were interested and motivated to do 
so because they thought it would be a useful process. 
'No, I have never done something like this before. Though I have been in a 
management position for just over two years; I never thought of doing something like 
this … when I saw the advertisement by our hospital pharmacy society, I thought it 
would be useful to give it a go, just to see where my practice was'.  
A55, male, leading edge practitioner, Australia  
B) Usability of the frameworks  
This code describes perception about clarity and ease of use of the two frameworks. The 
interview question that elicited the code aimed to explore participants' opinion about the 
frameworks.  
All interviewees indicated the wordings of the competencies and corresponding descriptors 
were unambiguous and easy to understand. 
'I thought the frameworks were quite clear in their description. Initially, I needed to 
get the examples close to me and refer to them as I was going through it. But once I 
got my head around what the terminologies were, then it was easy to use.' 
B11, female, leading edge practitioner, New Zealand 
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'The wording was clear in both framework, although, I found it got a bit repetitive 
after a while. I also understood and appreciated the explanatory notes attached'. 
B33, leading edge practitioner, Ireland  
'I thought the competencies and developmental descriptors were clear and I found 
them to be quite similar; so much so that I had to go back and look for differences 
between the frameworks'. 
A21, female, leading edge practitioner, Australia  
They reported some difficulties completing the framework in the first round but were more 
comfortable with the process by the second assessment. Some thought reflection and 
exposure to the framework in the first round might have made completing the second 
assessment easier.   
'When I first saw the framework, I thought wow … it felt a little bit overwhelming but 
when I read through the instructions and gave myself time to reflect, I felt more 
comfortable. The second round was a lot easier maybe because I sort of knew what 
the format was'. 
 B11, female, leading edge practitioner, New Zealand   
'I felt a bit lost the first time; I thought it was a bit difficult to comprehend. But by the 
second time I was quite familiar with the logic of the framework and knew what to 
do'. 
A55, male, leading edge practitioner, Australia  
'I actually found the second assessment easier to do. I can't remember which 
framework I used the second time but I remember I found it easier to do. I don’t know 
whether that was because it was easier, or maybe because I had already done it 
before, like a similar one, and was already familiar with the process'.  
B47, female, leading edge practitioner, Australia  
Others expressed difficulty with identifying appropriate evidence for use in supporting self-
assessment 
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'What evidence is needed is not clear in terms of the actual level of evidence. For 
example I regularly write and present half hour educational presentations for nurses 
and others; I don’t know where than sits in this framework. Also how do you provide 
evidence in the research cluster? Do you mean like writing a paper, presenting a 
poster at a conference or what?'  
B47, female, Australia, leading-edge practitioner  
'What I did find slightly difficult was selecting the right categories that my evidence 
goes into. I had to refer back to information you sent about all the different meanings 
and I don’t think all my evidence kind of neatly fitted into all the categories that were 
given. So, that probably was more difficult'. 
A35, female, Australia, Experience practitioner  
Some indicated that this initial difficulty might have resulted in them underestimating their 
perceived level of competence in some competencies.   
'I had an incidence the other day involving a work colleague … in the end I found 
myself thinking that may be I had underestimated my competence. I found myself 
thinking that may be if I actually searched through my hard drive and found 
everything I have done, may be I would have more evidence than I gave myself credit 
for'. 
A35, female, experience practitioner, Australia  
Others also thought they may have underestimated their competence in the first assessment  
'When I compared my assessment at the end, I saw that in some areas I thought I had 
progress but I couldn’t see how much work I had done over the three months period 
we had. But thinking back, it might be the fact that some of my projects may have 
been in motion at the time I did my first assessment but were completed, or more at an 
advance stage, when I did the second one. That may explain it because I do think that 
the frameworks were similar'.  
A48, male, experience practitioner, UK 
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Practitioners also reported that completing the framework was time consuming and required a 
lot of reflection. But, this was less so by the second assessment.  
'Even though I was quite familiar with the frameworks and evidence, I found it time 
consuming and difficult to do. I would say it was difficult to really get an accurate 
picture of it without spending a lot of time putting some sort of reflection into it, 
which is what I did in the first round. But by the second time I didn’t have to reflect so 
much on what the statements meant and what evidence to include since I had already 
gone through the process.' 
B5, female, leading edge practitioner, UK  
C) Similarity between frameworks 
This code describes participants' thoughts on the similarity between the two frameworks. The 
question that elicited this code aimed to explore perceptions about the two frameworks. 
All the participants thought the two frameworks were similar  
'… Without being too detailed, I think they were both quite similar in a lot of ways. 
There was a lot of duplication between them … generally I would say that the 
wordings of the framework were quite similar'.  
B33, leading edge practitioner, Ireland  
'I found the frameworks to be very similar and didn’t really see much difference. I 
know there was some gaps between doing the two assessments, but I do recall finding 
them to be similar in terms of wordings and description'. 
B50, female, leading edge practitioner, New Zealand  
'I found that the two frameworks were quite similar, I don’t think that even one of 
them showed any difference from the other in many respects'.  
A48, experienced practitioner, UK  
D)  Impact and relevance of the framework and self-assessment process 
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This code describes participants view about the assessment process. The question that elicited 
the code aimed to explore general opinion about the two self-assessments.  
The interviewees generally had positive opinions about the self-assessment process. They 
found the assessments to be useful in identifying practice gaps while also providing a road 
map for practice development.  
'I found the two self-assessments useful in identifying gaps in my practice that may 
limit my ability to become an advance practitioner. They also pointed out for me 
areas of advance practice that my current opposition does not offer, example master 
level competencies and making an impact at a national level'.  
A21, female, leading edge practitioner, Australia  
'It was a useful process because it helped me identify some areas of the areas where I 
haven’t done any particular work for one reason or the other; it gave me ideas about 
developing my practice in those areas'. 
A48, male, experience practitioner, UK 
At the end, I found it to be useful. It sort of gives you an overview of where you can go 
and how you can progress which is good … I found areas where I was interested in 
improving, some other areas I was fine with where I was and it wasn’t one of my 
priorities to improve in those areas'.  
A55, male, leading edge practitioner, Australia  
'It made me more conscious and a bit more aware of the things that I was doing. I 
suppose it gave me a little bit of perspective about where I was and so that was useful. 
It made me think about the scope or areas that I could be contributing to rather than 
just the clinical stuffs.'  
A51, female, leading edge practitioner, Australia  
Others said it gave them an opportunity to document and put together a practice portfolio. 
'I thought it was a useful process in terms of going through the competencies and 
thinking about how to put together a portfolio for faculty recognition in UK.' 
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B46, male, leading edge practitioner, UK 
'I think it was a helpful exercise, it made me realise I was doing more things than I 
had perhaps first thought and that to me was more a confirmation of my level of 
practice, which is helpful for my RPS faculty recognition application.'  
B5, leading edge practitioner, UK 
'I found the framework to be a methodical way to look at a portfolio of professional 
activity. I don’t think I would intuitively look at all the different dimensions and areas 
that the framework prompted me to do. So I actually found that very constructive and 
really useful and made me realise the breath of activity and how they could contribute 
to making me a better practitioner'. 
B33, female, leading edge practitioner, Ireland 
One participant indicated working towards developing competence in research as a result of 
going through the two self-assessments.  
'I think an area I plan to look at in the future is research … because there was a 
reasonable chunk of stuffs that were asked in relation to research and I looked at 
them and found myself going 'I'm not doing that, I'm not doing any of that. I mean 
with research you always go oh when I get the time, when I get the time; but now I 
know I actually need to make time to do it.'  
B11, female, leading-edge practitioner, New Zealand  
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4.7.3  Summary of the qualitative interview results  
Less than 50% of the interview participants had formal self-assessment experience prior to 
the study. Participants indicated that the wordings of the two frameworks were clear and 
unambiguous. They however expressed difficulty with understanding the requirements for the 
self-assessment in the first round. These difficulties centered on a lack of understanding of 
the terminologies and evidence needed to support self-assessment.  
The participants further indicated they found the second assessment easier to complete with 
some participants expressing that they thought this might have been due to the previous 
exposure to similar competencies in the first self-assessment and the opportunity for 
reflection this provided. 
The study participants also indicated that they found the process of self-assessment to be time 
consuming but were generally positive about its impact on practice. The positive effects 
reported included assisting in identifying learning needs and knowledge gaps. They indicated 
the frameworks clarified the expectations of advance practice with some of the participants 
reporting plans to undertake specific training in research. 
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4.8 Main Study Findings  
This overall goal of this study was to identify and evaluate advanced practice competencies 
in a global context. An initial literature review (conducted in stage 1 of this study) identified 
two advanced pharmacy frameworks: the RPS-APF (UK) and the APPF (Australia). These 
frameworks contained advanced pharmacy competencies adapted to practice in the United 
Kingdom and Australia respectively. 
Content analysis showed that the two frameworks had similar layout with the competencies 
and behaviours grouped under specific cluster themes (hereafter referred to as clusters) and 
across three distinct levels of advanced practice. In total, sixty-four advanced pharmacy 
competencies and 237 behaviours were identified from the two frameworks. Thirty of these 
competencies and 114 behaviours were from the APPF while the RPS-APF contained 34 
competencies and 123 behaviours.   
Content mapping of the two frameworks carried out in stage 2 of this study aimed to 
determine the competencies and corresponding behaviours common to the frameworks. The 
mapping exercise produced 30 pairs of competencies and 114 behavioural adjacencies. 
Specific semantic differences were observed and highlighted in the competency pairs and 
behavioural adjacencies. Five competency pairs contained competencies that were identical 
in their labels while sematic differences were observed in 25 (83%). Eleven (9.7%) of the 
behavioural adjacencies also contained behaviours that were identical in description while 
semantic differences were observed in 103 (90.3%).  
Consensus developed via a pragmatic approach to consensus building (conducted in stage 3) 
showed that despite the semantic differences between the two frameworks, 102 (89.5%) of 
the behavioural adjacencies formed from the content mapping comprised behaviours that 
were broadly similar. A crossover mapping experiment designed to evaluate the functional 
equivalence of the two frameworks (Stage 4) showed direct observed agreement between 
perceived levels of competence for matching competencies. Agreement of 50% and above 
was observed in 26 (86.7%) of the competencies identified from the frameworks. The lowest 
agreement (43%) was in the 'national priorities' competency while the highest (86%) was in 
the 'reasoning & judgement' competency.   
The Kappa statistic values showed less than excellent agreement in all 30 competencies, 
although, none had k-values less than 0.10. Slight to weak agreement (0.10<K<0.41) was 
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observed in 57% of the competencies while moderate to substantial agreement (0.40<k<0.81) 
was observed in 43%. Further evaluation using the Wilcoxon signed-rank test showed no 
within-subject difference between perceived levels of competence for the competencies in 
five clusters. A difference was however observed in the collaborative practice cluster and this 
was within the 'team work' competency. Cramer's V measure of association showed moderate, 
strong and perfect association between perceived levels of practice for 87% of the 
competencies. This suggests that the ranking of a competency in one framework was 
predictive of the ranking of the matching competency in the second framework for the entire 
sample for majority of the competencies (87%). 
However, comparison of the V values produced for the three main country groups in the 
study showed that Australia and New Zealand were less consistent in the ranking of 
competencies compared to the UK group. The New Zealand group showed a weak 
association for the 'motivation' competency (V=0.28); while the Australia group showed no 
association in the 'strategic context and strategic planning' competency (V≤0) and a weak 
association in the 'national priorities' and 'managing risk' competencies (V≤0.20). The UK 
group on the other hand showed an association for all the competencies evaluated.  
Disparity in the evidence used to support self-assessment was observed between the three 
levels of advanced practitioners. The results show that leading edge practitioners are more 
likely to be members of international, or regional committees, and are more likely to be 
involved in research. This is in contrast to the experienced practitioners that were mostly 
involved in staff management and in education and teaching roles. Specialist-in-training were 
generally least likely to be involved in research, management or leadership roles. They also 
were generally unable to provide evidence in support of their assessment.  
The semi-structured interviews conducted in the study demonstrated that the participants 
viewed the two frameworks as similar in content and description of competencies and 
behaviours. They also reported that the two self-assessments were useful in clarifying the 
expectations of advanced pharmacy practice, identifying gaps in practice and developing 
learning plans.   
The findings of the content analysis, expert panel review and consensus, and the crossover 
experiment suggest agreement and similarity between the advanced practice behaviours and 
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competencies in the two frameworks. It also underscores self-assessment as an important 
attribute of performance management in pharmacy practice.  
Full discussion of the study findings is provided in the Discussion section of this chapter 
(4.9).  
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4.9 Discussion  
4.9.1 Methodology  
A combination of a global survey of pharmacy organisations, systematic literature review and 
framework mapping via qualitative content analysis was used to identify the advanced 
pharmacy practice competencies in this study. Consensus developed via a pragmatic 
consensus building process involving a panel of experts and a crossover mapping experiment 
was used to evaluate the identified competencies. Qualitative interviews of the crossover 
experiment participants were conducted to obtain pharmacists' inputs about the framework by 
virtue of their professional roles as advanced practitioners in their respective countries.  
These methods were chosen based on evidence from published literature that show that 
pharmacy practice competencies are identified via a combination of systematic literature 
reviews and framework mapping using the content analysis technique (Pharmacy Council of 
New Zealand, 2011; Rutter et al., 2012; Thai Pharmacy Council, 2002; The Pharmaceutical 
Society of Ireland, 2013), and also evaluated via consensus and professional wide 
consultation involving self-assessment (Jones et al., 2012; Kennie-Kaulbach et al., 2012; 
Obiols, 2008).  
However, the reliability and reproducibility of the outcome of a content analysis may be 
limited due to the highly subjective nature of a content analysis technique (Graneheim and 
Lundman, 2004; Hsieh and Shannon, 2005; Krippendorff, 2013). Nonetheless, the qualitative 
content analysis conducted in this research was undertaken systematically according to the 
method outlined by Krippendorff (2013). It was conducted using the semantic description of 
each of the elements in the two frameworks while a panel of expert further reviewed the 
outcome of the content analysis, and interpreted and developed consensus on the meaning of 
the semantic differences observed. This design was used in order to limit the subjectivity 
associated with the technique and assure the reproducibility of the study findings.  
A convenience sample of experts was used in developing consensus in stage 3 of this study. 
This was done due to cost constrains and limited time available for the research which 
precluded the use of a Delphi or consensus development panel technique. The panel 
comprised 14 experts from hospital, academic, regulatory and administrative pharmacy. 
Though attempts were made to obtain representation from all areas of pharmacy; industrial, 
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pharmacy information, and military & emergency areas of practice were not represented in 
the panel.  
Since the panel meeting was conducted during the 2013 FIP annual conference of 
pharmacists and pharmaceutical scientists that held in Dublin, it meant that only experts who 
planned to attend the conference were able to participate in the meeting. Though the Delphi 
technique would have circumvented the difficulty associated with organising a face-to-face 
panel meeting due to the geographical location of the experts; the longer time required for 
organising and collating the results in the various rounds in a Delphi method made this 
approach impractical. Furthermore, the face-to-face meeting provided an opportunity to 
obtain further insight and data from group discussion in the panel. This approach was used 
based on evidence from published research that show that a modified nominal group and 
Delphi technique is a pragmatic and evidence-based methodology for developing consensus 
in pharmacy practice research (McMillan et al., 2016). 
Carryover effect is a major limitation of crossover studies (Jones and Kenward, 2003; Mills 
et al., 2009). Evidence from this study suggests exposure to the framework in the first 
assessment may have influenced self-assessed level of competence in the second assessment. 
However, challenges with obtaining a ‘matched pair’ sample made the crossover design more 
practical. Moreover, the crossover study design used also ensured that the study participants 
served as their own control, thereby limiting within-subject and within-group variability. 
Also, the findings of the qualitative interviews conducted in this research show that though 
the crossover effect may have provided an opportunity for reflection and so likely 
contributing to an increased self-awareness of gaps in practice; this did not result in a 
significant difference in individual assessment of matching competencies.  
The participant recruitment method is another source of potential bias in this study, 
particularly because the participants were self-selected. Studies show that self-selected 
participants are likely to be more intrinsically motivated than the general population (Olsen, 
2008). This recruitment method was however chosen to increase the chances of including 
participants from different practice areas in the study, although at the end of the study, the 
sample composition showed that majority of the study participants were in hospital practice. 
The crossover mapping experiment required the study participants to self-assess their practice 
using the two identified advanced pharmacy frameworks: the RPS-APF (UK) and the APPF 
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(Australia). Ranking of individual practice on the continuum of advanced practice delineated 
in the two frameworks was used as a proxy measure of the applicability to practice of the 
advanced pharmacy competencies identified. This means applicability of the two frameworks 
was evaluated implicitly in the crossover study. Feedback from some of the practitioners 
indicated this design was not ideal given that the self-assessment documents, which were 
wholly reproduced from the respectively frameworks (Appendix 12 & 13), should have been 
edited to include a 'not applicable' column for practitioners to indicate when they thought a 
competency was not applicable to their practice. A comment from one of the participants 
captures this point: 'the big confusion was around what to do when I thought I was below 
stage 1 on some competencies. Should I have selected stage 1 or leave all three boxes un-
ticked? There was no option of 'not applicable' or 'basic'. I felt at times that the tool assumed 
all pharmacists with several years of experience will fit into one category for all the 
competencies….'  
Also, the design of the crossover mapping experiment assumed that a change in self-assessed 
level of competence for a pair of matching competencies would be reflective of a difference 
between the two frameworks. The findings of this research indicate that while some of the 
participants of the crossover study may have been self-aware of their competence prior to the 
study (in light of the higher consistency in ranking observed in the UK and Australia group 
for most of the competencies); the three months washout period used in this study might have 
been too long. This is particularly important in light of evidence from the study by Goldsmith 
et al., (2001), which demonstrated an observable change in pharmacists' performance within 
three months of the use of a competency framework to identify gaps in practice. Therefore, 
the three-months washout period used in this study likely provided ample opportunity for 
further reflection and for some of the study participants to seek out new learning activities.  
Kappa statistics was used as a measure of chance-corrected intra-observer agreement. Paired 
data used in this research violates the assumption of independence for Chi-square related 
statistics like Kappa. However, mathematical modelling by Gwet (2007) show the Kappa-
statistics can be used for paired data and informed the decision to use this analytical method. 
Self-assessed level of practice was used as proxy measure of competence and actual 
performance in this study. However, evidence from published literature show that cognition 
does not always predict performance or behaviour (Cuthbert et al., 1999; Young et al., 2000). 
This feature likely affects the reproducibility of some of the findings of this study. 
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Furthermore, other studies have also demonstrate inconsistencies in self-assessed level of 
competence and actual abilities (Hodges et al., 2001; Regehr et al., 1996; While, 1994). 
Published studies show that highly skilled practitioners tend to underestimate their abilities 
while low skilled practitioners overestimate their abilities. This feature was observed in this 
research, although the change was not statistically significant.  
4.9.2 Content equivalence between the RPS-APF and APPF competency frameworks   
The two frameworks contained advanced pharmacy practice competencies that were 
described under cluster headings and across three distinct levels of practice. Consensus 
obtained in stage 3 of the study suggests that the RPS-APF contained 102 behaviours that 
were similar to matching behaviours in the APPF, and vice versa. These similar behaviours 
were from 23 (77%) of the 30 competency pairs identified from the two frameworks. Experts 
comments indicated the differences observed between the remaining behaviours was due to 
disparity in complexity of the behaviours described in the two frameworks.  
For example, the following expert comments were made in relation to a behavioural 
adjacency formed under the 'expert skills and expertise' competency theme: ‘the two 
behaviours are dissimilar. Demonstrating accountability is different from accepting 
accountability, as it is possible to accept accountability without necessarily demonstrating 
it’. This comment was made with respect to the behavioural adjacency “demonstrates 
accountability for the delivery of professional services and expertise via a team or directly to 
groups of patients/clients/users” AND “Accepts accountability for patient care services 
delivered directly to a defined patient group”.  
The disagreement on similarity was mainly under the 'expertise and expert skills' competency 
theme. This is likely due to the fact that this competency was adapted to patient care in the 
APPF (Australia) in contrast to the RPS-APF (UK), which described the competency broadly 
with reference to all areas of pharmacy practice.  
Overall, the expert review indicates that 90% of content of the two frameworks were similar. 
This is in line with evidence from the research on foundation level pharmacy practice 
competencies conducted by Bruno, (2011). It is also in line with evidence form published 
studies that have shown the applicability to practice of a competency framework adapted to 
country-specific needs. For example, a study by Rutter et al., (2012) demonstrate the 
applicability of a competency framework developed with the aid of the General Level 
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Framework (now the RPS-FLF of the United Kingdom) for pharmacy practice in Singapore 
(Rutter et al., 2012). Similar findings were demonstrated by Svetlana et al., (2014), which 
showed the applicability of a competency framework, developed with the aid of the General 
Level Framework (UK), for pharmacy practice in Serbia. It is also in line with the study by 
Carrington et al., (2011) which demonstrates the applicability of a competency framework, 
developed with the aid of the Advance to Consultant Level Framework (now the RPS-APF), 
for oncology pharmacy practice in Australia. 
4.9.3 Functional equivalence between the RPS-APF and APPF competency 
frameworks 
The crossover mapping experiment conducted in stage 4 of this study was designed to 
evaluate the functional equivalence of the two advanced pharmacy frameworks identified 
from the literature review. Functional equivalence was assessed by evaluating the: 
 Within-subject agreement between ranking of matching competencies; and  
 Association between within-subject rankings of the competencies.  
 
Direct observed agreement showed that the lowest agreement was in the 'national priorities' 
competency (43%) while the highest agreement was in the 'reasoning & judgement' 
competency (86%). Agreement of 50% (or more) was observed in 26 (87%) of the 
competencies in the frameworks. Evidence show that assessing direct percentage agreement 
can be misleading particularly because it does not account for the probability of chance 
agreement (Cohen, 1960; Viera and Garrett, 2005). Consequently, within-subject agreement 
was further evaluated using the chance–corrected measure of agreement: the Kappa (k) 
statistic.  
The k-values derived from the analysis was indicative of chance–corrected agreement ranging 
from weak agreement (k=0.13) in the 'governance' competency to substantial agreement 
(k=0.73) in the 'reasoning & judgement' competency. This means the chance-corrected 
agreement in the framework ranged from as low as 13% in the 'governance' competency to as 
a high as 73% in the 'reasoning and judgment' competency. These values also indicated slight 
to fair within-subject agreement (0.21<k<0.41) for majority of the competencies (57%) in the 
framework with none of the competencies showing excellent agreement. It indicated the 
chance-corrected agreement in most of the competencies was 21% to 40%, in contrast to the 
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direct observed agreement of 50% and above obtained for majority of the competencies 
(87%) in the framework. The disparity between chance-corrected agreement and the direct 
percentage agreement can be explained by evidence from the published literature that 
demonstrates that the k-statistic underestimates agreement (Cicchetti and Feinstein, 1990; 
Feinstein and Cicchetti, 1990). This therefore accounts for the low agreement indicated by 
the k-values.  
Since none of the competency showed excellent or perfect agreement (as indicated by the k-
statistic values), the Wilcoxon signed-ranked test was used to further evaluate within-subject 
difference in ranking. The result of this inferential test showed there was no statistical 
significant within-subject difference in ranking for all but one competency in the frameworks. 
The observed difference in within-subject ranking was under the 'teamwork' competency 
(median rank 1st-2nd assessment: 4–5; maximum cluster score attainable=6; p=0.043). Further 
evaluation showed that the inconsistency was from the UK and New Zealand country groups, 
although the disparity was not statistically significant within the country groups [UK: 
p=0.131; New Zealand: p=0.176]. Even though these inconsistencies in ranking were not 
statistically significant, it does suggest that participants generally underestimated their 
competence in the first assessment. This is further highlighted by the slight inconsistencies in 
ranking observed in other clusters including leadership (median rank 1st- 2nd assessment: 13–
14; maximum cluster score attainable = 15; p=0.370); management (median rank 1st- 2nd 
assessment: 18.5–19.5; maximum cluster score attainable= 24; p=0.231); and research & 
evaluation (median rank 1st- 2nd assessment: 13–13.5; maximum cluster score attainable = 18; 
p=0.143).  
These inconsistencies are likely due to the fact that more than half of the study participants 
did not have any formal self-assessment experience prior to the study. These participants 
were also not familiar with either of the two frameworks used in the crossover study. This 
unfamiliarity with the framework or with the self-assessment process was also evident from 
the interview with some of the study participants indicating they initially found the 
framework difficult to use in the first round. Comments from participants in group A and B 
obtained in the interview suggests that the difficulty was not related to the particular 
framework used in the first assessment. Examples of comments that showed this include: 'I 
felt a bit lost the first time; I thought it was a bit difficult to comprehend. But by the second 
time I was quite familiar with the logic of the framework and knew what to do' (Group A 
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participant), and 'When I first saw the framework, I thought wow … it felt a little bit 
overwhelming but when I read through the instructions and gave myself time to reflect, I felt 
more comfortable…' (Group B participant). 
This suggests that familiarity with the self-assessment process in the first round may have 
increased self-confidence and in so doing aided more accurate individual assessment of 
competence by the second round. This finding is in line with evidence from a study by 
Fitzgerald et al., (2003) which showed that self-assessment accuracy is influenced by task 
familiarity. However, this is in contrast to evidence from a study by Kruger and Dunning 
(1999) which showed that learners tend to overestimate their abilities, although, the authors 
also found that this overestimation was generally attenuated by further training and increased 
self-awareness of gaps in practice. On the other hand, the inconsistencies in ranking observed 
in this study may also indicate a change in perceived level of competence. Since the observed 
change showed that the participants ranked their practice higher in the second assessment, it 
is possible that the opportunity for reflection provided by the first assessment may have 
heighten self-awareness of depth and limitation of practice. Evidence from the qualitative 
interviews suggests this may have been the case for some of the participants. For instance a 
comment from a participant shows this: 'I had an incidence the other day involving a work 
colleague (…) in the end I found myself thinking that may be I had underestimated my 
competence. I found myself thinking that may be if I actually searched through my hard drive 
and found everything I have done, may be I would have more evidence than I gave myself 
credit for….'  
The observed change in ranking may have also been potentiated by the carryover effect 
inherent in crossover studies (Jones and Kenward, 2003; Mills et al., 2009). This is in line 
with evidence from the study by Brown et al., (2015), which demonstrated improvement 
understanding and greater confidence in perceived level of competence after a four-day 
competency-based training workshop involving a group of health professionals.  
In spite of the observed inconsistencies, Cramer's V values obtained in the study showed 
moderate, strong and perfect associations in within-subject ranking for majority of the 
competencies (87%). This included the 'teamwork' competency that showed a statistically 
significant difference in ranking of competence. The Cramer's V values obtained suggest that 
the competency ranking of the first assessment was predictive of the ranking in the second 
assessment.  
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The Australia and New Zealand were less consistent in the ranking of competencies 
compared to the UK. The UK group showed an association for all the competencies evaluated 
and this may be due to the fact that the members of this group were more likely to have had 
prior experience with self-assessment as indicated by the outcome of the interviews, 
particularly because the United Kingdom pioneered the use of the RPS-APF developmental 
framework for evaluation of competence through self-assessment for pharmacists (Davies et 
al., 2002; Modernising Pharmacy Career Programme, 2012; Royal Pharmaceutical Society of 
Great Britain, 2013b, 2003b) via the work of the Competency Development Group [CoDEG]. 
Overall, the study result indicates minimal disparity between the competencies in the two 
frameworks and this is in line with evidence from the studies included in the literature review 
reported in Chapter 2 of this thesis that have demonstrated similarity between countries with 
respect to applicability to practice of identified competencies. For example, studies by 
Meštrović et al., 2012 (Croatia), Svetlana et al., 2014 (Serbia), Coombes et al., 2010 
(Australia), and Rutter et al., 2012 (Singapore), demonstrates the existence of a common set 
of pharmacy practice competencies that are applicable to practitioners in these different 
countries. It corroborates evidence from the study by Bruno (2011), which showed that the 
competencies in the FIP Global Competency Framework are applicable to pharmacists in 64 
countries. 
Evaluation of the evidence used to support self-assessment demonstrates the two frameworks 
are capable of differentiating between the three distinct levels of advanced pharmacy 
practice. Leading-edge practitioners— which correspond to the highest level of advanced 
pharmacy practice— were more likely to be members of regional, national or international 
advisory committees. They were also more actively involved in research, and leadership roles 
at regional and international levels. Experienced practitioners on the other hand were more 
involved in staff management but were not likely to be involved in leadership or actively 
participating in research. Specialists-in-training were generally unable to support their self-
assessment with any of the evidence provided. They used the 'other documentation' evidence 
category: a feature that is in line with the practice profile expected of this group, as shown by 
evidence in the study by Obiols (2008). It is also in line with the practice profile expected of 
the different levels of advanced practitioner (The Advanced Pharmacy Practice Framework 
Steering Committee (APPFSC), 2012, p. 11). The overall finding of this study suggests the 
  264
existence of a set of advanced pharmacy practice competencies that are applicable to 
practitioners from the countries represented.  
4.10 Study Limitations  
In addition to the potential limitations discussed above, this study has a number of potential 
sources of bias: 
• The convenience sample of experts used to develop consensus in stage 3 of this study 
is a potential source of bias. Conducting the face-to-face panel meeting during the 
2013 FIP conference meant that only the experts attending the conference were able 
to participate. It also meant that expert pharmacists from countries or pharmacy 
organisations not affiliated with FIP were excluded.  As a result, the external validity 
of this study finding beyond the countries represented may be limited.  
• The panel proceedings and discussion was conducted in English language. This 
therefore excluded potential respondents from non-Anglophone countries that may 
otherwise have been interested in participating, thereby biasing the results and 
limiting the generalisability of these findings to these countries.  
• The sample size in the crossover mapping experiment is a potential source of bias. 
The majority (42/45, 93%) of the crossover study participants were in hospital 
practice with only one participant in community and academic practice. The study 
also had a limited number of countries represented. Consequently, further research 
involving advanced practitioners from more countries is required.  
• Furthermore, the crossover study participants were self-selected. As a result, it is 
possible that the findings of this research may have limited external validity to 
advanced practitioners that are less motivated to improve their practice compared to 
the study participants. 
• The two frameworks used in this study were developed via similar bibliographic 
sources. As such, this biases the interpretation of the study findings that show 
similarity in competencies and behaviours between the frameworks.   
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Chapter 5 CONCLUSION 
Health workforce quality influences health system performance. It plays a key role in the 
attainment of universal health coverage and equitable access to essential health services. 
Some of the strategies for improving health workforce quality include rapid workforce 
expansion in terms of increasing and sustaining the numbers of health workers and 
strengthening workforce capacity via education, training and developmental (World Health 
Organization, 2013, 2007).  
In recent years, health professional education has undergone some innovations, one of which 
has been the adoption of the competency-based education and training (CBET) model for 
both undergraduate and practicing health professionals. Although CBET has been widely 
used in teacher education since the mid-1960's in USA (McCowan, 1998), and in vocational 
education & training (VTE) in Europe since the mid 1980's (Winterton et al., 2006); its use in 
health professional education has only been actively promoted and implemented in recent 
years (Bates and Bruno, 2008; Frenk et al., 2010; Gruppen et al., 2012; The Draft CanMEDS 
2015 Physician Competency Framework - Series IV, 2015; World Health Organization, 
2013).  
A key attribute of the CBET model is the identification of the competencies required for 
effective, safe and consistent performance within the limit of professional practice (Brownie 
et al., 2011a). A compilation of these competencies produces a competency framework that is 
used to design education & training curricular, define scope of practice, regulate career entry 
and support expertise development (Brownie et al., 2011a). 
The systematic literature review presented in chapter 2 provides evidence of the usefulness of 
competency frameworks. Evidence from the studies included in the review in chapter 2 of 
this thesis show that when competency frameworks are used alongside practice standards, it 
helps improve pharmacists' performance, supports the attainment and maintenance of 
competence, promotes consistency of practice and fosters professional development 
(Antoniou et al., 2004; Austin et al., 2004, 2004; Brownie et al., 2011a; Coombes et al., 2011; 
Mills et al., 2005).  
In line with evidence, the two studies reported in this thesis aimed to identify and evaluate the 
competencies that are essential for global foundation and advanced pharmacy practice. This 
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chapter will discuss the overall implication for practice of the findings of this research and 
would provide recommendation for future research.  
Overall, the two studies reported in this research evaluated pharmacy practice competency 
frameworks. While the first study evaluated the FIP global competency framework for 
foundation level practice focusing regionally in Africa, the second study evaluated two 
national advanced pharmacy practice frameworks in a global context. The two studies aimed 
to answer two main questions: 
1. Are the competencies and behaviours in the FIP Global Competency Framework 
(GbCF v1) relevant to pharmacy practice in countries in Africa? 
2. Are there core competencies for advanced pharmacy practice?  
a. If so, would such competencies be applicable to advanced practitioners from 
different countries? 
b. Can a global competency framework for advanced pharmacy practice be 
developed from these competencies? 
The findings of the first study involving the evaluation of the FIP Global Competency 
Framework (GbCF v1) (reported in chapter 3) show that the competencies contained in the 
framework are broadly applicable to pharmacy practice in four countries in Africa.  It 
demonstrates that 90% of the GbCF v1 behaviours are essential for pharmacy practice in 
Nigeria, Ghana, Kenya and South Africa. It provides evidence of the applicability of these 
competencies for foundation level pharmacy practice in these countries although, with some 
specific inter-nation differences for seven of the GbCF v1 behaviours. Data from the study 
was not conclusive for ten of the African countries represented in the survey. These countries 
included Tanzania, Sudan, Uganda, Zambia, Zimbabwe, Egypt, Ethiopia, Lesotho, Namibia 
and Tunisia. However, the homogeneity of the survey responses obtained for all the 14 
countries represented suggest that the overall findings of this study may likely be 
generalisable.  
 
The results of the second study (chapter 4) demonstrate the existence of a set of pharmacy 
practice competencies that are relevant for advanced pharmacy practice in different countries. 
It provides preliminary evidence of the applicability of these competencies to a group of 
advanced practitioners from three of the countries represented and these were United 
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Kingdom, New Zealand and Australia. Evidence of the applicability of these competencies to 
practice in Ireland was inconclusive given that only one participant from the country was 
represented in the sample. Overall, due to limited number of countries represented, it is not 
possible to conclude that a global framework for advanced pharmacy practice has been or can 
be developed (based on data obtained in this thesis) and so further research is required.   
 
The findings of these two studies corroborate evidence of the existence of a set of 
competencies that are relevant for pharmacy practice in different countries (Bruno, 2011). 
These findings are also in consonance with similar evidence from the field of medicine that 
demonstrates cross-national applicability of the Canadian CanMEDS Physician Competency 
Framework to medical practice in Netherlands (Scheele et al., 2008), Denmark  (Danish 
Health and Medicines Authority, 2014; Ringsted et al., 2006) and Australia (The Royal 
Australian and New Zealand College of Psychiatrists, 2012).  
 
These findings therefore have a number of implications for pharmacy practice. The results of 
the study reported in Chapter 3 validates the FIP Global Competency Framework (GbCF v1) 
as a mapping tool that can be used to develop country-specific frameworks in some African 
countries. It provides evidence of the potential applicability of the framework to pharmacy 
practice in four countries in Africa: Nigeria, Ghana, Kenya and South Africa. It also provides 
evidence that was previously lacking on the relevance of these competencies in these 
countries while also demonstrating the feasibility of adapting the GbCF v1 framework to 
developing country-specific frameworks for pharmacy practice in these countries.  
 
Of particular interest is the finding that a high percentage of community pharmacists from the 
countries represented in the online survey indicated that the B13 (document and act upon 
dispensing errors) and B14 (implement and maintain a dispensing error report system and a 
near miss report system) behaviours were not relevant for their practice. This suggests 
community pharmacy respondents from these countries do not routinely carry out these 
activities although this may have been due to the response rate and/or that the pharmacists 
were self selecting. Nonetheless, this finding underscores the need to review current practice 
and incorporate robust dispensing processes in community practice that incorporate oversight 
functions by pharmacists in these countries. This should assure patient safety while also 
providing an avenue for prompt identification and action on potential medication errors.    
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Data from the study reported in Chapter 4 provide preliminary evidence of the existence and 
applicability to practice of the advanced pharmacy practice competencies contained in the 
RPS-APF and the Australian APPF. In light of similar evidence from other studies (Rutter et 
al., 2012; Bruno (2011); Svetlana et al., 2014; Carrington et al., 2012; Brown et al., 2012); 
these results suggests that the two advanced pharmacy frameworks evaluated in this study 
can be used as mapping tools for the development of other country-specific frameworks. It 
also suggests that the 30 broad competencies identified from the two frameworks can be 
compiled and further evaluated and validated through larger scale research studies involving 
advanced practitioners from more countries. 
The availability of a validated set of competencies for global pharmacy practice can provide 
an avenue for guidance on the expectations of practice. This will ensure shared understanding 
of the requirement of pharmacy practice between countries while also facilitating the 
definition of professional standards. From a leadership perspective, it can help facilitate the 
articulation of harmonised standards that can become aspirational for advanced practitioners 
at an individual level, and for national leadership bodies at an organisational level. The 
availability of harmonised standards for global pharmacy practice can assist the global 
quality assurance process by facilitating comparability of professional practice between 
countries, and in so doing promote parity in standards of care and aid skill mobility. 
 
The results of the crossover mapping experiment reported in chapter 4 indicate that 
pharmacists likely underestimated their competence in the first assessment. This suggests an 
initial lack of self-awareness of the breadth and depth of practice prior to exposure to the 
framework. This was in tandem with the results from the qualitative interview that also 
indicated that the opportunity for reflection and exposure to the competencies in the 
framework used for first self-assessment likely aided accurate assessment of competence with 
the second framework. This finding emphasises the need to promote reflective practice and 
routine self-assessment for pharmacy practitioners. This would potentially ensure that 
pharmacists are continuously self-aware of their capabilities and thereby provide the 
motivation and confidence needed to take on more responsibilities, ultimately aiding the 
efficient use of available skills. It would also facilitate self-awareness of gaps in practice and 
so facilitate self-directed learning for continuous professional development. 
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The findings of the two studies reported in this thesis showed that pharmacists considered the 
research-related competencies to be of low relevance to practice. This suggests that 
involvement in research is likely to be limited for the pharmacists that participated in the two 
studies. Since the studies included international pharmacists from different areas of pharmacy 
practice and with differing length of practice experience, the finding highlights the need to 
build research capacity in pharmacy globally. This is of particular importance in view of the 
changing healthcare environment where new and individualised therapies, technological 
advancements, and the aging population demand complex and evidenced-based 
pharmaceutical care services that optimise patient outcomes. As a result, high quality 
research studies designed to evaluate the effectiveness of novel drug products or 
pharmaceutical care strategies will need to be conducted and this would require the 
availability of trained pharmacists able to take on these responsibilities. 
 
The theory of andragogy posits that self-recognition of knowledge gaps triggers a readiness 
to learn in adult learners (Knowles, 1980; p.43). It is this self-recognition of practice 
limitations that motivates adult learners. The theory also asserts that adults would be more 
willing to learn when their learning activities are organised around areas that are immediately 
relevant to solving real life problems. This means that incorporating the identified pharmacy 
practice competencies shown to be relevant to practice into the learning activities of 
pharmacy practitioners would likely motivate and trigger a readiness and willingness to learn. 
This would potentially promote lifelong learning and ensure that pharmacy practitioners are 
capable, competent and continuously fit for practice.  
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5.1 Innovation in this research  
A pragmatic approach to consensus building was used in stage 3 of the advanced pharmacy 
practice study reported in chapter 4. This involved a combination of a modified Delphi and 
nominal group technique involving a panel of experts. This approach enabled the inclusion of 
expert practitioners that otherwise would not have participated because they did not plan to 
attend the FIP conference where the face-to-face panel meeting was conducted. The choice of 
the 2013 FIP annual conference of pharmacists and pharmaceutical scientists which held at 
Dublin as a venue for the conduct of the panel meeting provided an opportunity for the 
inclusion of international experts.  
Social media was actively used to raise awareness for the first study reported in this research. 
In using this approach, the survey invite containing the URL was disseminated using 
Facebook®, Twitter® and Blackberry Messenger® social media platforms. This information 
dissemination strategy proved useful for raising awareness and reaching pharmacists in 
different countries and should be considered for use in future research involving online 
surveys in pharmacy practice.  
The applicability and functional equivalence of two advanced pharmacy practice frameworks 
was evaluated in the second study via a crossover mapping experiment [reported in Chapter 4 
of this thesis]. This circumvented the need to recruit matched pairs of practitioners from the 
different countries. It also provides evidence of the feasibility of using this design in 
framework mapping and in the comparative evaluation of the applicability to practice of the 
identified competencies and could be useful for organisations and countries interested in 
developing specific frameworks.   
5.2 Future Research  
The study reported in Chapter 3 of this thesis has demonstrated the validity of the GbCF v1 
framework in four countries in Africa, based on the responding pharmacists.  Further work is 
now necessary with respect to obtaining stakeholders' and expert opinion on the relevance of 
these competencies in these countries. This would provide an opportunity for advocacy as 
well as a means for obtaining 'buy in' from policy makers and key persons of influence in the 
countries.  
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The validity of the competencies in other countries in the region, particularly non-
Anglophone countries, would need to be evaluated in future research. This is to enable 
further compilation of evidence of validity of the framework in this region. This means that 
further work will need to be done in translation of the GbCF v1 to the other languages used in 
the region. For instance, French is the dominant language used in 16 of the eighteen countries 
in West Africa while Arabic is the main language in all the seven countries in North Africa. 
Furthermore, a larger scale validation study is necessary in order to obtain inputs from 
practitioners in non-patient facing roles like industrial, administrative and academic 
pharmacy who practice in this region. This will ensure that evidence on the validity of the 
framework in these areas is obtained and possibly provide an opportunity for feedback and 
review of these draft competencies in relation to these specific areas of practice. 
Further work is also necessary to evaluate the applicability to practice of the 30 broad 
advanced pharmacy competencies identified in this research. Future research would need to 
include a larger cohort of advanced pharmacy practitioners than was obtained in this 
research. It would also need to include advanced practitioners from other countries and other 
practice areas like community, academic and industrial pharmacy to ensure availability of 
robust evidence from these groups. Furthermore, majority of the crossover study participants 
were leading edge practitioners (57%), as such research involving a larger cohort with more 
representatives from the experienced and specialists-in-training cadre of practice is necessary.   
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Appendix 1: Survey Invitation Email  
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 Appendix 2:  Survey Invitation Flyer 
 
 
Validation of the FIP Global Competency Framework (GbCF v1) in Countries in 
Africa 
Dear Pharmacist, 
The Development Team of the FIP Education Initiative, FIPEd, invites you 
to participate in an on-going survey of pharmacists practising in Africa. The 
overall goal of the study is to evaluate foundation level pharmacy practice in 
countries in Africa using the global competency framework (GbCF v1).  
The project aims to obtain inputs from pharmacists about the competencies 
contained in the FIP global competency framework, version 1 (GbCF v1).  
The questionnaire can be completed online on any internet-enabled mobile 
device or PC. Responses to the survey are uploaded directly on to the FIP 
database upon submission. 
If you require further information or should you have any questions, please 
contact:  
Miss Arit Udoh, Research Associate, FIPEd, arit.udoh.11@ucl.ac.uk 
Dr Andreia Bruno, Project Co-ordinator, FIPEd, education@fip.org 
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Appendix 3: List of FIP Member Organisations in Africa  
 
S/N Organisation  
 
Country 
 
1. Pharmacy Council of Ghana  Ghana 
2. Pharmaceutical Society of Kenya Kenya 
3. Ordre National des Pharmaciens de Madagascar Madagascar 
4. Pharmaceutical Association of Mauritius Mauritius 
5. Conseil Regional des Pharmaciens d’officine du Nord Morocco 
6. Conseil National de l’ordre des Pharmaciens du Mali Mali 
7.  Pharmaceutical Society of Nigeria Nigeria 
8. Rwanda Pharmacists Association Rwanda 
9. Ordre National des Pharmaciens du Senegal Senegal 
10. Pharmaceutical Society of South Africa  South Africa 
11.  Sudanese Pharmacists Union Sudan 
12. Pharmaceutical society of Uganda Uganda 
13. Pharmaceutical Society of Zambia  Zambia 
14. Pharmaceutical Society of Zimbabwe Zimbabwe 
15. Ordre National des Pharmaciens du Burkina Faso Burkina Faso 
16. 
Conseil National de L’ordre des Pharmaciens du 
Cameroun  
Cameroun  
17. 
Ordre National des Pharmaciens du Tchad 
N’Djamena 
Chad 
18. 
Comseil National de l’ordre des Pharmaciens du 
Congo 
Congo 
19. Pharmaceutical Society of Egypt Egypt 
20. Syndicate of Pharmacists in Arab Republic of Egypt  Egypt 
21. Eritean Pharmaceutical Association Eritea 
22. Ethiopian Pharmaceutical Association Ethiopia 
23. 
Conseil National de l’ordre des Pharmaciens de 
Guinea Conakry 
Republic of Guinea  
24. 
Conseil National de l’ordre des Pharmaciens de Cote 
d’Ivoire 
Cote d’Ivoire 
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Appendix 4: Online Forum of Pharmacists Contacted for the Survey 
 
i. Kenya Medical Practitioners, Pharmacists and Dentists Union (KMPDU) 
Facebook group available at https://www.facebook.com/groups/126614676824/  
ii. PharmacySA Facebook group available at 
https://www.facebook.com/groups/pharmacysa/  
iii. Social Pharmacy Network of Nigeria Facebook group available at 
https://www.facebook.com/groups/socialpharmacy/  
iv. Pharmacy Council of Nigeria Facebook group available at the link 
https://www.facebook.com/groups/Epharmacists/  
v. Pharmacist Action Group of Nigeria Facebook group available at the link 
https://www.facebook.com/groups/pagon.nigeria/  
vi. Pan-African Health Facebook group available at 
https://www.facebook.com/groups/511653725535743/  
vii. Pharmaceutical Society of Zambia, Copperbelt branch Facebook group available 
at https://www.facebook.com/groups/185888851441479/?fref=ts  
viii. The Uganda Community Pharmacists Fraternity available at 
https://www.facebook.com/groups/219323064879920/?fref=ts  
ix. Facebook Pharmacists and Doctors in Uganda 
https://www.facebook.com/groups/289641901104874/?fref=ts  
x. South Africa Pharmacy and Pharmaceutical Personnel Facebook group 
xi. Intern Pharmacy of Ghana Facebook group available at 
https://www.facebook.com/groups/272293606223881/  
xii. SA Pharmacy Today Facebook group available at 
https://www.facebook.com/groups/pharmacy2daysa/?fref=ts
  
Appendix 5: Survey Questionnaire  
Development Team  
Competency Development Domain | Validation of the GbCF v1 in an African Context 
     
Global Competency Framework v1 
Competent pharmacists have the potential to improve therapeutic outcomes and patients’ 
quality of life. Before competence can be determined, the specific competencies and 
behaviours that contribute to it must be identified. 
The aim of the overall project is to develop a global competency framework (GbCF) that 
includes behavioural statements, which can be adaptable to local needs and cultural contexts 
relevant to a global pharmaceutical workforce. This would be consistent with other health 
professions (eg, physicians) who have achieved a harmonised global consensus about 
competency. 
In the initial phase of the project, documents/frameworks were collected from around the 
world. Through consultation and review, these have been synthesised into this draft global 
version. Now we need your feedback about relevance or how well these behavioural 
statements fit your practice. 
As a pharmacist, your contribution is highly valuable, ensuring that the core competencies 
and behaviours you feel important to your daily work are incorporated in the global 
competency framework draft version survey. I hereby invite you to share your thoughts. 
Instructions: 
We will now ask you some specific questions about behavioural statements that constitute the 
provision of pharmaceutical services. The items are divided into four separate clusters: 
pharmaceutical public health, pharmaceutical care, organisation and management, and 
professional/personal competencies. 
Please think only about your own pharmaceutical practice and then rate each individual 
behavioural statement as relevant or not relevant to your practice. 
Please follow the directions and answer all questions. This is an anonymous, confidential 
questionnaire; responses will be reported in aggregate and no one respondent will be 
identifiable. Please answer honestly, reflecting actual practice rather than desired practice. 
This questionnaire should take no more than 20 minutes of your time. All contributions are 
highly valued, and we appreciate your time and effort.  
Many thanks for your contribution.  
For further information or if you have any enquiries about this questionnaire please 
contact Andreia Bruno or Arit Udoh. 
  
 Demographic Information: 
Country of residence: ____________________ 
Years Qualified: _______ 
Gender:  Female 
 
 
Male 
Current Status: Internship (still pre-registration while at university/college) 
 Pre-registration candidate (not yet registered or licensed)  
 Licensed/registered pharmacist 
 
Area of Practice: Academic Pharmacy 
 Administrative Pharmacy 
 Clinical Biology 
 Community Pharmacy 
 Hospital Pharmacy 
 Industrial Pharmacy 
 Laboratories and Medicine Control Section 
 Military and Emergency Pharmacy 
 Pharmacy Information 
 Other: 
  
Please think only about your own pharmaceutical practice and then rate each individual behavioural 
statement as relevant or not relevant to your practice. 
1. Pharmaceutical Public Health Competencies  
  
  
Competencies   Behaviours 
Highly 
Relevant 
Relevant Low 
Relevant 
Not 
Relevant 
   
1.1 Health 
promotion 
1.1.1 Assess the primary healthcare needs 
(taking into account the cultural and social 
setting of the patient) 
    
1.1.2 Advise on health promotion, disease 
prevention and control, and healthy lifestyle 
    
   
1.2 Medicines 
information 
and advice 
1.2.1 Counsel population on the safe and 
rational use of medicines and devices 
(including the selection, use, 
contraindications, storage, and side effects of 
non-prescription and prescription medicines)  
  
  
1.2.2 Identify sources, retrieve, evaluate, 
organise, assess and disseminate relevant 
medicines information according to the needs 
of patients and clients and provide 
appropriate information 
  
  
   
2. Pharmaceutical Care Competencies     
Competencies   Behaviours 
Highly 
Relevant 
Relevant Low 
Relevant 
Not 
Relevant 
   
2.1 Assessment 
of medicines 
2.1.1 Appropriately select medicines (e.g. 
according to the patient, hospital, 
government policy, etc) 
  
  
2.1.2 Identify, prioritise and act upon 
medicine-medicine interactions; medicine-
disease interactions; medicine-patient 
interactions; medicines-food interactions 
  
  
   
2.2 
Compounding 
medicines 
2.2.1 Prepare pharmaceutical medicines (e.g. 
extemporaneous, cytotoxic medicines), 
determine the requirements for preparation 
(calculations, appropriate formulation, 
procedures, raw materials, equipment etc.) 
  
  
2.2.2 Compound under the good 
manufacturing practice for pharmaceutical 
(GMP) medicines 
  
  
   
 
 
2.3 Dispensing  
2.3.1 Accurately dispense medicines for 
prescribed and/or minor ailments and 
monitor the dispense (re-checking the 
medicines) 
  
  
2.3.2 Accurately report defective or 
substandard medicines to the appropriate 
authorities 
  
  
2.3.3 Appropriately validate prescriptions,     
  
ensuring that prescriptions are correctly 
interpreted and legal 
2.3.4 Dispense devices (e.g. Inhaler or a blood 
glucose meter) 
  
  
2.3.5 Document and act upon dispensing 
errors 
  
  
2.3.6 Implement and maintain a dispensing 
error reporting system and a ‘near misses’ 
reporting system 
  
  
2.3.7 Label the medicines (with the required 
and appropriate information) 
  
  
2.3.8 Learn from and act upon previous ‘near 
misses’ and ‘dispensing errors’ 
  
  
   
2.4 Medicines  
2.4.1 Advise patients on proper storage 
conditions of the medicines and ensure that 
medicines are stored appropriately (e.g. 
humidity, temperature, expiry date, etc.) 
  
  
2.4.2 Appropriately select medicines 
formulation and concentration for minor 
ailments (e.g. diarrhoea, constipation, cough, 
hay fever, insect bites, etc.) 
  
  
2.4.3 Ensure appropriate medicines, route, 
time, dose, documentation, action, form and 
response for individual patients 
  
  
2.4.4 Package medicines to optimise safety 
(ensuring appropriate re-packaging and 
labelling of the medicines) 
  
  
   
2.5 Monitor 
medicines 
therapy 
2.5.1 Apply guidelines, medicines formulary 
system, protocols and treatment pathways 
  
  
2.5.2 Ensure therapeutic medicines 
monitoring, impact and outcomes (including 
objective and subjective measures) 
  
  
2.5.3 Identify, prioritise and resolve 
medicines management problems (including 
errors) 
  
  
   
2.6 Patient 
consultation 
and diagnosis 
2.6.1 Apply first aid and act upon arranging 
follow-up care 
  
  
2.6.2 Appropriately refer     
2.6.3 Assess and diagnose based on objective 
and subjective measures 
  
  
2.6.4 Discuss and agree with the patients the 
appropriate use of medicines, taking into 
account patients’ preferences   
  
  
2.6.5 Document any intervention (e.g. 
document allergies, medicines and food, in 
patient medicines history)  
  
  
2.6.6 Obtain, reconcile, review, maintain and 
update relevant patient medication and 
diseases history 
  
  
 
 
  
3. Organisation and Management Competencies     
  
Competencies  Behaviours 
Highly 
Relevant 
Relevant Low 
Relevant 
Not 
Relevant 
   
3.1 Budget and 
reimbursement 
3.1.1 Acknowledge the organisational 
structure 
  
  
3.1.2 Effectively set and apply budgets     
3.1.3 Ensure appropriate claim for the 
reimbursement 
  
  
3.1.4 Ensure financial transparency     
3.1.5 Ensure proper reference sources for 
service reimbursement 
  
  
   
 
 
 
3.2 Human 
Resources 
management 
3.2.1 Demonstrate organisational and 
management skills (e.g. know, understand 
and lead on medicines management; risk 
management; self management; time 
management; people management; project 
management; policy management.) 
  
  
3.2.2 Identity and manage human resources 
and staffing issues 
  
  
3.2.3 Participate, collaborate, advise in 
therapeutic decision-making and use 
appropriate referral in a multi-disciplinary 
team 
  
  
3.2.4 Recognise and manage the potential of 
each member of the staff and utilise systems 
for performance management (e.g. carry out 
staff appraisals) 
  
  
3.2.5 Recognise the value of the pharmacy 
team and of a multidisciplinary team 
  
  
3.2.6 Support and facilitate staff training and 
continuing professional development 
  
  
   
3.3 
Improvement 
of service 
3.3.1 Identify and implement new services 
(according to local needs) 
    
3.3.2 Resolve, follow up and prevent 
medicines related problems 
    
   
3.4 
Procurement  
3.4.1 Access reliable information and ensure 
the most cost-effective medicines in the right 
quantities with the appropriate quality 
  
  
3.4.2 Develop and implement contingency 
plan for shortages 
  
  
3.4.3 Efficiently link procurement to 
formulary, to push/pull system (supply chain 
management) and payment mechanisms 
  
  
3.4.4 Ensure there is no conflict of interest     
3.4.5 Select reliable supplies of high-quality 
products (including appropriate selection 
process, cost effectiveness, timely delivery) 
  
  
3.4.6 Supervise procurement activities     
3.4.7 Understand the tendering methods and 
evaluation of tender bids 
  
  
   
3.5 Supply 3.5.1 Demonstrate knowledge in store     
  
chain and 
management  
medicines to minimise errors and maximise 
accuracy 
3.5.2 Ensure accurate verification of rolling 
stocks 
  
  
3.5.3 Ensure effective stock management and 
running of service with the dispensary 
  
  
3.5.4 Ensure logistics of delivery and storage     
3.5.5 Implement a system for documentation 
and record keeping 
  
  
3.5.6 Take responsibility for quantification of 
forecasting 
  
  
   
3.6 Work place 
management 
3.6.1 Address and manage day to day 
management issues 
  
  
3.6.2 Demonstrate the ability to take 
accurate and timely decisions and make 
appropriate judgments 
  
  
3.6.3 Ensure the production schedules are 
appropriately planned and managed 
  
  
3.6.4 Ensure the work time is appropriately 
planned and managed 
  
  
3.6.5 Improve and manage the provision of 
pharmaceutical services 
  
  
3.6.6 Recognise and manage pharmacy 
resources (e.g. financial, infrastructure) 
  
  
4. Professional/Personal Competencies 
    
Competencies   Behaviours 
Highly 
Relevant 
Relevant Low 
Relevant 
Not 
Relevant 
   
4.1 
Communication 
skills  
4.1.1 Communicate clearly, precisely and 
appropriately while being a mentor or tutor 
  
  
4.1.2 Communicate effectively with health and 
social care staff, support staff, patients, carer, 
family relatives and clients/customers, using lay 
terms and checking understanding 
  
  
4.1.3 Demonstrate cultural awareness and 
sensitivity 
  
  
4.1.4 Tailor communications to patient needs     
4.1.5 Use appropriate communication skills to 
build, report and engage with patients, health and 
social care staff and voluntary services (e.g. verbal 
and non-verbal) 
  
  
   
4.2 Continuing 
Professional 
Development 
(CPD) 
4.2.1 Document CPD activities     
4.2.2 Engage with students/interns/residents     
4.2.3 Evaluate currency of knowledge and skills     
4.2.4 Evaluate learning     
4.2.5 Identify if expertise needed outside the scope 
of knowledge 
  
  
4.2.6 Identify learning needs     
4.2.7 Recognise own limitations and act upon them     
4.2.8 Reflect on performance     
   
 
4.3 Legal and 
regulatory 
4.3.1 Apply and understand regulatory affairs and 
the key aspects of pharmaceutical registration and 
legislation 
  
  
  
practice 4.3.2 Apply knowledge in relation to the principals 
of business economics and intellectual property 
rights including the basics of patent interpretatio 
  
  
4.3.3 Be aware of and identify the new medicines 
coming to the market 
  
  
4.3.4 Comply with legislation for drugs with the 
potential for abuse 
  
  
4.3.5 Demonstrate knowledge in marketing and 
sales 
  
  
4.3.6 Engage with health and medicines policies     
4.3.7 Understand the steps needed to bring a 
medicinal product to the market including the 
safety, quality, efficacy and pharmacoeconomic 
assessments of the product 
  
  
   
4.4 Professional 
and ethical 
practice 
4.4.1 Demonstrate awareness of local/national 
codes of ethics 
  
  
4.4.2 Ensure confidentiality (with the patient and 
other healthcare professionals) 
  
  
4.4.3 Obtain patient consent (it can be implicit on 
occasion) 
  
  
4.4.4 Recognise own professional limitations     
4.4.5 Take responsibility for own action and for 
patient care 
  
  
   
4.5 Quality 
Assurance and 
Research in the 
work place 
4.5.1 Apply research findings and understand the 
benefit risk (e.g. pre-clinical, clinical trials, 
experimental clinical-pharmacological research 
and risk management) 
  
  
4.5.2 Audit quality of service (ensure that they 
meet local and national standards and 
specifications) 
  
  
4.5.3 Develop and implement Standing Operating 
Procedures (SOP’s) 
  
  
4.5.4 Ensure appropriate quality control tests are 
performed and managed appropriately 
  
  
4.5.5 Ensures medicines are not counterfeit and 
quality standards 
  
  
4.5.6 Identify and evaluate evidence-base to 
improve the use of medicines and services 
  
  
4.5.7 Identify, investigate, conduct, supervise and 
support research at the workplace (enquiry-driven 
practice) 
  
  
4.5.8 Implement, conduct and maintain a reporting 
system of pharmacovigilance (e.g. report Adverse 
Drug Reactions) 
  
  
4.5.9 Initiate and implement audit and research 
activities 
  
  
   
4.6 Self-
management 
4.6.1 Apply assertiveness skills (inspire confidence)     
4.6.2 Demonstrate leadership and practice 
management skills, initiative and efficiency 
  
  
4.6.3 Document risk management (e.g. critical 
incidents) 
  
  
4.6.4 Ensure punctuality     
4.6.5 Prioritise work and implement innovative 
ideas 
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Appendix 6: Invitation to Participate in a Crossover Mapping 
Experiment  
 
 
Developing and Evaluating Competencies for Global Advanced 
Pharmacy Practice: Invitation to Participate 
6th January 2014 
Dear Pharmacist, 
The Development Team of the FIP Education Initiative (FIPEd) would like to invite 
you to participate in a study that forms part of a project by the Advanced Practice 
Domain of FIPEd. The overall goal of the project is to identify and evaluate the core 
competencies required for global advanced pharmacy practice. 
Preliminary studies in this project have identified two national competency 
frameworks for advance pharmacy practice: the Royal Pharmaceutical Society 
Advanced Pharmacy framework (RPS-APF)1 and the Advanced Pharmacy Practice 
Framework for Australia (APPF)2 . An initial mapping of the competencies and 
behaviours in the APPF against those of RPS-APF has been conducted. The results 
of this framework mapping were analysed and reviewed by a group of expert 
pharmacy practitioners and has provided preliminary information on the 
commonalities existing between the two competency frameworks. 
                                                 
1 Royal Pharmaceutical Society, 2013. The RPS Advanced Pharmacy Framework (APF), available at: 
https://www.rpharms.com/faculty-documents/rps-advanced-pharmacy-framework-guide.pdf 
2 The Advanced Pharmacy Framework for Australia, available at 
http://www.psa.org.au/download/standards/advanced-pharmacy-practice-framework.pdf. 
  
 
301
This current stage of the study builds on these preliminary investigations and aims to 
test the functional equivalence of the two frameworks. To this end, an assessment of 
competence using both frameworks in a group of advanced3 pharmacy practitioners 
from different countries is proposed.  
Study participants will be required to carry out an initial self-assessment using one 
framework and after a three-month ‘wash-out’ period, carry out another self-
assessment using the second framework.  
Comparative analysis of the outcomes of self-assessment produced by either 
framework in the same group of advanced practitioners will provide information on 
the functional equivalence of the two frameworks. 
A briefing document containing further details about the study has been prepared 
and is attached.   
Thank you and we look forward to hear from you. 
If you require more information, please contact any of the following persons: 
Arit Udoh, ucnvaud@ucl.ac.uk, Research Associate, FIPEd 
Dr. Andreia Bruno, education@fip.org, Project Co-ordinator and Researcher, FIPEd  
Prof. Ian Bates, Director,  FIPEd Development Team 
Ms Kirstie Galbraith, Domain Lead, Advanced Practice Competencies, FIPEd.   
  
                                                 
3 Advanced pharmacy practice is practice that is so significantly different from that achieved at initial registration that it 
warrants   recognition by peers of the expertise of the practitioner and the education, training and experience from which 
that capability was derived. 
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Appendix 7: Consent Form 
 
 
Practice A Cross-over Trial to Identify and Evaluate Advanced 
Pharmacy Competencies in a Global Context 
Researcher(s): Udoh A., Bruno A., Galbraith K., Bates I.  
Organisation:  FIP Education Initiatives (FIPEd), FIP Collaborating Centre, UCL 
School of Pharmacy, London, United Kingdom. 
1. I have read and understood the information about the project as provided in 
the Information documents attached.   
2. I have been given the opportunity to ask questions about the project and my 
participation.  
3. I agree that I will be required to carry out two self-assessments of 
competence in this study.  
4. I voluntarily agree to participate in the project.  
5. I understand I can withdraw at any time without giving reasons if I wish to. 
 
6. I have read and understood the procedures regarding confidentiality in this 
project.  
7. I, along with the Researcher, agree to sign and date this informed consent 
form.   
I freely give my consent to participate in this research study and have been given a 
copy of this form for my own information. 
Participant’s Initials and Signature:                                            Date:       
Researcher’s Initials and Signature:                                            Date:       
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Appendix 8: Reminder Email 
 
** Please disregard this email if you have already responded **  
 
Dear Practitioner, 
 
Here is a gentle reminder about completing the self-assessment document for the 
FIP advanced pharmacy crossover study. We ask you to please return the completed 
document using this medium. 
 
We thank you in advance for considering this request and would like to reassure you 
that your reply is strictly confidential and would not be shared with a third party 
 
Your contribution is greatly valued. 
With best wishes 
.  
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Appendix 9: Continuum of Advanced Pharmacy Practice 
Assumptions: 
A) Transition level in the APPF is equivalent to Advanced stage I in the RPS-
APF. 
B) Consolidation level in the APPF is equivalent to Advanced stage II in the 
RPS-APF. 
C) Advanced level in the APPF is equivalent to Mastery stage in the RPS-APF. 
 
Description of advanced practice:  
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Other definitions: 
1. Specialist in Training: Pharmacist with 1-2 years experience in a 
specific area of practice 
2. Experienced Practitioner: Pharmacists with at least three years 
experience in a specific area of practice  
3. Leading-edge Practitioner: Pharmacist with at least five years 
experience in a specific area of practice. 
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Appendix 10: FIP Advanced Pharmacy Framework Study: 
Interview invite 
 
Dear Colleague ...  
 
Thank you once again for being a part of the ongoing global advance pharmacy 
framework study.  
 
The research team would be grateful for your feedback and invite you to participate 
in a short interview. 
 
The interview would involve obtaining your opinion about the two self-
assessments and your general thoughts on the frameworks you used. 
 
I can initiate a 15-20 minutes telephone conversation to obtain the feedback.   
The call would be your own convenience and confidential.  
 
I look forward to your kind response. 
 
 
With best wishes, 
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Appendix 11: FIP Advanced Pharmacy Framework Study: 
Interview Schedule 
 
 
 
 
Interview	Schedule		
	
	
Part	1	–	The	Self-assessment	Process		
 
Please think about the two self-assessments you undertook for this study: 
 
A. Have you undertaken any self-assessment activity in the course of your 
practice prior to this study? 
 
Yes       No   
 
 
B. In general, what are your thoughts (or what do you think) of the two self-
assessments you undertook for this study? For example, please provide 
any thoughts you may have in relation to your practice  
 
 
 
 
 
Part	2	–	The	frameworks	
 
 
C. The following questions are aimed directly at obtaining your perspectives 
about the two frameworks used in this study.  
 
- What are your thoughts about the wordings and descriptions of the 
competencies in both frameworks (in terms of clarity or ambiguity)? 
Please give specific details where possible  
 
- What do you think of the design and layout of the two frameworks you
used? Please give specific details where possible and provide any 
suggestions for improvement if applicable  
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Appendix 12: RPS Advanced Pharmacy Framework Questionnaire 
  
 
 
	
	
	
	
	
	
HOW TO COMPLETE THE FRAMEWORK: 
 
The document is divided into two sections. 
 
Section 1 requires that you provide information relating to your current post, place of work and career 
progression. 
 
Section 2 requires that you rate your current level of practice using the competencies in the Royal 
Pharmaceutical Society Advanced Pharmacy Framework.  
 
This framework comprises six domains, each one divided into individual competencies and printed on 
shaded tables. You should first read through each competency domain (shaded tables) before 
commencing your self-assessment.   
 
A schematic description of the layout of each domain is given below using the ‘Expert Professional 
Practice’ domain as an example.  
 
 
 
 
 
 
 
 
 
 
 
Using the un-shaded tables, please assess your current level of practice for each competency 
(check ONE box only) and indicate the category of evidence you have available to support your 
assessment. Please check AS MANY evidence boxes that you think supports your assessment. Each 
evidence category provided represents a group of situations. Please refer to appendix 2 for a 
description of the evidence categories.  
 
An example of how to carry-out this self-assessment is given on the next page.  
 
Competency 
Domain and 
Descriptors   
Competency  Behavioural descriptors for each stage of 
advanced practice under the competency 
‘delivery of professional expertise’ 
 
 
 
 
 
 
 
 
 
A glossary to help interpret the terminology used in this framework is given in appendix 1. You will 
also find a description of the several examples that describe the evidence categories in appendix 2. 
Please read these before starting to complete the documentation.  
 
We recommend that this assessment exercise be undertaken in 3 sessions of 20 minutes. In making 
your judgements, we ask that you consider your previous experience, as well as the demands of your 
current position. 
 
 
Thank you for your participation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Indicate your self-assessed level 
of practice (see each 
“competency domain” for 
description) 
Indicate the specific evidence you have 
available to support your assessment (see 
appendix 2 for help). You can check as many 
evidence boxes as necessary  
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Section	1:		Demographic Details	
This section aims to obtain details on your current role and scope of practice. Your personal information is not 
going to be reported anywhere. It is only used to link your details with subsequent self-assessment in this project. 
 
Name:  
 
 
  
I currently work in (area of practice: i.e. paediatrics):  
 
The best description of my current level of practice in this area is (please select one description):  
 
“Specialist in Training” (i.e. I have been working in this area for between 1 and 2 years)   
“Experienced Practitioner” (i.e. I have been working in this area for more than 3 years)     
“Leading-Edge Practitioner” (i.e. I have been working in this area for more than 5 years and am recognised 
outside my organisation for the contribution I make)   
 
My career progression (please complete the following details):  
 
Job Title:  
  
Length of time employed in current post:   
 
Type of Employing Organisation:   
 
Length of time employed by this organisation:  
 
Number of years since qualifying as a pharmacist (after pre-registration/ pre-license training):   
 
Professional Qualifications (include all):   
 
To which Professional Organisations are you a member/fellow/affiliated?  
Section	2	
	
Please read through each competency domain (shown on shaded tables) before completing 
your self-assessment (using the un-shaded tables).
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1. Expert Professional Practice 
Improves standards of pharmaceutical care for patients. 
Competency 
Developmental Descriptors 
Advanced Stage I Advanced Stage II Mastery 
1.1  
Expert Skills and 
Knowledge 
Demonstrates general pharmaceutical skills 
and knowledge in core areas. 
Demonstrates in-depth pharmaceutical 
skills and knowledge in defined area(s). 
Advances the knowledge base in defined 
area(s). 
In addition for patient focussed roles: Is able 
to plan, manage, monitor, advise and review 
general pharmaceutical care programmes for 
patients in core areas. 
In addition for patient focussed roles: Is 
able to plan, manage, monitor, advise and 
review in-depth/complex pharmaceutical 
care programmes for patients in defined 
area(s). 
In addition for patient focussed roles:  
Advances in-depth/complex 
pharmaceutical care programmes for 
patients. 
1.2 
Delivery of Professional 
Expertise 
Demonstrates accountability for delivering 
professional expertise and direct service 
provision as an individual. 
Demonstrates accountability for the 
delivery of professional services and 
expertise via a team or directly to groups of 
patients/clients/users. 
Demonstrates accountability for the 
delivery of professional expertise at a 
defined higher level. 
May include providing expertise and 
service delivery nationally or at a strategic 
level. 
1.3 
Reasoning and 
Judgement 
 
Including: 
• Analytical skills 
• Judgemental skills 
• Interpretational skills 
• Option appraisal 
 
Demonstrates ability to use skills in a range 
of routine situations requiring analysis or 
comparison of a range of options. 
Demonstrates ability to use skills to make 
decisions in complex situations where 
there are several factors that require 
analysis, interpretation and comparison.  
Demonstrates ability to use skills to 
manage difficult and dynamic situations. 
Recognises priorities when problem-solving 
and identifies deviations from the normal 
pattern. 
Demonstrates an ability to see situations 
holistically. 
Demonstrates ability to make decisions in 
the absence of evidence or data or when 
there is conflicting evidence or data.  
1.4 Professional Autonomy 
Is able to follow legal, ethical, professional 
and organisational policies/procedures and 
codes of conduct. 
Is able to take action based on own 
interpretation of broad professional 
policies/procedures where necessary. 
Is able to interpret relevant policy and 
strategy, in order to establish goals and 
standards for others within the defined 
area(s). 
 
 
 
 
 
 
1. Expert Professional Practice Domain 
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1.1. Expert Skills and Knowledge 
Advanced stage 1  Advanced Stage 2    Mastery  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.2. Delivery of Professional expertise 
Advanced stage 1  Advanced Stage 2      Mastery  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.3. Reasoning and Judgment  
Advanced stage 1  Advanced Stage 2      Mastery  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.4. Professional Autonomy  
Advanced stage 1  Advanced Stage 2      Mastery  
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2. Collaborative Working Relationships 
Is able to communicate, establish and maintain working relationships and gain the co-operation of others. 
Competency 
Developmental Descriptors 
Advanced Stage I Advanced Stage II Mastery 
2.1  
Communication  
 
Including ability to: 
• Persuade 
• Motivate 
• Negotiate 
• Empathise 
• Provide 
• Reassurance 
• Listen 
• Influence  
And 
• Networking 
Skills 
• Presentation 
Skills 
 
Demonstrates use of 
appropriate 
communication to gain 
the co-operation of 
relevant stakeholders 
(including patients, senior 
and peer colleagues, and 
other professionals where 
possible).   
Demonstrates use of 
appropriately selected 
communication skills to 
gain co-operation of 
small groups of relevant 
stakeholders within the 
organisation. 
Demonstrates ability to 
present complex, 
sensitive or contentious 
information to large 
groups relevant 
stakeholders. 
Demonstrates ability to 
communicate where the 
content of the discussion 
is explicitly defined. 
Demonstrates ability to 
communicate where the 
content of the discussion 
is based on professional 
opinion. 
Demonstrates ability to 
communicate in a 
hostile, antagonistic or 
highly emotive 
atmosphere. 
 
2.2 
Teamwork and 
Consultation 
 
Demonstrates ability to 
work as a member of a 
team. 
Demonstrates ability to 
work as an 
acknowledged member 
of a multidisciplinary 
team. 
Works across 
boundaries to build 
relationships and share 
information, plans and 
resources.  
Recognises personal 
limitations and refers to 
more appropriate 
colleague(s) when 
necessary. 
Consulted with the 
organisation for advice 
which requires in-depth 
professional expertise. 
Sought as an opinion 
leader both within the 
organisation and in the 
external environment. 
 
 
 
 
 
 
2.     Collaborative Working Relationships 
                (Please see previous page) 
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2.1. Communication  
Advanced stage 1  Advanced Stage 2      Mastery  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.2. Teamwork and consultation  
Advanced stage 1  Advanced Stage 2      Mastery  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
312 
 
 
 
 
 
 
3.   Leadership 
          (Please see previous page) 
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3.1 Strategic Context 
Advanced stage 1  Advanced Stage 2     Mastery  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2  Governance  
Advanced stage 1  Advanced Stage 2      Mastery  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3   Vision  
Advanced stage 1  Advanced Stage 2      Mastery  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.4   Innovation  
Advanced stage 1  Advanced Stage 2      Mastery  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.5 Service Development 
Advanced stage 1  Advanced Stage 2      Mastery  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.6 Motivational  
Advanced stage 1  Advanced Stage 2      Mastery  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.  Leadership 
Inspires individuals and teams to achieve high standards of performance and personal development. 
 
Competency 
Developmental Descriptors 
Advanced Stage I Advanced Stage II Mastery 
3.1  Strategic Context 
Demonstrates understanding of the needs of 
stakeholders. 
 
Practice reflects relevant local and national 
policy.  
Demonstrates ability to incorporate 
relevant national policy to influence local 
strategy. 
Demonstrates active participation in 
creating relevant national policies. 
3.2 Governance 
Demonstrates understanding of the pharmacy 
role in governance.  
Influences the governance agenda for the 
team and/or service. 
Shapes and contributes to the 
governance agenda at a higher level.  
Implements this appropriately within the 
workplace.   
3.3 Vision 
Demonstrates understanding of, and 
contributes to, the workplace vision. 
Creates vision of future and translates this 
into clear directions for others.  
Convinces others to share the vision at a 
higher level. 
3.4 Innovation 
Demonstrates ability to improve quality within 
limitations of service.  
Recognises and implements innovation 
from the external environment. 
Takes the lead to ensure innovation 
produces demonstrable improvement. 
3.5 Service Development 
Reviews last year’s progress and develops 
clear plans to achieve results within priorities 
set by others. 
Develops clear understanding of priorities 
and formulates practical short-term plans in 
line with workplace strategy. 
Relates goals and actions to strategic 
aims of organisation and profession. 
 
3.6 Motivational 
Demonstrates ability to motivate self to 
achieve goals. 
Demonstrates ability to motivate individuals 
and/or the team. 
Demonstrates ability to motivate 
individuals and/or teams at a higher 
level.  May include more strategic 
motivational activities at local, institutional 
and national levels. 
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4. Management 
Organises and delivers service objectives in a timely fashion. 
Competency 
Developmental Descriptors 
Advanced Stage I Advanced Stage II Mastery 
4.1  
Implementing National 
Priorities 
Demonstrates understanding of the 
implications of national priorities for the team 
and/or service.  
Shapes the response of the team and/or 
service to national priorities. 
Accountable for the direct delivery of 
national priorities at a higher level. 
4.2  Resource Utilisation 
Demonstrates understanding of the process 
for effective resource utilisation. 
Demonstrates ability to effectively manage 
resources. 
Demonstrates ability to reconfigure the 
use of available resources. 
4.3 Standards of Practice 
Demonstrates understanding of, and 
conforms to, relevant standards of practice. 
Demonstrates ability to set and monitor 
standards of practice at team and/or 
service level. 
Accountable for the setting and 
monitoring of standards at a higher level. 
4.4 Managing Risk 
Demonstrates ability to identify and resolve 
risk management issues according to 
policy/protocol. 
Develops risk management 
policies/protocols for the team and/or 
service, including identifying and resolving 
new risk management issues. 
Is accountable for developing risk 
management policies/procedures at a 
higher level, including identifying and 
resolving new risk management issues. 
4.5 Managing Performance 
Follows professional and organisational 
policies/procedures relating to performance 
management. 
Is accountable for performance 
management for a team or group of 
personnel.  
Is accountable for performance 
management at a higher and/or 
institutional level. Refers appropriately to colleagues for 
guidance. 
4.6 Project Management  
Demonstrates understanding of the principles 
of project management. 
Demonstrates ability to successfully 
manage a project at team and/or service 
level. 
Demonstrates ability to successfully 
manage a project at a higher level. 
4.7 Managing Change 
Demonstrates understanding of the principles 
of change management. 
Demonstrates ability to manage a process 
of change for the team and/or service. 
Demonstrates ability to manage a 
process of change at a higher level. 
4.8    Strategic Planning 
Demonstrates ability to think 4-12 months 
ahead within a defined area. Plans the work 
programme to align with strategy. 
 
Demonstrates understanding of formal 
structures. 
Demonstrates ability to think over a year 
ahead within a defined area. 
 
Demonstrates understanding of culture 
and climate and ability to plan with the 
whole of the organisation in mind. 
Thinks long term and sector wide. Takes 
the long- term perspective. 
 
Demonstrates understanding of 
organisational politics and changes in the 
external environment. 
4.9 
Working Across 
Boundaries 
Demonstrates ability to extend boundaries of 
service delivery within the team. 
Demonstrates ability to extend the 
boundaries of the service across more 
than one team. 
Demonstrates the value of extending 
service delivery across boundaries in the 
external environment. 
   
 
 
4. Management  
      (Please see previous page) 
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4.1. Implementing National Priorities  
Advanced stage 1  Advanced Stage 2     Mastery  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.2. Resource Utilisation  
Advanced stage 1  Advanced Stage 2      Mastery  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.3. Standards of Practice  
Advanced stage 1  Advanced Stage 2      Mastery  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.4. Managing Risk  
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4.5. Managing Performance  
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4.6. Project Management  
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4.7. Managing Change 
Advanced stage 1  Advanced Stage 2      Mastery   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.8. Strategic Planning   
Advanced stage 1  Advanced Stage 2      Mastery  
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5. Education, Training & Development 
Supports the education, training & development of others. Promotes a learning culture within the organisation. 
Competency 
Developmental Descriptors 
Advanced Stage I Advanced Stage II Mastery 
5.1  Role Model 
Understands and demonstrates the 
characteristics of a role model to members in 
the team and/or service. 
Demonstrates the characteristics of an 
effective role model at a higher level. 
Is able to develop effective role model 
behaviour in others. 
5.2  Mentorship 
Demonstrates understanding of the mentorship 
process. 
Demonstrates ability to effectively mentor 
others within the team and/or service. 
Demonstrates ability to effectively mentor 
outside the team and/or service. 
5.3 
Conducting Education  
& Training  
Demonstrates ability to conduct teaching and 
assessment effectively according to a learning 
plan with supervision from a more experienced 
colleague. 
Demonstrate ability to assess the 
performance and learning needs of others. 
Demonstrates ability to design and 
manage a course of study, with 
appropriate use of teaching, assessment 
and study methods. 
Demonstrates ability to plan a series of 
effective learning experiences for others. 
5.4 
Professional 
Development 
Demonstrates self-development through 
continuous professional development activity. 
Facilitates the professional development of 
others. 
Shapes and contributes to the 
professional development strategy. 
5.5 
Links Practice and 
Education 
Participates in the delivery of formal education 
programmes. 
Participates in the education and training in 
an external environment. 
Shapes, contributes to or is accountable 
for the creation or development of higher 
education qualification(s). 
5.6 Educational Policy  
Demonstrates an understanding of current 
educational policies relevant to working areas 
of practice. 
Demonstrates ability to interpret national 
policy in order to design strategic 
approaches for local workforce education 
planning and development. 
Shapes and contributes to national 
education and workforce planning and 
development policy. 
 
 
 
5. Education, Training & Development 
      (Please see previous page) 
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5.1        Role Model 
Advanced stage 1  Advanced Stage 2     Mastery  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.2       Mentorship 
Advanced stage 1  Advanced Stage 2      Mastery  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.3       Conduct Education & Training   
Advanced stage 1  Advanced Stage 2      Mastery  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.4      Professional Development   
Advanced stage 1  Advanced Stage 2      Mastery  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.5       Links Practice and Education  
Advanced stage 1  Advanced Stage 2      Mastery  
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6. Research & Evaluation 
Uses research to deliver effective practice. Identifies and undertakes research to inform practice. 
Competency 
Developmental Descriptors 
Advanced Stage I Advanced Stage II Mastery 
6.1  Critical Evaluation 
Demonstrates ability to critically evaluate 
and review literature. 
Demonstrates application of critical 
evaluation skills in the context of working 
practice. 
Is recognised as undertaking peer 
review activities within working practice.  
6.2  
Identifies Gaps in The  
Evidence Base 
Demonstrates ability to identify where there 
is a gap in the evidence base to support 
practice. 
Demonstrates ability to formulate 
appropriate and rigorous research 
questions. 
Demonstrates ability to design a 
successful strategy to address research 
questions.  
6.3 
Develops and 
Evaluates Research 
Protocols 
Demonstrates ability to describe the core 
features of research protocols. 
Demonstrates ability to design a rigorous 
protocol to address previously formulated 
research questions. 
Demonstrates active involvement in the 
critical review of research protocols. 
6.4 Creates Evidence 
Demonstrates ability to generate evidence 
suitable for presentation at local level. 
Demonstrates ability to generate new 
evidence suitable for presentation at 
research symposia. 
Demonstrates authorship of primary 
evidence and outcomes in peer 
reviewed media. 
6.5 
Research Evidence Into 
Working Practice 
Demonstrates ability to apply the research 
evidence base into working practice. 
Demonstrates ability to apply research 
and evidence-based practice within the 
team and/or service. 
Is able to use research evidence to 
shape policy/procedure at an 
organisational and/or national level. 
6.6 
Supervises Others 
Undertaking Research  
Demonstrates understanding of the 
principles of research governance. 
Is able to contribute to research 
supervision in collaboration with research 
experts. 
Is a research project supervisor for 
postgraduate students. 
6.7 
Establishes Research 
Partnerships  
Demonstrates ability to work as a member of 
the research team. 
Demonstrates ability to establish new 
multidisciplinary links to conduct research 
projects. 
Demonstrates ability to show leadership 
within research teams concerning the 
conduct of specialist research. 
 
 
6. Research & Evaluation 
      (Please see previous page) 
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6.1  Critical Evaluation  
Advanced stage 1  Advanced Stage 2     Mastery  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6.2   Identifies gaps in the evidence base  
Advanced stage 1  Advanced Stage 2      Mastery  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6.3   Develops and Evaluates Research Protocols  
Advanced stage 1  Advanced Stage 2      Mastery  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6.4  Creates Evidence  
Advanced stage 1  Advanced Stage 2      Mastery  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6.4 Research Evidence into Working Practice   
Advanced stage 1  Advanced Stage 2      Mastery  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6.5   Supervises Others Undertaking Research  
Advanced stage 1  Advanced Stage 2      Mastery  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6.6   Establishes Research Partnerships  
Advanced stage 1  Advanced Stage 2      Mastery   
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Appendix 13: Advanced Pharmacy Practice Framework Questionnaire   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A glossary to help interpret the terminology used in this framework is given in appendix 1. You will 
also find a description of the several examples that describe the evidence categories in appendix 2. 
Please read these before starting to complete the documentation.  
 
We recommend that this assessment exercise be undertaken in 3 sessions of 20 minutes. In making 
your judgements, we ask that you consider your previous experience, as well as the demands of your 
current position. 
 
 
Thank you for your participation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Indicate your self-assessed level 
of practice (see each 
“competency domain” for 
description) 
Indicate the specific evidence you have 
available to support your assessment (see 
appendix 2 for help). You can check as many 
evidence boxes as necessary  
HOW TO COMPLETE THE FRAMEWORK: 
 
The document is divided into two sections. 
 
Section 1 requires that you to provide information relating to your current post, place of work and career progression. 
 
The Section 2 requires that you to rate your current level of practice using the competencies in the Advanced 
Pharmacy Practice Framework for Australia.  
 
This framework comprises five domains, each one divided into individual competencies and printed on shaded tables. 
You should first read through each competency domain (shaded tables) before commencing your self-assessment.   
 
A schematic description of the layout of each domain is given below using the ‘Expert Professional Practice’ domain 
as an example.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Using the un-shaded tables, please assess your current level of practice for each competency 
(check ONE box only) and indicate the category of evidence you have available to support your assessment. Please 
check AS MANY evidence boxes that you think supports your assessment. Each evidence category provided 
represents a group of situations. Please refer to appendix 2 for a description of the evidence categories.  
 
An example of how to carry-out this self-assessment is given on the next page.  
 
Competency 
Domain and 
Descriptors   
Behavioural descriptors for each level of 
advanced practice under the competency ‘use 
reasoning and judgment in assessing clinical 
situations’ 
 
Competency 
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Section	1:		Demographic Details	
This section aims to obtain details on your current role and scope of practice. Your personal information is not 
going to be reported anywhere. It is only used to link your details with subsequent self-assessment in this project. 
 
Name:  
 
 
  
I currently work in (area of practice: i.e. paediatrics):  
 
The best description of my current level of practice in this area is (please select one description):  
 
“Specialist in Training” (i.e. I have been working in this area for between 1 and 2 years)   
“Experienced Practitioner” (i.e. I have been working in this area for more than 3 years)     
“Leading-Edge Practitioner” (i.e. I have been working in this area for more than 5 years and am recognised 
outside my organisation for the contribution I make)   
 
My career progression (please complete the following details):  
 
Job Title:  
  
Length of time employed in current post:   
 
Type of Employing Organisation:   
 
Length of time employed by this organisation:  
 
Number of years since qualifying as a pharmacist (after pre-registration/ pre-license training):   
 
Professional Qualifications (include all):   
 
To which Professional Organisations are you a member/fellow/affiliated?  
Section	2	
	
Please read through each competency domain (shown on shaded tables) before completing 
your self-assessment (using the un-shaded tables).
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1. Expert Professional Practice 
Competency 
Developmental Descriptors 
Transition Level Consolidation Level  Advanced Level (Proposed credentialing level) 
 
1.1.  Acquire expert knowledge 
and skills 
Demonstrates general clinical 
knowledge in core practice areas  
 
Able to plan, manage, monitor, advise 
and review patient care in core practice 
areas  
Demonstrates comprehensive, high level 
clinical knowledge in defined practice 
area(s)  
Able to plan, manage, monitor advise and 
review patient care programs in defined 
practice area(s)  
Advances knowledge in defined practice area(s)  
 
Advances patient care programs in defined 
practice area(s)  
 
1.2.  Use reasoning and 
judgement in assessing 
clinical situations 
[Encompasses skills in 
interpretation, analysis, 
professional judgement and 
option appraisal] 
Demonstrates ability to compare options 
or apply analytical skills in a range of 
routine situations  
 
Demonstrates ability to recognise 
priorities when problem solving and 
identify deviations from the normal 
pattern  
 
Applies established practice/ 
therapeutic protocols in responding to 
clinical situations  
Demonstrates ability to make decisions in 
complex situation where several factors 
require analysis, interpretation and 
comparison  
 
Demonstrates ability to interpret and 
synthesise available evidence and/or data 
to assess clinical situations and therapeutic 
options  
 
Seeks guidance where variations to 
established practice/protocols are indicated  
Demonstrates ability to apply expertise to assess 
complex and dynamic situations  
 
Demonstrates ability to assess clinical situations 
and therapeutic options in the absence of 
evidence or data or where there is conflicting 
evidence or data  
 
 
Uses judgment to vary practice to respond to 
contextual requirements  
 
1.3. Deliver accountable and 
flexible patient care 
Accepts accountability for patient care 
services delivered directly to individual 
patients  
 
Applies expertise responsibly in delivery 
of patient care in routine situations  
 
Demonstrates capacity to identify 
research findings likely to impact on 
practice  
Accepts accountability for patient care 
services delivered to a defined patient 
group  
 
Accesses and applies evidence based 
advice/strategies in complex situations  
 
Demonstrates a responsible approach to 
integrating evidence into practice  
Accepts accountability for patient care services 
delivered in a defined practice area(s)  
 
Applies expertise confidently to provide services 
and advice in complex, unpredictable or 
unfamiliar circumstances  
 
Appraises and integrates new evidence in an 
innovative and collaborative approach to planning 
and delivery of patient care  
 
1.4.  Use Professional 
autonomy 
Uses expertise to contribute to the care 
of patients in routine situations  
 
Demonstrates ability to follow legal, 
ethical, professional and organisational 
policies/procedures and codes of 
conduct  
Uses available evidence and established 
practice procedures to provide input to 
patient care  
 
Demonstrates ability to act according to 
personal interpretation of broad 
professional polices/procedures where 
necessary  
Makes autonomous decisions about patient care 
that are informed by expert knowledge, clinical 
judgment, available evidence and treatment goals 
or outcomes  
Demonstrates ability to interpret government 
health care policy and strategy to establish 
policies/ procedures, codes and/or standards for 
others within defined practice area(s)   
 
 
 
 
 
1. Expert Professional Practice Domain 
                (Please see previous page) 
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1.1. Acquire Expert Skills and Knowledge 
 
Transition Level  Consolidation Level    Advanced Level   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.2. Use Reasoning and Judgment  
 
Transition Level  Consolidation Level   Advanced Level   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.3. Deliver accountable and flexile patient care 
 
Transition Level  Consolidation Level    Advanced Level   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.4. Use Professional Autonomy  
 
Transition Level  Consolidation Level    Advanced Level   
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2: Communication, collaboration and Team Work   
Competency 
Developmental Descriptors 
Transition Level Consolidation Level  Advanced Level (Proposed credentialing level) 
   
2.1. Use appropriate 
communication skills 
[Encompasses networking and 
presentation skills, and 
interdisciplinary collaboration, as 
well as ability to persuade, motivate, 
negotiate, empathise, reassure, 
listen and influence] 
 
Demonstrates use of appropriate 
communication to gain the co-
operation of individual patients, 
colleagues and other health 
professionals 
 
Demonstrates ability to communicate 
effectively where content of 
discussion is explicitly defined 
  
Demonstrates use of appropriately 
selected communication skills to gain 
co-operation of patients, colleagues, 
clinicians and/or managers 
 
Demonstrates ability to communicate 
effectively where the content of the 
discussion is based on personal 
opinion 
 
Demonstrates ability to present complex, 
sensitive or contentious information to large 
groups of patients, clinicians and/or managers  
 
Demonstrates ability to communicate effectively 
in a hostile, antagonistic or highly emotive 
atmosphere 
   2.2. Engage in teamwork and   
consultation 
 
Demonstrates ability to work as a 
member of the pharmacy team  
 
Recognises personal limitations and 
demonstrates ability to refer to more 
experienced colleagues  
 
Demonstrates ability to work as a 
member of a multidisciplinary team 
  
Accepts expert advice through 
consultation within the workplace/ 
organisation  
 
 
Works across workplace boundaries to build 
relationships and share information, plans and 
resources 
 
Provides expert advice within and beyond the 
workplace/organisation as a recognised opinion 
leader 
2.3. Work across boundaries  
 
Demonstrates ability to extend 
boundaries of service delivery within 
the pharmacy team 
 
Demonstrates ability to extend the 
boundaries of service delivery across 
more than one team 
 
Demonstrates the value of extending the 
boundaries of service delivery across 
professions and/or the external environment 
 
 
 
 
 
2. Communication, Collaboration and Team work  
                (Please see previous page) 
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2.1. Use Appropriate Communication Skills   
Transition Level  Consolidation Level    Advanced Level   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.2. Engage in Team Work and Consultation  
Transition Level  Consolidation Level    Advanced Level   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2.3. Work Across Boundaries  
Transition Level  Consolidation Level    Advanced Level   
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3a: Leadership and Management (a)   
Competency 
Developmental Descriptors 
Transition Level Consolidation Level  
Advanced Level (Proposed 
credentialing level) 
3.1. Understand strategic context 
and contribute to strategic 
planning  
Demonstrates understanding of the needs of 
stakeholders, and practice reflects 
government health care policy  
Understands formal structure in which they 
work  
Demonstrated ability to plan up to 12 months 
ahead and in alignment with established 
strategy  
Demonstrates ability to incorporate 
government health care policy or 
priorities to influence local strategy  
Understands culture and climate of 
the workplace  
Demonstrated ability to plan more 
than one year ahead taking account 
of strategic plan  
Participates in development of 
government health care policy/ strategy 
or priorities and leads its integration into 
local strategy  
Understands the internal and external 
practice environment  
Demonstrated ability to develop a long 
term plan taking a holistic view of the 
practice environment  
3.2. Understand and contribute to 
clinical governance  
Demonstrates understanding of the 
pharmacist’s role in clinical governance and 
practice reflects the workplace framework  
Influences the clinical governance 
agenda for the team  
Shapes and contributes to the clinical 
governance agenda of the workplace/ 
organisation  
3.3. Understand and contribute to 
the strategic vision  
Demonstrates understanding of, and 
contributes to, the vision for professional 
services  
Creates the vision for professional 
services and translates it into clear 
goals for the pharmacy team  
Influences groups of colleagues, 
clinicians and/or managers to share the 
vision for professional services  
3.4. Contribute to innovation and 
service development  
Demonstrates ability to improve the quality 
or range of services with limited supervision  
Applies priorities set by others to develop 
clear plans for services based on review of 
recent past performance  
Recognises and implements 
innovation from the external 
environment without supervision  
Develops future plans for 
professional services based on a 
clear understanding of priorities  
Leads efforts to ensure innovation 
produces demonstrable improvement in 
service delivery  
Relates goals and actions to strategic 
aims of the workplace or profession  
3.5. Motivate self and others  Demonstrates ability to self motivate to 
achieve goals  
Demonstrates ability to motivate 
individuals in the team  
Demonstrated ability to motivate 
individuals beyond the team  
3.6. Support and assist 
implementation of national 
priorities 
Demonstrates understanding of the 
implications of national health care priorities 
for the team 
Influences the response of the team 
to national health care priorities 
Leads response of the team to national 
health care priorities 
 
 
 
 
 
3a.  Leadership and Management 
     (Please see previous page) 
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3.1. Understand strategic context and contribute to strategic 
planning 
Transition Level  Consolidation Level    Advanced Level   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2.  Understand and contribute to clinical governance 
Transition Level  Consolidation Level    Advanced Level   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3.3.  Understand and contribute to the strategic vision 
Transition Level  Consolidation Level    Advanced Level   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.4.  Contribute to innovation and service development 
Transition Level  Consolidation Level    Advanced Level   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.5.   Motivate self and others  
Transition Level  Consolidation Level    Advanced Level   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3.6.   Support and assist implementation of national priorities 
Transition Level  Consolidation Level    Advanced Level   
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3b: Leadership and Management  Contd.  
Competency 
Developmental Descriptors 
Transition Level Consolidation Level  
Advanced Level (Proposed credentialing 
level) 
3.7. Understand and contribute to the 
effective use of resources 
 Demonstrates understanding of the 
process for effective resource utilisation 
Demonstrates effective 
management of resources 
Demonstrates ability to assess and reassign 
resources to improve effectiveness of use 
3.8. Contribute to the identification 
and effective management of risk 
Demonstrates ability to identify and 
resolve risk management issues using 
established policy/procedure 
Is accountable for developing risk 
policy/procedure for managing 
existing and newly identified risks 
at team level 
Is accountable for developing policy/ 
procedure for managing existing and newly 
identified risks beyond the team 
3.9. Promote improved performance Refers appropriate to colleagues for 
guidance as required  
Is accountable for performance 
management of team members 
Is accountable for performance management 
of the team as a whole 
3.10. Understand and undertake 
project management 
Contributes to performance 
management processes in accordance 
with established policy/procedure. 
Refers appropriately to colleagues for 
guidance as required 
 Demonstrates ability to 
successfully manage a project at 
team level 
Demonstrates ability to plan and supervise 
the implementation of a project 
3.11. Understand change 
management principles and lead 
change 
Demonstrates understanding of the 
principles of change management  
Demonstrates ability to manage a 
process of change for the team 
Demonstrates ability to lead a change 
process beyond the team/workplace or 
across principles  
3.12. Serve as a role model and 
mentor for others 
Understands and demonstrates the 
characteristics of a role model to 
members of the team 
 
Demonstrates understanding of the 
mentorship  
Demonstrates the characteristics of 
and effective role model within and 
beyond the team  
Demonstrates characteristics of an 
effective role model within and 
beyond the team  
Demonstrates ability to engender role model 
behaviour in others  
 
Demonstrates ability to effectively mentor 
outside the team 
 
 
 
 
 
3b. Leadership and Management contd. 
     (Please see previous page) 
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3.7.  Understand and contribute to the effective use of resources 
Transition Level  Consolidation Level    Advanced Level   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.8.   Contribute to the identification and effective management of 
risk 
Transition Level  Consolidation Level    Advanced Level   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3.9.   Promote improved performance 
Transition Level  Consolidation Level    Advanced Level   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.10.   Understand and undertake project management 
Transition Level  Consolidation Level    Advanced Level   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.11.    Understand change management principles and lead 
change 
Transition Level  Consolidation Level    Advanced Level   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3.12.   Serve as a role model and mentor for others 
Transition Level  Consolidation Level    Advanced Level   
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4. Professional and ethical practice 
Competency 
Developmental Descriptors 
Transition Level Consolidation Level  Advanced Level (Proposed credentialing level) 
 
4.1.  Apply and monitor standards of 
practice 
  
Demonstrates understanding of, 
and conforms to relevant standards 
of practice 
 
Accountable for setting and 
monitoring standards of practice 
at the team level 
 
Accountable for setting and monitoring 
standards of practice beyond the team 
 
4.2. Contribute to continuing 
professional development (CPD) of 
self and others 
 
 
 
Demonstrates self-development 
through regular CPD and the 
application of learning to practice 
 
Acts as a CPD facilitator for the 
profession 
 
Shapes and contributes to the CPD strategy for 
the profession or other disciplines 
 
 
 
4. Professional and ethical practice 
     (Please see previous page) 
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4.1. Apply and monitor standards of practice 
 
Transition Level  Consolidation Level    Advanced Level   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.2. Contribute to Continuing Professional Development (CPD) of 
self and others 
 
Transition Level  Consolidation Level    Advanced Level   
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5a. Critical Analysis, Research and Education  
     
Competency 
Developmental Descriptors 
Transition Level Consolidation Level  
Advanced Level (Proposed credentialing 
level) 
5.1.  Conduct of education and training Demonstrates an understanding 
of current educational policy 
 
Demonstrates ability to conduct 
teaching efficiently according to 
an agreed plan with guidance 
from a more experienced 
colleague 
 
Demonstrates ability to interpret national 
policy in order to design strategic 
approaches for local workforce 
education 
Able to assess the performance and 
learning needs of others  
Demonstrates ability to plan a series of 
effective learning experiences for others 
Shapes and contributes to national 
education policy 
 
Demonstrates ability to design and manage 
a course of study, with appropriate use of 
teaching assessment and study methods 
5.2. Links practice and education Participates in the formal 
education of undergraduate and 
postgraduate students 
Participates in the education and 
training of formal special interest groups 
in the external environment 
Shapes, contributes to, or is accountable 
for the creation or development of higher 
education qualification(s) 
5.3. Educational policy Demonstrates an understanding 
of current educational policies in 
health services 
Demonstrates ability to interpret national 
policy in order to design strategic 
approaches to local workforce education 
Shapes and contributes to national 
educational policy 
5.4. Undertake critical evaluation 
activities 
Demonstrated ability to critically 
evaluate literature sources 
 Demonstrated application of critical 
evaluation skills in the context of 
practice 
Recognised as undertaking peer review 
activities in practice 
5.5. Identify gaps in evidence base Demonstrates ability to identify 
gaps in the evidence  base for 
practice 
Demonstrates ability to formulate 
appropriate and rigorous research 
questions to address evidence gaps 
Demonstrates ability to design an 
appropriate research strategy to address 
research questions 
 
 
 
 
 
5a. Critical Analysis, Research and Education  
         (Please see previous page) 
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5.1. Conduct of education and training 
Transition Level  Consolidation Level    Advanced Level   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.2. Links practice and education  
Transition Level  Consolidation Level    Advanced Level   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.3. Educational policy  
Transition Level  Consolidation Level    Advanced Level   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.4. Undertake critical evaluation activities 
Transition Level  Consolidation Level    Advanced Level   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.5. Identify gaps in evidence base 
Transition Level  Consolidation Level    Advanced Level   
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5b. Critical Analysis, Research and Education contd. 
 (Please see previous page) 
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5.6.  Design and deliver research projects to address gaps in the 
evidence base 
Transition Level  Consolidation Level    Advanced Level   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.7.  Apply research evidence into practice 
Transition Level  Consolidation Level    Advanced Level   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.8.  Supervise others undertaking research 
Transition Level  Consolidation Level    Advanced Level   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.9.  Establish research partnerships 
Transition Level  Consolidation Level    Advanced Level   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5b. Critical Analysis, Research and Education contd. 
     
Competency 
Developmental Descriptors 
Transition Level Consolidation Level  
Advanced Level (Proposed 
credentialing level) 
 
5.6  Design and deliver research 
projects to address gaps in the 
evidence base 
 
Demonstrates ability to describe the 
core features of research protocols 
 
Demonstrates ability to generate 
evidence suitable for presentation at 
the local level 
 
Demonstrates ability to design a 
research protocol to address 
previously formulated research 
questions 
Demonstrates ability to generate new 
evidence suitable for presentation at 
research symposium 
 
Demonstrates active involvement in 
critical review of research protocols 
 
Demonstrates authorship of primary 
evidence outcomes in peer reviewed 
media 
 
5.7  Apply research evidence into 
practice 
 
Demonstrates ability to apply research 
into own practice 
 
Demonstrates ability to apply 
evidence-based practice within the 
team 
 
Is able to use research evidence to 
shape workplace/organisational 
policy/procedure 
 
5.8  Supervise others undertaking 
research 
 
Demonstrates understanding of 
research governance 
 
Is able to contribute to research 
supervision in collaboration with 
research experts 
 
Is a research project supervisor for 
postgraduate students 
 
5.9  Establish research partnerships 
 
Demonstrates ability to work as a 
member of a research team 
 
Demonstrates ability to establish new 
multidisciplinary links to conduct 
research projects 
 
Demonstrates ability to show leadership 
within research teams concerning the 
conduct of research 
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Appendix 14: Expert Panel Invite and Briefing Note  
 
 
	
Developing	a	Global	Competency	Framework	for	Advanced	Pharmacy	
Practice 
Invitation	to	Participate	in	an	Expert	Panel	
Dear Expert Pharmacy Practitioner, 
In recognition of your expertise in the field of pharmacy, the Development Team of 
the FIP Education Initiative (FIPEd) would like to invite you to participate in an 
expert panel being conducted to assess the feasibility of developing a global 
competency framework for advanced pharmacy practice. This work is being 
conducted as part of the Advanced Practice Domain of the Education Development 
Team of FIPEd. 
Previous research carried out in 2004 by the CoDEG research group in the United 
Kingdom, identified the competencies required for advanced level pharmacy 
practice
4
. These competencies were validated and subsequently synthesised by the 
Royal Pharmaceutical Society of Great Britain (via consensus development panels) 
into a valid practitioner development tool for advanced level pharmacy practice, the 
‘RPS Advanced Pharmacy Framework’ (RPS-APF)
5
. 
In 2012, a competency framework for advanced pharmacy practice in Australia was 
developed from a similar bibliographic source. This framework, called the ‘Advanced 
Pharmacy Practice Framework for Australia’ (APPF), contained competencies that 
had been adapted to the local needs of the pharmacy workforce in Australia
6
. The 
                                                 
4 Meadows N., Webb D., McRobbie D., Antoniou S., Bates I., Davies G., 2004. Developing and validating a competency 
framework for advanced pharmacy practice. Pharmaceutical Journal, 273 (7327) 789-792 
5 Royal Pharmaceutical Society, 2013. The RPS Advanced Pharmacy Framework (APF), available at: 
https://www.rpharms.com/faculty-documents/rps-advanced-pharmacy-framework-guide.pdf 
6 The Advanced Pharmacy Framework for Australia, available at 
http://www.psa.org.au/download/standards/advanced-pharmacy-practice-framework.pdf. 
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aim of this expert panel is to test for parity between the RPS-APF and the APPF 
frameworks. The objectives are to: 
- Obtain expert opinion on the results of a mapping exercise carried out 
between the APPF and the RPS-APF.  
- Obtain consensus opinion on the final framework derived from this mapping 
exercise.   
A report containing all the comments and consensus opinions provided by the 
expert panel will be generated and forwarded to all members for a review and 
approval. 
Confidentiality 
All responses and discussions are strictly confidential. No information identifying any 
member of this panel will be revealed to a third party. All data collected will be kept 
in locked filling cabinets at the Department of Practice & Policy, UCL School of 
Pharmacy, United Kingdom. 
Further Information 
Further information about the scope of discussion as well as the session plan and 
other documents is attached. These documents contain relevant information that will 
enable you reach an informed decision about your participation. 
 If you require more information, please contact any of the following: 
- Arit Udoh, ucnvaud@ucl.ac.uk, Research Associate, FIPEd 
- Prof. Ian Bates, Director,  FIPEd Development Team 
- Dr. Andreia Bruno, education@fip.org, Project Co-ordinator and Researcher, 
FIPEd  
- Ms Kirstie Galbraith, kirstie.Galbraith@monash.edu, Domain Lead, 
Advanced Practice Competencies, FIPEd. 
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Developing	a	Global	Competency	Framework	for	Advanced	Pharmacy	
Practice 
Briefing	Notes 
This expert panel is being conducted as part of a study by the Development Team 
of the FIP Education Initiative (FIPEd). The study aims to develop and evaluate 
advanced level pharmacy practice in a global context and is in two stages. The aim 
of this expert panel is to obtain qualitative information in a systematic manner, from 
a group of expert practitioners involved in the development and recognition of 
advanced pharmacy practice around the world.  
Experts from countries with a defined advanced pharmacy practice cadre will be 
invited to participate in an expert panel. Panel members will number between 20-24 
members and a member of the panel will be invited to facilitate the group 
discussion. Members of the panel will be provided with the results of a framework 
mapping exercise carried out between the RPS Advanced Pharmacy Framework 
(RPS-APF) and the Advanced Pharmacy Practice Framework for Australia (APPF). 
Using a modified Delphi method, individual members of the expert panel will be 
requested to provide their professional opinion and rate their level of agreement with 
the outcome of the framework mapping. Consensus on a given item will be achieved 
when unanimous agreement or disagreement is attained on a particular item. 
During the meeting, panel participants will also be given an opportunity to discuss 
their opinions with other experts and this discussion session is expected to provide 
an avenue for debate, clarification and discussions on items where consensus has 
not been reached. The overall aim of this meeting is to reach group consensus and 
agreement on the results of the mapping exercise. A report of the discussions, 
comments and consensus opinion expressed during this meeting will be collated 
and fed back to the panel for review and approval.   
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Expert Panel Meeting        
FIP Congress, Dublin 2013 
Session Outline: 
1. Introduction  
a) Introduction of panel members (10mins) 
b)  Presentation of aims and objectives of meeting (5mins) 
2. Presentation of opinion on the outcomes of the framework mapping (10mins) 
3. Review of each cluster and further discussions (30mins) 
4. Clarification on areas of non-consensus (20mins) 
5. Final consensus and agreement (10mins) 
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Appendix 15: List of Publication and Conferences Attended 
 Udoh, Arit., Bruno, A., Bates, I., (2013). Developing Foundation Level 
Pharmacy Practice in Africa. Abstract and poster submitted for the PhD day 
presentation, 19th April 2013, UCL school of Pharmacy.  
 Udoh. A. Better Quality Pharmacy Education Produces Better Pharmacists. 
International Pharmacy Journal 2013; 31: 41-42.  
 Udoh, Arit., Bruno, A., Bates, I., (2013). Developing and Evaluating 
Advanced Level Pharmacy Practice Competencies in a Global Context. 
Abstract and poster presented at the 73rd FIP World Congress of Pharmacy 
and Pharmaceutical Sciences, 31 Aug. to 5th Sept. 2013, Dublin, Ireland. 
 Udoh, A., Bruno, A., Bates, I., (2014). Developing the Global Pharmacy 
Workforce: An Opportunity for Stakeholders' Engagement in Africa. The 
African Pharmacist 2: 41-42. 
 Udoh, Arit., Bruno, A., Bates, I., (2014). Evaluating Advanced Level 
Pharmacy Practice Competencies in a Global Context. Abstract and poster 
presented at the 74th FIP World Congress of Pharmacy and Pharmaceutical 
Sciences, 31st Aug. to 4th Sept. 2014, Bangkok, Thailand. 
 Udoh, Arit., Bruno, A., Bates, I., (2015). Evaluating Advanced Pharmacy 
Practice Competencies in a Global Context. Abstract and PhD day 
presentation, 24th April 2015, UCL school of Pharmacy.  
Other science related publication: 
• Two genes linked to up to ten percent of severe violent crime | BioNews 2014 
| Arit Udoh | available at http://www.bionews.org.uk/page_466049.asp 
• Study suggests novel genetic mechanism behind HIV immunity | BioNews 
2014 | Arit Udoh | available at http://www.bionews.org.uk/page_468307.asp 
• Gene variants protects Latin-American women from Breast Cancer | 
BioNews 2014 | Arit Udoh | available at 
http://www.bionews.org.uk/page_466049.asp 
• Smoking can erase the 'Y' chromosome | BioNews 2014 | Arit Udoh | 
available at http://www.bionews.org.uk/page_478242.asp 
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Conferences attended: 
 International Conference of Pharmacists and Pharmaceutical Sciences, FIP 
Centennial conference, Oct. 3rd to 8th  2012, Amsterdam, Netherlands. 
 Conference of Medical Communication, UCL Institute of Education, 10th 
July, 2013 
 International Conference of Pharmacists and Pharmaceutical Sciences, 31 
Aug. to 5th Sept. 2013, Dublin, Ireland. 
 International Conference of Pharmacists and Pharmaceutical Sciences, 31 
Aug. to 4th Sept. 2014, Dublin, Ireland. 
 Get Your Career Going. Early career conference, UCL Institute of 
Epidemiology and Healthcare, 19th Feb., 2015.  
 Conference of Medical Communication, University of Westminster, 1st July, 
2015. 
Training and certifications: 
• Certificate of completion, Good Clinical Practice (GCP), National Institute 
for Health Research, United Kingdom (September, 2015). 
• Certificate of completion, Research Data and Confidentiality, Medical 
Research Council (MRC), United Kingdom (November, 2015). 
• Certificate of completion, Research and Human Tissue Legislation, Medical 
Research Council (MRC), United Kingdom (December, 2015). 
• Design and Interpretation of Clinical Trials. Bloomberg School of Public 
Health, John Hopkins University. Coursera® Verified Certificate, License 
AWDT3W2QE2 (April, 2015). 
• Health Literacy and Communication for Health Professionals. University of 
Nebraska Medical Centre. Coursera® Verified Certificate, License 
T5K699YCPN (December, 2014).  
• Associate Fellow, Higher Education Academy of United Kingdom, 
(December, 2014). 
• Associate Fellow, Centre for the Advancement of Learning and Teaching 
(CALT), University College London (December, 2014). 
• Science Reporting and Communication Internship, 17th October to 16th 
December 2014, BioNews UK.  
• Health in Numbers: Quantitative Methods in Clinical & Public Health 
Research. Harvard School of Public Health, Edx® courseware platform 
(January, 2013). 
